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Summary 
Patients’ expectations pre-treatment for cancer can impact on subsequent treatment 
experiences. The existing literature is conflicted about whether expectations should 
be positive or realistic, with some studies reporting expectations as predictors of 
experiences and some studies highlighting the expectations-experiences gap as more 
important. Research has been narrow in focus and there exists no broad measure of 
expectations. Clinical Nurse Specialists (CNSs) manage expectations, therefore their 
perspectives are important but are currently under-researched. This thesis aimed to 
explore patients’ expectations of cancer treatment more broadly, develop and 
validate new measures, and better understand CNSs’ perceptions. The thesis consists 
of six empirical studies.  Study 1 qualitatively explored patients’ (n=16) expectations 
of cancer treatment.  It highlighted a broader range of expectations than in the 
literature and suggested a role for the expectations-experiences gap.  Study 2 
designed two measures, validating them in a cross-sectional sample of cancer 
patients (n= 200).  This produced a 39-item measure of expectations and a matched 
36-item measure of experiences.  Study 3 used the above sample to explore the 
expectations-experiences relationship and found that the expectations-experiences 
gap may be particularly important in a wide range of experiences.  Study 4 measured 
expectations and experiences longitudinally but recruitment difficulties resulted in a 
case study of one cancer patient, which showed support for the findings from Study 
3.  Study 5 qualitatively explored CNSs’ (n=8) beliefs about patient expectations and 
found that CNSs believe balancing hope and honesty is the best approach to their 
management.  Study 6 qualitatively explored CNSs’ (n=8) experiences of providing 
care and found that it was challenging but rewarding.  This thesis contributes a 
broader understanding of patient expectations, facilitates their measurement and 
suggests that setting more realistic pre-treatment expectations is preferable.  It shows 
that CNSs believe in balancing hope and honesty and that their roles are challenging 
but rewarding.  
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Chapter One  
Literature Review: Setting the Scene 
 
1.1 Cancer: Definition, Prevalence, Causes and Consequences 
1.1.1 Definition 
Cancer is a condition that arises when normal cell growth in the body is interrupted 
by changes to the genes that control this process, which result in abnormal growth 
and division of cells that then invade surrounding tissues and potentially also other 
organs and structures (National Cancer Institute, 2018; World Health Organisation 
(WHO), 2018).  Normal, healthy cells grow and divide according to the body’s 
demands, and when they are old or damaged they are programmed to die, to be 
replaced with new, healthy cells (National Cancer Institute, 2018; Pardee, Stein, & 
Bronstein, 2009).  In cancer, the process of programmed cell death is disrupted, cells 
that are old and damaged do not die and continue to divide, and new cells are formed 
that are surplus to the body’s requirements, which can then form a growth or tumour 
(National Cancer Institute, 2018; Pardee et al., 2009). 
Cancer is often described as a single condition in common parlance but there 
are actually around 200 different types of cancer, that can occur almost anywhere in 
the body, with three main groupings (National Cancer Institute, 2018; WHO, 2018; 
Pardee et al., 2009).  The first, carcinomas, are solid cancers arising from epithelial 
cells, the layers of cells on most of the surfaces of the body and its organs, and 
accounting for around 90% of all cancers (National Cancer Institute, 2018; Pardee et 
al., 2009).  The second, sarcomas, are solid cancers arising from connective tissue 
cells, for example, muscle and bone (National Cancer Institute, 2018; Pardee et al., 
2009).  The third, leukaemia and lymphoma, are blood cancers and do not form solid 
tumours but instead their cells proliferate in an area and displace normal cells 
(National Cancer Institute, 2018; Pardee et al., 2009).  In addition to these three main 
categories, there are also multiple myelomas (cancers that begin within plasma 
cells), melanomas (cancers than begin within cells that become melanocytes, the 
cells that produce pigment in the skin or other tissues, for example, the eyes), brain 
and spinal cord tumours, germ cell tumours (cancers that begin within the cells that 
form sperm or eggs), and neuroendocrine tumours (cancers that begin within the 
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cells that release hormones into the blood) (National Cancer Institute, 2018).  Within 
these types there are many subtypes that are biologically different and so all cancers 
cannot be managed in the same way (WHO, 2018).  This diversity makes medical 
cancer management a complex process, with no single, simple solution. 
 1.1.2 Prevalence 
Cancer affects a growing number of individuals with evidence now suggesting that 
half of all people born after 1960 will develop cancer at some point in their lifetime 
(Ahmad, Ormiston-Smith, & Sasieni, 2015).  In the United Kingdom (UK), there are 
over 360,000 new diagnoses of cancer per year, which equates to one new diagnosis 
every two minutes (Cancer Research UK, 2018).  This figure has increased by 13% 
since the early 1990s and is predicted to continue rising (Cancer Research UK, 
2018).  Although there are over 200 types of cancer, figures from new cancer 
diagnoses in 2015 showed that four types combined accounted for over half (53%) of 
all new cancer cases in the UK: breast (15%), prostate (13%), lung (13%) and bowel 
(12%) (Cancer Research UK, 2018).  Globally, the most common types of cancer in 
men are lung, prostate, colorectal, stomach and liver (WHO, 2018).  For women it is 
breast, colorectal, lung, cervix and stomach cancer (WHO, 2018). 
 1.1.3 Causes 
Cancer is ultimately caused by changes to the genes that control the process of 
normal cell functioning, as described above (National Cancer Institute, 2018; Pardee 
et al., 2009).  These genetic changes can be hereditary; there are now a number of 
known cancer-related genes and genetic testing has become possible in recent years 
to screen for these (National Cancer Institute, 2018; Pardee et al., 2009).  
Environmental and lifestyle factors can also give rise to changes in genes by causing 
damage to the deoxyribonucleic acid (DNA), such as exposure to certain chemicals 
or radiation (National Cancer Institute, 2018; Pardee et al., 2009). 
It has been estimated that 42.7% of all new cancers in the UK in 2010 were 
attributable to past exposures to certain environmental or lifestyle-related factors, 
with this figure being slightly higher for men (45.3% versus 40.1% in women) 
(Parkin, Boyd, & Walker, 2011).  This figure did also differ by cancer type.  For 
leukaemia and gall bladder cancers, for example, it was much lower, at 15.1% and 
18.3% respectively; for eight of the eighteen cancer types included (oral cavity and 
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pharynx, oesophageal, stomach, colorectal, larynx, lung, mesothelioma, melanoma 
and cervical cancer) the figure was over 50%, with four of these being over 90% 
(oral cavity and pharynx, larynx, mesothelioma, and cervical cancer) (Parkin et al., 
2011). 
Of the 14 environmental and lifestyle factors analysed by the paper, smoking 
was by far the single biggest risk factor for both men and women, accounting for 
19.4% of cancer cases overall but 23.0% of male cancer cases and a slightly more 
modest 15.6% for women (Parkin et al., 2011).  When considered by cancer type, 
smoking is attributable for much higher numbers of cases in certain types of cancers.  
Estimates suggest that as many as 85.6% of cases of lung cancer in the UK in 2010 
can be attributed to smoking, for cancers of the larynx the figure is suggested to be 
70.9%, oesophageal cancers 65.5% and oral cavity and pharynx cancers 64.5% 
(Parkin et al., 2011). 
The next biggest environmental or lifestyle risk factor is overweight and 
obesity, estimated to have accounted for 5.5% of all cancers in the UK in 2010 
(Parkin et al., 2011).  Whilst the figures for this are far lower than smoking, they are 
not insignificant, particularly for certain cancer types.  During 2010, overweight and 
obesity are thought to have accounted for just over a third of cancers of the uterus, 
just under a quarter of kidney cancers and around one fifth of both oesophageal and 
gall bladder cancers in the UK (Parkin et al., 2011).  For gall bladder cancers, 
overweight and obesity were the only environmental or lifestyle factor found 
attributable (Parkin et al., 2011). 
 1.1.4 Consequences 
Cancer can be a life-limiting condition.  Worldwide, it is the second leading cause of 
death, accounting for 8.8 million deaths in 2015 (WHO, 2018).  It causes over a 
quarter of all deaths in the UK and around 450 people die from cancer every day, 
which equates to roughly 164,000 people every year (Cancer Research UK, 2018).  
Mortality rates have been decreasing since the early 1970s and are predicted to 
decrease by 15% between 2014 and 2035 (Cancer Research UK, 2018).  Although 
more individuals will be diagnosed with cancer, mortality rates are set to decrease, 
meaning that larger numbers of people will survive cancer, making a focus on 
psychological consequences of cancer and its treatment even more pertinent. 
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A diagnosis of cancer can evoke a number of psychological reactions, in part 
due to its potential to be life-limiting.  Death and dying are high in patients’ thoughts 
(Abdollahzadeh, Moodi, & Khanjani, 2017; Sterckx et al., 2013).  When patients are 
diagnosed shock is very common but patients can also feel a sense of helplessness, 
anxiousness, depression, disbelief and a tendency towards denial (Abdollahzadeh et 
al., 2017; Sterckx et al., 2013).  A cancer diagnosis can make a patient feel very out 
of control and there is a lot of uncertainty about the future (Abdollahzadeh et al., 
2017; Sterckx et al., 2013).  There are therefore a range of potential negative 
psychological consequences of receiving a cancer diagnosis. 
1.2 Cancer Treatment 
Advances in cancer treatment are being made but surgery, chemotherapy and 
radiotherapy are still the mainstay of cancer treatment (Cancer Research UK, 2018).  
Surgery is the most common primary treatment for cancer with 45% of people 
diagnosed with the most common cancers in England in 2013-2014 having received 
surgery to resect a tumour as a primary cancer treatment (Public Health England & 
Cancer Research UK, 2018).  In the same period, in England, 28% of all patients 
received chemotherapy as a primary treatment and 27% received radiotherapy 
(Public Health England & Cancer Research UK, 2018).  Guidelines from the 
National Institute for Health and Care Excellence (NICE) provide an outline for 
healthcare professionals about which treatments should be selected for which 
cancers, according to the disease characteristics (NICE, 2018). 
The intent of cancer treatment is generally described as either curative or 
palliative.  Curative treatments are those which aim to produce longer-term disease-
free intervals.  Palliative treatments are aimed at managing the cancer or its 
symptoms but not eradicating the cancer entirely.  Treatment of palliative intent is 
commonly associated with end of life care but it can be about managing the size of 
the tumour to give patients similar longevity to those treated with curative intent; this 
approach to cancer treatment is becoming increasingly common (Neugut & 
Prigerson, 2017). 
1.3 The Experience and Psychological Impact of Cancer Treatment 
Cancer, like many other health conditions, presents a stressful situation to patients.  
Psychological distress is common amongst cancer patients undergoing treatment and 
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cancer treatment can have a significant impact on patients’ quality of life (QOL) 
(Sterckx et al., 2013; Skilbeck et al 2003).  Evidence from a meta-analysis suggests 
that around 30-40% of adult cancer patients in treatment experience depression, 
anxiety or adjustment disorder (Mitchell et al., 2011). 
Cancer treatments can produce a range of physical side effects, which 
compound the stress of having received a cancer diagnosis.  These are a result of 
treatments damaging healthy cells as well as cancer cells and will differ according to 
treatment type and dosage but also due to individual differences in patients’ 
physiological reactions to treatments (Pardee et al., 2009).  Common side effects of 
cancer treatment include fatigue, pain, nausea and vomiting, weight loss or gain, hair 
loss, diarrhoea and constipation (Aaronson et al., 1993). 
Taking pain as an example of a common side effect of cancer and its 
treatment demonstrates the impact that specific physical side effects can have on 
patients.  Among cancer patients who were experiencing pain, approximately two-
thirds of patients were found to be experiencing depression, anxiety, or both, with an 
associated negative effect on QOL (Utne et al., 2010).  Patients who were 
experiencing neither anxiety or depression, reported less interference of pain on their 
everyday lives (Utne et al., 2010). 
There are also psychosocial effects of cancer treatment that can additionally 
have a significant impact on patients.  For example, treatment can impact social 
relationships, the normal activities of daily living such as work, housework and 
hobbies, the patient’s ability to care for themselves, and their identity (Carelle et al., 
2002; Zebrack, 2001; Mor, Allen, & Malin, 1994).  Carelle et al. (2002) examined 
cancer patients’ perceptions of the physical and psychosocial side effects of 
chemotherapy.  They found that the social impact, i.e. the impact that their cancer 
treatment could have on their family or partner, to be perceived as the most severe 
side effect of chemotherapy (Carelle et al., 2002).  The physical side effects of hair 
loss and fatigue were ranked next, showing they were considered severe (Carelle et 
al., 2002).  These were followed by two psychosocial side effects of treatment; the 
effect of treatment on work and home duties, and its effect on social activities 
(Carelle et al., 2002).  The presence of physical and psychosocial factors within the 
top five treatment-related concerns in this study demonstrate that treatment can have 
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a broad impact on patients and provides further evidence for the psychosocial impact 
of cancer treatment.  The greater proportion of psychosocial factors near the top of 
this list indicates that their impact can be quite severe and is a focus for cancer 
patients. 
Reduced QOL during treatment has clear implications for patients’ 
experiences of cancer treatment but there is evidence to suggest that there may also 
be lasting effects of this.  The impact of cancer treatment on QOL can endure post-
treatment (Thornton, Perez, Oh, & Crocitto, 2011).  In addition to this, well-being 
during or shortly after treatment has been found to be a significant predictor of much 
longer-term well-being (Carver, Smith, Petronis, & Antoni, 2006; Carver et al., 
2005).  As well as these psychological consequences, there are potentially 
physiological consequences in terms of survival because QOL during treatment has 
even been evidenced to be a stronger predictor of overall survival than other medical 
prognostic factors (Movsas, et al., 2009).  It could be argued that QOL reflects 
medical factors because factors such as physical side effects and prognosis may 
impact upon it, but perhaps QOL is the better predictor because it encompasses all 
aspects of patients’ treatment experiences: physiological, psychological and social. 
Treatments therefore have physical and psychological side effects that further 
compound the difficulties already faced by patients having received a cancer 
diagnosis.  Experiences of treatment can be very difficult for cancer patients and the 
effects on their lives can endure long after treatment has ended.  It is therefore 
important to consider the factors that can influence patients’ experiences of cancer 
treatment to help improve experiences at the time of treatment and reduce the lasting 
impact that negative treatment experiences may have. 
1.4 Influences on Patients’ Experiences of Cancer Treatment 
Cancer and its treatment can have a significant impact on patients’ lives but there are 
factors that influence patients’ experiences of cancer treatment for the better or for 
the worse.  These will now be discussed in terms of medical factors, social support 
and psychological factors. 
 1.4.1 Medical factors: type of cancer, prognosis and type of treatment 
Medical factors such as the type of cancer, prognosis and type of treatment influence 
patients’ experiences of cancer treatment for various reasons.  There are different 
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side effects associated with different cancers and different prognoses; generally 
speaking the more advanced the prognosis, the greater the side effects experienced; 
the type and prognostic indicators of a patient’s cancer will also determine the 
approach to treatment (Public Health England & Cancer Research UK, 2018). 
With different cancer types being associated with different prognoses and 
treatments, there are clear ensuing differences in patients’ experiences, due to 
differing common side effects and longevity.  There is some evidence to suggest that 
pancreatic cancer patients, for whom prognoses are generally very poor and 
treatments may be more intensive, experience more psychological distress, including 
significantly higher rates of depression, when compared to patients with other cancer 
diagnoses (Clark, Loscalzo, Trask, Zabora, & Philip, 2010).  Not all cancer types 
were represented in this study, as any cancer type with fewer than 100 responses was 
excluded from the analyses, so it is not clear whether pancreatic cancer patients 
experience more psychological distress than patients with all types of cancer 
diagnoses.  A large range of different cancer types were included, however, so it 
appears that pancreatic cancer may have a larger impact on patients than many other 
diagnoses.  Research has also suggested that lung cancer patients have lower QOL in 
the weeks immediately after diagnosis, than in other cancer types (Esbensen, 
Osterlind, Roer & Hallberg, 2004). However, this study only included patients over 
65 who had a diagnosis of either breast, lung, gynaecological or colorectal cancer, so 
it is unclear from this study whether this lower QOL would compare with other 
diagnoses.  In addition, this data was collected immediately following diagnosis and 
does not appear to hold during treatment (Esbensen, Osterlind & Hallberg, 2007).  It 
is therefore possible that some cancer types affect patients worse than others 
psychologically, but this is by no means conclusive. 
There is some evidence to suggest that different treatment types may impact 
upon patients’ experiences of cancer treatment.  Research has shown that patients 
undergoing chemotherapy experience higher levels of anxiety than patients 
undergoing radiotherapy, and that this anxiety is associated with lower QOL that 
may continue into the longer-term (Schreier & Williams, 2004).  There is also some 
suggestion that chemotherapy may predict higher levels of distress longer-term, 
measured 5-13 years post-treatment, than other treatment modalities (Carver et al., 
2006; Carver et al., 2005).  These studies included only women with breast cancer, 
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so it is unclear whether the same result would be found in the wider cancer 
population.  One study that included patients with different types of cancers found 
that type of treatment had no significant effect on patients’ QOL (Parker, Baile, 
Moor, & Cohen, 2003). 
Although prognosis helps to determine treatment type and intensity, there 
does not appear to be an effect of prognosis on cancer patients’ treatment 
experiences.  A study that included patients with different types of cancers found that 
stage of disease had no significant effect on QOL (Parker et al., 2003).  There 
additionally appear to be no significant differences in depression, anxiety and 
adjustment disorder in those treated with curative or palliative intent, further 
supporting the diminished role of prognosis determining psychological outcome of 
cancer treatment (Mitchell et al., 2011). 
There is therefore some evidence to suggest that chemotherapy may predict 
worse treatment experiences than other treatment modalities but this has not been 
widely explored.  In addition, cancer type may influence experiences of treatment, 
with pancreatic cancer patients having the worst experiences overall.  The evidence 
for differing experiences according to prognosis suggests, however, that this has 
little effect on patients’ experiences.  The role of medical variables in determining 
how positive or negative patients’ experiences of cancer treatment are may therefore 
be limited to cancer and treatment type. 
 1.4.2 Social support 
As well as medical factors, the patient’s wider context can make a difference to their 
experiences of cancer treatment.  Social support has been evidenced to influence 
experiences of cancer treatment, including support from the patient’s usual social 
network and support from the healthcare professionals that patients encounter as a 
result of their cancer diagnosis and treatment. 
 1.4.2.1 The patient’s usual social network 
There is a huge amount of evidence to suggest that social support influences 
experiences of health conditions.  Studies of patients from across different cancer 
and treatment types have found that social support has a range of psychological 
benefits and can therefore influence patients’ experiences of cancer treatment.  
Social support, specifically having adequate availability and effectively accessing 
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social support, has been shown to predict lower levels of depression and anxiety, and 
better QOL, wellbeing and psychological adjustment (Cai, Zhou, Yu, & Wan, 2011; 
Parker et al., 2003; Hann et al., 2002; Bloom, Stewart, Johnston, Banks & Fobair, 
2001; Helgeson & Cohen, 1996).  The benefits seem to hold irrespective of age or 
gender (Hann et al., 2002).  In breast cancer patients, there is evidence to suggest 
that social support in the year following treatment is predictive of not just cross-
sectional psychological outcomes, but longer-term outcomes measured over 5-13 
years post-treatment (Carver, et al., 2006; Carver et al., 2005). 
The benefits of social support may be a function of others helping patients to 
cope.  Friedman et al. (2006) found that having self-perceived adequate levels of 
social support helped cancer patients to cope better with the difficulties they faced 
during treatment.  Having social support, particularly emotional support, has also 
been reported by patients as being particularly important for them (Sterckx et al., 
2013; Helgeson & Cohen, 1996).  Therefore, social support has many evidenced 
benefits to cancer patients and patients themselves see the value of it. 
 1.4.2.2 Healthcare professionals 
Although social support from friends and relatives is clearly important, support from 
others may also be necessary.  Within cancer care patients encounter a number of 
different healthcare professionals (HCPs) throughout their treatment pathway.  
Placed, as HCPs are, as a relative-stranger who is knowledgeable of a patient’s 
condition, the HCP is a potentially important source of support to cancer patients, 
providing a different kind of support than they could get from their usual social 
network (Kristiansen, Tjornhoj-Thomsen, & Krasnik, 2010).  This slightly more 
detached relationship means that the HCP has less of an emotional attachment to the 
patient, making it easier for patients to be open with them without fear of causing 
them distress (Kristiansen et al., 2010). 
The quality of the patient-HCP relationship can also have important 
implications for help seeking across conditions, and cancer is no exception, with a 
better-quality relationship reducing help seeking delays, even when treatment-related 
side effects are life-threatening (Oakley, Taylor, Ream, & Metcalfe, 2017).  In terms 
of patients’ experiences of cancer treatment, if help is sought early for treatment-
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related side effects, they may be able to be managed and therefore their potential 
impact on the patient could be lessened; whether this be related to mortality or QOL. 
The way the HCP responds and their attitude towards patients can further 
impact patients’ experiences of cancer treatment.  A higher level of HCP empathy, as 
perceived by the patient, for example, has been shown to be related to higher patient 
satisfaction and lower patient distress during cancer treatment (Lelorain, Bredart, 
Dolbeault, & Sultan, 2012).  It is clear, therefore, that the HCP has a role in 
providing support, developing a good-quality relationship and demonstrating to the 
patient that they care, which can impact on patients’ experiences of cancer treatment. 
The multidisciplinary team (MDT) has emerged as an effective way of 
managing cancer care, with Clinical Nurse Specialists (CNSs) seen as an integral 
part of this team and vital in providing holistic care in line with a biopsychosocial 
model of health (McPhillips et al., 2015; Tarrant, Sinfield, Agarwal, & Baker, 2008).  
The CNS role has been in existence for some time now both within cancer care and 
in the wider healthcare context.  Within this wider context, evidence suggests that 
the CNS has a pivotal role in providing patient care and influences patient 
experiences by responding to their needs (La Sala, Connors, Pedro, & Phipps, 2007).  
Specifically within cancer care, it is now a recommendation that all cancer patients 
should be introduced to a CNS at the point of diagnosis (Dempsey, Orr, Lane, & 
Scott, 2016).  Research shows that patients and colleagues of the cancer CNS are 
generally very positive about the role and having access to a CNS (Ling, McCabe, 
Brent, Crosland, & Brierley-Jones, 2017; Droog, Armstrong, & MacCurtain, 2014; 
Ling, McCabe, Brent, & Crosland, 2013; Hardie & Leary, 2010; Ream et al., 2009; 
Wells et al., 2008; Jack, Oldham, & Williams, 2003).  The cancer CNS has a varied 
role acting as a consistent source of support and information for patients and carers, 
being a key part of the MDT, providing clear communication to patients, and 
coordinating patient experiences.  Evidence suggests that CNSs perform well in all 
of these areas (Hardie & Leary, 2010; Marchand, 2010; Pollard et al., 2010).  Having 
a consistent source of support in the form of the CNS is particularly appreciated by 
patients (Ling et al., 2017; Kristiansen et al., 2010).  There is also evidence to 
suggest that the provision of a CNS can have a range of positive health outcomes, 
such as reduced mortality and length of hospital stay (Bryant-Lukosius et al., 2015).  
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It is therefore understandable that CNSs have become a valued and integral part of 
caring for cancer patients and optimising patient experiences of cancer treatment. 
As well as the evidence suggesting that CNSs provide care that improves 
patient experiences of cancer treatment, research also indicates that the CNS role is 
cost-effective.  In a systematic review of randomised controlled trials (RCTs) 
studying the cost-effectiveness of the CNS role in transitional care, Bryant-Lukosius 
et al. (2015) concluded that the provision of the CNS was cost-effective due to 
positive health outcomes, such as reduced length of hospital stays.  Although such 
outcomes are clearly beneficial for patients’ experiences of cancer treatment, they 
also reduce costs, which has its own advantages, particularly in the context of a 
financially strapped National Health Service (NHS) in the UK.  There is much 
support for the role of the CNS in providing high quality, cost-effective care 
(Gurzick & Kesten, 2010; Douglas et al., 2003).  It is clear, therefore, that the care 
provided by a CNS can impact upon patients’ experiences of cancer treatment. 
Despite their evident utility, there is evidence that the CNS role brings both 
professional and personal challenges.  Amongst oncology HCPs, levels of stress, 
burnout and fatigue have been found to be particularly high (Eelen et al., 2014; Jones 
et al., 2013; Girgis, Hansen, & Goldstein, 2009; Najjar, Davis, Beck-Coon, & 
Doebbeling, 2009; Trufelli et al., 2008; Sherman, Edwards, Simonton, & Mehta, 
2006; Isikhan, Comez, & Danis, 2004; Ramirez et al., 1995).  Some evidence 
suggests that these negative effects may be higher in oncology HCPs than HCPs 
from other disciplines and that higher levels of contact with cancer patients predict 
more negative effects (Eelen et al., 2014; Girgis et al., 2009).  This lends support to 
the idea that working directly with cancer patients can have a negative impact on the 
HCP. 
In a systematic review of the literature, Turner, Kelly and Girgis (2011) 
concluded that there was understandably an emotional response from oncology 
HCPs to the suffering and decline of patients, but that this was often left unmanaged.  
This can lead to high levels of distress in oncology HCPs, which they may self-
manage by using adverse coping strategies, mostly avoidant, and usually involving 
substance abuse of some description (Turner et al., 2011).  This distress can also 
directly impact patient care as distressed HCPs make poorer decisions, and do not 
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communicate as well with patients and members of their professional network 
(Turner et al., 2011). 
The majority of this research seems to focus on the physician or the 
oncologist in particular and less attention has been given to the role of the CNS.  The 
few studies that have focused on CNSs, however, similarly show high levels of 
stress, distress and burnout (Wahlberg, Nirenberg, & Capezuti, 2016; Sharma, Sharp, 
Walker, & Monson, 2008).  Wahlberg et al. (2016) found that the biggest challenges 
relating to the oncology nurse’s role that contributed to their distress were their role 
demands, lack of support from organisations, and caring for patients who were 
suffering and dying, plus seeing death.  Sharma et al. (2008) found high levels of 
burnout and psychiatric morbidity in colorectal CNSs, and CNSs who scored highly 
were more likely to be dissatisfied with their work and have a desire to retire as soon 
as it was affordable.  There are therefore clear implications for staff retention. This 
study also suggests that the elevated levels of burnout and psychiatric morbidity 
were not related to workload (Sharma et al., 2008).  This lends further support to the 
notion that it is the type of work and having increased contact with cancer patients 
that is challenging, rather than having high workloads per se. 
As well as the economic pressures that lack of staff retention brings, in an 
already struggling healthcare system in the UK, burnout, fatigue and job-related 
concerns are clearly important issues for the HCP personally and this should not be 
considered lightly.  These factors have also been evidenced to impact on patients’ 
experiences of cancer treatment.  In a systematic review of the oncology literature, 
De Vries et al. (2014) found that increased levels of fatigue and burnout amongst 
HCPs were associated with lower quality communications with patients, poorer 
patient outcomes and lower patient-perceived empathy, very much in line with the 
aforementioned findings regarding HCP distress and patient experiences. 
Despite the pressures of the role and associated psychological impact, some 
evidence suggests that oncology HCPs believe that there are benefits to their roles, 
including being able to help others emotionally, having a team to consult for 
emotional support, learning, and understanding the value of their work for patients 
(Rohan & Bausch, 2009).  Rohan and Bausch (2009) additionally found that working 
in oncology gave HCPs a different perspective on life, which was largely positive, 
  
13 
 
such as a greater appreciation of the value of life, relationships and family.  This 
qualitative study was conducted with HCPs generally and not just CNSs so it is not 
clear whether this would apply to CNSs more directly.  Another study does provide 
some support for the idea of the CNS finding rewards in their role.  Dias, Leite, 
Ramires and Bicho (2017) found a good level of job satisfaction amongst nurses 
working with cancer patients, the strongest predictor of which was having a sense of 
achievement, but receiving recognition and responsibility also had a positive 
influence.  Since the CNS role involves responsibility, and providing care to patients 
may involve a sense of achievement, it could be argued that this increases the CNS’s 
likely satisfaction with their role, however this is not yet supported by current 
research.  These studies were conducted in America and Portugal so it would be of 
interest to explore the rewards of the role of the CNS in the context of the UK NHS.  
Differences between the healthcare systems may present different challenges, 
perhaps heightened with the organisational and financial pressures faced within the 
NHS. 
One study compared mental health CNSs in America and the UK and found 
several differences in the focus of their care; UK nurses were primarily focused on 
the availability of a range of services, whereas for American nurses, quality of 
services was at the fore (Nolan, Bourke, & Doran, 2002).  UK CNSs believed that 
structural changes to the healthcare service were driving changes to their roles and 
that the effects on patients were less of a focus (Nolan et al., 2002).  UK mental 
health CNSs described the main challenges of their role to be managing an 
increasing workload, and having poorly defined, uncertain roles (Nolan et al., 2002).  
UK mental health CNSs also faced a pressure to refresh their knowledge but 
received little funding for training and development (Nolan et al., 2002).  These 
results from a mental health setting appear to echo the aforementioned results from 
oncology settings but an exploration to understand whether this applies to UK 
oncology CNSs would be beneficial. 
It would therefore seem that although the role of the CNS is valuable and 
cost-effective, there are challenges faced which may have psychological implications 
for the CNS and a knock-on effect on patient experiences.  In addition to the 
limitations of the existing research previously mentioned, the UK-based studies have 
also been quantitative so have not provided a detailed understanding of the CNS role, 
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its challenges and the psychological impact on the CNS as a whole. There is 
therefore a need for an in-depth exploration of the impact of caring on the CNS 
within the present UK NHS.  Within the thesis, therefore, the impact on the CNS of 
caring for cancer patients will be qualitatively explored, both in recognition of the 
personal implications for HCPs and the potential impact that the HCP’s 
psychological state could further have on patients’ experiences of cancer treatment. 
 1.4.3 Psychological factors: trait versus state approaches 
Psychological factors can also influence patients’ experiences of cancer treatment.  
This has been explored within two broad approaches.  The first, a trait approach, 
focuses on more fixed, global, personality-related factors and how these can 
influence how patients react to cancer treatment.  For example, research has focused 
on optimism versus pessimism to understand whether either personality trait can 
predict psychological outcomes.  This research has generally found that optimists 
have better psychological outcomes of cancer treatment than pessimists (Carver, et 
al., 2006; Carver et al., 2005).   
In addition, a trait approach has been used to understand approaches to 
coping with stressful situations, as which cancer and its treatment can certainly be 
described.  A trait approach to coping distinguishes “monitors”, individuals who 
directly face a situation, finding information and getting assistance, from “blunters”, 
individuals who tend to avoid the situation and may deny its occurrence (Miller, 
1987).  Review evidence suggests that research into trait approaches to coping with 
cancer treatment has generally found that monitors have better outcomes, in a 
biopsychosocial sense, when provided with more information about their treatment 
and blunters when they are given less information about their treatment (Miller, 
1995).  In this way, the approach informs how information provision can be tailored 
to different types of patients.  However, the same review has also found that 
monitors who are negative about the outcomes they will experience from treatment, 
may be quite vulnerable and require HCPs to be quite selective about the information 
they provide and how it is framed (Miller, 1995).  Therefore, a psychological trait 
approach to understanding patients’ experiences of cancer treatment would suggest 
that optimists generally fair better than pessimists, and that information provision 
should be tailored to patients’ individual differences. 
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However, a trait approach has limitations.  An individual’s generalised traits 
may not represent their response to a specific situation.  Although someone is 
generally optimistic, for example, in the face of a cancer diagnosis they may feel 
more pessimistic than usual because their outlook could be influenced by things 
other than their personality.  If, say, the optimist has witnessed a lot of deaths from 
cancer within their network in the past, they may feel more negative about their own 
cancer diagnosis and treatment than would be their usual standpoint.   
The second approach to exploring the psychological factors that can 
influence patients’ experiences of cancer treatment is a state approach, which 
considers individual responses and reactions to the actual situation presented, rather 
than generalised personality traits.  This approach is preferential because, as well as 
the personality-related factors measured in the trait approach, it encompasses the 
whole array of factors that could influence a patient’s outlook and responses, 
including history of cancer.  In this way a state approach has the potential to explain 
more of the variability in patients’ experiences of cancer treatment and provides 
greater specificity as it is context specific.  The remainder of the thesis therefore 
focuses on a state approach to understanding patients’ experiences of cancer 
treatment. 
 1.4.3.1 A state approach to understanding coping 
The origins of coping were in psychoanalysis, first being conceptualised in terms of 
traits that individuals possessed that allowed them to adaptively respond to stressful 
situations, then termed defence mechanisms (Freud, 1992).  In line with the general 
perspective on a trait approach discussed above, this way of understanding coping 
has received much criticism.  Much of this centres on the position that even if 
dispositional coping traits could predict significant amounts of variance in outcomes, 
they would not give researchers a clear picture of the relationship between coping 
and outcomes because there are many possible mediators in the relationship 
(Holroyd & Lazarus, 1982).  If someone usually favours an approach, or acts in a 
certain way, it does not necessarily mean that they did in the specific situation of 
interest.  This suggests that a trait approach may be too simplistic as it assumes that 
individuals’ behaviour remains unchanged in the face of different situations, 
according to key personality traits.  Moreover, it describes a very limited approach to 
coping, which has also been criticised because it is thought that individuals may 
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employ a range of strategies simultaneously to cope with stressful situations 
(Holroyd & Lazarus, 1982). 
As study in this area progressed, the early trait-based ideas were developed 
and expanded, with coping being understood in less rigid terms (Lazarus & 
Folkman, 1984; Haan, 1965).  Therefore, despite these origins, and a continued 
interest for some, in a trait approach to understanding reactions to such situations, 
coping research has long been predominantly studied from a more flexible state 
perspective (Carver & Connor-Smith, 2010). 
Within a state approach to understanding the psychological factors that can 
influence patients’ experiences of cancer treatment, coping is a key area that has 
been a major focus for research.  Unlike the monitoring or blunting conceptualisation 
within a trait approach described above, the state approach to coping understands 
this in terms of the methods individuals utilise to cope with the actual situation itself, 
i.e. cancer and its treatment, and how these can impact on psychological outcomes 
(Lazarus & Folkman, 1984).  There exists an extensive literature on coping, focusing 
on the state approach, both within and outside of cancer care.  Despite this, it was 
discovered that no synthesis of the literature on coping with cancer and its relation to 
cancer patients’ psychological outcomes had been completed.  Therefore, in order to 
synthesise findings in this area, a systematic review was conducted.  What follows in 
the next chapter is a systematic review of the impact of psychological coping, from a 
state perspective, on psychological outcomes, namely QOL and wellbeing, during 
cancer treatment. 
1.5 Towards Understanding the Role of Expectations of Cancer Treatment and 
Their Impact on Outcomes 
This chapter has described the literature in terms of a background to cancer diagnosis 
and its consequences, cancer treatment and patients’ experiences thereof, and some 
of the factors that can impact upon patients’ experiences of cancer treatment such as 
medical factors, social support and psychological factors.  This highlights a role for 
coping in patients’ experiences of cancer treatment.  The specific role of coping will 
now be examined in a systematic review in the next chapter.  
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Chapter Two 
The Impact of Psychological Coping on Psychological 
Outcomes for People Being Treated for Cancer:  
A Systematic Review 
 
2.1 Overview 
The literature reviewed in the previous chapter showed that cancer and its treatment 
can negatively impact patients’ lives, and that there are factors that can help to 
ameliorate these effects.  Amongst these were psychological factors, including 
personality and coping.  Coping has the potential to be important but it was 
identified that despite many empirical studies having been conducted, no previous 
systematic review has addressed the relationship between coping and psychological 
outcomes in cancer patients.  Therefore, this chapter presents a systematic review, 
which aimed to explore whether psychological coping impacts upon quality of life or 
wellbeing for cancer patients at the time of their treatment. 
2.2 Introduction 
A diagnosis of a physical illness such as cancer has been understood in terms of 
crisis theory (Moos & Schaefer, 1984).  Crisis theory is a framework that can be 
used to examine how individuals cope with a diagnosis of cancer and its ensuing 
treatments and work to minimise the impact it has on their state of equilibrium 
(Moos & Schaefer, 1984).  The theory posits that individuals strive for this 
equilibrium, they desire normality, and so will employ strategies in order to return to 
this state if disruptions occur, as may almost certainly be the case in cancer 
treatment; in this way individuals are seen as self-regulatory (Moos & Schaefer, 
1984).  A major part of this process is to select methods of coping with the crisis that 
the individual has been presented with, which it is suggested then result in either 
‘healthy adaptation’ or a ‘maladaptive response’ and therefore potentially have 
consequences for longer-term psychological morbidity (Moos & Schaefer, 1984). 
These methods of coping have received much attention within the literature.  
There are divergent ways in which they have been categorised and understood and 
therefore different methods of studying them, which stem from different theoretical 
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perspectives (Skinner, Edge, Altman, & Sherwood, 2003).  The two predominant 
approaches to understanding coping are problem-focused versus emotion-focused 
and approach versus avoidance (Roth & Cohen, 1986; Lazarus & Folkman, 1984).  
The first of these, problem- versus emotion-focused coping, distinguishes between 
coping that tackles the problem by making attempts to actively manage it in some 
way, and coping that deals with the emotion created by the stressor (Lazarus & 
Folkman, 1984).  Although distinct, these are posited to often be used in an 
interrelated and complimentary way (Lazarus, 2006).  The second, approach versus 
avoidance coping, distinguishes between coping that actively tackles the stressor and 
any resulting emotions, and coping that aims to evade the stressor and any resulting 
emotions (Roth & Cohen, 1986).  These approaches to categorising coping have 
received criticism for being too simplistic and not adequately representing the 
complexities of coping in action, but research conducted with patients nonetheless 
tends to favour one of these two approaches (Carver & Conner-Smith, 2010; Skinner 
et al., 2003). 
Psychological coping is an area of interest within the cancer literature that 
has attracted attention from previous reviewers, who have explored the relationship 
between coping and physical outcomes, in terms of survival and recurrence rates 
(Petticrew, Bell, & Hunter, 2002).  The authors of this review concluded that 
psychological coping style did not have any significant impact on survival rates of 
cancer nor reduce the risk of recurrence in this population.  The suggestion was that 
it was not appropriate to intervene and encourage patients to adopt a particular 
coping style over another as it would not impact upon these physical outcomes 
(Petticrew et al., 2002).  The review, however, only focused on physical outcomes 
and did not consider psychological outcomes and whether these are related to 
methods of coping. 
Although coping interventions may be deemed inappropriate on the grounds 
that they will not influence these physical outcomes, it remains possible that there 
may be some impact of psychological coping on psychological outcomes such as 
quality of life (QOL) and wellbeing.  The impact of psychological coping on such 
outcomes has received much attention within the cancer literature.  There is evidence 
from a review to suggest that coping type may be related to QOL in haematological 
cancer patients, with fighting spirit found to have a positive relationship with QOL 
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and helplessness-hopelessness a negative one (Allart, Soubeyran, & Cousson-Gelie, 
2013).  However, this study reviewed a wide range of psychosocial factors as 
determinants of QOL, including only two studies that addressed coping and therefore 
does not provide a comprehensive depiction of the relationship between coping type 
and QOL.  In addition, included studies were not limited to the period of treatment 
and so the perspective provided on coping could include those who were pre- or 
significantly post-treatment, thus the focus was cancer patients, expressly 
haematological cancer patients, and not their experiences of treatment more 
specifically. 
No review has previously been conducted to provide a detailed synthesis of 
the findings from studies of the relationship between psychological coping and 
psychological outcomes in cancer patients undergoing treatment.  This review 
therefore assesses the evidence to date for relationships between psychological 
coping and psychological outcomes, namely QOL and wellbeing, for patients 
undergoing cancer treatment. 
2.3 Objective 
The aim of the review was to explore whether psychological coping relates to 
psychological outcomes, namely quality of life and wellbeing (QOL/WB), in patients 
being treated for cancer. 
2.4 Research Questions 
By examining the existing literature, the review sought to understand whether the 
psychological coping style adopted by an individual with cancer can impact upon 
their psychological outcomes (quality of life and wellbeing).  The research question 
addressed was: How does psychological coping impact upon psychological 
outcomes (quality of life and wellbeing) for patients being treated for cancer? 
2.5 Criteria for Inclusion 
 2.5.1 Types of participants 
The review included studies in which the participants were adults (18 years and 
over) with cancer.  In addition, participants must have been at least three months 
post-diagnosis.  However, the aim was to capture patients during treatment so those 
studies judged to include predominantly those in remission or any other long-term 
post-treatment status, were excluded, as were those that focused on end of life care.  
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If studies included carers or relatives of persons with cancer, this data did not form 
part of the review, only data about persons with cancer were included. 
 2.5.2 Study design 
Observational, cohort studies were included in the review.  No intervention studies to 
change coping were identified that met the inclusion criteria.  Studies which included 
a psychological intervention aimed at improving quality of life or wellbeing were 
excluded on the grounds that this may have influenced results regarding relationships 
between coping and quality of life or wellbeing.  Qualitative studies were excluded 
as this methodology limited conclusions about the relationship between the 
independent variable (coping) and the dependent variables (quality of life and 
wellbeing). 
 2.5.3 Types of outcome measure 
The review focused on psychological outcomes for those with cancer, whereby the 
outcome was measured during or shortly after their treatment.  Studies were 
excluded if outcomes were measured prior to or significantly after treatment.  Where 
other data were not available, this was judged according to data reporting the length 
of time since diagnosis.  Outcomes of interest were quality of life and wellbeing 
(QOL/WB). 
2.6 Search Strategy for Identification of Studies 
Electronic databases were searched using the University of Surrey library databases 
page.  Databases were searched using the following descriptors: 1 “cancer”; 2 
“coping”; 3 “quality of life”; 4 “QOL”; 5 “wellbeing”.  These terms were selected 
based on their occurrence during an investigatory look at the available literature and 
were the piloted in PsycINFO and PubMed in different combinations, in order to 
ascertain the optimal search field entries. 
An extensive search of the literature was then conducted.  Studies in English 
up to December 2015 were searched using the following databases: PsycINFO, 
PubMed, The Cochrane Library Database, EMBASE, PsycArticles, CINAHL and 
Web of Science.  The reference lists of relevant studies were also checked for other 
articles; titles were entered into the Google Scholar search engine in order to source 
abstracts. 
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2.7 Methods 
Titles and abstracts of articles found in the search were screened to ensure they met 
the inclusion criteria.  For those that appeared potentially suitable, full text versions 
were sourced.  Where these were conference abstracts, authors were contacted 
directly with requests for more study information.  Full texts obtained were further 
scrutinised to ensure they met the inclusion criteria.  Reference lists of articles 
identified for inclusion were searched for studies that may have been relevant but 
had not yet been included in the review.  Titles were assessed to discover whether 
they potentially met the inclusion criteria but no further articles were identified.  
Studies were excluded if patients’ cancer treatment was not the primary period of 
time focussed upon; they were not in English language; they were interventions 
aimed at improving quality of life or wellbeing; they were pilot studies; studies were 
qualitative; they involved children or adolescents. 
The search elicited a total of 4421 articles.  After the initial screen of titles 
and abstracts excluded irrelevant articles, full texts were obtained for 45 articles.  On 
the basis of the inclusion criteria, 21 full texts were excluded.  This was mostly on 
the basis that the addition detail in the full texts highlighted that participants in the 
studies were not currently receiving treatment; measures were given either shortly 
post-diagnosis, or post-treatment.  Some further studies were excluded on the 
grounds that the results did not examine the relationship between different types of 
coping and quality of life or wellbeing directly, for example, one study summed the 
coping types rather than looking at differences between them, and in another, the 
outcome was more closely related to mood than quality of life or wellbeing.  This 
process is detailed in the flow diagram on the next page, which is based on that of 
The PRISMA Group (2009).  Ethical approval was not necessary as this was a 
review of the literature.  
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Figure 2.1: Systematic Review PRISMA (2009) Flow Diagram 
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 2.7.1 Description of studies1 
After all exclusions there were twenty-four articles that were of relevance to the 
review.  The studies were conducted in a range of countries: six in the USA (1-6); 
two each in Turkey, Australia, Japan and China (7-14); and one each in France, 
Sweden, Spain, Hong Kong, The Netherlands, Canada, Finland, Germany, Nigeria 
and Iran (15-24).  There were fifteen cross-sectional studies (2,4-
9,13,14,16,17,20,21,23,24) and nine longitudinal (1,3,10-12,15,18,19,22). The sizes 
of the samples ranged from 20 to 1276 patients in total.  With regards to cancer type, 
most study participants had solid tumours but not all, and the locations of these were 
varied.  Some studies did not exclude patients on the basis of cancer type whereas 
others focused on one type of cancer over others.  Treatment types being undertaken 
included surgery, chemotherapy and radiotherapy with some studies being very 
inclusive and others including only certain treatment modalities.  Several studies did 
not report the treatment type or provided only limited information regarding this.  
The coping types included in the studies varied widely, as will be further examined 
within the synthesis below.  The studies used the following measures: seven used the 
COPE or the Brief COPE questionnaire (2,3,5,8,9,13,23); two used the Coping 
Inventory for Stressful Situations (CISS; 11,12); and one each used the Ways of 
Coping Checklist (WCC; 15), The Coping Flexibility Questionnaire (CFQ; 18), The 
Utrecht Coping List (UCL; 19), The Ways of Coping Inventory (WCI; 7), Ways of 
Coping Questionnaire (WOC; 21), The WOC-CA, an adapted version of the Ways of 
Coping (WOC) scale specifically for breast cancer patients (4), The Medical Coping 
Modes Questionnaire (MCMQ; 14), The Mental Adjustment to Cancer scale (MAC; 
16), The Stressors and Coping Strategies for Cancer Inventory (ISEAC; 17), The 
Illness Management Questionnaire (IMQ; 1), The Coping with Colorectal Cancer 
Questionnaire (CCRC; 10), The Coping Scale (6), the Jalowiec Coping Scale (JCS; 
20), The Endler and Parker coping questionnaire (24), and a six item German 
language measure with the abbreviated name FEKB (22). 
                                                 
1 The Vancouver referencing style has been utilised for the studies included in the review, to enhance 
readability. A reference list for these studies, numbered accordingly, is available at the end of this 
chapter. 
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 2.7.2 Methodological quality2 
Methodological quality was assessed using the Centre for Research and 
Dissemination’s (CRD; 2009) criteria for critical appraisal of cohort studies for 
guidance, as well as the advice of Petticrew and Roberts (2006).  Assessment took 
place using a pre-devised checklist that was based on the Critical Appraisal Skills 
Programme (CASP) Cohort Study Checklist (2015).  Three reviewers were involved 
in the appraisal process and independently assessed the quality and risk of bias in the 
studies that were included.  These assessments were compared and any 
disagreements were resolved through discussion.  A fourth reviewer was available to 
help resolve these discussions but it was not necessary to involve them.  Studies 
were awarded a score based upon these appraisals, with the intention that this would 
indicate overall study quality. 
Sections A (‘Are the results of the study valid?’) and B (‘What are the 
results?’) of the CASP checklist were used but section C (‘Will the results help 
locally?’) was omitted as it was not relevant for the purposes of this review (CASP, 
2015).  This meant there were eight questions to answer about each study.  Once the 
response to each question was finalised, it was given a numeric score, according to 
whether the study had met the criteria.  A response of ‘yes’ attracted two points, and 
‘no’ was zero.  Where questions were marked with ‘can’t tell’, they were scored with 
one point, as the data were not reported and therefore may, or may not, have met the 
criteria.  These numbers were then summed to give an overall quality score.  The 
maximum a study could have scored was 16, and actual values ranged from four to 
16.  Studies scoring 14 or over were rated as strong, those scoring between 11 and 14 
were rated moderate, and those scoring under 11 weak.  Overall, there was one 
strong study (10), seven moderate (1,7,9,12,20,21,22) and the remaining 16 were 
weak (2-6,8,11, 13-19,23,24).  The scoring system for answers to each question and 
cut off points for strong, moderate and weak studies were discussed and agreed 
amongst the three reviewers who conducted the critical appraisals. The overall 
quality of the studies was not particularly strong and this was considered when 
drawing conclusions about the data. 
                                                 
2 The assessment of the individual studies for quality was jointly conducted between myself, Sarah 
Golding and Leah Marks, to add rigour to this process. I wish to extend my thanks to them for their 
dedicated work in completing this task. 
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2.8 Results 
Studies assessed to have a higher methodological quality will be given more 
credence than the lower quality studies (CRD, 2009; Petticrew & Roberts, 2006).  
The decision on how to present the results highlighted an interesting problem with 
synthesising results from these studies.  In the twenty-four included studies, there 
were seventeen different measures of coping.  This meant that researchers had used 
differing theoretical backgrounds within which to frame their studies.  The first step 
in synthesis therefore was to identify the categories under which to synthesise the 
results, which was challenging, particularly given that there is no mutually agreed 
universal way of categorising coping (Carver & Connor-Smith, 2010).  It was 
decided, however, to draw upon the framework suggested by Carver and Connor-
Smith (2010) who outline the different types of coping, how they have been 
categorised and researched.  It is this paper that ultimately informed the categories 
under which the synthesis is presented in this review.  The results are presented first 
in terms of problem- versus emotion-focused coping; then approach versus avoidant 
coping; and finally, an attempt is made to combine these analyses. 
 2.8.1 Analysis 1: problem- versus emotion-focused coping 
Problem-focused coping involves taking actions directed at eliminating or evading a 
stressor or lessening its impact; and emotion-focused coping aims to minimise the 
distress a stressor causes (Carver & Connor-Smith, 2010). 
 2.8.1.1 Problem-focused coping 
Sixteen of the included studies included some form of problem-focused coping: 
‘active’ or ‘proactive’ (five studies: 2,5,13,14,23), ‘problem-solving’ or ‘planning’ 
(this included ‘restraint’, which is planning in the sense that it is an active decision to 
defer action, and ‘suppression of competing activities’, which involves avoiding 
distraction and focusing on the ‘problem’ that an individual is facing; ten studies: 
5,7,8,11-13,15,17-19), ‘distraction’ (four studies: 5,13,17,22), ‘lifestyle 
reorganisation’ (including accommodating to the illness and relaxing-easing, which 
relates to searching for physical conditions that provide comfort and calm; three 
studies: 4,10,17), and ‘information seeking’ (three studies: 1,6,22). 
Some studies included more than one type of problem-focused coping and so 
in total there were 25 analyses of problem-focused coping and quality of life or 
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wellbeing (QOL/WB).  Of these, 15 were non-significant (1,5,10-13,15,17,19,22).  
One of these studies was the only study in the review that had been judged to be 
methodologically strong so these findings hold a lot of weight.  The problem-focused 
coping type of distraction, in particular, had no significant results in any of the 
included studies. 
Of the ten analyses with significant findings, eight suggested that greater use 
of problem-focused coping related to higher QOL/WB (1,2,7,8,14,17,18,23).  One 
study suggested that problem-focusing coping accounted for 24.4% of the variance 
in physical wellbeing (8).  However, one of these studies only found that greater use 
of problem-focused coping predicted more improvement in physical quality of life 
and not with other aspects (1). 
The remaining two significant analyses suggested that greater use of 
problem-focused coping related to lower QOL/WB (5,6).  One of these related 
specifically to ‘suppression of competing activities’ as a coping type (5).  This could 
help to illuminate why there are divergent relationships within the problem-focused 
coping literature, although this is a weaker study and therefore the results should be 
treated with caution.  Whereas problem-focused coping may have some benefit, this 
finding suggests that being too focused on the problem, and ignoring any 
distractions, may be detrimental to quality of life (5).  It could also perhaps help to 
account for the other non-significant findings.  It is possible that a certain amount of 
attention on the problem may be helpful but if this reaches too high a level, it may 
actually have an adverse effect on quality of life.  Further support for this could be 
seen within the ‘lifestyle reorganisation’ coping type.  Two of the three studies that 
included this had non-significant findings (1,10).  The third included ‘relaxing-
easing’ as a sub-type of lifestyle reorganisation and found a positive relationship 
between this and emotional wellbeing (17).  Relaxing-easing could be seen as a more 
moderate form of lifestyle reorganisation and thus provide a benefit to quality of life 
because it does not involve large lifestyle changes, merely seeking solace when 
required. 
 2.8.1.2 Emotion-focused coping 
Twenty-two of the included studies included some form of emotion-focused coping: 
‘emotion-focused’ (four studies: 8,11,12,15), ‘seeking social support’ (eleven 
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studies: 2-5,10,13,15,17,19-21), ‘positive reframing’ or acceptance’ (twelve studies: 
3-7,10,13,17,20-23), ‘rumination’ or ‘anxious preoccupation’ (four studies: 
1,10,16,22), ‘avoidance’ (ten studies: 4,9,11,12,14,16,17,19,20,21), ‘denial’ 
(including distancing and palliative coping. Nine studies: 3-5,10,13,15,17,20,21), 
‘substance abuse’ (one study: 13), ‘wish fulfilment’ (two studies: 6,17), ‘maintaining 
activity’ (one study: 1), ‘venting’ or ‘catharsis’ (five studies: 5,6,13,17,20), ‘religion’ 
(seven studies: 5,7,10,13,19,22,23), ‘humour’ (three studies: 5,10,13), ‘helplessness’ 
or ‘hopelessness’ (four studies: 7,14,16,17), and ‘self-blame’ (two studies: 6,13). 
Overall, the results were very mixed.  Studies frequently contained an 
analysis of more than one type of emotion-focused coping so there were a total of 59 
analyses between emotion-focused coping and QOL/WB.  Of these, 32 were non-
significant (1-3,5,6,10,11,13,15-17,19,20-22); 18 suggested a negative relationship 
between emotion-focused coping and QOL/WB (1,4-9,11-17,19,21) and 9 a positive 
relationship (3,4,7,10,21-23). 
The results become clearer when they are examined in terms of the different 
types of coping included under the emotion-focused coping umbrella.  Some of the 
coping types included do not appear to have a significant effect on QOL/WB, 
namely the use of humour, substance abuse, maintaining activity, rumination or 
anxious preoccupation and seeking social support (1,2,5,10,13,15-17,19-21).  The 
last two of these categories did contain studies that had significant findings but these 
tended to be of poorer methodological quality and were fewer in number than those 
that had non-significant findings. 
There is substantial support to suggest that several of the emotion-focused 
coping types have a negative relationship with QOL/WB.  The evidence is quite 
convincing that greater use helplessness or hopelessness, self-blame, avoidance and 
emotion-focused coping as a global term all relate to poorer QOL/WB (4,6-9,11-
15,17,19,21). 
The results for the remaining coping types within emotion-focused coping 
(positive reframing or acceptance, denial, wish fulfilment, venting or catharsis, and 
religion) were less clear but some suggest a more complex relationship between 
emotion-focused coping and QOL/WB may be present. 
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With positive reframing or acceptance, for example, seven of the twelve 
included studies showed significant relationships between at least one kind of 
positive reframing or acceptance and QOL/WB (3,4,10,17,21-23).  These were 
largely in a positive direction in that greater use of this coping style related to higher 
quality of life, but one study found a negative correlation (17).  This was the only 
study to include stoicism, which seemed logical to group with positive reframing and 
acceptance as it was viewed as accepting the situation and enduring it.  However, 
perhaps there is something different about stoicism in regards of it maybe being 
more forced than other aspects of acceptance.  The findings do suggest that positive 
reframing or acceptance as a coping style may potentially have some benefit but 
given the number of non-significant findings within this coping type no firm 
conclusion could be drawn in regard to this. 
Denial is another complex coping type under emotion-focused coping.  
Overall, at first glance there seemed to be no significant relationship between denial 
as a form of coping and QOL/WB, particularly that held longitudinally.   However, 
there were some interesting results that suggested that early on in the treatment 
pathway there may be a positive relationship between denial and QOL/WB but in the 
later stages, the relationship may be in the opposite direction.  This is particularly the 
case with distancing as a form of denial (4,21).  One study was conducted cross-
sectionally with patients soon after diagnosis (3-4 months post-diagnosis) and found 
a significant positive correlation between distancing and quality of life (21).  A 
second study was conducted cross-sectionally with patients who were a mean of 3.23 
years post-diagnosis and found a significant negative correlation between distancing 
and quality of life (4).  A methodologically strong longitudinal study provides some 
further support for this in that it found a significant positive correlation between 
palliative coping at baseline but at follow up the relationship was not significant 
(10).  The follow up was only after 7 months, so perhaps the differing results 
regarding denial are more about the timing of measurement than other factors.  This 
does suggest that denial may be protective of QOL/WB in the early stages following 
diagnosis.  Following this, perhaps there is a period where it makes no significant 
difference to quality of life. Then, in the later stages, it is detrimental. 
The final more complex emotion-focused coping type is religion.  Four of the 
seven studies found no significant relationship between religion and QOL/WB 
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(10,13,19,22).  Two studies found that higher use of religion as a coping strategy 
was related to higher quality of life; one on all domains and the other on all except 
physical wellbeing (7,23).  One study, however, found a significant negative 
correlation between religion and quality of life (5).  This study had the weakest 
methodological quality and so results should be viewed with caution.  The findings 
overall are quite mixed but suggest that there may not be a conclusive relationship 
between the use of religion for coping and QOL/WB.  The mixed results could 
suggest a greater complexity to this coping style.  If religion is used as a solution, i.e. 
patients genuinely believe that praying, for example, will help them in their cancer 
experience, then perhaps this is where the benefit lies.  If, however, it is used as a 
last resort, for example, then perhaps it is less helpful. 
 2.8.1.3 Summary 
There is some suggestion that problem-focused coping can be effective at protecting 
QOL/WB during cancer treatment.  However, there are limits to this and the 
available evidence suggests that using this coping type too earnestly may actually be 
detrimental.  Use of emotion-focused coping as a coping type does not appear overall 
to be conclusively positive or negative.  It is only by examining the coping types 
contained within it that more can be discovered and even then, some of the results 
remain quite mixed. 
The results are slightly clearer then for problem-focused coping, and this 
would appear to be more broadly protective of QOL/WB than emotion-focused 
coping, but the results here are not conclusive. Emotion-focused coping can also be 
beneficial, depending on the type, which suggests that simply pitting one against the 
other may be either an oversimplification or a misguided way of categorising coping 
types. 
 2.8.2 Analysis 2: approach versus avoidant coping 
Approach and avoidant coping differ in their response to the stressor.  Approach 
involves actively tackling the stressor and any related emotions, whereas avoidant 
coping aims to evade them (Carver & Connor-Smith, 2010). 
 2.8.2.1 Approach coping 
Sixteen studies included some form of approach coping: ‘approach’ (used by one 
study as an overarching coping style, which consisted of active, planning, positive 
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reframing, acceptance, using emotional support and using instrumental support (9)), 
‘fighting spirit’ or confrontative’ (two studies: 16,20), ‘active’ or ‘proactive’ (five 
studies: 2,5,13,14,23), and ‘problem-solving’ or planning’ (ten studies: 5,7,8,11-
13,15,17-19). 
Two studies included two types of approach coping each in their analyses so 
within the sixteen studies there were a total of eighteen analyses (5,13). Ten of the 
eighteen analyses found no significant relationships between approach coping and 
QOL/WB (5,9,11-13,15,17,19,20). 
Eight analyses found significant relationships between approach coping and 
QOL/WB (2,5,7,8,14,16,18,23).  Of these, seven found that greater use of approach 
coping related to aspects of higher QOL/WB (2,7,8,14,16,18,23).  One study 
suggested approach coping accounted to 24.4% of the variance in physical wellbeing 
(8). 
The final study with a significant finding found that the approach coping 
style ‘suppression of competing activities’ was related to lower quality of life so a 
relationship in the opposite direction to the other findings (5).  As similarly 
mentioned within problem-focused coping, this could indicate that too direct an 
approach to coping, whilst paying little attention to anything other than the cancer, 
its treatment and the associated problems, may be detrimental to QOL/WB. 
It is therefore possible that a certain amount of attention on the problem and 
approaching the issues faced may be helpful but if this reaches too high a level, it 
may actually have an adverse effect on quality of life.  This is interesting given that 
there is a lot of focus on approach coping in a cancer setting, particularly viewing 
cancer as an opponent to be defeated (Rom, Miller & Peluso, 2009). 
The results here should be treated with caution, as the studies that included 
approach coping were generally weak methodologically.  Only four of the sixteen 
studies were judged to be of moderate quality and none were strong. 
 2.8.2.2 Avoidant coping 
Nineteen studies included some form of avoidant coping, often including more than 
one type: ‘avoidance’ (ten studies: 4,9,11,12,14,16,17,19-21), ‘denial’ (nine studies: 
3-5,10,13,17,19,20,21), ‘substance abuse’ (one study: 13), ‘wish fulfilment’ (two 
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studies: 6,17), ‘maintaining activity’ (one study: 1), ‘venting’ or ‘catharsis’ (five 
studies: 5,6,13,17,20), ‘religion’ (seven studies: 5,7,10,13,19,22,23), ‘humour’ (three 
studies: 5,10,13), ‘hopelessness’ or ‘helplessness’ (four studies 7,14,16,17), and 
‘self-blame’ (two studies: 6,13). 
All the coping types included under avoidant coping were also included 
under emotion-focused coping above.  However, emotion-focused coping had four 
other coping types included.  The results here are therefore similar and like emotion-
focused coping the studies had more non-significant than significant findings.  These 
also varied greatly amongst the different types of avoidant coping, as they did with 
emotion-focused coping. 
These will not be covered again in detail but in sum, substance abuse, 
maintaining activity, humour, and venting or catharsis had no significant 
relationships with QOL/WB (1,5,6,10,13,17,20).  The results for denial, religion and 
wish fulfilment were more mixed, making drawing firm conclusions more difficult 
but suggesting a more complex relationship between these types of coping and 
QOL/WB (3-7,10,13,17,19-23). The remaining avoidant coping types (avoidance, 
hopelessness or helplessness and self-blame) all suggest a negative relationship 
between avoidance and QOL/WB (4,6,7,9,12-14,17,19,21). 
 2.8.2.3 Summary 
The results from approach coping were similar to those from problem-focused 
coping in that approach coping was largely found to be beneficial to QOL/WB but 
could be detrimental when overused.  Avoidant coping would appear to have a 
negative effect on QOL/WB but, as with emotion-focused coping, this may not 
always be a simplistic relationship.  Therefore, approach coping may be more 
broadly beneficial, when used to a suitable degree, than avoidant coping.  This may 
be more convincing than with the problem- versus emotion-focused coping analysis 
but there are still also some limitations, as the evidence suggests that avoidant 
coping is not always negative. 
2.8.3 Analysis 3: combining the previous analyses 
What now follows is an attempt to combine the previous analyses of problem-
focused versus emotion-focused coping and approach versus avoidant coping.  
Although these four types of coping are often studied in their respective pairs, as two 
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as opposing means of coping, the coping types contained within them are not 
mutually exclusive.  Approach coping can be problem-focused, approaching the 
problem in order to try and solve it, but it may also be emotion-focused if the focus 
of an individual’s approach is managing their emotions, for example, by seeking 
social support. 
Likewise, emotion-focused coping can be approach or avoidant coping.  
Where used as described above, the individual is using it in the manor of an 
approach but emotion-focused coping may be avoidant when it becomes less 
problem-focused, such as in the case of denial or substance abuse. 
This final analysis was conducted in an attempt to clarify whether coping 
types are better categorised in this way and if the results are more uniformly 
synthesised when this approach is taken. 
 2.8.3.1 Problem-focused approach coping 
Thirteen studies included some form of problem-focused approach coping: ‘active’ 
or ‘proactive’ (five studies: 2,5,13,14,23) and ‘problem-solving’ or ‘planning’ (ten 
studies: 5,7,8,11-13,15,17-19).  Where significant relationships were found between 
problem-focused approach coping and QOL/WB, they tended to be in the direction 
that great use of this coping type was related to better QOL/WB (2,7,8,14,18,23), 
with one study suggesting that it accounted for 24.4% of the variance in physical 
wellbeing (8).  This suggests that using this coping type could be beneficial.  
However, one study did find that ‘suppression of competing activities’, a sub-type 
within problem-focused approach coping, was related to lower quality of life (5).  As 
mentioned previously, this suggests that placing too much focus on the problem and 
approaching it too directly may be detrimental to quality of life. 
Within this category, there were also eight relationships examined that failed 
to meet the level of significance (5,11-13,15,17,19).  The above divergence of 
suppression of competing activities from the other relationships found could perhaps 
help to account for these non-significant findings, in that this may be more complex 
than a simple linear relationship.  However, the studies included within this category 
were also generally weak, with only two studies being of moderate methodological 
quality, so the mixed findings may instead be a result of this (7,12). 
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 2.8.3.2 Emotion-focused approach coping 
Seventeen studies included at least one form of emotion-focused approach coping: 
‘seeking social support’ (eleven studies: 2-5,10,13,15,17,19-21), ‘positive reframing’ 
or ‘acceptance’ (twelve studies: 3-7,10,13,17,20-23), and ‘rumination’ or ‘anxious 
preoccupation’ (four studies: 1,10,16,22). 
The results from these studies suggest that emotion-focused approach coping 
may be positively related to QOL/WB (3,4,10,21-23).  However, there are limits to 
this as there were many non-significant findings and some in the opposite direction 
(1,2,4,5,10,13,15-17,19-21).  The findings of a negative relationship tend to relate to 
the aspects of emotion-focused approach coping that allude to coping in a very 
focused manor, such as rumination or anxious preoccupation and stoicism (1,16,17).  
This could suggest that a certain amount of emotion-focused approach coping is 
helpful but being too emotion-focused and approaching the situation too much could 
be detrimental to QOL/WB.  This seems to be the case when examining the positive 
reframing or acceptance and rumination or anxious preoccupation data together.  
However, the seeking social support findings clearly suggest that there is no 
significant relationship between the use of this coping type and QOL/WB 
(2,5,13,10,15,17,19-21).  There is more evidence for this in terms of the quantity of 
papers that suggest this but also in terms of their quality.  Three of the studies with 
non-significant findings were rated as strong or moderate and are amongst the 
highest quality in the review. 
Therefore, like problem-focused and other approach-oriented types of coping, 
emotion-focused approach coping appears to have potential benefit when used a 
reasonable amount but can be negative if overused. 
 2.8.3.3 Emotion-focused avoidant coping 
Nineteen studies included at least one type of emotion-focused avoidant coping: 
‘avoidance’ (ten studies: 4,9,11,12,14,16,17,19-21), ‘denial’ (including distancing 
and palliative coping. Nine studies: 3-5,10,13,17,19-21), ‘substance abuse’ (one 
study: 13), ‘wish fulfilment’ (two studies: 6,17), ‘maintaining activity’ (one study: 
1), ‘venting’ or ‘catharsis’ (five studies: 5,6,13,17,20), ‘religion’ (seven studies: 
5,7,10,13,19,22,23), ‘humour’ (three studies: 5,10,13), ‘helplessness’ or 
‘hopelessness’ (four studies: 7,14,16,17), and ‘self-blame’ (two studies: 6,13). 
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Overall, these tended to suggest that greater use of emotion-focused avoidant 
coping was related to poorer QOL/WB (4-6,7,9,12-14,17,19,21).  There were, 
however, exceptions to this.  Firstly, there were a large number of non-significant 
findings (1,3,5,6,10,11,13,16,17,19,20,22).  Secondly, a small number of the 
findings indicated a relationship in the opposite direction (7,10,21,23).  These fell 
under the denial and religion coping types within the emotion-focused avoidant 
coping category.  The differences between the results within their respective 
categories have been discussed previously but positive relationships for denial may 
be explained by the timing of when this is used within the cancer pathway, and 
religion may depend upon how religion is being utilised within the category.  Some 
of the non-significant findings can be encompassed by these explanations also but 
some are still unexplained. 
This suggests that using emotion-focused avoidance coping may generally be 
detrimental to QOL/WB but that at times it may not be and can even be beneficial. 
 2.8.3.4 Summary 
Similar to the previous analyses, problem-focused approach coping and emotion-
focused approach coping both appear to benefit QOL/WB.  This also appears to be 
limited to situations where the coping type does not lead the individual to be too 
focused on the problem to the extent that they suppress other activities, for example.  
This analysis has helped to clarify this relationship by suggesting that this 
relationship is present whether the approach coping is problem- or emotion-focused. 
Emotion-focused avoidant coping was overall found to have a negative effect 
on QOL/WB.  However, there were some instances where this could be beneficial, 
suggesting that, for example, denial can be useful at times.  In particular, where 
participants used denial soon after diagnosis, it could be protective of QOL/WB, 
whereas later in their treatment pathway, it had no effect, and even later it had a 
detrimental effect.  This suggests an element of timing in the relationship between 
the use of emotion-focused avoidant coping and QOL/WB. 
All the avoidant coping types in the included studies were emotion-focused, 
rather than problem-focused.  Therefore, this analysis helped to determine the 
difference between emotion-focused approach coping and emotion-focused avoidant 
coping.  Emotion-focused approach coping was more uniformly positive, whereas 
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emotion-focused avoidant coping was usually negative.  There were limits to this 
that suggest the benefits or detriments to QOL/WB may depend upon the extent to 
which the coping type is used and also the timing of its use. 
2.9 Discussion 
The aim of the review was to understand whether the psychological coping type used 
relates to the psychological outcomes of quality of life and wellbeing (QOL/WB) in 
patients being treated for cancer.  This was examined in terms of problem- versus 
emotion-focused coping, and approach versus avoidant coping, as these are the ways 
of categorising coping most predominant in the literature (Carver & Connor-Smith, 
2010; Roth & Cohen, 1986; Lazarus & Folkman, 1984).  A combined analysis 
explored problem-focused approach coping versus emotion-focused approach coping 
versus emotion-focused avoidant coping in an attempt to address some of the 
criticisms levelled at the above approaches to categorisation (Carver & Connor-
Smith, 2010; Skinner et al., 2003). 
The results indicate that greater use of problem-focused, approach, and 
problem-focused approach coping often relates to higher QOL/WB.  However, for 
these coping types the findings suggest that there may be a limit to this, in that the 
sub-types of these coping types that are most focused on the problem and 
approaching it directly tended to show a negative relationship with QOL/WB, which 
suggests that too much focus can be detrimental. Further to this, the large number of 
non-significant findings may support the notion that the benefits of using these 
coping types depend upon the degree to which they are utilised. 
Use of both emotion-focused and avoidant coping was found to have 
negative relationships with QOL/WB, although the results were more mixed than 
with the above coping types.  Emotion-focused and avoidant coping had positive 
relationships with QOL/WB in some studies, particularly when the sub-types within 
these categories were analysed. 
The mixed results here indicate a more complex relationship between coping 
type and QOL/WB, as suggested by the literature criticising conventional approaches 
to coping (Carver & Connor-Smith, 2010; Skinner et al., 2003).  The current review 
has highlighted that the benefits to cancer patients found by using a particular type of 
coping may depend on the extent to which it is utilised.  It was noted that where 
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certain types of coping were used in a very focused way they could have a negative 
effect on QOL/WB, where a positive relationship was found with more subtle use of 
the coping type.  Non-significant findings here could potentially indicate a middle 
ground where the patient is too focused for the coping type to be beneficial but not 
enough for it to be detrimental. 
The current review also supports a notion that the timing of the use of the 
coping type may also be important.  The results are particularly indicative of this in 
the case of the coping sub-type denial.  Studies that included denial measured 
relatively early in the treatment pathway found a positive relationship between the 
use of denial and QOL/WB.  Where this was measured a little later in the treatment 
pathway, study results were not significant, indicating that there was no significant 
impact, either positive or negative, of using denial.  In studies that measured denial 
longer-term post-diagnosis, it was found to negatively relate to QOL/WB.  This 
could indicate that although use of denial may be helpful in the early stages of cancer 
treatment, it may cease to benefit and even become detrimental when relied upon 
later into the treatment pathway.  As this was not directly addressed in any of the 
included studies, this warrants further examination with direct comparisons. 
It also must be noted that there are a lot of non-significant findings amongst 
the included studies.  Taken with the aforementioned points regarding the timing and 
degree of use of coping types, it would appear that there is a more complex 
relationship between coping type and QOL/WB than has been examined in the 
included literature, providing further support for the arguments against studying 
coping in this way (Carver & Connor-Smith, 2010; Skinner et al., 2003).  As noted 
by Carver and Connor-Smith (2010), the coping literature suffers from the lack of a 
uniform way of defining coping and this is certainly evident with the early results 
here.  In this review, the fact that seventeen different measures of coping were 
utilised in the included studies shows that there are many different approaches being 
used and different theoretical backgrounds being drawn upon. 
Carver and Connor-Smith (2010) also suggested that combining coping types 
may not be suitable because a coping type will rarely belong exclusively and neatly 
in one coping category.  The authors concluded that approach versus avoidant coping 
was the best fit of the existing categorisation methods but that it still had limitations 
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(Carver & Connor-Smith, 2010).  However, problem- versus emotion-focused 
coping remains a central method of viewing coping that has been frequently utilised 
within the included papers and the wider literature. 
In an attempt to provide a synthesis of the existing literature that may address 
some of these concerns, therefore, as well as analysing the findings in terms of the 
traditional approaches described, the current review also attempted a combined 
analysis of these categorisations.  This involved performing analyses of ‘problem-
focused approach coping’, ‘emotion-focused approach coping’, and ‘emotion-
focused avoidant coping’.  By analysing the results of the included studies first in the 
separate analyses and then in the combined analysis, the review also aimed to 
examine the suitability of amalgamating coping types in this way. 
The results of this combined analysis suggest that problem-focused approach 
coping is a suitable way to summarise problem-focused coping and approach coping.  
Results under each of these headings were very similar and provided clear evidence 
about this type of coping.  The use of emotion-focused approach and emotion-
focused avoidant coping also proved effective.  It helped to differentiate between 
different types of emotion-focused coping, and the different types of approach 
coping, which also clarified the relationship between emotion-focused coping and 
QOL/WB. 
The main drawback of the combined approach was that it was not possible to 
synthesise as many sub-types of coping under the combined coping types, as some 
could not be placed under any heading because they did not clearly relate to one 
particular coping category.  For example, ‘approach’ was one of the coping types in 
the initial analysis and the available information suggested that this included both 
problem- and emotion-focused approach coping.  The analyses therefore were not as 
inclusive as those conducted separately and this method of categorising coping types 
also does not entirely negate Carver and Connor-Smith’s (2010) concerns about 
coping types belonging to more than one category.  However, it does provide a 
promising alternative to approach versus avoidant coping, which was favoured by 
Carver and Connor-Smith (2010). 
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2.10 Conclusions 
The results of the review indicate that the type of psychological coping that cancer 
patients engage in can have an impact on QOL/WB.  This effect appears to be 
dependent on the degree to which the coping type is utilised and where the patient is 
on the treatment pathway.  The methodological quality of the included studies was 
generally rated as moderate at best and therefore the conclusions drawn should be 
viewed with caution.  However, this review has provided some interesting insights 
into the use of psychological coping and presented a promising alternative method of 
categorising coping styles that begins to address some of the problems with other 
methods and could help to fuel a more coherent view of coping.  In addition to 
studying which coping types are being utilised, future research should also focus on 
when and how they are being employed. 
2.11 Towards Understanding the Role of Expectations of Cancer Treatment and 
Their Impact on Outcomes 
This chapter has explored the relationship between psychological coping and the 
psychological outcomes of QOL and wellbeing and highlights that coping can 
impact upon patients’ experiences of cancer treatment.  The connection between this 
and patients’ expectations will be discussed in the next chapter, which will also 
describe the theories and literature related to patients’ expectations of cancer 
treatment, thus providing the theoretical framework for the thesis. 
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Chapter Three 
Literature Review: Theoretical Framework 
 
3.1 Introduction: Patients’ Expectations of Treatment 
Patient experiences of cancer treatment are influenced by a range of factors including 
social support and coping as described in the previous two chapters.  One key factor 
is patients’ expectations of cancer treatment which both influence and are influenced 
by the support received and coping strategies used.  These expectations and the ways 
in which they impact upon patient experiences of treatment are the focus of the 
current chapter.  
As the previous chapter suggested, different types of coping may be more, or 
less, useful at different points within patients’ pathways.  This is perhaps 
unsurprising given that different circumstances will be experienced at different 
times, which may require different responses.  It may therefore be helpful to think of 
coping with a diagnosis of cancer and coping with treatment for cancer as two 
distinct, yet intertwined, processes. 
From a self-regulatory perspective, being diagnosed with a health condition 
leads to an appraisal process that informs the coping methods selected by patients 
(Moos & Shaefer, 1984; Leventhal, Brissette, & Leventhal, 2003).  An immediate 
response to a diagnosis of cancer may be more focused on the illness itself, rather 
than treatments and what they may entail.  Initial appraisals, therefore, although they 
may involve some treatment-related appraisals, are likely to be shrouded in the 
emotional response to diagnosis and any symptoms associated with the cancer itself.  
It follows that this would then facilitate selection of coping strategies aimed at the 
response to the diagnosis of cancer. 
As this process gets underway, usually in fairly quick succession, new 
information is received by patients about the treatments that they face in light of their 
cancer diagnosis.  How they incorporate this new information into their appraisals of 
their situation may be influenced by their approach to coping with the diagnosis.  For 
example, where methods of avoidance coping such as denial are being heavily 
utilised, the realities of treatment may also be denied.  In contrast, where approach or 
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problem-focused strategies dominate, more information about their upcoming 
treatment may be incorporated into their appraisals.  In this way, coping strategies 
selected in immediate response to a diagnosis of cancer could help shape patients’ 
pre-treatment expectations of their treatment. 
Expectations of treatment then form part of a new appraisal process 
considering treatment-related information, which could then have implications for 
patients’ ongoing coping strategies, including coping with treatment.  This new 
appraisal process could therefore be seen as a mediator of changing coping strategies 
in light of new information and changing circumstances.  Such junctures as this 
could form a vital part of patients’ ongoing selection of coping strategies appropriate 
to the point they are at in their cancer pathway.  Patients’ expectations of cancer 
treatment could form part of this appraisal process and therefore influence changes in 
coping strategies used in the face of cancer treatment. 
Expectations are not just important in relation to coping, however.  As will be 
discussed in the remainder of the chapter, expectations can have a direct effect on 
patients’ experiences of cancer treatment in their own right.  There are also potential 
implications when experiences do not match these expectations, which will also be 
described.  The role of expectations will be addressed in terms of three key 
theoretical perspectives (response expectancy theory, expectancy violations theory 
and preparation for treatment), the role of HCPs and measurement issues. 
3.2 Key Theoretical Perspectives 
There are three key theoretical perspective which have been used to explore the role 
of patient expectations.  These are response expectancy theory and the placebo and 
nocebo effects, expectancy violations theory, and preparation for treatment, and will 
now be addressed. 
 3.2.1 Response expectancy theory and the placebo and nocebo effects 
A seminal theory with regards to expectations is response expectancy theory.  
Developed by Kirsch (1985), the theory posits that expecting a certain outcome 
drives a psychobiological process that can make that outcome more likely to occur.  
Response expectancy theory is suggested as an explanation for the occurrence of 
placebo effects, as having positive expectations about treatment efficacy leads to 
positive experiences of treatment efficacy (Kirsch, 1985). 
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Although there is much support for the presence of placebo effects in other 
conditions, in the cancer literature a systematic review concluded that there is little to 
no evidence of the placebo effect present in cancer treatment, in terms of tumour 
response being affected by expectations (Chvetzoff & Tannock, 2003).  This would 
suggest that treatment efficacy expectations have little physiological effect on 
tumour response in cancer treatment.  However, the review only included studies of 
patients with metastatic disease who may be least likely to experience a tumour 
response altogether, including from active treatments, due to the advanced stage of 
their disease, so it is unclear whether these findings would hold in those with better 
prognoses.  This highlights an important difficulty in conducting placebo research in 
other prognoses, because it would be unethical to subject patients to a placebo 
treatment when there is a known active treatment that can produce significant tumour 
responses. 
There are other important reasons for studying treatment efficacy 
expectations, not just their potential influence on tumour response, which primarily 
involve patients’ psychological outcomes.  Koller et al. (2000) studied cancer 
patients undergoing radiotherapy and found that more positive treatment efficacy 
expectations were related to higher QOL, at least in the short-term.  Similar results 
have been found with stroke patients, in that more positive recovery-related 
expectations relate to fewer depressive symptoms (Hobson, Ramessur, & Wray, 
2001).  There is also some evidence in other health conditions that positive 
expectations are related to more positive psychological outcomes, but these findings 
are not universal (Engel, Hamilton, Potter, & Zautra, 2004; Sears, et al., 2004; Lee, 
et al., 2003; Mahomed, et al., 2002; Leedham, Meyerowitz, Muirhead, & First, 
1995).  The general findings regarding positive expectations are consistent with 
findings from the literature on hope in cancer care, where hope has been found to 
relate to happiness, life satisfaction, and psychological distress in the sense that all 
outcomes are improved with higher levels of hope (Wnuk, Marcinkowski, & Fobair, 
2012; Rustoen, Cooper, & Miaskowski, 2010). 
It would therefore seem that although there may be little physiological effect 
of having more positive treatment efficacy expectations, there do seem to be 
psychological effects.  Therefore, they should still be included in research primarily 
for their potential to influence psychological outcomes. 
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Response expectancy theory is also suggested as a mechanism for nocebo 
effects, in that expecting negative outcomes such as treatment-related side effects 
can result in their occurrence (Kirsch, 1985).  Research in the context of cancer has 
explored expectations of treatment-related side-effects.  There is a large body of 
literature in this area, so much so that three separate meta-analyses have been 
conducted within the past ten years (Devlin, Denson, & Whitford, 2017; Colagiuri & 
Zachaerie, 2010; Sohl, Schnur, & Montgomery, 2009).  The first of these, conducted 
by Sohl et al. (2009), was not limited by cancer, treatment or side effect type but was 
dominated by chemotherapy and its common side effects, nausea and vomiting, 
reflecting their prevalence in the literature in this area.  The meta-analysis concluded 
that cancer treatment side effect expectations can lead to an increased likelihood of 
experiencing the related side effect, with a moderate effect size (Sohl et al., 2009).   
The second meta-analysis included solely studies that focused on the 
relationship between expectations and experiences of nausea in patients treated with 
chemotherapy, and likewise found that nausea expectations could predict 
experiences but with a small effect size (Colagiuri & Zachaerie, 2010).  The final 
meta-analysis is much more up-to-date, therefore including more recent research, it 
did not limit study selection to certain treatment and side effect types, and explored 
wider factors involved in the expectations-experiences relationship in more detail 
(Devlin et al., 2017).  Similar to the findings from the first meta-analysis, overall a 
significant, moderate expectation-experience relationship was found (Devlin et al., 
2017; Sohl et al., 2009).  Additional analyses within this study found no significant 
differences between side effects that were perceived as objective and those that were 
subjective, which is interesting because it lends support to a notion that expectations 
can influence actual side effects experienced rather than patients’ perceptions of side 
effects (Devlin et al., 2017).  Results also indicated that there were differences 
between side effects in terms of the strength of the expectations-experiences 
relationship.  Pain and fatigue have the strongest effect, whilst nausea and vomiting 
have much smaller effect sizes, and due to the dominance of nausea and vomiting in 
the literature, this may suggest that the overall effect that can be produced by side 
effect expectations has been underestimated (Devlin et al., 2017). 
This research has therefore uncovered a role for expectations in cancer 
treatment-related side effect experiences and suggests that having negative pre-
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treatment expectations about side effects can lead to more negative treatment 
experiences of the related side effect.  The predominant focus on chemotherapy, and 
nausea and vomiting, does limit the findings in this area, although there is some 
suggestion that this relationship is found in other treatment modalities and their 
related side effects with larger effect sizes in some instances (Devlin et al., 2017; 
Sohl et al., 2009).  Research in this area would benefit from a greater focus on a 
breadth of treatment modalities and side effects. 
Response expectancy theory and the evidence associated with it would 
therefore suggest that, at least in terms of treatment efficacy and side effects, 
fostering positive expectations may be preferable, to encourage more positive 
experiences of cancer treatment. 
 3.2.2 Expectancy violations theory 
Response expectancy theory therefore focuses on expectations as predictors of 
experiences.  The approach, however, does not address the gap between expectations 
and experiences and the impact this could have on patients.  Expectancy violations 
theory maintains that where individuals’ expectations are not met, it increases 
arousal and leads to a cognitive process of evaluating the violation of the 
expectations as either positive or negative (Burgoon & Hale, 1988).  Positive 
evaluations result in more positive consequences, and negative evaluations more 
negative consequences, when compared to unviolated expectations (Burgoon & 
Hale, 1988).  This theory has its roots in understanding social interactions and has 
received far less attention in the context of healthcare. 
Expectancy violations theory may, on one hand, provide further support for 
the above-mentioned standpoints by suggesting that individuals may be motivated to 
get what they expect, in preference to a negative violation of expectations.  However, 
it also poses a different perspective with regards to managing expectations.  If 
information given to an individual is framed positively to create positive 
expectations and the subsequent experience is more negative than expected, 
expectancy violations theory would suggest that individuals would have worse 
psychological outcomes than if these expectations were more realistic (Burgoon & 
Hale, 1988).  This could suggest that when patients’ experiences of cancer treatment 
are worse than their pre-treatment expectations, there may be a detrimental effect on 
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QOL.  Further theoretical support for this position is provided when considering 
Calman’s (1984) definition of QOL.  Calman (1984) suggested that QOL represents 
the gap between an individual’s hopes and expectations, and their current 
experiences.  Both of these theoretical standpoints, therefore, suggest that realistic 
expectations may be preferable to more positive ones. 
Little research explores this in the context of health conditions and cancer is 
no exception to this.  The limited evidence that is available in the cancer literature 
does, however, tend to suggest support for the role of expectancy violations theory.  
Maguire, Hanly, Drummond, Gavin and Sharp (2017) measured prostate cancer 
patients’ retrospective accounts of whether their experiences of treatment side effects 
were better, worse or the same as expected.  In line with what expectancy violations 
theory may predict, they found that where patients’ side effect experiences were 
worse than expected, QOL was much lower than other patients’ QOL, and that 
where patients’ side effect experiences were better than expected, QOL was much 
higher than other patients’ QOL (Maguire et al., 2017).  However, these were 
survivors’ reflective self-reports and it is therefore unclear if there has been some 
influence of recall on evaluations of expectations in relation to experiences, 
particularly as participants were up to 5 years post-diagnosis.  In addition, the 
research includes only prostate cancer patients and would benefit from being 
extended into other cancer types.  A further study that included a range of cancer 
types did also produce similar findings in that participants whose experiences were 
more favourable than they had expected them to be were more likely to have a 
higher QOL (Wan, Counte & Cella, 1997).  This study also suffers the limitation of 
measuring expectations retrospectively. 
Winterling, Glimelius and Nordin (2008) provided some further support for 
an expectancy violations perspective in the context of cancer that involved a 
prospective design.  The period of interest, however, was survivorship, in that 
expectations were measured shortly after treatment was completed, related to 
expectations of the future, and experiences of survivorship formed the outcome.  The 
study found that where experiences of survivorship were more negative than 
expected, QOL was lower and psychological distress was higher (Winterling et al., 
2008). 
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In Koller et al.’s (2000) study of cancer patients undergoing radiotherapy, 
mentioned above, where a positive relationship was found between expectation of 
treatment efficacy and QOL, there were some interesting additional findings that 
could potentially also lend support to an expectancy violations perspective.  
Interestingly, Koller et al. (2000) found that there were a number of patients in their 
study who believed that their treatment was of curative intent, when it was in fact 
palliative, in the sense of managing symptoms, despite having been correctly 
informed.  This reflects other research, which suggests that cancer patients often 
mistake their treatment intent (Weeks et al., 2012).  It is also congruent with the 
wider literature showing that patients, particularly those with serious conditions such 
as cancer, regularly misinterpret information provided to them or are unable to 
process everything that is being communicated to them (Godwin, 2000; Ley 1989). 
In Koller et al.’s (2000) study, those patients who believed their treatment 
was curative when it was in fact palliative initially would have had unrealistically 
high treatment efficacy expectations, thus creating false hope.  Although this was 
protective of QOL in the short-term, once these patients realised their treatment was 
in fact palliative their QOL decreased significantly, without any associated drop in 
objective measures of health status, and was lower than those who had understood 
that their treatment was palliative from the onset (Koller et al., 2000).  In terms of 
expectancy violations theory, the patients in this study had their initially positive 
treatment efficacy expectations negatively violated and this appears to have led to a 
detrimental effect on QOL. 
Within the wider literature of other health conditions, only a handful of 
studies have results that could inform an expectancy violations perspective.  
Research in patients undergoing surgery for epilepsy, bone marrow transplantation, 
and liver transplantation have all provided support for the idea that where 
experiences are more negative than expectations, there are negative psychological 
consequences (Holzner et al., 2001; Andrykowski et al., 1995; Rose, Derry & 
McLaughlan, 1995).  The expectations in question were treatment efficacy 
expectations or expectations of returning to a normal life, and the psychological 
outcomes were QOL, depression and anxiety levels, and psychological distress.  A 
study of stroke patients, however, found no significant relationship between patients’ 
violated expectations of recovery and depression (Hobson et al., 2001).  This study 
  
48 
 
did suffer from a small sample size, however, so the failure to reach significance 
may have been due to lack of power.  All these studies suffer from methodological 
limitations, particularly in relation to their measurement, and therefore results should 
be treated with caution.  More detail is provided on these measurement problems in 
the ‘Measuring Expectations of Treatment’ section, below. 
In summary, whilst response expectancy theory indicates that positive 
expectations should be encouraged in order to promote better patient experiences, in 
contrast, an expectancy violations perspective challenges this perspective and 
highlights that when experiences do not live up to expectations, more negative 
experiences may result compared to when expectations are lower and more realistic 
from the beginning.  Accordingly, whilst response expectancy theory focuses on the 
expectations per se, expectancy violations theory focuses on the gap between 
expectations and experiences. 
Research in this area is limited and would benefit from further attention to 
provide more evidence for a role of expectancy violations in patients’ experiences of 
cancer treatment.  As the literature is still limited to side effect expectations and 
treatment efficacy expectations, not expectations more broadly, this should include 
expanding this into other areas of expectations that patients may experience. 
 3.2.3 Preparation for treatment 
The role of patient expectations is also intrinsic to the research exploring preparation 
for treatment.  Preparation for treatment was first considered in the context of 
surgical treatments where Janis (1958) suggested the importance of the information 
provided to patients in influencing outcomes.  Janis (1958) posited that providing 
patients with accurate information, about both the physical medical procedures and 
the sensations likely to be felt, would allow patients to psychologically prepare for 
the experience of treatment.  This was said to occur through the mental rehearsal of 
the anticipated experiences associated with the treatment, allowing the patient to 
develop realistic expectations, in turn facilitating better coping. 
Since this original assertion, a large body of healthcare research has provided 
support for this position.  It has long been evidenced that providing appropriate 
information to patients before treatment can lead to preferential outcomes for 
patients (Johnson, Morrissey, & Leventhal, 1973; Egbert, Batit, Welch, & Bartlett, 
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1964).  A meta-analysis of the preparation for surgery literature focused on the type 
of information provided to patients, making a distinction between information about 
the physical medical procedures and information about the sensations likely to be felt 
(Suls & Wan, 1989).  Thus, they tested Janis’ (1958) assertion that accurate and 
effective information provided in the preparation for treatment must include both 
elements.  Consistent with Janis’ (1958) position, the results showed that preparation 
for treatment that included the provision of both kinds of information had a larger 
benefit to patient outcomes; namely negative affect, pain ratings, and other-rated 
distress; than providing either type alone (Suls & Wan, 1989). 
Another, more recent, meta-analysis that focused on psychological 
preparation for surgery also concluded that preparation is beneficial, but additionally 
sought to clarify which particular outcome variables benefit (Johnston & Vogele, 
1993).  Specifically, being adequately prepared for surgical treatment has shown a 
reduction in negative affect, pain, pain medication requirements, and length of 
hospital stay; and an improvement in behavioural and clinical measures of recovery, 
physiological measures, and satisfaction with the care provided (Johnston & Vogele, 
1993).  This represented all outcome variables included within the meta-analysis, 
and therefore suggests preparation can impact upon a wide range of outcomes. 
This research has also been extended into treatments other than surgery, 
including radiotherapy and chemotherapy treatments for cancer.  Due to the 
dissimilar nature of various aspects of these treatments and surgery, such as the 
longer duration over which they usually occur, research has explored whether 
preparation for treatment can impact outcomes in these settings (Aranda et al., 2012; 
Burish, Synder, & Jenkins, 1991; Johnson, Lauver, & Nail, 1989; Johnson, Nail, 
Lauver, King & Keys, 1988). 
Intervention studies involving radiotherapy treatment for cancer have found 
that provision of detailed, concrete information can lead to less disruption to 
patients’ usual activities (Johnson et al., 1989; Johnson et al., 1988).  This lends 
support to the idea that the benefits of preparation for treatment extend beyond 
surgery.  These studies did not find an effect of preparation on negative mood, which 
could suggest the benefits are more limited, however, the sample characteristics are 
likely to have influenced findings as prognoses were good and the presence of very 
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negative mood was rare (Johnson et al., 1989; Johnson et al., 1988).  If mood was 
already reasonably positive, the effect an intervention could have would be limited, 
and therefore including a more heterogenous sample would help to explore this 
further. 
Research in this area also seeks to explain the effects of preparation using 
self-regulation theory, by suggesting that preparatory information allows patients to 
create a schema about treatment that reduces the gap between expectations and 
experiences of treatment, reducing uncertainty and facilitating problem-solving 
coping (Johnson et al., 1989; Johnson et al., 1988; Leventhal & Johnson, 1983).  
Johnson et al. (1989) provide some support for this position by demonstrating a 
mediating role of similarity of expectations and experiences, and understanding of 
experiences, in the relationship between the preparatory information intervention and 
disruption to usual activities.  Focusing on expectations, although the gap between 
expectations and experiences did explain a small amount of the variance, the analysis 
was not significant (Johnson et al., 1989).  There are problems with the way the 
expectations-experiences gap was measured in this study, however, which may have 
influenced the findings.  Firstly, the question was posed to patients after treatment, 
asking them to reflect on whether their experiences were as expected, relying on 
subjective accounts of this that may have been influenced by recall and perceptions 
of expectations being influenced by experiences.  Secondly, the expectations-
experiences gap was measured in terms not only of experiences of treatment but also 
in terms of treatment planning, so encompassing how the preparatory information 
compared to what they were expecting.  It would therefore be interesting to expand 
this perspective by aiming to understand whether the gap between expectations of 
just treatment itself, measured pre-treatment, and experiences of treatment mediates 
the positive effects of preparation for treatment. 
Evidence from chemotherapy treatment for cancer suggests that there may 
also be benefits of preparing patients for treatment here too (Aranda et al., 2012; 
Burish et al., 1991).  Burish et al. (1991) tested the effect of a coping preparation 
intervention on knowledge of cancer and its treatment, experiences of side effects 
and negative affect, and coping abilities, including disruption to usual activities.  The 
intervention had a positive effect on all factors.  Knowledge was assessed using 
patient questionnaires, which were marked for accuracy by patients’ healthcare 
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professionals, as well as patient perceptions of the adequacy of information provision 
(Burish et al., 1991).  This knowledge, therefore, could have led to more realistic 
expectations and thus may have produced the other positive results found, but this is 
not clear as the relationship was not addressed directly.  Findings here are in line 
with those from preparation for surgery, and mostly also with those from preparation 
for radiotherapy, with one exception.  The intervention here had a positive effect on 
negative affect, whereas findings from radiotherapy suggest no influence of 
preparation for treatment on mood (Burish et al., 1991; Johnson et al., 1989; Johnson 
et al., 1988).  These divergent findings could be explained by different samples, with 
perhaps baseline levels of negative affect being lower overall in the present, 
chemotherapy-related study. 
Although still congruent with a benefit being provided of preparation for 
chemotherapy, Aranda et al.’s (2012) findings were a little different to this.  They 
conducted a randomised controlled trial of an individually-tailored, evidence-based, 
supportive, educational intervention aimed at preparing cancer patients for 
chemotherapy and found that patients in the intervention group reported fewer unmet 
needs than the control, usual care (Aranda et al., 2012).  Consistent with the findings 
from radiotherapy, there were no significant between-group differences in 
psychological distress (Aranda et al., 2012).  In addition, symptom burden did not 
differ for all bar one symptom, vomiting (Aranda et al., 2012).  Vomiting occurred 
significantly less frequently, was less severe and less bothersome in the intervention 
group than in the control group (Aranda et al., 2012).  This indicates that additional 
information provision and preparation may have an influence on patient satisfaction 
with the information provided but that the potential impact on symptom burden and 
psychological distress is more limited.  That said, the control group receiving usual 
care were also given an educational session by a nurse pre-chemotherapy and the 
quality of this is unclear.  If this were high quality, then perhaps there was not 
enough of a difference between the control and the intervention methodology to 
produce a significant difference in outcomes.  Further, patients reflected on unmet 
pre-treatment needs, and as a result, responses may have been influenced by 
experiences. 
The theory and evidence related to preparation for treatment therefore 
provides an interesting perspective on cancer patients’ pre-treatment expectations.  It 
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highlights the benefits that may be found of providing patients with realistic 
expectations of their upcoming treatment.  This idea is in line with expectancy 
violations theory, as it suggests a need to minimise the gap between expectations and 
experiences.  Preparation for treatment also supports the notion of considering 
expectations more broadly than simply focusing on treatment efficacy and treatment-
related side effects, evidencing that disruption to usual activities can be a significant 
treatment outcome related to feeling prepared for treatment.  Although this provides 
an interesting perspective and potential alternative view on expectations, research 
that directly examines cancer patients’ pre-treatment expectations in comparison to 
treatment experiences, in order to measure the gap between the two and its effects, is 
lacking. 
 3.2.4 Summary of the key theoretical perspectives 
The three key theoretical perspectives in relation to patients’ expectations of cancer 
treatment are therefore response expectancy theory, expectancy violations theory and 
preparation for treatment.  Response expectancy theory suggests that expectations 
predict experiences and therefore advocates promoting positive pre-treatment 
expectations.  In contrast, expectancy violations theory suggests that negatively 
violated expectations could lead to more negative treatment experiences than if no 
violation occurs, thus advocating more realistic pre-treatment expectations.  
Preparation for treatment suggests that if accurately and adequately prepared, 
patients cope better with treatment and thus have better experiences, which likewise 
advocates more realistic pre-treatment expectations.  Due to their conflicting nature, 
it is not clear which stance is best for patients and therefore this needs further 
investigation. 
3.3 Measuring Expectations of Treatment 
Expectations are therefore key to predicting and improving patients’ experiences of 
cancer treatment.  How they are measured, however, is problematic and different 
measures focus on different aspects of expectations, making synthesising findings 
difficult.  Different approaches to measurement will now be addressed. 
The narrow focus of the majority of the cancer treatment expectations 
literature also has implications for the measurement of pre-treatment expectations.  
Even drawing on the wider literature with other health conditions, measures of 
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expectations can be quite narrow.  Studies in other conditions acknowledge the lack 
of a measure of expectations, often creating their own but without using rigorous 
methods or attempting to validate them (e.g. Winterling et al., 2008; Hobson, et al., 
2001).  Reflecting this, there is no suitable, broad measure that encompasses all 
aspects of expectations discussed above, that can be used with relation to cancer 
treatment.  Different types of expectations have, in general, instead been measured 
more in isolation and where measures have a broader focus, their development has 
limitations. 
Treatment efficacy, for example, can be measured using the Stanford 
Expectations of Treatment Scale (SETS), which was developed for measuring 
treatment efficacy expectations in clinical trials (Younger, Gandhi, Hubbard, & 
Mackey, 2012).  This does not, however, include any other aspects of pre-treatment 
expectations.  Likewise, the response expectancies research studying expectations of 
treatment-related side effects mentioned above has most commonly used the Side 
Effect Expectancy Questionnaire (SEEQ) and visual analogue scales (VAS) to 
measure pre-treatment expectations (Devlin et al., 2017).  Both of these methods of 
measuring expectations are limited in that they include solely items relating to side-
effects and do not consider expectations more broadly, as it is hoped is clear is the 
preferable stance.  The SEEQ includes 16 chemotherapy-related side effects so its 
applicability to other treatment modalities would be more limited (Cassileth et al., 
1985).  These factors together make these measures unsuitable in their current form 
for use in studying expectations more broadly. 
Slightly more reflective of a broader perspective is the Cancer Therapy 
Satisfaction Questionnaire (CTSQ), a 16-item measure of patients’ perceptions of 
their cancer treatment and its outcomes (Abetz, et al., 2005).  Expectations are 
compared to experiences within the measure but in a retrospective way.  The 
measure does not, therefore, facilitate the longitudinal, prospective study of the 
expectations-experiences relationship.  It does, however, provide a broader 
perspective on expectations than some other measures. 
Another measure that attempts to encompass a broader approach to studying 
expectations within the context of cancer care is the recovery-related expectations 
questionnaire (RRE), although it does not include treatment efficacy expectations 
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(Winterling, et al., 2008).  This is, however, focused on expectations and experiences 
of cancer survivorship, measuring expectations shortly after treatment has ended.  
Although it may be anticipated that there is scope for adapting this for use in the 
context of cancer treatment, this is problematic.  There are several limitations of the 
methods used to develop the measure, including that it was based only on the 
existing literature of cancer survivors’ experiences.  This should be part of 
developing the measure but a more integral part would be their expectations.  There 
appears to be no exploration of the types of things patients expect from the 
survivorship period, either within any existing literature or by exploring this anew.  
There is a necessity to understand more about what patients expectations in a 
particular context are, using qualitative methods, before attempting to design 
quantitative measures (Staniszewska, 1999).  In addition, no procedures appear to 
have been conducted to attempt to validate the measure. 
The Cancer Treatment Survey (CaTS) is a measure of patients’ preparation 
for treatment with radiotherapy and chemotherapy that could be considered in this 
context (Schofield et al., 2012).  The measure assesses the detriments in the 
information and assistance that patients feel they have been provided with by 
healthcare professionals by enquiring about areas in which they require more 
information or assistance (Schofield et al., 2012).  It is therefore more suited to use 
in understanding whether an intervention targeted at improving preparation for 
treatment has been effective than being suitable in exploring what patients are 
expecting of treatment prior to its commencement.  Similar to this, there exist several 
measures that relate to expectations of care rather than expectations of treatment 
outcome or impact (Bowling & Rowe, 2014; Peck et al., 2000; Kravitz, Callahan, 
Azari, Antonius, & Lewis, 1997; Williams, Weinman, Dale & Newman, 1995). 
A measure of patients’ expectations of new treatments for rheumatoid 
arthritis exists that is a much broader prospective expectations measure than any that 
exist within the cancer literature, including aspects of expectations such as treatment 
efficacy and the impact of treatment on both usual activities and care delivery 
(Hofmann, et al., 2013).  It is, however, very focused on rheumatoid arthritis as a 
long-term condition and the management thereof.  There is a section on impact of 
treatment in terms of care delivery that includes items relating to expectations of 
various aspects of their ongoing care, including not needing to change medication as 
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frequently and being more able to be involved in treatment decisions.  These would 
perhaps not be as relevant for cancer treatment related expectations due to the 
different nature of treatment.  The treatment efficacy expectations items included in 
the measure are related to improving symptoms of the condition such as pain, 
swelling and stiffness, which is quite different to treatment efficacy expectations in 
cancer, which may be more focused on mortality.  Collectively, this would make the 
scale very difficult to adapt for use in relation to cancer treatment expectations.  Side 
effect expectations are also not explicitly measured. 
When looking to study expectations more broadly, there is therefore an added 
difficulty that there is no well-developed, broad measure of patients’ expectations 
that can be used within the context of cancer treatment. 
3.4 The Role of the Healthcare Professional in Managing Expectations 
The three key theories of expectations therefore suggest different approaches to 
improving patient outcomes.  In particular, whilst response expectancy theory 
suggests that patient expectations should be positive, expectancy violations theory 
and the research exploring preparation for treatment indicate that expectations should 
be managed to be made more realistic.  To date, little is known about the best 
approach due to the paucity of research in this field together with appropriate 
measures.  This has implications for how healthcare professionals (HCPs) should 
interact with their cancer patients during treatment. 
As described in Chapter 1, HCPs can influence patients’ experiences of 
cancer treatment directly in terms of the care and support they provide.  Within the 
context of preparation for treatment and patients’ expectations, however, there lays 
another way in which the HCP can influence patients’ treatment experiences, and 
this is through the ways in which they manage patients’ expectations. 
The way information is framed in healthcare communications has long been 
established to influence how treatments are perceived by patients (Tversky & 
Kahneman, 1981).  Therefore, the HCP’s framing of information has the potential to 
impact upon patients’ expectations of cancer treatment.  The information received 
and retained from HCPs has been shown to have a significant influence on patients’ 
expectations of cancer treatment (Llewellyn, McGurk, & Weinman, 2005). 
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There tends to be a focus on positive expectations in cancer care and HCPs 
play an active part in creating this positive outlook, especially in relation to treatment 
efficacy (Taylor, Wells, Hubbard & Worth, 2016; Jarrett & Payne, 2000).  This is 
problematic because, as discussed, the evidence surrounding patients’ expectations 
does not conclusively suggest that positivity is the best stance, particularly in the 
longer-term. 
This highlights two things.  Firstly, it is important for research to understand 
what HCPs believe regarding patients’ expectations and experiences of cancer 
treatment, as these may influence the management of patient expectations.  
Secondly, there is a clinical utility to studying patients’ expectations of cancer 
treatment.  If research can establish what it is best for patients to expect in relation to 
their treatment, HCPs can use this information to help inform how they manage 
those expectations to encourage the best possible outcomes. 
3.5 Summary 
Research into patients’ expectations of cancer treatment has been limited in its 
scope, with most of the focus being on expectations of treatment efficacy and 
treatment side effects, and there are also conflicting findings.  A response 
expectancies perspective would suggest encouraging positive expectations of cancer 
treatment, in order to maximise treatment efficacy and minimise treatment-related 
side-effects.  Contra to this, expectancy violations theory would suggest that setting 
more realistic expectations would be preferential, even if this is more negative.  The 
theory highlights the importance of the gap between expectations and experiences 
and suggests that where experiences are more negative than expected, there are 
detrimental effects on QOL.  In line with this perspective, preparation for treatment 
would also support encouraging more realistic expectations, in order to facilitate 
better coping. 
More research has been conducted with expectations as predictors of 
experiences, less addresses the expectations-experiences gap from an expectancy 
violations perspective.  Where such research has been conducted, it suffers 
methodologically largely due to the use of poor quality, un-validated measures, often 
taking retrospective accounts of expectations.  Such measures are often produced 
specifically for the studies that use them but appropriate steps appear not to be taken 
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during the development to ensure that they are robust.  One measure, for example, 
bases item generation on the existing literature of patients’ experiences but does not 
attempt to address the dearth of knowledge about what patients’ expectations are, in 
order to better inform this process.  A qualitative understanding of patients’ 
expectations is necessary to create a good quality, broad measure of expectations.  
Where better quality measures of expectations do exist, that could be used 
prospectively, they have a narrow focus and do not concentrate on a broad range of 
patients’ expectations of cancer treatment.  For these reasons, measurement of 
expectations is generally problematic. 
Despite the lack of clarity about what it is best for patients to expect, 
positivity is valued in the context of cancer care and often co-created between 
patients and HCPs; HCPs can help to manage expectations.  Therefore, their beliefs 
and perspectives about patients’ expectations and experiences are important, as is 
understanding the impact that providing care has upon HCPs themselves, because 
this has implications for their abilities to communicate effectively and care for 
patients. 
There is therefore the need for research to explore patients’ expectations of 
cancer treatment more broadly and further consider the implications for the 
expectations-experiences gap.  In order to do so, a new, robust, appropriately 
developed measure of patients’ expectations is needed, to reflect this broader 
perspective, with a matched measure of experiences of treatment to allow for direct 
comparison between the two variables.  To inform the process of item generation, 
further exploration of patients’ pre-treatment expectations is required.  As HCPs play 
an important part in managing patients’ expectations, research is needed to 
understand their beliefs about patients’ expectations and experiences of cancer 
treatment.  The Clinical Nurse Specialist (CNS) is an appropriate focus for this due 
to their close working relationship with cancer patients.  This can be further 
supported by exploring CNS’ experiences of providing care to patients and the 
impact this has on them as professionals, to understand the difficulties that may be 
faced with managing expectations. 
3.6 Aims of this Thesis 
The aims of the Ph.D. were therefore to: 
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• Explore patient experiences of cancer treatment and their beliefs about the 
role of their expectations 
• Develop quantitative measures of treatment expectations and experiences 
• Assess the relationship between treatment expectations and experiences 
• Explore CNS’ beliefs about patients’ expectations and experiences 
• Explore CNS’ experiences of managing patients through treatment 
experiences 
3.7 Thesis Structure 
To address these aims the thesis consists of the following empirical studies: 
• Study 1 (Chapter 4) 
Title: Patients' Expectations of Cancer Treatment: A Qualitative Study 
Aim: To explore patient experiences of cancer treatment and the role of their 
expectations 
Design: Qualitative 
• Study 2 (Chapter 5) 
Title: The Development and Validation of Two New Measures: The 
Expectations of Cancer Treatment Questionnaire and the Experiences of 
Cancer Treatment Questionnaire 
Aim: To develop and validate matched quantitative measures of expectations 
and experiences of cancer treatment 
Design: Cross-sectional, measure development and validation 
• Study 3 (Chapter 6) 
Title: A Cross-Sectional Study of the Relationship between Expectations and 
Experiences 
Aim: To assess the relationship between treatment expectations and 
experiences 
Design: Cross-sectional 
• Study 4 (Chapter 7) 
Title: The Relationship between Expectations and Experiences: A Clinical 
Case Study 
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Aim: To assess the relationship between treatment expectations and 
experiences 
Design: Case study 
• Study 5 (Chapter 8) 
Title: Healthcare Professionals’ Beliefs about Patients’ Expectations and 
Experiences of Cancer Treatment: A Qualitative Study 
Aim: To explore CNS’ beliefs about patients’ expectations and experiences 
of cancer treatment 
Design: Qualitative 
• Study 6 (Chapter 9) 
Title: The Impact on Clinical Nurse Specialists of Caring for Cancer Patients: 
A Qualitative Study 
Aim: To explore CNS’ experiences of managing patients through treatment 
experiences 
Design: Qualitative 
3.8 Towards Understanding the Role of Expectations of Cancer Treatment and 
Their Impact on Outcomes 
This chapter has described the literature and theories relating to patients’ 
expectations of cancer treatment and highlighted the gap in the literature.  This 
highlights a role for expectations in impacting patients’ experiences of cancer 
treatment but that there are conflicting views as to what it is best for patients to 
expect.  This requires further study with a broader range of expectations as a focus 
and to address the measurement issues that have been illustrated, which is what the 
Ph.D. aimed to do.  The chapter has also outlined the aims of the Ph.D. and the 
structure of the thesis.  The following six chapters present the empirical work 
conducted in the Ph.D., beginning with an in-depth qualitative exploration of 
patients’ expectations of cancer treatment in the next chapter.  
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Chapter Four 
Study 1. Patients’ Expectations of Cancer Treatment:  
A Qualitative Study 
 
4.1 Overview 
The literature discussed in the previous chapters highlights the potential impact 
cancer and its treatment can have on patients, and some of the factors that can 
ameliorate this, including coping and patients’ expectations.  Three theories were 
outlined, relating to patients’ expectations of cancer treatment; response expectancy 
theory, expectancy violations theory and preparation for treatment; which have 
conflicting views on whether patients should hold positive or more realistic 
expectations.  Research in this area has generally had a narrow focus on 
expectations, with no broader exploration of these expectations. The present chapter 
therefore presents a study that aimed to provide an in-depth understanding of cancer 
patients’ expectations in the context of their experiences. 
4.2 Introduction 
Response expectancy theory suggests that what an individual expects to occur can 
have an influence on what actually does occur (Kirsch, 1985).  From this 
perspective, patients’ expectations about their cancer treatment have been studied 
with regards to the physical side effects that can occur from such treatments.  
Response expectancies research indicates that if cancer patients expect a certain side 
effect to occur, then they are much more likely to experience that side effect; this has 
particularly been found with chemotherapy-induced nausea and vomiting (Sohl, et 
al., 2009).  This perspective is also interested in treatment efficacy expectations in 
terms of the placebo effect but there is little evidence to support such effects in 
cancer treatment (Chvetzoff & Tannock, 2003).  There is, however, evidence that 
treatment efficacy expectations may influence psychological factors such as quality 
of life (QOL) during treatment (Koller et al., 2000).  Thus, a response expectancies 
perspective states that expectations predict experiences and would suggest that 
positive pre-treatment expectations are preferable. 
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In contrast, expectancy violations theory argues that the gap between 
expectations and experiences is more important, suggesting that if experiences are 
worse than expected, it leads to more negative outcomes (Burgoon & Hale, 1988).  
Research with cancer patients supports this perspective in relation to physical side 
effects of treatment and treatment efficacy (Maguire et al., 2017; Koller et al., 2000).  
This would therefore suggest that encouraging more realistic pre-treatment 
expectations is preferable.  In line with this, a preparation for treatment perspective 
suggests that where patients are provided with accurate information, they can 
psychologically prepare for their upcoming treatment, facilitating better coping and 
outcomes (Janis, 1958). 
Research with cancer patients has therefore explored expectations of 
treatment efficacy and physical side effects and their relationship with physiological 
and psychological outcomes.  This has usually been conducted quantitatively. It is 
not clear whether there are other aspects of the treatment that patients have pertinent 
expectations about, as previous research has not provided an in-depth, qualitative 
exploration of the expectations patients have prior to starting cancer treatment.  
Research has also yet to discover whether patients perceive that these expectations 
could have, or have had, an impact on their experiences.  In addition, these factors 
have largely been studied in isolation.  There is, however, a complex relationship 
between treatment, the healthcare professional and the patient, and the interaction 
that occurs between them.  By studying expectations about a specific aspect of 
patients’ cancer treatment experiences, such as treatment efficacy or physical side 
effects, the research in this area may have failed to account for interaction effects 
and any other factors that could be involved.  Research is needed to address this gap. 
4.3 Aims of the Present Study 
The current study therefore aimed to provide a broad, in-depth, qualitative 
exploration of patients’ expectations of cancer treatment and how these manifest in 
their subsequent experiences, across different cancer types and treatment modalities. 
4.4 Method 
 4.4.1 Design 
The study used qualitative methods to gain an in-depth insight into participants’ 
expectations of cancer treatment and how they believed these expectations related to 
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their subsequent experiences.  Semi-structured one-to-one interviews were 
conducted due to the potentially private nature of what participants would disclose 
and to access an appropriate level of detail about expectations and experiences of 
cancer treatment without curtailing the possibility of participants discussing points 
that they felt were important to raise. 
 4.4.2 Sample 
Men (n=4) and women (n=12) aged between 19 and 82 who were either currently 
experiencing, or had in the past experienced, some form of treatment for cancer were 
interviewed.  Those who had finished their treatment were a maximum of two years 
post-treatment at the time of interview.  Participants’ cancers were of varying types: 
six participants had breast cancer, three Hodgkin’s lymphoma, two non-Hodgkin’s 
lymphoma, and one each had endometrial, ovarian, bladder, renal and skin cancer.  
Treatment types and combinations also varied, with six participants having received 
just one type of treatment and ten having received two or more treatment types.   Of 
those who had received one treatment type, three participants had surgery, two 
chemotherapy, and one radiotherapy.  The ten who had received more than one 
treatment had received various combinations of surgery, chemotherapy, 
radiotherapy, hormone treatment and targeted therapy.  Further detail is available in 
Tables 4.1 and 4.2. 
Table 4.1: Participant Background Information 
Pseudonym Gender Age Ethnic 
Origin 
Education Occupation Children? Number of 
Dependents 
Kimberly Female 48 White 
American 
Postgraduate 
Degree 
Project Officer, 
Self-employed 
Yes 2 
Penelope Female 22 White 
British 
A-Level Student No 0 
Anna Female 19 White 
Russian 
Diploma Student No 0 
Julie Female 56 White 
British 
Postgraduate 
Degree 
Research 
Director 
Yes 0 
Albert Male 82 White 
British 
Postgraduate 
Degree 
Visiting 
Lecturer, Self-
Employed 
Yes 0 
David Male 59 White 
British 
GCSE Workshop 
Technician 
Yes 2 
Sally Female 68 White 
British 
A-Level Retired 
Volunteer 
Complementary 
Therapies 
Yes 0 
Neil Male 54 White 
British 
Degree Company 
Director 
Yes 1 
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Pseudonym Gender Age Ethnic 
Origin 
Education Occupation Children? Number of 
Dependents 
Jenny Female 26 White 
British 
Degree Senior 
Fundraiser 
No 0 
Jocelyn Female 49 White 
British 
Degree Student 
Learning 
Advisor 
Yes 2 
Rebecca Female 56 White 
British 
Degree People 
Development & 
Coaching 
(Nurse), Self-
Employed 
Yes 0 
James Male 24 White 
British 
Postgraduate 
Degree 
Administrator No 0 
Carol Female 64 White 
British 
Diploma Primary 
Teacher 
(Retired) 
Yes 0 
Beverly Female 41 White 
British 
Degree Previously 
Sales Advisor 
but 
unemployed 
Yes 3 
Elizabeth Female 58 White 
British 
Degree Sales and 
Marketing 
No 0 
Francis Female 64 White 
British 
A-Level Retired No 0 
 
Table 4.2: Participant Cancer and Treatment Information 
Pseudonym Cancer Type Time Since 
Diagnosis 
Treatment Type(s) Time Since 
Treatment 
Kimberly Breast 2 years, 4 
months 
Surgery, chemotherapy 1 year, 10 
months 
Penelope Non-Hodgkin’s 
Lymphoma 
3 years Chemotherapy 2 years 
Anna Hodgkin’s 
Lymphoma 
2 years Chemotherapy, 
radiotherapy 
1 year, 6 months 
Julie Endometrial 1 year, 3 months Chemotherapy, surgery 1 year 
Albert Bladder 5 years Surgery 4 months 
David Non-Hodgkin’s 
Lymphoma 
11 months Radiotherapy 7 months 
Sally Skin 1 year, 2 months Surgery 1 year, 1 month 
Neil Renal 8 months Surgery 7 months 
Jenny Hodgkin’s 
Lymphoma 
2 years, 11 
months 
Surgery, chemotherapy 2 years 
Jocelyn Breast 1 year, 2 months Chemotherapy 7 months 
Rebecca Breast 5 years, 7 
months 
Chemotherapy, surgery 7 months 
James Hodgkin’s 
Lymphoma 
1 month Chemotherapy Current 
Carol Breast 5 months Surgery, chemotherapy Current 
Beverly Breast 1 year, 2 months Surgery, hormone 
therapy 
Current 
Elizabeth Breast 1 year, 8 months Surgery, chemotherapy, 
radiotherapy 
1 year 
Francis Ovarian 1 year, 9 months Chemotherapy, surgery, 
targeted therapy 
3 months 
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 4.4.3 Interview schedule 
A semi-structured interview schedule was designed to create the opportunity for 
participants to go into detail about their expectations before starting treatment and 
how these expectations changed throughout their treatment experience (Appendix 
A).  It was also the intention to allow participants to reflect on whether they believed 
that their expectations had influenced their experiences in any way.  The schedule 
began by asking participants about the period before they started their treatment and 
encouraged them to discuss the concerns they had at that time, what information they 
were being given, what they had expected from treatment and what they had 
expected to happen during treatment.  A key question here was: ‘So overall, what did 
you expect from the treatment before you started it?’.  The schedule then moved on 
to cover aspects of the expectations participants had during treatment, how these 
were different from before treatment and, where applicable, how the expectations 
differed for different treatment types that participants had experienced.  A central 
question here was: ‘How, if at all, did your expectations for future treatment sessions 
change once you had started treatment?’.  The final part of the interview schedule, 
before participants were asked if they had anything further to add, focused on 
participants’ beliefs about whether and how their expectations for treatment had 
influenced their experiences of treatment.  This was centred on the question: ‘How, 
if at all, do you think the expectations you had before treatment influenced your 
experiences during treatment?’.  This question was experienced as difficult to answer 
for some of the earlier participants interviewed.  It was therefore necessary to add 
further prompts to the interview schedule and perhaps explain the question in some 
cases.  Doing so resolved the previous issues and meant that it was not necessary to 
omit the question, or overly alter the schedule.  Otherwise, the original schedule was 
successful in eliciting the required detail and therefore remained unchanged.  There 
were several prompts included in the schedule for most questions but it was rarely 
necessary to draw upon them as most participants spoke with sufficient depth and 
breadth without needing to be prompted. 
 4.4.4 Procedure 
A favourable ethical opinion was gained from the University Ethics Committee for 
participants being recruited through their employment or enrolment at the 
University, or as a result of being known to those who were employed or enrolled at 
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the University (Appendix B).  Ethical approval was also gained from a National 
Health Service (NHS) Research Ethics Committee for those participants recruited 
directly through their clinical care team at an oncology centre in the South East of 
England (Appendix C).  Advertisements were placed on notice boards within the 
University, inviting interested individuals to get in contact for more information 
(Appendix D).  The clinical care team at the oncology centre were asked to advertise 
the study to their patients using leaflets similar to the posters that were put up at the 
University, again asking interested individuals to contact the researcher (Appendix 
E).  The study was also subsequently advertised by asking participants recruited 
through the University to pass the details on to anyone they knew who may wish to 
participate. 
In all cases, interested individuals were provided with an information sheet 
(Appendix F) and asked to read it and consider whether they would like to 
participate or not.  No time restrictions were applied for this decision to be made but 
if the researcher had not had any response from the interested individual, a single 
reminder email was sent.  For volunteers, a convenient time and location was 
arranged to conduct the interview, either at the oncology centre or on the University 
site, as applicable.  For some recruited via the University, telephone interviews were 
conducted as it was more suitable for the participants in question.  For all 
participants, written consent was obtained prior to interview, either in person, via 
email or by post (copy of the Consent Form available in Appendix G).  Background 
information questionnaires were also given just prior to interview, in the same 
format as the consent but subsequent to receiving consent.  In the interest of 
consistency, one researcher conducted all interviews.  Interviews commenced with a 
reiteration of the purpose of the study and rights to withdraw or refuse to answer 
particular questions.  It was also confirmed whether audio recording was permitted 
by the participant, which it was in all cases.  The interview schedule was followed, 
then participants were thanked and debriefed (copy of the Debrief Sheet available in 
Appendix H).  Interviews were conducted between November 2015 and August 2016 
and lasted between 27 and 46 minutes. 
 4.4.5 Data analysis 
Audio recordings were transcribed verbatim; anonymised using pseudonyms and by 
omitting identifying information.  The transcripts were analysed using thematic 
  
66 
 
analysis, due to the flexibility this would afford to ground analyses in the data 
(Braun & Clarke, 2006).  The five stages of thematic analysis were used to analyse 
the data (Braun & Clarke, 2006).  Firstly, ‘data familiarisation’ began during 
interviews, continued during the process of transcribing the interviews and upon 
further review of the finished transcripts.  Next was ‘initial code generation’ and 
‘searching for themes’; transcripts were coded, and codes were collated and 
synthesised into groups that contained similar concepts, which were then used to 
develop initial ideas for themes and subthemes.  The two final stages ‘reviewing and 
refining themes’ and ‘theme definition and labelling’ were conducted by reviewing 
the initial theme suggestions in conjunction with the coded transcripts, to decide 
which quotations would be used under which theme and to check the suitability of 
the themes.  At this point it was felt that some adjustments were necessary in order 
that the themes more accurately reflected the data.  This process was repeated twice 
more, before the themes and subthemes were finalised, as presented below and 
summarised in Table 4.3.  
Table 4.3: Themes and Subthemes 
Themes Subthemes Transcending Theme: 
1. Facing a Challenge i. Being faced with one’s own mortality 
ii. Facing the uncertainty of treatment 
iii. The challenge of a changing identity 
Searching for Stability 
and Certainty 
i. Creating a new routine 
and normality 
ii. Focusing on the 
treatment process 
iii. Focusing on the 
outcome of treatment 
2. Encountering Tensions 
or Disconnects 
i. Knowing but not knowing 
ii. Differences between expectations and 
experiences 
iii. Experiencing shock or relief 
3. Investing in 
Healthcare Professionals 
and Treatment 
i. Putting trust in the healthcare professionals 
ii. Putting trust in the treatment 
iii. Viewing treatment as a necessary evil 
 
An inductive approach was taken to analysis, meaning themes were grounded 
in the data, as evidenced by the quotations selected.  This approach aimed to provide 
a broader exploration of patients’ expectations and experiences that was not 
constrained by the previous literature.  As this study took an inductive approach to 
thematic analysis, data saturation was confirmed during this analysis when it was 
established that no new themes could be developed with the addition of further 
participants (Saunders et al., 2018).  Data were also analysed for the purpose of scale 
development which is reported in the next chapter. 
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4.5 Results 
The ways in which patients described their expectations and experiences of cancer 
treatment can be described using three themes: ‘facing a challenge’, ‘encountering 
tensions or disconnects’, ‘investing in healthcare professionals and treatment’; with a 
transcending theme of ‘searching for stability and certainty’.  These themes are 
further split into subthemes, as per Table 4.3, and will now been detailed in turn and 
illustrated with exemplar quotes. 
 4.5.1 Theme 1: facing a challenge 
The prospect of having cancer and its related treatment created various challenges 
for participants, which then became evident throughout their experiences.  These are 
described by three subthemes: i) being faced with one’s own mortality; ii) facing the 
uncertainty of treatment and iii) the challenge of a changing identity. 
 4.5.1.1 Being faced with one’s own mortality 
A diagnosis of cancer results in various emotional reactions; shock and fear being 
amongst the most common.  Participants in this study were no exception to this in 
what they experienced, viewing cancer as a reminder of their mortality and 
something to be feared.  For example, for Albert, hearing the word cancer was 
‘alarming’ (Albert) and one of the first things on Jenny’s mind was death: ‘Honestly 
I think I mean I’d just turned 23 in the December like a week before I was admitted 
to hospital and I- my first thing I said to my mum was I’m too young to die’ (Jenny). 
In older participants, this perception of cancer as a death sentence seemed to 
stem from their past and recalling a time when prognoses were much worse than they 
are today, such as in Kimberly’s case: ‘I think from my upbringing where you said 
the word cancer in a whisper and it was just like it was this terrifying thing that 
hopefully you would never get’ (Kimberly).  However, interestingly younger 
participants did still often have a strong fear of cancer, but they cited different 
sources for where this originated: ‘when you hear the word cancer […] as a teenager 
I watched so many movies and books where the person always dies at the end so […] 
I was obviously freaking out about that’ (Anna). 
This was apparent though to varying degrees, as some participants felt that it 
was not as bad as it could have been: 
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It’s quite a good one to get in the sense that you know it’s not going 
to kill you, it’s probably not going to come back, really good chance 
of turning it round OK, just going to be a year out of your life when 
you can’t really do a great deal and be pretty useless but other than 
that you know the prognosis is good and it’s not too bad so there’s 
lots of things that it could have been that were far worse than what it 
was (James) 
Although James appears to have been quickly reassured by a good prognosis, there 
was mention of death, suggesting that it was something to be considered and that 
perhaps it was still of concern. 
 4.5.1.2 Facing the uncertainty of treatment 
Treatment itself also represented for most, something to be feared.  This was 
sometimes discussed in terms of the treatment experience very generally: ‘I was 
really dreading it’ (Kimberly) or about a specific treatment type ‘I was very scared of 
having chemo’ (Francis).  Often, the fear was reflected upon as being greater due to 
the treatment having been novel to the participant: ‘being fortunate as to have not 
having been ill and not having general anaesthetic before […] I was a bit fearful of 
general anaesthetic and surgery’ (Neil). 
The anticipation and experience of undertaking cancer treatment was made 
particularly difficult by the uncertainties that participants faced: ‘treatment is a very 
difficult time to live with because you’re- it’s the unknown’ (Sally). 
Generally, not feeling prepared enough made it difficult for participants to 
cope.  Beverly’s description of her experiences of recovery from surgery exemplify 
this: 
I think because of the way, because I wasn’t fully prepared then I did 
get very depressed because it was coping with—it’s coping with the 
physical side of it. Yeah it’s coping with the physical side of it and 
coping with the diagnosis, it’s everything, it’s all too much (Beverly) 
In addition, participants reported that experiencing a side effect they were not 
expecting was more difficult to cope with than experiencing those they were 
expecting: ‘The ones that you don’t prepare for almost hit you harder because 
they’ve never been mentioned, you’re not prepared for what’s happening, how your 
body’s dealing with what you’re going through’ (Jenny).   
This is a particularly challenging situation to manage, however, given that, as 
noted by some participants, there exists great difficulty in predicting which particular 
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side effects will be experienced, as there is a great deal of variability between 
patients: ‘they don’t really know what your experience is going to be like and you 
don’t know either so you end up sometimes finding out information kind of a lot 
farther down the road than you needed it but that wasn’t anybody’s fault’ 
(Kimberly); ‘you just do what you can do really you don’t know how the treatment’s 
going to affect you’ (Carol). 
At times a surprise for participants were the psychological effects of 
treatment, which were sometimes thought to have been less of a focus when 
information about treatment was communicated to them: 
She [Clinical Nurse Specialist] went through things with me and just 
generally what to expect from the treatment so in terms of side effects 
like mouth ulcers that sort of thing.  I wouldn’t say there was too 
much on like the psychological side of things that I’d say I struggled 
more with than the actual physical side effects. (Penelope) 
This, for some, also extended to the treatment process, with being unprepared for the 
procedures being psychologically quite difficult.  Anna described how she felt when 
she first experienced radiotherapy, having had no previous knowledge of what it 
would be like and already experiencing anxiety:  
you’re like laying down and you- since my area was this one 
[gesturing to her throat] I had like a mask on my face and on my 
throat and like I could barely breathe and I was like that for like 20 
minutes […] and it’s hard (Anna) 
Conversely, feeling prepared was something that often ameliorated the difficulty of 
participants’ experiences.  Having time to think about a treatment, ask questions and 
adjust to what was happening was something that was helpful.  For example, Jocelyn 
explained her feelings about the surgery she had following chemotherapy: ‘I’d had 
all the time going through chemo to plan for the surgery so […] I had time to adjust 
and ask questions and everything else so I felt quite comfortable with the surgery’ 
(Jocelyn). 
Knowing what would happen, in terms of the treatment procedure was also 
found to be helpful.  For example, James explained his chemotherapy procedures:  
[There are] four different things, they have to flush each time so they 
do it in the same order, they do it in the same way and you know 
what’s going to happen and it is nice when you go knowing what’s 
going to happen. (James) 
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 4.5.1.3 The challenge of a changing identity 
Participants also spoke about the challenges that cancer and its treatment made to 
their identity.   This was described in terms of their appearance, with hair and weight 
being a major focus of their attention when describing expected and experienced 
effects of treatment.  For some this was assumed to be as a result of vanity, for 
example, Carol: ‘I knew that I would lose my hair and for me that’s been the worst 
thing because I’m vain I suppose really’ (Carol).  Others realised this was a concern 
because of the change in identity hair loss can bring: ‘I’ve always had this beautiful, 
thick, lovely long hair and that was like a big part of my identity’ (Kimberly); ‘I had 
hair up to here, it was like really thick, really nice and healthy […] people don’t 
realise but your hair really matters in terms of like your femininity and how you feel 
and stuff like that’ (Anna).  The concept of loss of hair as a challenge to identity is 
further supported by those who had less to lose to begin with, who were less worried 
about losing their hair as it would not result in a big change in their identity, such as 
James: ‘obviously the main one most people have a concern about is losing their 
hair. I’m not really too fussed cause I had short hair before and like I’ve got it cut 
short now’ (James). 
This was also borne out in concerns about how participants would appear to 
others if they were to change in appearance, for example Penelope’s concerns about 
losing her hair and needing to wear a wig: ‘I think it suddenly then hit me that 
actually that’s what’s going to happen I’m going to have to lose my hair and like I’m 
just going to look really different and it’s really obvious that’s a wig’ (Penelope). 
This change is something that was also experienced during treatment and 
commented upon by some, such as Jenny: ‘I was 23, I had no hair and it was very 
clear that I wasn’t just some girl who’d shaved her head. I had no eyebrows, I had no 
eyelashes, I was three stone heavier. I looked like a cancer patient’ (Jenny). 
Being identifiable as a cancer patient was a particular concern for some, who 
felt that they would prefer to keep things private but would not be able to do so if 
they had, for example, lost a lot of hair, or weight, and developed the stereotypical 
look of a cancer patient.  These concerns were described in terms of expectations, in 
that participants recalled being concerned about this prior to treatment; how they 
were going to look and if treatment would change that: 
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We’ve all seen people in supermarket with the head scarf on and you 
make assumptions about that – you feel sorry for them, you pity them, 
[…] you peg them instantly as the person suffering from cancer, and 
you make all kinds of assumptions based on that and […] I did not 
want this to be a public process. I didn’t want people to know unless I 
wanted them to know and to me if I was walking round bald there’s 
no way of keeping it private. So that was really hard. […] I just didn’t 
really want to deal with other people’s assumptions about what I was 
going through or not going through (Kimberly) 
Participants also described how treatment had changed them as a person.  Some 
reported having expected this to occur, such as Kimberly: ‘I knew it was going to be 
really transformative in many ways but I didn’t know how and so I guess I just, I 
figured I was going to end up a different person really at the end of it all’ 
(Kimberly); and Jenny ‘I knew I wasn’t going to be me as I was pre being ill. I knew 
it would change me physically and I knew I had to change my attitude’ (Jenny); 
although it is not clear whether this is an accurate recollection due to the reflective 
nature of the interviews.  There was some desire expressed to avoid this ‘I wanted to 
try and keep me as close to me as I could, even though I knew stuff was going to 
change’ (Jenny) but others saw it as a positive opportunity. 
Together with the physical differences anticipated and experienced, this 
demonstrates what a challenge to identity cancer and its treatment have been for 
these participants. 
 4.5.1.4 Summary 
Cancer and its treatment was a time of challenge.  The foci of participants’ accounts 
of the challenges that confronted them were being faced with their own mortality, 
facing the uncertainty of treatment, and the challenge of a changing identity. 
The cancer diagnosis evokes shock, fear and serves as a reminder of 
mortality; something that has widely been acknowledged in the literature (e.g. 
Abdollahzadeh, Moudi, & Khanjani, 2017; Landmark & Wahl, 2002).  The current 
research highlighted different sources of participants’ perceptions of cancer, which 
appeared to differ according to age.  Older participants were more likely to draw on 
experiential factors such as having family history of cancer and poor outcomes.  
Younger participants, however, held quite negative views of cancer due to more 
fictional sources, like films and books, for example, where storylines involved 
negative outcomes for cancer patients, particularly younger cancer patients. 
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The prospect of treatment compounded this as there were many unknown and 
uncertain elements to this, which also often left participants feeling unprepared.  
Feeling unprepared for the effects of treatment made it more difficult to cope, 
whereas those aspects they felt more prepared for were easier for them to manage.  
This aligns with previous research with cancer patients, which has also found that the 
time of treatment presents many uncertainties (Shaha, Cox, Talman, & Kelly, 2008).  
The preparation for surgery literature also suggests that feeling prepared can 
ameliorate some of the difficulties patients have (Janis, 1958).  The current study 
complements this by adding evidence that preparedness is useful, not only with 
surgical treatment but across other modalities also. 
Participants were also faced with the challenge of a changing identity, both in 
terms of physical appearance and in respect of their personal outlook.  Appearance-
wise there was a lot of focus on hair and weight, with these not frequently being 
viewed in terms of vanity but more often in terms of being identifiable as a cancer 
patient.  There were concerns for participants about being perceived as a cancer 
patient and the repercussions this may have, such as attracting unwanted attention 
and pity, not being able to keep their diagnosis private.  Concerns about a changing 
physical appearance and the associated impact on patients’ social identity is 
something that is echoed elsewhere in the literature (Harcourt & Frith, 2008).  In 
addition, personal development and post-traumatic growth are much researched and 
there is a large amount of evidence that this occurs with cancer patients (Connerty & 
Knott, 2013).  The current findings therefore add further support to the existing 
findings in this area. 
 4.5.2 Theme 2: encountering tensions or disconnects 
From this initial state of facing the challenges and uncertainties that a cancer 
diagnosis and anticipating the start of treatment had generated, participants reflected 
on their experiences of treatment and how this presented a series of tensions or 
disconnects when compared to what they had been expecting.  This is detailed in 
terms of the following sub themes: i) knowing but not knowing; ii) differences 
between expectations and experiences; iii) experiencing shock or relief. 
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 4.5.2.1 Knowing but not knowing 
At times, it was apparent that although patients thought they were fairly well-
informed about what their cancer treatment would entail, they realised when 
treatment began that they had not really known as much as they had first thought: ‘I 
wasn’t imagining at all what it could be like’ (Anna). 
Participants sometimes reflected on having made practical arrangements but 
realised that they had not necessarily thought more deeply about what it would be 
like as an experience.  Jocelyn exemplified this standpoint: 
the practical sides of how to deal with it I’d probably thought about, I 
probably had all the childcare and everything in place because of that 
but I don’t think I’d really thought about reality of what I was going 
to feel (Jocelyn) 
Some participants expressed that it was difficult to really imagine what the 
experience would be like, such as Penelope: ‘in terms of physical side effects, […] I 
couldn’t really picture, I dunno, it’s hard to think in your head ‘oh yeah I’m going to 
feel like this, like this amount of time’’ (Penelope).  Sometimes this was thought to 
be as a result of how quickly participants had gone from diagnosis to treatment: ‘it 
all happened in a short period of time. I don’t think I had the time to really process 
what was going on’ (Anna). 
Previous experience of cancer treatment appeared to assist this, with 
participants knowing more fully what to expect, although not if participants had not 
experienced the type of treatment they received this time: ‘[It was good] knowing 
some of what could happen from the first time but I was still very naïve about the 
chemo and all that aspects of it because I hadn’t experienced that at all’ (Jocelyn).  
Having some more in-depth biological or medical knowledge, without previous 
treatment experience, did also seem to make for more realistic expectations: 
I’ve done biology myself and I know kind of a bit about how it works 
and things like that so I knew a fair bit about the background behind it 
and you know the reasons why, how the treatment works, how it 
affects you, you know everyone’s different but I kind of had a decent 
idea about what was going to happen (James) 
One participant, Jenny, who had never previously had treatment, did express a view 
that perhaps being a little more naïve may be an advantage: ‘I think I’d deal with it a 
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lot worse if I had to do it again because […] I know what to expect, I know how 
tough it’s going to be’ (Jenny). 
This all suggests that there are different levels of knowing; patients may have 
been well-informed and been familiar with what they believed would happen but not 
actually known what that would be like in reality.  It was only upon reflection, when 
participants had experienced their treatment, that they realised they had not known as 
much as they had thought. 
 4.5.2.2 Differences between expectations and experiences 
There were therefore differences between the expectations participants held before 
treatment and the experiences they had during treatment, and these were recalled in 
various different ways.  For some this was generally positive, such as Elizabeth: ‘I 
felt I coped much better with the treatment than I had expected to.’ (Elizabeth).  
Specific side effects, side as pain and vomiting, were cited as not being as bad as 
anticipated: ‘I woke up and I just had some pain but not much pain. I didn’t have that 
terrible pain they talked about you know where I thought I was having a heart attack, 
none of that’ (Julie); ‘Having had [a negative] previous experience being put to sleep 
was fine because it was much better waking up. I was expecting I would be sick I 
was in modest degree but much less [than] that first time.’ (Albert).  In addition, it 
was sometimes expressed that it was easier to cope with the effects of treatment than 
had been expected: ‘the actual symptoms were unpleasant but much more 
manageable than I thought, on a day to day basis and I never became an invalid’ 
(Kimberly).  The period in which treatment would have an effect was occasionally 
referred to as being much shorter than expected, for example with Neil’s recovery 
from surgery: ‘Things went better than planned because I was sort of discharged 
very quickly […] and things like the wounds and stuff healed up very quickly’ 
(Neil). 
For others, experiences were worse than anticipated, on the whole, such as in 
Anna’s case: ‘since I thought that my cancer was so simple I didn’t expect the 
treatments to be that rough you know so I was really not expecting it’ (Anna).  At 
times, things occurred that were completely unexpected, such as a particular side 
effect.  Anna, again, expressed this in relation to her radiotherapy treatment:  
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I didn’t expect it to have any physical side effects actually because I 
didn’t understand how rays could actually affect me […] but I did 
have a lot of side effects like […] a lot of panic attacks, heart burn 
and very, very, very hard for me to swallow really hard to eat it was 
like impossible to eat or drink something (Anna) 
Some found that treatment affected them psychologically much more than they had 
expected.  Penelope described how she had not anticipated it to affect her 
psychologically: 
Didn’t expect the psychological effect of it all either. Like the anxiety 
attacks, that sort of thing. Which I know some people don’t 
necessarily have that much of, they have more issues like physical 
side of things, […] but for me it was more psychological – definitely 
wasn’t expecting that (Penelope) 
Some just generally found it much harder to cope than they had expected, as 
exemplified by Jenny when she spoke about her experiences of chemotherapy: ‘you 
had a bad week after chemo and then by the time you’re feeling better it’s chemo 
week again. And just that constant cycle, that kind of wore you down, which I 
definitely wasn’t prepared for’ (Jenny). 
The impact on daily life was much greater than expected for some 
participants, such as Beverly: ‘I didn’t feel very prepared for the actual surgery really 
and how completely incapacitated I would be. It was just unbelievable’ (Beverly).  
For some, this concern focussed on a particular aspect of daily life, such as in 
David’s case, where the impact on work was central: ‘I thought I would have the 
treatment and be back to work within about 2 weeks but it didn’t work quite like 
that’ (David). 
 4.5.2.3 Experiencing shock or relief 
For those who had more positive expectations, or perhaps who were a little detached 
from the reality of the situation, treatment was more of a shock, with some 
associated adverse consequences.  An example of this can be seen in Penelope’s 
explanation of why she believed she had experienced panic attacks:   
I suppose my expectations were just so flawed weren’t they because I 
didn’t really pick up on, I didn’t really think I’d have […] any sort of 
anxiety from it and stuff like that, like hadn’t really thought through 
that, I dunno that things could go wrong on the treatment day. […] 
Some things came as a bit of a surprise and you had to deal with it as 
it comes […] I just hadn’t really taken stuff in and that’s why my 
expectations were not correct.  So I guess that’s why they influenced 
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my experience of treatment because they were just so different to 
actually what actually did happen (Penelope) 
Conversely, for those who reflected on having had particularly negative pre-
treatment expectations of what they were going to experience during treatment, some 
relief was experienced when treatment was not as bad as they had anticipated.  For 
example, Francis: ‘I was extremely nervous […but] it wasn’t as bad as what I 
thought it was going to be, which is good.’ 
There were also some participants for whom the experience was fairly well-
matched to their expectations, who did not appear to experience either shock or 
relief, but these participants were those who had some more in-depth knowledge of 
cancer, including biological knowledge and oncology nursing experience.   
This shows the significance of whether participants really know what to 
expect or not, linking back to the ‘knowing but not knowing’ sub-theme.  If patients 
do not realistically know what to expect then they will have created their own ideas 
about what the experience will be like, which will usually transpire to be either more 
positive or more negative than the reality. 
 4.5.2.4 Summary 
Participants reflected upon their experiences in relation to their expectations and in 
so doing showed that they had encountered various tensions or disconnects.  Most 
found that even when they had thought they had known what to expect from 
treatment, when they experienced it, it was not as they had imagined.  There were 
often large differences between participants’ pre-treatment expectations and their 
experiences, as reflected upon, either for the better or for the worse.  Further, the 
findings can be viewed to tentatively suggest three groups of patients.  The first, 
those with initially positive treatment experience expectations, or perhaps for whom 
the reality and severity of their situation had not been realised, who were then 
shocked at the harsh reality of treatment.  The second, those with initially negative 
treatment experience expectations, who thought the impact on daily life would be 
severe and they would suffer significantly from treatment side effects, who were 
then relieved when the treatment experience was not as bad as anticipated.  The third 
and final group had fairly well-matched expectations and experiences.  The third 
group was made up of two participants, both of whom had some additional oncology 
knowledge, with one having worked as a nurse in an oncology setting and the other 
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having studied the biology of cancer and its treatment.  These findings are 
particularly interesting as they pose a potential challenge to the conventional wisdom 
of response expectancy theory and research, which suggests that expectations are 
generally self-fulfilling, in that expecting a particular outcome is predictive of its 
more frequent occurrence (Kirsch, 1985; Chvetzoff & Tannock, 2003; Sohl, et al., 
2009).  By providing an in-depth exploration of patients’ expectations and 
experiences of their cancer treatment, the current study has identified an interesting 
avenue for further research into the relationship between expectations and 
experiences.  Encompassing the concepts from this research will allow for a richer 
quantitative exploration in this area than has previously been conducted. 
 4.5.3 Theme 3: investing in healthcare professionals and treatment 
From the early stages of their experiences, strategies were used by participants to 
help them to cope with the challenges that cancer and its treatment presented.  Being 
faced with their own mortality and the uncertainty of treatment, in particular, led 
participants to invest in the healthcare professionals and the treatment, in order to 
assist them.  The details of this are described in terms of: i) putting trust in the 
healthcare professionals; ii) putting trust in the treatment; iii) viewing treatment as a 
necessary evil. 
 4.5.3.1 Putting trust in the healthcare professionals 
It was evident throughout participants’ narratives that they put a lot of trust in their 
healthcare professionals.  They viewed them as experts with the knowledge and 
judgement to make the right decisions and do the best they could for the patient: ‘my 
only concern is that he knows what he’s talking about and that’s that’ (Elizabeth); 
‘they’re gonna do their best no matter what’ (David).  This instilled a confidence in 
the outcomes and efficacy of treatment: ‘if you’re telling me that this is going to be 
fine why would I entertain any dramatic different thoughts’ (Rebecca); ‘Of course I 
didn’t technically know the medical details all I know is that they were doing their 
best for me and I felt in every case reassured’ (Albert); ‘the consultant he’s he was 
brilliant in making me feel really confident that the treatment was going to work’ 
(Penelope); ‘they all seemed just terribly confident that everything would be fine and 
I decided to believe them’ (Kimberly). 
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In addition, there was trust and confidence in the treatment plan that was 
decided upon: ‘they were recommending that it was probably better to go down that 
route so I realised that it would be important to do it’ (Beverly); ‘I was told and I’ve 
got no reason to doubt it that the surgeon’s opinion was that that was what was 
necessary, he wouldn’t do that unless that was what was needed’ (Carol); ‘I just took 
on board what the surgeon thought was necessary to do and went along with it, 
without question’ (Carol); ‘I trusted them and I felt like this was probably the right 
approach’ (Jocelyn); ‘I just accepted everything. I was like OK I better listen to them 
and I better do what they say’ (Jocelyn); ‘To be honest I don’t think I knew what to 
expect they just told me I had to have this done. And I know that sounds stupid but 
you’re very vulnerable I think’ (Sally); ‘I was quite happy to pretty much put myself 
in the hands of the professionals’ (Kimberly); ‘I just accepted pretty much what they 
told me, I did what they told me and—that might have made me more relaxed in a 
way’ (Kimberly). 
Trust in healthcare professionals also helped to ameliorate some of the 
concerns participants had about the treatment experience, such as side effects:  
I was yeah very scared of chemo and of course you think of chemo 
you think of throwing up, not feeling very well […] I had to see the 
chemo nurse and she gave me a DVD to watch and she talked me 
through it all as well and so there was obviously things you can take 
if you feel sick and these things and did relax me a bit (Francis) 
This was further evident when participants spoke of shared decision making, which 
was apparent with most participants, they described such involvement as being quite 
difficult as they were unsure what to do, often preferring to be advised on the best 
course of action and trying to refer the decision back to the recommendations of the 
healthcare professionals.  Beverly exemplified these difficult feelings: ‘It was quite 
hard you know I just want to be told this is the best course of action and you know 
you don’t get told that.’ (Beverly).  Further, Elizabeth’s explanation of her treatment 
decision shows one way in which more guidance was elicited from the healthcare 
professional: 
He said to me what did I want to do, which I think is a very, very 
difficult question to ask. Because I had an option to have no 
chemotherapy at all […] and I said well I don’t know what, what 
you’re suggesting, I think I asked him if it was somebody in his 
family what would he do (Elizabeth) 
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 4.5.3.2 Putting trust in the treatment 
Emerging from this trust in the healthcare professionals, there was a trust in the 
treatment itself.  Most participants were extremely positive about the expected 
efficacy of their treatment.  Participants showed a high degree of confidence in 
treatment, they believed it would work for them, including David: ‘It was going to 
be successful, there was no fear of a doubt that it was going to work […] I had every 
confidence I was going to walk out of there fine’ (David).  Kimberly also had high 
expectations for treatment efficacy: 
I never really thought I’d die. Not at all. I don’t know why but yeah I 
just decided that I wasn’t going to like seek out negative information 
when it all just seemed to be really positive. […] I just stayed really 
positive but not in a denial sense you know like sometimes I feel like 
people say “well you know positive thinking” and no I just didn’t 
think- I never really seriously entertained that option (Kimberly) 
Although some, such as Beverly, did express reservations:  
Because they were so positive about everything it did give me, did 
make me feel positive that OK it’s not going to be a real problem. But 
it’s always there in the back of your mind still. It doesn’t matter how 
much someone says to you it’s fine you know, it’s still there in the 
back of your mind well yeah but what if? (Beverly) 
Given the good prognoses apparent in many participants’ cancers, it is less clear 
whether this positive efficacy expectation would be seen in those with poorer 
prognoses.  One participant, James, expressed the view that he would have been 
hopeful even with a poorer prognosis, just that having a better prognosis took a 
certain amount of pressure off: ‘I think personally I’d always have liked to think that 
I’d get rid of it regardless of how bad it was but having a good prognosis means you 
don’t think about that, you think well you’re going to be better regardless’ (James). 
By putting their trust in treatment, along with trusting their healthcare 
professionals, participants created a sense of hope. 
 4.5.3.3 Viewing treatment as a necessary evil 
There were often very positive efficacy expectations, which were often accompanied 
by very negative treatment experience expectations.  Many had thought treatment 
would be extremely difficult to endure and have a huge impact on their life.  Despite 
how negative participants often expected the experience to be, there was little 
question of whether to have treatment or not: ‘I was very accepting that I had to go 
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through the process and that it was going to be really tough[...]but I didn’t ever feel 
that it was the wrong thing to be doing’ (Jocelyn). 
Treatment was viewed as a necessary evil; participants expected it to be a 
difficult thing to endure but they needed to experience it in order to survive and 
viewed this as ‘a good trade off’ (Julie):  
I didn’t mind the fact that you know, everything had to change for 
those months because hopefully it was going to help me to live 
(Francis) 
I knew that I just had to kind of stiff upper lip and get on with it 
because like it was six months and it was going to be pretty hard so 
the quicker I just got my head round and the fact that I thought there’s 
nothing I can do it’s this or dying, the sooner I was like right I can do 
it and got on with it (Jenny).  
The idea that treatment was necessary was something that seemed to be reinforced 
by the healthcare professionals when they were communicating treatment 
information and the trust placed in both healthcare professionals and the treatment 
itself was also a major contributor to this. 
 4.5.3.4 Summary 
The challenge of treatment and the fear that cancer evoked, meant participants here 
placed a lot of trust in their healthcare professionals.  A previous systematic review 
of the literature found trust levels to be similarly high between cancer patients and 
their healthcare professionals, partially consonant with the reasons found here, 
although trust has not been a major research focus (Hillen, de Haes, & Smets, 2011).  
The current findings add weight to the argument that trust should be more of a focus 
in research as it clearly helped participants to cope and ameliorated some of their 
fears.  Trust has also been found to aid communication and decision making, and 
treatment adherence (Hillen et al., 2011).  This is interesting in light of the current 
findings as participants here placed trust in their healthcare professionals and often 
wanted to be advised on the best course of action, delegating decision making to the 
professionals, rather than being too much more involved in the decision process.  
Participants also placed a lot of trust in the treatment itself, perhaps as a result of 
their trust in the healthcare professionals.  This could better explain why previous 
research has found trust in the healthcare professionals to be linked to cancer 
treatment adherence. 
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In this way, participants were seen to be investing in healthcare professionals 
and treatment.  By placing their trust in the healthcare professionals and the 
treatment being suggested, treatment gave them hope for the future and for positive 
outcomes. 
Treatment was often expected to involve very negative experiences but there 
was rarely any question of whether or not participants would have the treatment.  
Participants seemed to view treatment as a necessary evil.  In terms of a cost-benefit 
analysis, the costs of difficult side effects, and the impact treatment might have on 
daily life, were outweighed by the main benefit, which was the chance of survival. 
 4.5.4 Summary of themes 
Cancer and its treatment represents a time of significant challenge for patients, in 
terms of threat to life expectancy but also factors such as the impact it will have on 
their identity and the uncertainties that facing treatment creates.  It is clear that 
patients place their trust in the healthcare professionals and their treatment, this 
creates a sense of hope for positive outcomes and means that treatment is viewed as 
a necessary evil.  The expectations patients had before beginning treatment were 
often very different to their treatment experiences, either positively or negatively. 
Further those who had more positive expectations often felt shock when treatment 
was worse than expected, whereas those who held more negative pre-treatment 
expectations appeared to experience some relief when treatment was not as bad as 
they had expected. 
 4.5.5 Transcending theme: searching for stability and certainty 
Transcending these themes was a search for stability and certainty which can be seen 
to permeate all levels of the transcripts.  Patients placing their trust in the healthcare 
professionals and the treatment, creating this sense of hope for positive outcomes 
and seeing treatment as a necessary evil, could be viewed as creating some stability 
and certainty for themselves at this uncertain time.  Further support for this can be 
seen in various other strategies employed by participants to search for this stability 
and certainty.  These include attempts to create a new routine and gain some 
normality.  There were also apparent in participants’ expectations and experiences, 
differing focuses of their attention, either on the treatment process or on the 
outcome.  These are now described in more detail. 
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 4.5.5.1 Creating a new routine and normality 
Facing the challenge and uncertainty of cancer treatment threatened participants’ 
normal life, their routines and their future plans.  There were desires and efforts 
described by some to try to minimise the impact cancer and its treatment had, such as 
Penelope and Rebecca: ‘there was talks of me—whether I should go home or not and 
have treatment there in [town] but I felt like I still wanted to carry on with, you 
know, life here’ (Penelope); ‘It just didn’t dominate my life […]. It was something 
that happens and I had to do all the right things I had to respond appropriately, have 
the treatment’ (Rebecca). 
Try as participants might to keep things as normal as possible, cancer and its 
treatment did disrupt normal life; in part exacerbated by encountering tensions or 
disconnects between expectations and experiences.  However, a new routine 
emerged, as the treatment experience became more familiar.  The treatment 
procedures became more routine for most: ‘it seemed to get easier. […] I just got in 
there, walked down, walked in, got it done, and walked out again (David)’; ‘you do 
just kind of get into a rhythm with it’ (Kimberly).  Even when being under such 
close medical scrutiny was very unfamiliar to Francis, she exemplified how this new 
routine emerged: 
you get used to going to hospital because you’re not used to going to 
hospital.  I mean this is my second home now you know. So you get 
used to people prodding and pulling you about and I just found it, you 
start to relax the more you get used to it. It’s amazing how you can 
adjust and how you just you know even when you’re in hospital you 
can just- you just sort of adjust to that’s your daily routine (Francis) 
At times it was evident that participants had incorporated treatment into their 
everyday lives, as though it was just another thing they had to do. For example, 
Anna: ‘I talked to my friends and said I can’t do this I have chemo tomorrow you 
know like it was like normal.  It was just like it was part of my routine’ (Anna).  This 
was also described by some in terms of the side effects experienced; how these could 
be predicted and became part of the routine.  For example, Elizabeth spoke about her 
chemotherapy: 
it’s very much a routine and a cycle and […] I knew that directly after 
the chemotherapy I’d be fine it takes about two or three days to kick 
in with the side effects and then I knew in a couple of weeks’ time I’d 
be feeling stronger before the next cycle (Elizabeth) 
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However, there was also a desire to get back to normal as soon as possible following 
treatment, which was seen with a number of participants, such as Francis: ‘I was you 
know focusing on it working and hopefully like that my life would get back to 
normal once it was all finished’ (Francis). 
 4.5.5.2 Focusing on the treatment process 
The focus for participants was, at times, on the treatment process itself and not the 
outcome or what would happen when treatment finished.  This often took the form of 
focusing on particular aspects of the impact of treatment, such as how it would affect 
daily life, for example time off work: ‘I expected to be in hospital for 3 to 5 days, I 
expected to be off work for about 4 to 6 weeks’ (Neil) or just their general lifestyle 
or plans that had been made: ‘my main concern was that they could say what they 
wanted but I had to leave the country because I was going on safari so my main 
concerns weren’t really about the treatment it was about my lifestyle. My concerns 
about- it was my lifestyle really, how would it affect my lifestyle because I wanted to 
I had certain things I wanted to do and I didn’t want to be sort of particularly 
impacted or slowed down by the treatment.’ (Rebecca) 
It was common to compartmentalise and just concentrate on the next thing 
that was going to happen to them, another way of coping with the challenge of 
cancer treatment and its uncertainty: ‘I was just going to have to react as each thing 
happened and deal with it.’ (Jocelyn) 
Sometimes this appeared to be conscious and effortful, such as in Julie’s 
case: ‘immediately before I had the surgery I just decided to stay in the moment and 
focus on that and not worry about what would and wouldn’t happen and I just kept 
doing mindfulness stuff and just you know making myself do that really’ (Julie).  At 
other times, this appeared to be something that was not realised until after treatment, 
when the reality and enormity of what the participant had been through caught up 
with them, as Penelope found: ‘you’ve gone through the treatment and that phase 
afterwards, that’s when it all sort of hits you and then it’s like oh actually this is what 
you’ve just gone through but during time you kind of go[…]from one treatment to 
the next[…]and then afterwards it’s like oh actually that’s what’s happened’ 
(Penelope).  Others, such as David, described this more in the sense that it was a 
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personality trait to be more relaxed about things: ‘I’m one of those easy-going type 
of people and I just take things as they happen that’s all you can do.’ 
As part of their investment in healthcare professionals, and in particular 
treatment, any concerns or uncertainty about outcomes were often suppressed until 
after treatment was finished, with treatment being the focus until that point:  
the thing that was foremost in my mind was wanting the surgery to be 
done quickly, wanting to wake up knowing that it had been done by 
keyhole surgery. And then of course having got through that then of 
course wanting to know the results of the biopsy (Neil) 
 4.5.5.3 Focusing on the outcomes of treatment 
To cope with facing the challenge of cancer treatment, participants would also 
sometimes focus on the outcome of the treatment, rather than think about the 
treatment process. 
The idea of wanting to ‘get through it’ or ‘get it done’ was common to many 
participants (e.g. Carol, Francis, James, Jocelyn).  This was at times, but not always, 
connected with a desire to be able to return to life as usual, such as is demonstrated 
here by Sally: ‘I was lucky I had a focus as well to get myself well because I wanted 
to get this qualification under my belt you know. And I just wanted a normal life.  
You do get to a stage when you think I just want a normal life back’.  It was also 
evident with Francis: ‘Well I was strangely pleased to be having it. And I didn’t 
mind I was you know focusing on it working and hopefully like that my life would 
get back to normal once it was all finished’. 
Some participants did not wish to receive too much information about 
treatment prior to beginning it, in order not to overload themselves.  Instead, wishing 
to just ‘keep [their] head down and have it be over with’ (Kimberly) or they ‘just 
wanted it dealt with and didn’t really want to know [more about the treatment]’ 
(Neil).  Often what participants were very focused on knowing was how effective 
their treatment would be, as in Jenny’s case: ‘I didn’t really want to know about it, 
all I wanted to know was am I going to be OK’.  This shows a strong need for 
investment in the treatment. 
These different foci were not mutually exclusive in individual participants.  
Throughout their experiences, participants shifted their focus from the process of 
treatment itself, concentrating on one step at a time, and the outcome, getting 
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through the challenge of treatment and being well again.  If the process became 
difficult, then focusing on the outcome made it more bearable by reminding them 
that it is worth the suffering because treatment is going to help them and that there 
will be an end to it.  Feelings of uncertainty or fear about the ultimate outcome or 
being overwhelmed by how far away the end was and how much there was to 
experience before then, led participants to concentrate more on the here and now of 
treatment, the part they were more certain about.  This shifting of focus suggests that 
there was a need to search for certainty at what was a very uncertain time and that 
patients could draw their attention to certain aspects of what they were experiencing 
in order to manage that and gain a sense of stability. 
 4.5.5.4 Summary 
The findings here indicate that participants were searching for stability and certainty 
as they travelled down their pathway, to cope with the challenge they faced.  There 
were two key ways in which they appeared to do so.  The first was to create a new 
routine and a new normal during their treatment and incorporate treatment into their 
daily lives, adjusting to their new circumstances.   
Baker et al. (2016) suggested that cancer patients simultaneously try to hold 
on to their old routines and create a new normal, in order that they can grow and 
change as a result of their cancer experience.  This could be the case here also, but 
the current research adds to this by suggesting that routine and normality are utilised 
to maintain this sense of stability and certainty during treatment.  This not only 
facilitates the transformation that cancer and its treatment can bring about but also 
assists adjustment to the experience of treatment and makes this challenging time 
more manageable.  This is particularly pertinent as patients are increasingly being 
treated for cancer over longer periods of time and treatment is becoming more about 
longer-term management of the cancer than eliminating it entirely.  Increasing 
numbers of patients will never reach the survivorship phase in the classic sense of its 
meaning but their condition will be managed.  Therefore, showing that patients have 
this ability to adjust and create a new normal may be a useful finding when 
considering this form of cancer treatment management. 
The second way participants searched for stability and certainty was by 
altering their focus between the treatment process and the outcome of treatment.  At 
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times participants reflected on how they focused on the treatment, taking one step at 
a time, and did not worry about the outcome until later.  At other times, they told of 
how they focused on the outcome, being well and getting back to normal.  These foci 
were not always mutually exclusive to participants and when they spoke of their 
experiences it appeared that most participants concentrated on one or the other at 
different points during their treatment pathway.  It seemed that this shifting of focus 
occurred in order that participants could focus on what was most stable or certain.  
When the outcome seemed distant and out of reach, participants could concentrate 
on taking one step at a time to make things more manageable.  When treatment was 
particularly difficult, they could visualise the end point and remember what they 
were putting themselves through it for.  In this way, they were able to shift their 
focus to the element of their future that appeared most certain and stable. 
4.6 Discussion 
Patients described their expectations and subsequent experiences of cancer treatment 
in relation to three themes: facing a challenge, encountering tensions or disconnects, 
investing in healthcare professionals and treatment.  Transcending these themes was 
a search for stability and certainty. 
The search for stability and certainty was used to combat the challenge and 
uncertainty that facing cancer treatment presented.  In particular, investing in 
healthcare professionals and treatment, putting trust in them, and seeing treatment as 
a necessary evil, created a sense of positivity about treatment outcomes and life 
expectancy that made patients feel more certain of their future. 
In terms of the previous literature regarding treatment efficacy expectations, 
at the heart of the placebo effect is an expectation that the treatment in question will 
be effective (Kirsch, 1985).  Response expectancies for side effects also follow a 
similar pattern, in that expecting a particular side effect has been shown to mean that 
this side effect is more likely to occur (Sohl et al., 2009).  This would suggest that in 
terms of physical side effects and efficacy expectations, a more positive outlook 
could be advantageous.  However, the evidence to date suggests that there are little 
or no placebo effects associated with cancer treatment and therefore, to the extent 
they can be studied, the benefits there are seemingly limited (Chvetzoff & Tannock, 
2003). 
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From a psychological perspective, positive expectations regarding treatment 
efficacy have been found to be protective of quality of life in the short-term but these 
benefits may well be short-lived (Koller et al., 2000).  Based on previous research, it 
is therefore questionable from both a physiological and psychological perspective, 
whether a positive expectation of treatment efficacy is advantageous overall.  The 
findings in the current study that there was a lot of trust placed in healthcare 
professionals and treatment, and that treatment was viewed as a necessary evil, 
suggest that patients strive for positive expectations about treatment efficacy.  
Holding such expectations also allowed participants to focus on the outcome when 
treatment was difficult, shifting their focus in the search for certainty and stability, 
helping them to cope.  This adds weight to the previous research, which suggests that 
positive treatment efficacy expectations may lead to more positive treatment 
experiences (Koller et al., 2000).  However, how this relationship progresses over 
time still warrants further investigation. 
The current research is also interesting when taken together with another 
aspect of Koller et al.’s (2000) study, which suggests that patients can shift their 
focus and appear to almost be choosing what they want to believe but remain aware 
of reality on some level.  This was found in relation to patients’ expectations 
regarding treatment intent, where Koller et al. (2000) further discovered that 
patients’ expectations become more realistic when they are faced with undeniable 
indicators that the intent was palliative, such as severe symptoms.  Once this 
occurred, the patient’s focus would shift towards symptoms and their management, 
rather than the more unrealistic expectation of a cure (Koller et al., 2000).  This shift 
seems to be viewed as a forced acceptance of reality but it could also be a way of 
focusing on managing the process in the here and now, rather than focusing on the 
life-limiting outcome.  Along with the current findings, this adds support to the idea 
that patients with cancer shift their focus to manage their situation, adjust and 
maintain a sense of stability and certainty. 
Although holding more positive expectations about treatment efficacy may 
be advantageous to treatment experiences, the same may not be the case for side 
effect expectancies.  When participants were expecting treatment side effects to be 
severe, and therefore held very negative expectations in this regard, they experienced 
a sense of relief when side effects were not as bad as they had expected and often 
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described their treatment experience in more favourable terms than others did.  
Conversely, those who had more positive pre-treatment expectations, experienced 
shock at the severity of side effects.  This relationship is interesting because it adds a 
complexity to the previous expectancies research, which simply shows that 
expecting a particular outcome makes it more likely to occur (Kirsch, 1985; Sohl et 
al., 2009).  It may be the case, therefore, that although expecting a particular side 
effect has this physiological effect, that side effect is easier to cope with because it 
was expected. Given that response expectancies do not account for all side effects 
that occur, it could tentatively be suggested that a more negative or realistic 
expectation in this regard is preferential to having an unrealistically positive 
expectation, more in line with a preparation for treatment perspective and expectancy 
violations theory (Burgoon & Hale, 1988; Janis, 1958). 
Expectations regarding the impact on daily life followed the same pattern as 
side effect expectations.  When participants expected the impact on daily life to be 
great, they could plan and prepare, both physically and psychologically, for this 
eventuality.  This likewise led to feelings of relief when the impact was not as great 
as expected.  Those who felt that many aspects of their life were unexpectedly 
impacted, were less well prepared for this and found it more difficult to manage.  
The previous literature has neglected expectations about daily life but the current 
research shows that it is an area of expectations that warrants inclusion.  There are 
parallels with side effects but also some distinct differences and their inclusion will 
add breadth and depth to the investigation of patients’ expectations of cancer 
treatment. 
4.6.1 Limitations 
Due to the study’s aim to qualitatively explore expectations and how these 
manifested in subsequent experiences, participants were reflecting on past 
expectations and experiences.  Although the retrospective nature of the interviews 
was useful for exploring the overall picture, it has the limitation that recall may have 
been affected by subsequent experiences and outcomes.  Participants in this study 
mostly had good prognoses and had experienced positive outcomes from treatment.  
This may have led them to reflect more positively about their expectations and 
experiences.  There were, however, differences in how positively or negatively 
participants recalled their expectations and experiences, which did not appear to be 
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related to outcomes but this does not negate the need for further study with 
prospective methods.  That stated, this exploratory study has uncovered a potentially 
divergent relationship between expectations and experiences, compared to previous 
research, which warrants further investigation.  It also provides support for the idea 
that there is a need to measure pre-treatment expectations more broadly and to 
explore the relationship between these and experiences. 
4.7 Conclusion 
The current study explored cancer patients’ expectations of their treatment and how 
these manifested in their experiences.  Findings suggest a broader range of 
expectations are the focus for patients than have previously been examined and that 
there is potentially a more complex relationship between cancer patients’ 
expectations and experiences than has previously been studied.  Expectations about 
psychological side effects and the impact on daily life are pertinent, in addition to 
physical side effects and treatment efficacy expectations; and these expectations do 
not appear to necessarily be self-fulfilling, as the response expectancies literature 
would suggestion.  This warrants further attention using quantitative measures.  Data 
from the current study have been analysed separately to inform the design of a new 
measure of cancer patients’ expectations of treatment, reported in the next chapter, 
which will aid the investigation of this relationship, utilising the broader range of 
expectations uncovered here. 
4.8 Towards Understanding the Role of Expectations of Cancer Treatment and 
Their Impact on Outcomes 
Previous research has highlighted a role for patients’ expectations in their 
experiences of cancer treatment but the focus has been narrow.  This chapter has 
explored patients’ broader expectations of cancer treatment and their relation to 
treatment experiences.  It has highlighted a wider range of expectations than were the 
focus of previous research and suggests some support for an expectancy violations 
perspective in that participants whose expectations were negatively violated 
experienced shock when treatment was worse than expected, and those whose 
expectations were positively violated experienced relief when treatment was better 
than expected.  This relationship will be quantitatively examined in the following 
chapters, beginning with the development and validation of new measures of cancer 
treatment expectations and experiences in the next chapter.  
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Chapter Five 
Study 2. The Development and Validation of Two New 
Measures: The Expectations of Cancer Treatment 
Questionnaire and the Experiences of Cancer Treatment 
Questionnaire 
 
5.1 Overview 
The literature reviewed in Chapter 3 highlighted the importance of patients’ 
expectations, due to their potential to influence patients’ experiences of cancer 
treatment.  It identified that there are three theories integral to this area; response 
expectancy theory, expectancy violation theory, and preparation for treatment; with 
conflicting views as to whether patients’ expectations should be positive or more 
realistic and it is not clear which is best.  The tools for measuring patients’ 
expectations were also reviewed, with a conclusion that there are no suitable 
measures of expectations of cancer treatment that include a broad range of 
expectations and can be used to prospectively explore the relationship between 
expectations and experiences.  The previous chapter, Chapter 4, provided some 
support for an expectancy violations theory perspective by suggesting that there were 
consequences when patients’ experiences did not match their expectations.  It also 
highlighted a broader range of expectations than are usually explored in research that 
can be used to inform the development of a new measure of patients’ expectations.  
This chapter, therefore, presents a study that utilised this data alongside the existing 
literature to develop and validate two new measures: The Expectations of Cancer 
Treatment Questionnaire and the Experiences of Cancer Treatment Questionnaire. 
5.2 Introduction 
Expectations of cancer treatment have the potential to impact upon experiences of 
said treatment but the emphasis in previous research had largely been limited to 
studying expectations of treatment efficacy and side effects (Chapter 4).  In 
particular, different types of expectations have, in general, been measured more in 
isolation, focusing on treatment efficacy or side effect expectations, for example 
(Devlin et al., 2017; Younger et al., 2012).  Where measures have a broader focus, 
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they have limitations in that they either measure expectations in comparison to 
experiences retrospectively, their development lacks rigour, or there has been no 
attempt to validate them (Winterling et al., 2008; Abetz et al., 2005; Hobson, et al., 
2001).  One, better quality measure of patients’ expectations of new treatments for 
rheumatoid arthritis exists that is a broader prospective measure of expectations, but 
it is very focused on rheumatoid arthritis as a long-term condition and the 
management thereof, with some notable differences between this treatment and that 
of cancer (Hofmann et al., 2013).  This would therefore make the scale unsuitable to 
adapt for use in relation to cancer treatment expectations.  Further, when seeking to 
study expectations more broadly, there is no well-developed, broad measure of 
patients’ pre-treatment expectations that can be used within the context of cancer 
treatment. 
The literature has therefore failed to explore a wider range of expectations as 
predictors of patients’ treatment experiences.  It has also largely neglected the study 
of the gap between expectations and experiences of cancer treatment, and the 
consequences thereof.  This has meant that there may be an oversimplification of the 
processes involved and in addition, there are potentially areas that may have been 
overlooked.  By gaining a wider range of knowledge about patients’ expectations 
and the impact they can have on treatment experiences, healthcare professionals 
could be better informed about how to manage patients’ expectations of their cancer 
treatment. 
Consequently, the qualitative study presented in the previous thesis chapter 
was conducted and revealed that there are indeed a wider range of expectations 
patients hold before beginning cancer treatment, such as those relating to 
psychosocial side effects and the impact on daily life (Chapter 4).  These warranted 
further investigation using quantitative methods, but no suitable measure existed that 
would allow this, even when drawing upon the literature from conditions other than 
cancer.  The present study therefore drew upon the breadth of expectations described 
by patients in the previous study to develop two new measures of expectations and 
experiences of cancer treatment. 
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5.3 Aims of the Present Study 
The study in this chapter therefore aimed to develop a new measure of patients’ 
expectations of cancer treatment, drawing on the findings from the previous chapter, 
as well as the existing literature, to help inform the development.  In order to directly 
compare expectations and experiences, a further aim was to develop a matched 
measure of experiences of cancer treatment. 
5.4 Method 
 5.4.1 Design 
This study used a cross sectional design whereby participants were asked to 
complete the newly devised measures of their treatment expectancies and treatment 
experiences.  This chapter will describe item generation, face validity, initial piloting 
and scale validation for both new measures. 
 5.4.2 Item generation, face validity and initial piloting 
 5.4.2.1 Item generation 
The data from the qualitative study (Study 1) presented in the previous chapter 
(Chapter 4) were used to inform item generation.  The sample for this qualitative 
study were twelve women and four men who had received, or who were currently 
receiving, cancer treatment.  Participants were interviewed and encouraged to reflect 
on their expectations and experiences of cancer treatment freely but within a semi-
structured interview schedule.  The transcribed data were examined separately for 
the purposes of the qualitative study and item generation.  For the current purposes, 
transcripts were examined for any reference to expectations, which were transferred 
into one document.  A process of pooling similar extracts together then began, with 
two researchers in consultation over the similarity of statements and agreeing the 
final pooled groups.  Once this was decided, the phrasing deemed most suitable and 
representative for an item was chosen from amongst the statements in each group, 
generating an initial item list. 
Following this, the existing literature and measures were consulted to ensure 
that the items generated reflected the previous research in this area, and that no key 
concepts were omitted, and also ensuring the initial items were over-inclusive so as 
to allow for later deletion.  Existing measures that informed this process include 
existing measures of expectations, such as the Stanford Expectations of Treatment 
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Scale (SETS), which was developed for measuring treatment efficacy expectations in 
clinical trials (Younger et al, 2012); the Side-Effect Expectancy Questionnaire 
(SEEQ) used to measure side effect expectations (Devlin et al., 2017); and the 
recovery-related expectations questionnaire (RRE) used to measure cancer survivors’ 
expectations of survivorship (Winterling et al., 2008).  Validated measures of 
patients’ QOL and functioning were also consulted in order to provide a perspective 
on what patients’ might realistically expect in this regard, with the European 
Organization for Research and Treatment of Cancer’s QOL questionnaire (EORTC 
QLQ-C30; Aaronson et al., 1993), the Sickness Impact Profile (Bergner, Bobbitt, 
Carter & Gibson, 1981), and the Bristol Activities of Daily Living Scale (BADLS) 
informing items in this area (Bucks, Ashworth, Wilcock, & Siegfried, 1996). 
 5.4.2.2 Face validity 
An initial version of the Expectations of Cancer Treatment Questionnaire was 
created using the items generated.  In order to assess the face validity of the items, 
columns were added to this that invited feedback regarding items’ relevance in the 
scale and for comments.  A set of questions were added to the end of the 
questionnaire, asking for more general feedback on the scale as a whole.  These 
were: ‘Do you feel the questionnaire would measure pre-treatment expectations in 
cancer patients?’, ‘What other expectations did you have?  Are there any 
questions/statements you would add to the above?’, ‘What do you feel about the 
length of the questionnaire?’ and ‘Any other comments or queries regarding the 
questionnaire:’.  A copy of this can be viewed in Appendix I. 
This was initially sent to three health psychology researchers and one 
psychology researcher, inviting their feedback on the scale items and asking for 
opinions on the format in which the questionnaire invited responses on the relevance 
of items and general comments about items.  For one of these researchers, English 
was not their first language and therefore they also made comment on the wording 
from the perspective of a non-native English speaker.  As a result of the feedback 
received from all researchers, adjustments were made to the scale wording and item 
order and another version of the scale was generated (see Appendix J). 
This new version was then sent to ten cancer patients, past and present, 
inviting their feedback, one of whom was an experienced psychology researcher in 
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addition to having been a cancer patient.  The scale was also sent to a Macmillan 
healthcare professional and psycho-oncology researcher, who provided further 
feedback.  This included instructions on the completion of the feedback for the 
questionnaire, which can be viewed in Appendix K.  Responses were received from 
six of the cancer patients.  The feedback was collated into one document, in order 
that it could be more easily reviewed, which is included in Appendix L.  Please note, 
not all respondents providing feedback actually remarked on the relevance of each 
item, which is why the numbers do not calculate to equal the total number of 
respondents.  It is of interest that so many respondents did not indicate their answer 
to the relevance question.  On reflection, it may have been better to include the 
instructions at the start of the questionnaire, in the same document.  The instructions 
were separate for practical formatting reasons and because it was not felt that this 
would be detrimental but perhaps this contributed to lower response rates to the 
relevance question.  Alternatively, the instructions may have been too wordy or 
complex and should have been simplified so that respondents were more likely to 
read them in full and follow the instructions. 
The summary document was reviewed item by item, by the researcher along 
with the academic supervisor and decisions were made regarding necessary 
adjustments.  This led to a number of changes being made to the measure, item 
wording was adjusted, some additional items were added and some were removed.  
This led to the generation of the version of the scale to be carried forward for further 
validation, Appendix M.  The scale consisted of 64 items, categorised into four areas 
of expectations: efficacy, physical effects, psychological effects, and impact on daily 
life.  This was intended to be over-inclusive to allow for items to be removed during 
validation. 
This version of the questionnaire was then used to design the Experiences of 
Cancer Treatment Questionnaire, a scale that was matched to the Expectations of 
Cancer Treatment Questionnaire, in order that the relationship between expectations 
and experiences can be directly analysed.  The Experiences of Cancer Treatment 
Questionnaire consisted of 51 items, which resembled all items from the 
Expectations of Cancer Treatment Questionnaire, except for those from the 
‘efficacy’ subscale.  A copy of the Experiences of Cancer Treatment Questionnaire 
is included in Appendix N. 
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 5.4.3 Scale validation 
The next step was to validate the measures in a sample of cancer patients.  There are 
many divergent views on the number of participants required to carry out scale 
validity testing (Mundfrom, Shaw & Ke, 2005).  Some researchers suggest that vast 
numbers of participants are required and that the larger the sample the better 
(Comrey & Lee, 1992).  Others suggest that the ratio of participants to items is more 
important but there are disparities between researchers’ opinions about what this 
ratio should be (Cattell, 1978; Everitt, 1975).  However, there is evidence to suggest 
that the minimum number of participants per item for construct validity testing can 
be as low as three per item in order to adequately analyse the data (Cattell, 1978).  
Due to this evidence, and for pragmatic reasons, it was decided that the validation 
study would aim to recruit three participants per item.  Therefore, validation of the 
Expectations of Cancer Treatment Questionnaire would require a minimum of 192 
participants. 
 5.4.3.1 Sample 
The sample consisted of 200 participants (21 men, 177 women, 1 other, and 1 not 
specified) aged from 29 to 77 years old, with a mean age of 51.6.  The majority of 
participants were White British (n= 187), did not have dependent children and were 
employed at the time of treatment.  Further details of participants’ demographic 
information are included in Table 5.1 on the next page. 
Participants had either received treatment in the past (n= 135) or were 
currently receiving treatment (n= 65), for a range of cancer types, including breast 
(n= 97), gynaecological (n= 35), gastrointestinal (n= 29) and head and neck cancers 
(n=23).  Time since diagnosis ranged from 2 weeks to 19 years, with a mean of 3 
years.  Participants had received a range of cancer treatments including surgery, 
chemotherapy and radiotherapy, either alone or in conjunction with other modalities, 
with curative (n= 167) or palliative (n= 33) intent.  Further details of participants’ 
cancer and treatment are available in Table 5.2, on the next page. 
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Table 5.1: Participant Demographic Information 
Variable Number of Participants 
Ethnicity White British = 187 
White Irish = 3 
White Other = 2 
White American = 1 
White Ashkenazi Jewish = 1 
White and Asian = 1 
Mixed Irish and Native American = 1 
Mixed White European Indian Caribbean = 1 
Indian = 1 
Pakistani = 1 
Chinese = 1 
Education GCSE(s)/Equivalent = 56 
Undergraduate Degree = 54 
Postgraduate Degree = 41 
A-level(s)/Equivalent = 40 
None = 8 
Not specified = 1 
Employment Status at Time of Treatment Employed = 123 
Retired = 30 
Self-employed = 26 
Unemployed = 18 
Student = 3 
Children Yes = 153, number 
dependent: 
None = 72 
Two = 39 
One = 27 
Three = 8 
Four = 4 
Not specified = 2 
Five = 1 
No = 47 
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Table 5.2: Participant Cancer and Treatment Background Details 
Variable Number of Participants 
Cancer Type Breast = 97 
Gynaecological = 35 
Gastrointestinal = 29 
Head and neck = 23 
Blood = 3 
Breast and gynaecological = 3 
Lung = 2 
Neuroendocrine = 2 
Prostate = 1 
Bone = 1 
Gynaecological and blood = 1 
Breast, head and neck, and angiosarcoma = 1 
Teratoma = 1 
Not specified = 1  
Current or Most Recent Treatment Radiotherapy = 66 
Chemotherapy = 59 
Surgery = 36 
Other = 46 
 
 5.4.3.2 Procedures 
Ethical approval was gained from the University ethics committee (Appendix O), 
following which advertisement began on social media.  This took the form of a text-
based photograph that invited interested individuals to contact the researcher for 
more information or to click on the web link to a Qualtrics survey page (Appendix 
P).  This photograph was shared on Twitter and Instagram but Facebook was the 
main medium utilised.  In addition to sharing generally and encouraging others to do 
the same, administrators of Facebook groups and pages related to cancer were 
contacted for the purposes of sharing within their group.  Where permission was 
granted, either the researcher gained access to the relevant group or page and shared 
the photograph, or the administrator shared the photograph themselves, depending on 
the administrator’s preference.  A total of 200 groups and pages were contacted, 63 
of which agreed to advertise the study. 
Upon clicking on the survey link, interested individuals were presented with 
a participant information sheet giving more detail about the study (Appendix Q).  
They were the invited to click next if they wished to participate, with the next page 
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showing a consent form (Appendix R), which required agreement before they could 
proceed.  Consenting participants then clicked through to the background 
information questions, the Expectations of Cancer Treatment Questionnaire and the 
Experiences of Cancer Treatment Questionnaire.  200 participants completed the 
Expectations of Cancer Treatment Questionnaire, of whom 183 also completed the 
Experiences of Cancer Treatment Questionnaire.  Following completion, participants 
were presented with debrief information (Appendix S). 
Data were downloaded and entered into the SPSS statistics package, where 
they were analysed using factor analysis. 
5.5 Results 
 5.5.1 Expectations of cancer treatment measure 
Factor analysis was conducted, initially including the 68 items of the expectations 
measure, with relevant items reversed, using oblique rotation as it could not be 
assumed that the factors would be uncorrelated.  The analyses were run with an 
unforced number of factors; due to the exploratory nature of the factor analyses it 
would not have been justified to restrict outputs to a specified number of factors.  All 
analyses were interpreted using a threshold of 0.4 for factor loading (Field, 2013; 
Hosany & Gilbert, 2010). 
 5.5.1.1 Step 1: initial factor analysis 
The first factor analysis output is shown in Table 5.3, on the following page, with 
item loadings of 0.4 or greater highlighted in yellow.  Loadings between 0.3 and 0.4 
are bold, to show that loadings here are approaching the set threshold.  This analysis 
produced a 15-factor model.  Most of the factors had good face validity and some 
initial approximate labels were given to the first 12 factors.  These are detailed in 
Table 5.4 but include factors relating to physical side effects, psychological effects, 
impact on daily life and treatment efficacy.
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Table 5.3: Initial Factor Analysis Output (64 Expectations Items) 
Item 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 
Expect51R .835 .008 .011 -.021 .038 -.018 .018 -.030 -.054 .062 -.116 .073 .026 .122 .175 
Expect47R .790 .037 .061 -.132 -.113 -.077 -.110 .147 .126 .024 .096 -.161 -.045 .123 -.046 
Expect48R .778 -.054 -.074 .012 .058 -.071 .067 .006 -.056 .051 .050 -.082 -.001 .010 -.094 
Expect50R .725 -.074 -.017 .104 .076 -.080 .007 .044 -.143 .090 .099 .007 .006 -.027 -.042 
Expect38R .684 .029 .094 .017 .065 .096 .088 .073 -.237 -.063 .050 .027 .082 -.167 -.013 
Expect37R .503 .059 .146 -.030 .051 .091 -.103 .290 -.215 -.094 .123 -.122 -.038 -.089 .090 
Expect43R .394 .045 .000 .267 .127 .046 .254 -.171 -.276 .187 -.182 -.130 -.202 -.044 -.118 
Expect59 -.005 .916 .035 -.029 .048 -.047 .015 -.014 .051 .018 -.004 .016 .052 -.014 .042 
Expect53 .031 .915 .021 .016 .025 -.044 .106 -.099 -.021 .014 .011 .049 -.026 -.060 .034 
Expect56 -.029 .905 -.016 .026 .026 -.073 .047 -.005 -.010 .019 .032 .007 .129 .009 .002 
Expect55 -.068 .902 -.144 .039 -.028 .013 -.009 .051 -.058 -.068 .061 -.066 -.109 .041 .036 
Expect58 -.020 .887 .015 -.038 .121 .061 -.139 .129 .025 -.020 -.012 .066 -.100 -.031 .059 
Expect52 .009 .866 .030 .057 .004 .035 -.133 .109 -.008 -.034 -.047 .002 -.216 -.041 -.056 
Expect54 .069 .648 -.010 .098 .009 .005 .096 -.083 -.026 .040 .014 -.056 .414 .067 -.151 
Expect57 .050 .639 -.006 -.016 .153 -.021 .054 -.063 -.005 .020 -.009 -.086 .502 .062 -.103 
Expect60 .007 .614 .030 -.057 .117 -.076 -.024 -.121 .016 -.002 .032 -.126 .493 .063 -.062 
Expect3R -.029 -.050 .926 .088 -.024 .082 -.027 -.015 -.020 .118 -.024 .007 -.006 -.049 -.022 
Expect10R .032 -.012 .875 -.002 -.003 .064 .028 .046 .037 -.140 .066 .012 .037 .069 .048 
Expect18R .058 .003 .820 .004 .045 -.096 .006 .016 .100 .027 -.028 -.054 -.060 -.073 .096 
Expect8R -.148 -.094 .388 .096 -.002 -.031 .157 .171 -.156 .333 .049 -.356 .174 .078 -.084 
Expect21 .036 .088 .019 .783 -.088 .044 .052 .036 .085 .012 .181 .094 -.007 .048 -.013 
Expect6 .027 -.023 -.088 .745 .101 -.129 .000 .007 .073 -.031 -.085 -.055 -.004 .045 .009 
Expect13 .046 -.069 .095 .742 .029 -.153 .028 .039 .132 .036 .090 .058 .067 -.112 .008 
Expect32 -.131 .066 .097 .703 .024 -.064 -.142 .110 -.051 .039 -.009 .108 .030 .102 -.089 
Expect15 -.055 .045 -.104 .591 -.089 .018 .063 .026 -.105 -.091 .051 -.083 -.141 .364 .055 
Expect29 .041 .263 .148 .420 .144 .000 -.268 -.142 -.058 .015 .027 -.021 .134 .162 .030 
Expect26 -.041 .218 .191 .417 .093 -.084 -.170 -.278 -.162 -.002 -.042 -.028 .168 .147 .005 
Expect7 -.040 .233 -.151 .409 .106 .074 .004 -.099 -.101 -.017 .009 -.127 -.143 .376 .201 
Expect62 -.007 .030 .004 -.006 .957 -.034 -.020 .064 -.006 -.013 -.049 -.015 .003 .020 -.006 
Expect63 -.051 .005 .012 -.061 .950 -.013 .056 .006 -.023 -.039 .060 .047 -.011 .011 .011 
Expect64 -.003 -.013 -.007 -.019 .937 -.044 .077 -.067 .007 -.036 .025 .073 -.045 -.012 .015 
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Item 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 
Expect61 .062 .045 -.023 -.015 .928 .002 .019 .050 .040 -.025 -.012 -.009 .010 .049 -.024 
Expect30R .044 -.029 -.023 .104 .033 -.820 -.018 .073 .076 .019 .021 -.044 .050 -.116 -.093 
Expect28R -.086 .126 -.016 .103 .081 -.764 -.009 .042 -.057 -.022 -.079 -.073 -.022 -.047 .061 
Expect25R .090 .011 -.116 .085 .055 -.758 .067 .058 .009 .025 .082 -.045 .044 -.061 .051 
Expect49R .159 .076 .219 -.150 -.008 -.489 .139 -.097 -.152 -.104 .067 .204 -.090 .441 -.116 
Expect45R -.006 .020 .195 -.022 .001 -.459 -.002 -.038 -.283 .022 -.020 -.168 -.323 .236 -.052 
Expect20R .188 -.023 .150 .005 .072 -.424 .139 .225 .124 -.071 -.012 .152 -.043 -.049 .318 
Expect5R .021 -.110 -.056 .008 -.149 -.411 .128 .225 -.122 .067 -.080 .114 .229 .158 .405 
Expect31R -.005 -.141 -.088 -.061 .102 -.083 .695 -.028 -.087 .112 .099 -.054 .145 -.082 .081 
Expect14R -.029 .078 .194 .073 .027 .009 .674 .201 .037 -.100 -.024 -.067 .020 .011 -.061 
Expect22R .019 -.029 .045 -.028 .159 -.075 .605 .055 .026 .125 .046 -.092 -.144 -.083 .141 
Expect2R .052 -.008 .059 .004 .014 -.002 -.026 .880 -.057 -.002 -.048 -.037 .051 .091 -.134 
Expect9R .057 .044 -.001 .068 .029 -.072 -.040 .840 -.014 .018 -.004 -.002 .001 -.015 .084 
Expect17R .032 .058 -.030 .092 -.049 -.049 .174 .777 .000 .011 .037 .014 -.079 -.072 .075 
Expect42R .168 .066 -.096 .057 .048 .160 .122 .049 -.691 -.086 .157 -.047 .081 -.139 .152 
Expect40R .111 -.006 .017 -.235 .010 -.105 .024 .134 -.661 .041 .015 .099 -.052 .181 -.039 
Expect36R .128 .048 .091 -.108 .013 -.116 -.093 .093 -.629 .134 .155 -.036 -.031 -.015 -.032 
Expect41R .316 .011 -.052 -.049 .020 -.129 .013 .056 -.538 .065 .031 .034 .004 -.042 -.010 
Expect46R .336 -.129 -.065 .145 .031 -.161 -.146 -.067 -.420 -.056 .087 -.352 .060 -.204 -.029 
Expect4R .167 -.051 .046 .014 -.137 .051 .023 -.015 -.033 .794 .011 .073 .043 .034 .122 
Expect11R -.014 .027 .410 -.075 .021 -.019 .154 .130 -.079 -.618 -.018 -.174 .042 -.023 .145 
Expect16R -.067 .102 .135 -.133 -.013 -.071 .148 .134 .012 .609 .056 -.165 -.050 -.044 .047 
Expect39 .158 .074 .062 .087 .031 .036 .223 -.120 .174 -.005 .745 .158 -.001 .000 -.092 
Expect34 -.082 -.022 -.027 .127 .017 -.056 -.265 -.009 -.089 .063 .736 -.116 -.090 -.067 .135 
Expect44 -.040 -.015 -.021 -.085 .020 .013 .109 .092 -.239 -.003 .725 -.028 .092 .137 -.080 
Expect24R .204 .086 .048 -.072 -.181 -.099 .273 .001 .022 -.165 -.054 -.631 .002 .016 -.004 
Expect33R .198 .054 .114 -.221 .052 -.111 .010 .109 .254 .129 .104 -.559 -.097 -.045 .135 
Expect1R -.203 -.125 .310 .019 .081 .058 .105 .297 -.176 .324 .008 -.444 .149 .051 -.103 
Expect27 .100 -.092 .022 .117 .245 .117 -.112 -.057 .047 -.061 -.052 .005 .187 .636 -.010 
Expect23 .011 -.014 -.100 .211 .104 .135 -.133 .076 .123 .133 .134 .003 -.044 .628 -.011 
Expect19R .066 .130 .343 -.063 -.011 .021 .117 .028 -.095 .131 -.035 -.006 -.112 -.041 .643 
Expect35R .104 .176 .096 .031 -.066 -.138 .158 .178 -.325 .033 -.029 .219 -.115 -.077 -.407 
Expect12R -.041 -.075 .038 .230 -.078 -.341 .177 .177 -.116 .017 -.051 .068 .346 -.087 .364 
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Table 5.4: Factor Labels for Initial Factor Analysis 
Factor Description 
1 Self-care 
2 Hope / Cure 
3 Hair 
4 Positive Outlook 
5 Trust in Healthcare Professional 
6 Negative Emotion 
7 Pain 
8 Fatigue 
9 Social Impact 
10 Weight 
11 Impact on Daily Life 
12 Gastro 
13 - 
14 - 
15 - 
 
Despite this initially promising output, some items double-loaded, others did not 
load on any of the factors and the total number of items needed to be reduced so that 
the final measure would not create undue response burden with future participants.  
Therefore, the following factor analyses aimed to explore the data in order to 
produce a model with a reduced number of items that fit within the factors of the 
model better.  The analyses were conducted with an interest in maintaining the 
integrity of the scale, which was developed based upon qualitative data and the other 
previous literature and was therefore evidence-based.  As this initial factor analysis 
supported this evidence, the subsequent factor analyses aimed to produce a similar 
model. 
 5.5.1.2 Step 2: removing factors lacking face validity 
The next step was to remove items from the analysis that only loaded on factors 13 
to 15 in the first factor analysis (items 19, 23, 27 and 35). The output from this 
second analysis in shown in Table 5.5.  This analysis produced a 13-factor model.  
The factors were fairly similar to those in the initial factor analysis but no items 
double-loaded.  Three items failed to load on any factor (items 12, 45 and 49) but 
their loading on one particular factor was over 0.3, showing they approached the 
loading level.  Although this factor model improved upon the initial factor analysis, 
it was necessary further reduce the number of items as this still stood at 60.
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Table 5.5: Second Factor Analysis Output (60 Expectations Items) 
Item 1 2 3 4 5 6 7 8 9 10 11 12 13 
Expect51R .807 .008 .052 .021 .053 -.048 .073 -.008 -.117 -.026 .002 .016 -.110 
Expect48R .774 -.079 -.057 -.011 .063 -.047 .040 -.006 .058 -.032 -.048 .010 .045 
Expect50R .723 -.045 -.016 .080 .063 -.058 .098 .033 .108 -.107 .023 .027 -.026 
Expect38R .722 -.029 .052 -.043 .033 .107 -.080 .097 .058 -.113 -.115 .128 -.020 
Expect47R .714 .056 .084 -.119 -.081 -.086 .011 .082 .099 .074 .032 -.153 .131 
Expect37R .511 .082 .105 -.047 .027 .053 -.096 .264 .133 -.102 .044 -.026 .140 
Expect43R .430 .062 -.015 .204 .106 .053 .141 -.117 -.106 -.213 .035 .168 .125 
Expect46R .417 -.139 -.123 .089 -.011 -.128 -.048 -.027 .111 -.221 -.071 -.039 .278 
Expect52 .007 .888 .019 .077 -.005 .030 -.023 .066 -.034 -.024 .069 -.086 .061 
Expect58 -.026 .843 .018 -.018 .112 .038 -.002 .131 -.011 .023 -.055 -.089 -.053 
Expect55 -.065 .822 -.134 .093 -.031 -.006 -.085 .037 .061 -.050 -.096 .012 .083 
Expect53 .038 .811 .037 .022 .008 -.044 .023 -.094 .008 -.019 -.181 .156 -.078 
Expect59 -.017 .776 .051 -.019 .039 -.062 .028 -.012 -.011 .037 -.251 .047 -.050 
Expect56 -.036 .707 -.006 .036 .017 -.076 .024 .010 .034 -.008 -.364 .056 -.053 
Expect3R -.019 -.026 .888 .055 -.039 .111 .122 -.011 -.023 -.050 .007 .009 .019 
Expect10R .008 -.002 .861 .012 .002 .062 -.126 .037 .070 -.008 -.005 .017 -.010 
Expect18R .072 .015 .772 -.041 .030 -.100 .023 .041 -.032 .098 .017 .022 .049 
Expect21 .041 .048 .024 .757 -.085 .065 .027 .057 .171 .104 -.025 .058 -.119 
Expect6 .043 -.024 -.076 .714 .084 -.111 -.009 .000 -.072 .095 .008 .022 .026 
Expect32 -.112 .018 .064 .697 .017 -.023 .037 .105 .002 -.052 -.064 -.116 -.069 
Expect15 -.034 .067 -.039 .663 -.038 -.005 -.063 -.001 .050 -.096 .086 -.023 .063 
Expect13 .047 -.107 .056 .623 .006 -.130 .031 .055 .079 .160 -.060 .072 -.056 
Expect7 -.009 .200 -.070 .526 .136 .015 -.008 -.077 .018 -.057 .029 -.070 .078 
Expect29 .056 .148 .120 .490 .141 .018 .028 -.101 .027 -.015 -.181 -.219 .006 
Expect26 -.003 .101 .134 .483 .092 -.047 .006 -.213 -.034 -.090 -.208 -.125 .038 
Expect62 .007 -.006 -.014 .024 .961 -.015 -.007 .069 -.052 .010 -.030 -.027 .045 
Expect63 -.050 -.033 .006 -.047 .940 -.005 -.041 .011 .078 -.012 -.028 .043 -.035 
Expect61 .075 -.004 -.024 .020 .929 .024 -.020 .050 -.012 .052 -.054 -.010 .017 
Expect64 .005 -.008 -.003 -.002 .912 -.025 -.023 -.067 .030 .008 .032 .093 -.077 
Expect25R .056 .011 -.104 .030 .040 -.767 .029 .017 .096 .001 -.009 .068 .039 
Expect30R .006 -.019 -.046 .022 .009 -.763 .017 .021 .038 .023 -.018 -.003 .062 
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Item 1 2 3 4 5 6 7 8 9 10 11 12 13 
Expect28R -.079 .108 -.022 .076 .056 -.729 -.028 .026 -.074 -.081 -.023 .018 .071 
Expect20R .153 -.008 .150 -.026 .062 -.463 -.068 .242 -.026 .128 .074 .140 -.117 
Expect5R .020 -.171 .001 .070 -.111 -.453 .052 .255 -.089 -.063 -.095 .129 -.111 
Expect12R -.016 -.160 .034 .196 -.092 -.390 .010 .211 -.061 .024 -.176 .273 -.061 
Expect49R .099 .082 .246 -.006 .054 -.383 -.083 -.100 .043 -.333 .004 -.018 -.155 
Expect4R .156 -.071 .067 .002 -.113 .014 .683 .031 .029 -.014 -.021 .039 -.044 
Expect11R .015 -.020 .347 -.058 .016 -.047 -.562 .139 -.033 -.013 -.073 .124 .159 
Expect16R -.043 .087 .127 -.148 -.026 -.086 .447 .120 .066 .020 -.002 .166 .189 
Expect2R .026 -.008 .068 -.005 .029 .021 .004 .812 -.028 -.125 -.035 -.083 .033 
Expect9R .050 .069 .006 .040 .027 -.097 .019 .811 .008 .008 .047 -.028 .003 
Expect17R .035 .123 -.015 .043 -.056 -.064 .004 .748 .044 .028 .116 .193 -.018 
Expect44 -.055 -.038 -.010 -.051 .023 .002 -.011 .057 .685 -.190 -.071 .061 .035 
Expect39 .068 .061 .061 .048 .042 .028 .000 -.119 .628 .101 -.005 .140 -.114 
Expect34 -.019 -.027 -.035 .134 .005 -.037 .063 .051 .588 .021 .043 -.167 .060 
Expect40R .151 .005 .022 -.151 .015 -.064 .031 .147 .031 -.663 -.010 .005 -.077 
Expect36R .188 .056 .034 -.087 -.009 -.094 .109 .111 .178 -.522 -.013 -.035 .097 
Expect41R .348 .039 -.082 -.048 -.012 -.109 .050 .069 .056 -.452 -.001 .086 .002 
Expect42R .284 .024 -.133 .043 .001 .105 -.093 .105 .168 -.404 -.093 .207 .070 
Expect45R .064 .087 .199 .069 .016 -.330 .014 -.006 -.027 -.342 .125 -.043 .101 
Expect57 .046 .194 -.034 -.024 .150 -.003 -.008 -.014 -.001 .026 -.819 -.026 .016 
Expect60 .000 .200 .013 -.048 .118 -.072 -.025 -.080 .034 .048 -.740 -.087 .055 
Expect54 .061 .282 -.025 .103 .013 .035 .016 -.049 .027 -.022 -.653 .026 -.002 
Expect31R -.003 -.115 -.062 -.092 .064 -.091 .071 -.043 .074 -.061 -.042 .709 .036 
Expect22R .037 .080 .080 -.070 .114 -.108 .092 .041 .029 .038 .159 .580 .076 
Expect14R -.028 .059 .203 .029 .033 -.007 -.095 .163 -.021 -.005 -.058 .507 .066 
Expect1R -.197 -.156 .245 .048 .080 .081 .279 .249 .013 -.162 -.122 .109 .530 
Expect24R .224 .063 .077 -.075 -.145 -.118 -.146 -.029 -.034 .070 -.059 .196 .467 
Expect8R -.148 -.147 .338 .121 .005 -.011 .292 .133 .056 -.157 -.155 .143 .409 
Expect33R .197 .055 .149 -.216 .049 -.129 .091 .090 .078 .249 .027 .024 .393 
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 5.5.1.3 Step 3: checking reliability 
Reliability analyses using Cronbach’s alpha statistics were conducted for the 13 
factors in this analysis, to assist with the identification of items to be deleted.  When 
reviewing this data, it became apparent that the ‘weight’ factor was not reliable (α = 
0.08).  This was due to the inclusion of items in the same factor pertaining to both 
weight loss and weight gain.  These items may score in opposite directions, as it is 
unlikely, but not impossible, that individuals would expect to both gain and lose 
weight.  However, expecting either equates to expecting more side effects and so 
therefore there is a problem with scoring these items.  In addition, it is intended for 
the measure that a higher score overall equates to more positive cancer treatment 
expectations and conversely a lower score equates to more negative expectations.  
Although weight is a common cancer side effect, hence its initial inclusion in the 
scale, it is problematic.  In addition to the aforementioned difficulties, in terms of 
expectations, weight loss or weight gain cannot be assumed to be viewed as 
negative.  Depending on patients’ circumstances prior to treatment, either of these 
side effects may be viewed as a positive of treatment rather than a negative, although 
in reality they can be extreme and unpleasant. 
 5.5.1.4 Step 4: removing problematic ‘weight’ items and re-running the 
factor analysis 
The next step, therefore, was to remove the problematic items from the ‘weight’ 
factor from the analysis (items 4 and 11).  Item 16 (the third weight item) relates to 
loss of appetite.  Whilst this loaded with the weight items when they were included 
in the analysis, its exclusion here may have been premature as it did not hold the 
same problems as the other items from this factor did.  The decision was made to 
return all items to the analysis with the two problematic weight-related items 
excluded, on the basis that they may have unduly influenced the initial model and 
that any items removed before they were, may have been incorrectly excluded. 
Based on factor loadings, reliability analyses and face validity, a series of 
factor analyses followed this line of testing, in an attempt to reduce the overall 
number of items and produce an acceptable model for the scale.  The final factor 
analysis conducted in this step produced a very promising model, the output of 
which is shown in Table 5.6, below. 
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This was almost selected as the final solution.  However, to achieve the 38-
item solution shown, it was necessary to remove item 24, which was problematic for 
face validity.  Item 24 related to the gastro side effect of constipation and it was felt 
that it was not acceptable to have a scale that did not have this common cancer 
treatment side effect, especially as there was a gastro side effect relating to diarrhoea 
included.  The decision was therefore made to continue exploring the data with 
factor analysis, to discover whether there was an acceptable solution that contained 
both items, particularly considering the initial solution with no items removed almost 
achieved this. 
 5.5.1.5 Step 5: re-evaluating items removed in step 4 and re-running factor 
analyses 
With this in mind, the analyses conducted as part of step 4 were studied, to ascertain 
whether the removal of any particular items may have had undue influence.  It was 
discovered that the second item removed, item 12, had a reasonable impact on the 
analysis, partly positive for the model but partly negative.  The following series of 
factor analyses therefore included item 12.  This included removing items that had 
previously been removed after item 12.  For example, items 49 and 27 were 
removed, as these items had similar loadings for more than one factor.  Their 
removal produced a reasonable model but there was a thirteenth factor that lacked 
face validity, some items had similar loadings on more than one factor and some of 
the factors contained too many items.  In the following analysis, item 5 was also 
removed because it loaded on factor 13 but also approached the loading threshold in 
two other places, only one of which had face validity.  It was possible that its 
removal would also solve the issues with the problematic thirteenth factor.  The 
gastro subscale was the best it had been and the model as a whole fit well.  All 
factors had face validity but the twelfth factor was made up of some of the items 
from another factor. Item reduction was still required.
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Table 5.6: Final Factor Analysis of Step 4 (38 Expectations Items) 
Item 1 2 3 4 5 6 7 8 9 10 11 
Expect2R .840 .018 .070 .067 -.056 -.083 .014 .015 -.123 .056 .100 
Expect9R .785 -.034 -.002 .053 .133 .025 .005 .010 -.010 -.008 .018 
Expect17R .724 -.099 -.049 -.010 .129 .073 .169 .003 .004 -.021 .009 
Expect63 -.017 .944 -.001 -.016 .017 .031 .048 .022 -.038 .051 .005 
Expect64 -.061 .910 -.007 .010 .034 .002 .080 -.014 .007 .006 -.065 
Expect61 .034 .876 -.030 .043 -.001 -.014 .014 .097 .030 -.072 .042 
Expect10R .032 .041 .918 .016 -.023 .058 .019 -.009 -.030 .061 -.126 
Expect3R -.085 -.069 .914 .056 -.063 -.054 -.004 -.033 -.042 .007 .112 
Expect18R .013 .000 .744 -.058 .119 -.039 .011 .018 .090 -.078 .136 
Expect15 .087 -.058 .003 .771 -.033 .024 .025 .011 .012 -.063 -.099 
Expect23 .017 .121 -.058 .557 -.141 .081 -.165 -.037 -.011 .063 .122 
Expect7 -.024 .114 -.069 .519 .037 .028 -.158 .176 .034 -.098 -.026 
Expect26 -.207 .071 .134 .448 .127 -.002 -.085 .307 -.033 -.046 -.008 
Expect13 .030 -.006 .072 .447 .212 .112 .069 -.007 .125 -.005 -.016 
Expect30R -.012 .008 .000 -.031 .811 .051 .017 -.029 -.013 -.006 .009 
Expect28R .032 .077 .021 .012 .770 -.095 -.026 .102 -.068 .072 -.016 
Expect5R .224 -.073 -.048 .109 .411 -.112 .122 -.158 -.088 -.018 .064 
Expect39 -.100 .037 .040 .046 -.013 .660 .115 .029 .057 -.042 -.149 
Expect44 .029 .065 -.004 .006 -.027 .643 .066 -.022 -.258 .142 .082 
Expect34 .074 -.033 -.058 .089 -.027 .578 -.115 .006 .035 -.017 .127 
Expect31R -.023 .070 -.047 -.076 .057 .075 .702 -.098 -.054 -.054 .071 
Expect22R .108 .095 .076 -.075 .063 .034 .540 -.059 .036 -.118 .073 
Expect14R .244 .087 .181 -.007 .047 -.032 .510 .131 .047 .003 -.010 
Expect54 -.001 .033 -.074 .055 -.023 .018 .109 .869 .012 -.016 .045 
Expect60 -.062 .124 -.029 -.060 .028 .005 .010 .774 .029 .031 .102 
Expect52 .123 .018 .083 .035 .005 -.005 -.186 .575 -.061 .006 -.128 
Expect40R .130 .101 .013 -.035 -.025 -.050 -.029 -.085 -.719 -.089 .011 
Expect36R .002 -.050 .066 -.054 .123 .178 -.067 .019 -.658 -.120 .162 
Expect41R -.010 .013 -.061 -.072 .166 .111 -.015 -.018 -.546 -.297 -.006 
Expect35R .064 -.082 .043 -.021 .062 .012 .110 .160 -.409 -.052 -.090 
Expect51R .078 .091 .059 .002 .046 -.066 -.049 -.150 -.065 -.749 -.094 
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Item 1 2 3 4 5 6 7 8 9 10 11 
Expect38R .140 .041 .071 -.153 -.039 .141 .072 .053 -.164 -.650 -.132 
Exper48R -.134 -.076 -.108 .109 -.025 -.016 .111 .100 -.025 -.630 .147 
Expect43R -.097 .065 .030 .149 .023 -.073 .097 .048 -.190 -.468 .077 
Expect37R .304 .044 .163 -.121 -.005 .203 -.057 -.009 -.160 -.438 -.052 
Expect1R .133 .002 .262 .102 -.042 -.012 .167 -.002 -.189 .100 .590 
Expect16R .062 -.130 .099 -.071 .063 .069 .182 .037 -.032 -.018 .446 
Expect33R .173 .073 .141 -.299 .098 .106 -.112 .011 .197 -.235 .400 
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 5.5.1.6 Step 6: item reduction 
The following series of factor analyses attempted to reduce the number of items 
based on this model, with the assistance of reliability analyses of the factors in the 
model and using previous factor analysis results as a guide as to which items to 
remove.  However, none of the solutions were successful in producing an acceptable 
model.  The final of these was a reasonable solution but some factors still required 
further item reduction and the loadings on the gastro items were not ideal.  The 
output of this factor analysis is shown in Table 5.7, on the next page. 
 5.5.1.7 Step 7: further item reduction 
Following this another series of factor analyses were conducted to test the removal 
of various combinations of items in an attempt to reduce the number of items whilst 
maintaining the face validity of the factors, none of which provided an acceptable 
solution.  One of these was identified as being potentially close to a solution and 
revisited in order to explore another avenue of testing with it, based on some of the 
knowledge gained whilst testing other models.  A single item was removed from 
this, item 18, and the solution was viable.  This solution was almost accepted as the 
final version, particularly when another series of factor analyses failed to reduce the 
number of items and maintain an acceptable model.  The output from this factor 
analysis is shown in Table 5.8, below. 
 5.5.1.8 Step 8: running reliability analyses on the model 
Reliability analyses were good for all factors in this solution (α > 0.6).  However, for 
the factor measuring trust in the healthcare professional the Cronbach’s alpha value 
was above 0.9 (α = 0.95).  In addition, removing any of the three items would not 
have reduced this value a significant amount.  It was therefore concluded that the 
three items were too similar, may actually be measuring the same thing and only one 
of them was necessary in the measure.  The decision was made to remove two of the 
items and just leave item 61, which was selected because from a face validity 
perspective it could stand alone in the measure and was the most representative of 
the three items overall.  The resulting factor analysis was an acceptable solution.  
The output from this factor analysis is shown in Table 5.9, below. 
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Table 5.7: Factor Analysis Output for Step 6 (50 Expectations Items) 
Item 1 2 3 4 5 6 7 8 9 10 11 
Expect48R .779 .036 -.092 -.057 -.038 .070 .081 .014 -.088 .023 .032 
Expect51R .777 .078 .047 -.053 -.050 .042 -.085 .015 -.080 -.102 .025 
Expect47R .721 -.077 .047 .098 -.049 -.022 .122 -.104 .065 .037 -.154 
Expect38R .660 -.031 .092 -.050 .064 -.029 .082 -.053 -.242 -.097 .137 
Expect37R .486 -.070 .150 -.042 .012 -.042 .135 -.255 -.144 .001 -.079 
Expect43R .468 .189 -.033 -.092 .020 -.025 -.100 .111 -.227 .149 .130 
Expect24R .328 -.141 .070 .128 -.109 -.151 -.032 .001 .107 .250 .122 
Expect21 .004 .775 .016 .089 .072 -.067 .170 -.083 .063 -.115 .123 
Expect32 -.146 .716 .055 .001 -.044 -.069 -.008 -.079 -.084 .000 -.086 
Expect6 .059 .704 -.074 -.057 -.152 .018 -.075 .020 .066 .005 .026 
Expect13 .019 .654 .072 .022 -.157 .071 .088 -.018 .088 -.036 .125 
Expect15 .015 .640 -.054 .031 -.010 -.019 .031 -.044 -.049 .026 -.077 
Expect7 .068 .497 -.100 -.138 .009 -.196 .002 .041 .021 .063 -.129 
Expect29 .042 .492 .110 -.135 -.001 -.271 .022 .144 -.021 .028 -.178 
Expect26 -.007 .474 .136 -.086 -.063 -.258 -.041 .261 -.102 .054 -.087 
Expect23 .007 .452 -.068 -.134 .160 .040 .108 -.011 .061 .100 -.219 
Expect3R -.063 .058 .907 .033 .081 .064 -.018 .083 -.094 .127 -.036 
Expect10R -.026 -.014 .866 -.036 .055 -.020 .056 -.014 -.019 -.015 -.037 
Expect18R .067 -.033 .791 -.028 -.083 -.004 -.028 -.020 .091 .037 .002 
Expect19R .158 -.024 .332 .006 -.099 -.017 -.032 -.136 .101 .044 .129 
Expect63 -.064 -.077 .034 -.979 -.031 -.002 .057 -.024 -.010 -.009 .019 
Expect64 -.019 -.030 .016 -.930 -.052 .013 .012 .036 .013 -.059 .078 
Expect61 .068 .012 -.021 -.890 .009 -.068 -.019 -.050 .053 .026 .006 
Expect30R -.024 .004 -.019 .010 -.831 .004 .039 .029 -.034 .028 -.046 
Expect25R .043 .024 -.083 -.046 -.798 -.008 .087 -.012 -.025 .019 .015 
Expect28R -.058 .068 .017 -.066 -.741 -.100 -.087 -.022 -.062 .018 -.042 
Expect20R .155 .005 .189 -.071 -.448 .077 -.034 -.255 .105 -.159 .122 
Expect12R -.055 .229 .092 .082 -.417 .075 -.042 -.127 -.040 .020 .274 
Expect56 -.065 .011 -.043 -.026 -.040 -.964 .047 -.023 .008 -.023 .080 
Expect59 -.035 -.049 .013 -.055 -.037 -.917 .004 -.012 .063 -.034 .021 
Expect52 .013 -.007 .030 -.011 .005 -.765 -.035 -.099 -.032 -.064 -.196 
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Item 1 2 3 4 5 6 7 8 9 10 11 
Expect54 .008 .139 -.050 -.043 .023 -.669 .033 .103 -.065 .078 .115 
Expect44 -.068 -.060 -.007 -.033 -.008 -.018 .694 -.042 -.196 .088 .038 
Expect39 .036 .044 .048 -.056 .005 -.062 .601 .104 .036 -.080 .117 
Expect34 .011 .139 -.035 .015 -.017 .050 .590 -.037 .052 .044 -.133 
Expect9R .001 .073 .016 -.018 -.104 -.013 -.011 -.797 -.019 .047 -.033 
Expect2R -.014 .048 .035 -.020 .032 .009 -.057 -.797 -.129 .134 -.065 
Expect17R .007 .056 -.015 .058 -.039 -.038 .039 -.788 .008 .001 .168 
Expect40R .179 -.106 .015 -.050 -.059 .050 .025 -.142 -.574 .064 -.041 
Expect36R .189 -.092 .058 .011 -.150 -.011 .174 -.047 -.539 .198 -.110 
Expect41R .324 -.040 -.053 .012 -.167 .007 .064 -.038 -.473 .047 .034 
Expect42R .260 .006 -.042 -.028 .039 -.077 .176 -.058 -.452 .015 .160 
Expect35R .071 -.054 .046 .053 -.105 -.149 .022 -.110 -.403 -.028 .023 
Expect33R .332 -.219 .089 -.032 -.089 -.038 .089 -.106 .359 .332 -.018 
Expect1R -.107 .048 .118 -.036 .038 .074 -.018 -.142 -.075 .851 .045 
Expect8R -.080 .133 .223 .031 -.048 .045 .035 -.035 -.090 .713 .104 
Expect16R .009 -.098 .074 .080 -.066 -.043 .091 -.090 .039 .397 .141 
Expect31R .022 -.078 -.076 -.067 -.094 .093 .090 .031 -.063 .162 .690 
Expect22R .076 -.087 .081 -.117 -.107 .041 .035 -.107 .052 .107 .497 
Expect14R -.009 .007 .168 -.067 .037 -.143 -.041 -.225 .015 .091 .493 
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Table 5.8: Factor Analysis Output for Step 7 (41 Expectations Items) 
Item 1 2 3 4 5 6 7 8 9 10 11 
Expect51R .798 -.050 .036 .002 -.034 -.102 -.006 .036 -.047 .121 -.034 
Expect48R .735 -.082 .064 -.091 -.060 .074 .050 .004 -.138 .029 .115 
Expect38R .715 .054 -.054 .071 -.030 .104 -.038 .149 -.172 -.087 -.115 
Expect47R .678 .028 .054 .042 .088 .117 -.078 -.171 .049 -.090 .175 
Expect37R .504 .069 -.009 .150 -.041 .146 -.241 -.077 -.100 -.130 .018 
Expect43R .398 .043 .016 -.031 -.090 -.106 .121 .127 -.290 .208 .139 
Expect59 -.044 .887 .034 .003 -.058 .003 -.005 .051 .068 -.006 .021 
Expect52 -.017 .804 .020 .021 -.020 -.023 -.080 -.198 -.022 -.052 -.001 
Expect54 -.004 .631 -.007 -.037 -.035 .041 .084 .147 -.079 .205 .024 
Expect30R -.017 -.004 .845 -.018 .003 .045 .038 -.049 -.031 -.051 .030 
Expect25R .028 -.001 .803 -.084 -.056 .073 -.001 .001 -.053 -.012 .064 
Expect28R -.053 .095 .760 .022 -.063 -.104 -.019 -.042 -.077 .073 .000 
Expect12R .005 -.082 .424 .108 .101 -.029 -.154 .287 .038 .186 -.086 
Expect20R .209 -.060 .417 .089 -.062 -.050 -.285 .128 .191 -.051 -.064 
Expect3R -.042 -.052 -.037 .923 .014 -.045 .079 -.043 -.080 .055 .054 
Expect10R .024 .051 -.029 .910 -.046 .060 -.012 -.046 .064 -.074 -.065 
Expect19R .161 .005 .064 .266 .005 -.080 -.167 .151 .108 .033 .138 
Expect63 -.071 -.013 .031 .039 -.981 .040 -.002 .010 -.034 -.050 -.004 
Expect64 -.011 -.025 .049 .013 -.924 -.012 .043 .071 .015 .014 -.049 
Expect61 .046 .061 -.004 -.020 -.886 -.018 -.032 .003 .032 .028 .035 
Expect44 -.069 -.004 -.002 .018 -.026 .690 -.044 .055 -.236 -.036 .049 
Expect39 .074 .075 .002 .044 -.043 .611 .107 .123 .094 .007 -.057 
Expect34 .002 -.064 .009 -.051 .014 .571 -.068 -.131 .013 .132 .066 
Expect9R .017 .000 .049 -.006 .003 -.011 -.872 -.017 -.002 .086 .003 
Expect2R -.029 -.020 -.031 .058 -.015 -.037 -.792 -.070 -.165 .003 .039 
Expect17R -.001 .040 .033 -.069 .059 .046 -.780 .150 .018 -.037 .049 
Expect31R .017 -.124 .080 -.043 -.071 .100 .024 .690 -.055 -.102 .114 
Expect22R .059 -.046 .072 .032 -.117 .025 -.137 .514 .057 -.083 .149 
Expect14R -.023 .144 -.003 .161 -.073 -.030 -.209 .472 .003 -.076 .063 
Expect40R .179 -.077 .049 .036 -.059 -.006 -.139 -.033 -.602 -.055 -.017 
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Item 1 2 3 4 5 6 7 8 9 10 11 
Expect36R .166 -.006 .128 .062 .001 .149 -.076 -.078 -.587 -.028 .113 
Expect35R .066 .157 .135 .030 .045 .026 -.093 .019 -.426 -.114 -.076 
Expect42R .286 .084 -.048 -.038 -.009 .179 -.072 .189 -.409 .020 -.071 
Expect7 .032 .225 .017 -.082 -.113 .010 .016 -.105 .002 .519 .011 
Expect13 .013 -.014 .221 .058 .039 .120 -.042 .091 .101 .505 -.102 
Expect29 .042 .304 .017 .094 -.106 .046 .062 -.134 .006 .503 -.073 
Expect23 -.017 -.010 -.137 -.039 -.106 .127 -.030 -.193 .038 .465 .019 
Expect33R .199 -.004 .051 .067 -.067 .054 -.096 -.031 .200 -.140 .555 
Expect16R -.088 .006 .013 .059 .070 .049 -.125 .181 -.084 .051 .465 
Expect8R -.147 -.068 .055 .384 .027 .047 -.068 .141 -.221 .225 .417 
Expect24R .220 .148 .112 .090 .102 -.028 .033 .110 .005 -.146 .369 
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Table 5.9: Factor Analysis Output for Step 8 (39 Expectations Items) 
Item 1 2 3 4 5 6 7 8 9 10 
Expect51R .771 -.070 .064 .014 -.097 -.013 -.050 -.085 .120 -.038 
Expect48R .733 -.082 .073 -.086 .080 .049 -.024 -.160 .042 .108 
Expect38R .678 .035 -.028 .083 .108 -.041 -.153 -.222 -.097 -.110 
Expect47R .665 .009 .057 .048 .116 -.089 .181 .026 -.112 .174 
Expect37R .510 .083 -.012 .150 .150 -.243 .059 -.117 -.117 .013 
Expect43R .387 .040 .022 -.028 -.106 .123 -.148 -.305 .235 .144 
Expect59 -.072 .901 .050 .014 .005 -.007 -.043 .040 -.003 .027 
Expect52 -.028 .829 .017 .027 -.023 -.084 .204 -.039 -.043 .003 
Expect54 -.052 .611 .022 -.022 .041 .083 -.125 -.112 .197 .040 
Expect61 .195 .289 -.016 -.020 .048 .046 -.213 .068 .240 -.072 
Expect30R .004 .011 .836 -.023 .044 .040 .052 -.026 -.073 .029 
Expect25R .053 .025 .794 -.091 .074 .002 -.007 -.046 -.019 .064 
Expect28R -.029 .120 .753 .016 -.104 -.016 .025 -.069 .075 -.005 
Expect12R -.055 -.137 .469 .112 -.034 -.155 -.217 .000 .110 -.039 
Expect20R .218 -.048 .433 .088 -.047 -.284 -.145 .181 -.056 -.072 
Expect3R -.042 -.056 -.035 .918 -.045 .083 .051 -.076 .046 .074 
Expect10R .042 .069 -.036 .905 .064 -.014 .013 .069 -.064 -.078 
Expect19R .147 -.006 .082 .262 -.082 -.168 -.135 .099 .019 .159 
Expect44 -.066 .003 -.016 .015 .692 -.042 -.060 -.234 -.031 .051 
Expect39 .061 .069 .013 .050 .613 .104 -.128 .079 .001 -.062 
Expect34 .007 -.069 .007 -.052 .571 -.069 .134 .019 .134 .067 
Expect9R .021 .003 .051 -.009 -.014 -.879 .006 .000 .099 .002 
Expect2R -.007 .000 -.046 .055 -.034 -.784 .039 -.150 .027 .026 
Expect17R -.024 .024 .049 -.069 .043 -.779 -.122 .002 -.061 .070 
Expect31R -.016 -.135 .100 -.042 .106 .033 -.687 -.071 -.127 .128 
Expect22R .057 -.030 .075 .030 .032 -.131 -.555 .059 -.074 .137 
Expect14R -.042 .147 .005 .166 -.027 -.208 -.498 -.008 -.079 .056 
Expect40R .194 -.055 .021 .028 -.002 -.137 .007 -.592 -.025 -.012 
Expect36R .169 .001 .104 .052 .146 -.075 .087 -.588 -.017 .139 
Expect35R .041 .147 .131 .029 .022 -.094 .010 -.451 -.134 -.050 
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Item 1 2 3 4 5 6 7 8 9 10 
Expect42R .244 .061 -.033 -.033 .178 -.073 -.169 -.445 .010 -.043 
Expect7 .032 .227 .029 -.077 .007 .012 .064 .005 .575 -.004 
Expect29 .028 .304 .042 .103 .049 .063 .112 -.005 .535 -.078 
Expect23 .000 .002 -.131 -.036 .131 -.025 .149 .055 .519 .000 
Expect13 -.047 -.063 .278 .066 .116 -.041 -.039 .064 .450 -.065 
Expect33R .253 .042 .022 .057 .058 -.092 -.004 .234 -.107 .526 
Expect16R -.106 -.010 .013 .046 .043 -.120 -.133 -.075 .029 .515 
Expect8R -.155 -.082 .051 .372 .042 -.064 -.114 -.203 .217 .453 
Expect24R .206 .125 .107 .089 -.035 .023 -.076 -.001 -.180 .382 
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 5.5.1.9 Step 9: further item reduction 
Item 61, the remaining trust in the healthcare professional item, approached the 
loading threshold on the factor with the items that related to treatment extending life, 
being curative and being successful.  Reliability analysis was conducted on the 
potential four item factor and was good (α = 0.78).  With a particular focus on the 
inter-item correlations, the factor was examined to see whether the removal of one 
item would produce an acceptable factor and if the loading of item 61 could be 
improved.  The decision was made to remove item 52 (relating to treatment being 
curative) for two reasons.  The first, this was highly correlated with item 59 (r = 
0.74) and therefore it would not be necessary to have both items.  The second, this 
had the lowest inter-item correlation with item 61 (r = 0.25) and its removal 
therefore had the potential to increase the loading item 61 would have on the factor. 
Removing item 52 led to the factor analysis is shown in Table 5.10 on the 
next page, with the item loadings highlighted in light blue based on the factor they 
have been accepted as being in.  The loading for item 43 (0.39) is just below the 
threshold loading value of 0.4 but this was deemed acceptable as it does not 
approach the loading threshold on another factor and has good face validity within 
the self-care factor.  Its deletion would lead this factor to be less rich from this 
perspective.  Items 24 and 61 are also just below this threshold (0.38 and 0.37 
respectively) but also do not approach loading on any of the other factors and have 
good face validity in the gastro side effects and treatment efficacy factors 
respectively.  Item 19 has the lowest factor loading of any in the solution (0.26).  Its 
loading values are extremely low on all factors bar this one its face validity with the 
appearance-related side effects is very good.  Without this item, the factor would just 
contain hair-related side effect items and not weight-related side effects.  Its 
inclusion is therefore important from this perspective.  In addition to this, reliability 
analyses are very good for the factor with this item included (α = 0.76).  With this in 
mind, and considering the overall solution is more than acceptable, the decision was 
made that the inclusion of item 19 within the appearance-related side effects factor 
was justified. 
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Table 5.10: Factor Analysis Output for Step 9 (38 Expectations Items) 
Item 1 2 3 4 5 6 7 8 9 10 
Expect51R .780 -.049 .054 .012 -.102 .069 -.003 -.086 .123 -.045 
Expect48R .730 -.052 .075 -.087 .085 .034 .054 -.157 .022 .104 
Expect38R .669 .076 -.029 .079 .107 .130 -.047 -.220 -.126 -.110 
Expect47R .663 -.045 .058 .051 .114 -.158 -.094 .018 -.095 .166 
Expect37R .506 .048 -.011 .150 .146 -.063 -.250 -.121 -.113 .011 
Expect43R .385 .111 .024 -.028 -.098 .138 .129 -.296 .186 .140 
Expect59 -.071 .816 .055 .030 -.011 -.070 -.046 .021 -.057 .020 
Expect54 -.083 .741 .027 -.028 .034 .013 .042 -.114 .066 .053 
Expect61 .190 .366 -.020 -.020 .045 .161 .036 .072 .178 -.075 
Expect30R -.001 -.002 .838 -.022 .048 -.046 .034 -.026 -.073 .028 
Expect25R .051 .020 .792 -.089 .076 .015 -.002 -.046 -.018 .060 
Expect28R -.031 .121 .748 .017 -.104 -.031 -.023 -.070 .064 -.005 
Expect12R -.048 -.118 .453 .109 -.040 .252 -.142 -.001 .144 -.047 
Expect20R .217 -.045 .426 .087 -.049 .149 -.283 .181 -.044 -.078 
Expect3R -.035 -.084 -.038 .918 -.046 -.028 .089 -.081 .072 .074 
Expect10R .034 .078 -.029 .912 .069 -.047 -.025 .069 -.089 -.076 
Expect19R .156 -.023 .071 .264 -.091 .158 -.163 .095 .048 .147 
Expect44 -.070 .010 -.015 .015 .689 .064 -.046 -.232 -.027 .049 
Expect39 .057 .091 .013 .051 .615 .118 .099 .082 -.011 -.068 
Expect34 .010 -.082 .010 -.051 .572 -.113 -.066 .018 .150 .068 
Expect31R -.009 -.104 .070 -.048 .098 .765 .060 -.068 -.076 .096 
Expect22R .064 .002 .057 .029 .025 .581 -.120 .064 -.050 .113 
Expect14R -.054 .226 .001 .162 -.027 .454 -.218 .000 -.124 .046 
Expect9R .018 -.003 .051 -.011 -.012 -.018 -.880 -.002 .097 .000 
Expect2R -.015 -.001 -.042 .051 -.031 -.059 -.792 -.151 .015 .029 
Expect17R -.025 -.001 .047 -.069 .041 .118 -.779 .001 -.045 .062 
Expect40R .194 -.056 .018 .026 -.007 .004 -.134 -.596 -.016 -.011 
Expect36R .173 -.029 .102 .054 .141 -.063 -.073 -.592 .000 .136 
Expect35R .042 .105 .131 .031 .021 -.016 -.098 -.447 -.129 -.049 
Expect42R .242 .090 -.036 -.035 .174 .159 -.072 -.443 -.004 -.044 
Expect23 .012 .032 -.140 -.036 .127 -.133 -.016 .051 .522 .003 
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Item 1 2 3 4 5 6 7 8 9 10 
Expect7 .035 .301 .031 -.075 .011 -.101 .013 .006 .508 .001 
Expect29 .026 .384 .043 .103 .046 -.167 .051 -.007 .462 -.067 
Expect13 -.037 -.015 .266 .064 .114 .062 -.026 .063 .456 -.066 
Expect33R .250 .034 .030 .057 .063 .002 -.102 .239 -.125 .526 
Expect16R -.098 -.021 .005 .048 .037 .171 -.117 -.077 .052 .499 
Expect8R -.150 -.030 .050 .370 .045 .135 -.061 -.199 .202 .440 
Expect24R .195 .135 .118 .089 -.030 .053 .010 .004 -.220 .383 
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 5.5.1.10 Step 10: final face validity analyses, reliability analyses and the 
final scale 
This final factor analysis produced a 10-factor solution with 38 items.  One final 
assessment of the face validity was conducted and although overall this was deemed 
to be acceptable, there was one item that had not been included in this analysis that it 
was necessary to re-introduce.  This was item 1, which pertained to the physical side 
effect of nausea.  Given the high prevalence of this side effect in cancer treatment, it 
is not justified to have a scale that includes patients’ expectations of physical side 
effects without having an item measuring nausea.  The decision was therefore made 
to include this in the gastro subscale. 
The final solution is detailed in Table 5.11.   
Table 5.11: Details of Factors and Items within the Final Solution (39 Items, 10 
Factors) 
Factor Grouping 
Label 
Factor Grouping 
Label 
Factor Label Number 
of Items 
Treatment Efficacy (1 Factor) 3 
Treatment 
Consequences (9 
Factors) 
 
 
 
 
 
 
 
Physical Side Effects 
(4 Factors) 
Appearance 3 
Pain 3 
Fatigue 3 
Gastro 5 
Psychological Side 
Effects (2 Factors) 
Negative Emotion 5 
Positive Outlook 4 
Impact (3 Factors) Self-Care 6 
Impact on Daily Life 3 
Social Impact 4 
 
Table 5.12, on the next page, details the Cronbach’s Alpha reliability 
analyses conducted on each of the factors.  Alpha values are all acceptable and range 
between 0.66 and 0.87. 
A copy of the final Expectations of Cancer Treatment Questionnaire is 
available in Appendix T.  The items removed following the factor analyses have 
been deleted but the order the remaining items is presented has not been changed to 
allow easier comparison with the original questionnaire.  However, for further use, it 
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is intended that the item order be adjusted so that similar items are not presented 
sequentially wherever possible. 
Table 5.12: Cronbach’s Alpha Reliability Analyses for All Factors in the Final 
Solution 
Factor α Value 
Treatment Efficacy 0.70 
Appearance 0.76 
Pain 0.75 
Fatigue 0.87 
Gastro 0.79 
Negative Emotion 0.84 
Positive Outlook 0.68 
Self-Care 0.87 
Impact on Daily Life 0.66 
Social Impact 0.76 
 
 5.5.2 Experiences of cancer treatment measure 
Having finalised the expectations of cancer treatment measure, the experiences of 
cancer treatment measure required refinement.  Of the 200 participants who had 
completed the expectations measure, 183 completed the experiences measure.  Of 
these 122 had received treatment in the past and 61 were currently receiving 
treatment.  There was therefore both prospective and retrospective data, which could 
not be entered into a factor analysis together as this would not provide a viable 
solution.  Neither of these groups of participants were large enough to conduct a 
factor analysis on the entire set of items.  For the purposes of the utility of the 
experiences measure, it is necessary that the items contained within match the items 
in the expectations measure.  Given the smaller sample that completed the 
experiences measure in any given group, it was not possible to conduct the factor 
analyses together in an attempt to produce a solution that suited both scales.  The 
items selected for the expectations measure therefore guided the content of the 
experiences measure. 
Given that the item content was being driven by the expectations measure, 
factor analyses were not conducted but reliability analyses were.  The items and 
factors matched to those in the expectations scale were analysed using Cronbach’s 
Alpha, with exception of the treatment efficacy factor, as these items are not relevant 
to the experiences scale.  Details of these analyses are included in Table 5.13, below.  
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Alpha values were acceptable, although a little high on some factors, and ranged 
between 0.60 and 0.91.  The experiences of cancer treatment are therefore presented 
as a 9-factor scale with 36 items, detailed within Table 5.14. 
Table 5.13: Cronbach’s Alpha Reliability Analyses for Factors in Experiences Scale 
Factor α Value 
Appearance 0.76 
Pain 0.82 
Fatigue 0.91 
Gastro 0.74 
Negative Emotion 0.89 
Positive Outlook 0.73 
Self-Care 0.90 
Impact on Daily Life 0.60 
Social Impact 0.75 
 
Table 5.14: Details of Factors and Items within the Experiences Scale (36 Items, 9 
Factors) 
Factor Grouping Label Factor Label Number 
of Items 
Physical Side Effects (4 Factors) Appearance 3 
Pain 3 
Fatigue 3 
Gastro 5 
Psychological Side Effects (2 Factors) Negative Emotion 5 
Positive Outlook 4 
Impact (3 Factors) Self-Care 6 
Impact on Daily Life 3 
Social Impact 4 
 
A copy of the final Experiences of Cancer Treatment Questionnaire is 
available in Appendix U.  This represents the wording for the version of the 
questionnaire that is intended to be presented to participants who have received 
treatment in the past.  As with the expectations questionnaire, the item order has not 
been altered so that this final version of the questionnaire can be compared to the 
original version but the order should be changed for future use. 
Therefore, at the end of the process of scale development two measures were 
finalised.  The first was of expectations of cancer treatment and consisted of 10 
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subscales, called ‘Treatment Efficacy’, grouped alone; ‘Appearance’, ‘Pain’, 
‘Fatigue’, and ‘Gastro’, grouped as ‘Physical Side Effects’; ‘Negative Emotion’ and 
‘Positive Outlook’, grouped as ‘Psychological Side Effects’; ‘Self-Care’, ‘Impact on 
Daily Life’ and ‘Social Impact’, grouped as ‘Impact’; and 39 items.  The second 
measured experiences of cancer treatment and consisted of nine subscales, called 
‘Appearance’, ‘Pain’, ‘Fatigue’, and ‘Gastro’, grouped as ‘Physical Side Effects’; 
‘Negative Emotion’ and ‘Positive Outlook’, grouped as ‘Psychological Side Effects’; 
‘Self-Care’, ‘Impact on Daily Life’ and ‘Social Impact’, grouped as ‘Impact’, and 35 
items. 
5.6 Discussion 
The Expectations of Cancer Treatment Questionnaire is a 39-item self-report 
measure that can be used alone or in conjunction with its matched counterpart, the 
36-item Experiences of Cancer Treatment Questionnaire.  It reflects how positive or 
negative patients’ expectations are overall towards their cancer treatment based on 
their expectations of physical side effects (appearance, pain, fatigue, and gastro-
intestinal), psychological side effects (negative emotion and positive outlook), and 
impact (self-care, impact on daily life, and social impact); and how positive or 
negative their expectations related to treatment efficacy are.  The experiences 
measure reflects how positive or negative patients’ experiences of cancer treatment 
are based on physical and psychological side effects, and impact.  These 
characteristics of cancer treatment expectations and experiences include aspects from 
the previous literature and have been enriched with reference to data gained 
qualitatively in the previous chapter (Chapter 4). 
Previous research has been narrow in its focus and explored expectations 
largely in terms of treatment efficacy and treatment side effects but the qualitative 
data from the previous chapter indicated that patients also have expectations in terms 
of a broader range of factors, including the impact cancer treatment would have 
socially and on daily life, and the psychological effects of treatment (Chapter 4).  
The two measures developed in the present chapter have successfully captured this 
broader notion of patient expectations and experiences of cancer treatment.  The 
Expectations of Cancer Treatment Questionnaire allows a broader exploration of the 
expectations patients have of their cancer treatment.  When used with the 
Experiences of Cancer Treatment Questionnaire, it enables a rich and encompassing 
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study of the relationship between expectations and experiences that has not 
previously been possible.  This includes facilitating a more thorough investigation of 
the implications of the gap between expectations and experiences. 
The current exploratory validation of the Expectations of Cancer Treatment 
Questionnaire suggests that it successfully represents the included expectations, with 
well-defined subscales.  Reliability analyses suggest that all subscales on both the 
Expectations of Cancer Treatment Questionnaire and the Experiences of Cancer 
Treatment Questionnaire have good internal consistency and are therefore reliable. 
 5.6.1 Limitations 
The main limitation to this study is that the sample obtained all provided 
retrospective data on their expectations of cancer treatment, as they were measured 
during or after treatment.  The initial intension of the measure was to be used in a 
prospective manor by measuring patients’ expectations prior to their cancer 
treatment but there were major difficulties in recruiting a sample of this nature, in the 
quantities required for validation.  The time post-diagnosis and prior to treatment is a 
very difficult and sensitive time for patients (Abdollahzadeh et al., 2017; Sterckx et 
al., 2013).  It may also be a time when altruism is understandably low, as patients are 
attempting to cope with the shock and fear of a cancer diagnosis.  In addition, 
pragmatically, this is also often a small window of opportunity in terms of recruiting 
patients at the correct timepoint, as there may well be very little time between 
diagnosis and initiation of treatment. 
The decision was therefore made to gain retrospective data that would inform 
item deletion and reduce the scale to a more manageable length.  This then facilitates 
more confirmatory factor analyses to be conducted on a smaller number of items, 
which consequently require fewer participants, at a later date. 
5.7 Conclusion 
Research is needed to gain a more detailed understanding of the relationship between 
cancer treatment expectations and experiences.  The Expectations of Cancer 
Treatment Questionnaire and the Experiences of Cancer Treatment Questionnaire 
will help to facilitate this by providing more inclusive measures than have previously 
been available, and by allowing the direct calculation of the gap between 
expectations and experiences.  Further validation is required to confirm the current 
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findings, but the results suggest validity and reliability are both good, and extended 
exploration is warranted.  The next chapter will explore the relationship between 
expectations and experiences of cancer treatment, utilising these measures. 
5.8 Towards Understanding the Role of Expectations of Cancer Treatment and 
Their Impact on Outcomes 
Previous measures of expectations have been narrow in their focus.  Study 1 
highlighted the breadth of expectations about cancer treatment.  This chapter drew 
upon this previous qualitative study to develop and validate two new measures: The 
Expectations of Cancer Treatment Questionnaire and the Experiences of Cancer 
Treatment Questionnaire.  These provide tools for broader, more inclusive 
exploration of the relationships between expectations and experiences than was 
previously possible.  The first step in doing so is presented in the next chapter.  
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Chapter Six 
Study 3: A Cross-Sectional Study of the Relationship 
between Expectations and Experiences 
 
6.1 Overview 
The qualitative study in Chapter 4 explored patients’ expectations and experiences of 
cancer treatment and highlighted how they were much broader than just efficacy and 
side effects.  In line with this, the quantitative study in Chapter 5 developed and 
validated two new measures of expectations and experiences of cancer treatment.  
Research indicates that patients’ expectations of cancer treatment have the potential 
to influence patients’ experiences of cancer treatment and there may also be 
implications when patients’ experiences do not match their expectations.  This 
chapter will now explore the relationships between patients’ expectations of cancer 
treatment and their experiences using the measures developed in the previous 
chapter. 
6.2 Introduction 
One perspective on the expectations-experiences relationship comes from response 
expectancy theory, which suggests that expecting a certain outcome makes that 
outcome more likely to occur (Kirsch, 1985).  This has been explored within the 
cancer literature in relation to treatment efficacy expectations and treatment side 
effect expectations.  Treatment efficacy expectations research has a focus on the 
placebo effect and although there is a lot of support for the presence of placebo 
effects in other conditions, in the cancer literature a systematic review concluded that 
there is little to no evidence of the placebo effect present in cancer treatment 
(Chvetzoff & Tannock, 2003).  Treatment efficacy expectations are also important, 
however, because they have the potential to influence psychological outcomes.  
Koller et al. (2000) studied cancer patients undergoing radiotherapy and found that 
more positive treatment efficacy expectations were related to higher QOL, at least in 
the short-term.  This is consistent with findings from the literature on hope in cancer 
care, where hope has been found to relate to a range of positive psychological 
outcomes (Wnuk et al., 2012; Rustoen et al., 2010). 
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Research from this perspective has also explored expectations of treatment-
related side effects.  There is a large body of literature in this area and three separate 
meta-analyses have been conducted that have all concluded that expecting a 
particular side effect makes its occurrence much more likely (Devlin et al., 2017; 
Colagiuri & Zachaerie, 2010; Sohl et al., 2009).  Devlin et al.’s (2017) meta-analysis 
was the most up to date and comprehensive, including a wider range of cancer and 
side effect types but was still restricted in that the majority of the research in this 
area has been conducted with patients undergoing chemotherapy, and concentrated 
on nausea and vomiting as side effects.  This research therefore suggests that holding 
negative pre-treatment expectations about side effects can lead to more negative 
treatment experiences of the related side effect.  Response expectancy theory and the 
evidence associated with it would therefore suggest that, at least in terms of 
treatment efficacy and side effects, fostering positive expectations may be preferable, 
to encourage more positive experiences of cancer treatment. 
Another important consideration, however, is the gap between expectations 
and experiences, and the implications this could have.  Expectancy violations theory 
maintains that where individuals’ expectations are not met, it increases arousal and 
leads to a cognitive process of evaluating the violation of the expectations as either 
positive or negative (Burgoon & Hale, 1988).  Positive evaluations result in more 
positive consequences, and negative evaluations more negative consequences, when 
compared to unviolated expectations (Burgoon & Hale, 1988).  This theory has its 
roots in understanding social interactions and has received far less attention in the 
context of healthcare but could suggest that if patients had positive pre-treatment 
expectations, as the above perspective would claim to be optimal, and the subsequent 
experience were more negative than expected, patients would have worse 
psychological outcomes than if these expectations had been more realistic.  There is 
little evidence exploring this within the cancer literature but that which is available 
does tend to lend support to this perspective by demonstrating that QOL can be 
affected in ways that would be anticipated by this theory (Maguire et al., 2017; 
Winterling et al., 2008; Koller et al., 2000; Wan et al., 1997).  There are 
methodological limitations within these studies which, together with their limited 
number, means that these findings should be treated cautiously and this relationship 
needs further exploration.  However, the perspective provides a challenge to the 
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conclusions drawn from response expectancy theory, providing a cautionary note on 
promoting positive pre-treatment expectations due to the implications if these are not 
met, and suggesting that more realistic expectations may be preferable. 
Further support for providing realistic expectations of cancer treatment is 
found in the preparation for treatment literature.  The theory suggested that providing 
patients with accurate information, about both the physical medical procedures and 
the sensations likely to be felt, would allow patients to psychologically prepare for 
the experiences of treatment, developing realistic expectations and facilitating better 
coping (Janis, 1958).  There is a large body of research across different health 
conditions to support this position, where surgery is the treatment of interest 
(Johnston & Vogele, 1993; Suls & Wan, 1989; Johnson et al., 1973; Egbert et al., 
1964).  This research has also been extended into treatments other than surgery, 
including radiotherapy and chemotherapy treatments for cancer, with similar 
findings (Aranda et al., 2012; Burish et al., 1991; Johnson et al., 1989; Johnson et al., 
1988).  Similar to an expectancy violations perspective, these studies suggest setting 
realistic pre-treatment expectations but they do, however, have problems with 
sampling and measurement of expectations so this would benefit from further 
exploration. 
The evidence to date presents two opposing perspectives on patients’ pre-
treatment expectations; in short, being positive versus being more realistic.  The 
qualitative study of patients’ expectations of cancer treatment presented in Chapter 4 
tends to lend support in favour of more realistic expectations, within the context of a 
broader range of expectations than has been covered in the quantitative literature in 
the area thus far. Research is needed to clarify these relationships quantitatively, 
including these broad range of expectations. 
6.3 Aims of the Present Study 
The study in this chapter aimed to explore the relationship between expectations and 
experiences, including a broad range of expectations.  It further sought to begin to 
better understand the implications of the expectations-experiences gap and the 
impact this could have on patients’ experiences of cancer treatment. 
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6.4 Method 
 6.4.1 Design 
The study used a quantitative cross-sectional design.  Within subjects comparisons 
were made between participants’ ratings of their expectations of cancer treatment 
(Treatment Efficacy and Treatment Consequences (Physical Side Effects – Fatigue, 
Appearance, Pain and Gastro; Psychological Side Effects – Negative Emotion and 
Positive Outlook; Impact – Impact on Daily Life, Social Impact and Self-Care)) and 
their experiences of cancer treatment (Treatment Consequences (Physical Side 
Effects – Fatigue, Appearance, Pain and Gastro; Psychological Side Effects – 
Negative Emotion and Positive Outlook; Impact – Impact on Daily Life, Social 
Impact and Self-Care)).  All data were retrospective. 
 6.4.2 Sample 
200 participants who were either currently experiencing, or had in the past 
experienced, some form of treatment for cancer, in the United Kingdom, were 
recruited.  The sample consisted of women (n= 177) and men (n= 21) aged between 
29 and 77, with cancers of varying types and who had experienced a range of 
treatments, including surgery (n= 36), chemotherapy (n= 59), radiotherapy (n= 66) 
and other treatments (n= 46).  These treatments were either of curative (n= 167) or 
palliative (n= 33) intent.  The time since the current diagnosis ranged from 2 weeks 
to 19 years, with a mean of 3 years.  Further detail is available in Tables 5.1 and 5.2 
(see previous chapter). 
 6.4.3 Measures 
Measures were completed at one timepoint. Background information questionnaires 
were used to gain demographic, cancer and treatment-related data.  The newly 
developed Expectations of Cancer Treatment Questionnaire (EXPECT-CTQ; 
Appendix T) was administered to gain retrospective data about what participants 
expected before they began treatment for cancer.  The matched Experiences of 
Cancer Treatment Questionnaire (EXPER-CTQ; Appendix U) was delivered in one 
of two formats, depending on whether participants were currently receiving 
treatment or had done in the past, to gain data about participants’ experiences of 
cancer treatment.  Subscales scores were computed for Treatment Efficacy, 
Appearance, Pain, Fatigue, Gastrointestinal (Gastro), Negative Emotion, Positive 
Outlook, Self-Care, Impact on Daily Life and Social Impact, and total scores were 
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computed for Physical Side Effects, Psychological Side Effects, Impact, and the sum 
of these three, Treatment Consequences. 
 6.4.4 Procedure 
Ethical approval was gained from the University Ethics Committee before 
advertisement and recruitment began (Appendix O).  Advertisement took place on 
social media with the use of a text-based photograph that had text with it that 
provided a link straight to the Qualtrics online survey (Appendix P).  The 
advertisement was shared on various social media outlets, including Twitter and 
Instagram but Facebook was the main resource used.  As well as sharing the 
advertisement, Facebook groups were searched who had a connection to cancer in 
some way, administrators of these groups were approached and asked for permission 
to share the advertisement in their group. They were given the option to post this in 
their group or for the researcher to do so. 
The advertisement invited interested individuals to click the link or contact 
the researcher for more information. Upon clicking the survey link, the first page 
presented was a participant information sheet giving more detail about the study, 
which again encouraged contact of the researcher if there were more questions 
(Appendix Q).  This asked individuals to carefully consider whether they would like 
to participate or not and applied no time restrictions on this decision. 
Those who wished to participate were invited to click through to the next 
screen where they were asked to provide consent (a copy of the Consent Form is 
available in Appendix R) and asked screening questions to ensure they met the 
eligibility criteria.  Following this, participants were presented with background 
information questions, followed by the expectations measure and finally the 
experiences measure.  On completion of the measures, participants were shown a 
written debrief sheet (Appendix S) that gave details of where to go for support if 
they had been affected by their participation.  Data were collected between May and 
July 2017. 
 6.4.5 Data analysis 
Data were screened for outliers and checks were carried out to ascertain whether 
parametric assumptions had been violated.  The data were then analysed in the 
following ways: 
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1. To assess the relationships between expectations and experiences using the 
individual subscales and total scores with correlational analyses for both past 
treatment experiences and current treatment experiences 
2. To assess the relationships between treatment efficacy expectations and 
treatment experiences using correlational analyses for both past treatment 
experiences and current treatment experiences 
3. To assess the relationships between treatment efficacy expectations and 
treatment experiences using correlational analyses according to different treatment 
types (i.e. surgery vs radiotherapy vs chemotherapy) for past treatment experiences 
4. To calculate and describe the gap between treatment expectations and 
experiences for both past treatment experiences and current treatment experiences 
5. To assess the role of treatment efficacy expectations in explaining the gap 
between treatment expectations and experiences using correlational analyses for both 
past treatment experiences and current treatment experiences 
6. To assess the role of the gap between expectations and experiences in 
explaining experience using correlational analyses and ANOVAs for both past 
treatment experiences and current treatment experiences 
In all cases, non-parametric tests were used wherever parametric assumptions were 
violated. 
6.5 Results 
The results first show the relationships between expectations and experiences. This 
analysis was conducted in the most detail to explore relationships between subscales 
of expectations and experiences, taking this to the level of, for example, appearance 
or pain, as well as analysing physical side effect subscales as a group ‘Total Physical 
Side Effects’.  Subsequent analyses were conducted at the group level and included 
‘Total Physical Side Effects’, ‘Total Psychological Side Effects’, and ‘Total Impact’, 
and these groups were additionally analysed together in some instances as ‘Total 
Treatment Consequences’.  ‘Treatment Efficacy Expectations’ formed its own 
subscale that was analysed in relation to the other aspects of expectations and to 
experiences in all bar the first and last analyses.   
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A higher score for expectations indicates more positive expectations, which, for 
physical side effects means that a higher score equates to a lower expectation of their 
occurrence.  A higher score on the experiences measures indicates more positive 
experiences. 
6.5.1 Do expectations of cancer treatment relate to experiences of cancer 
treatment? 
 6.5.1.1 Using subscales 
Correlational analyses were conducted on the subscales of the expectations and 
experiences of cancer treatment questionnaires, with the sample split according to 
whether treatment was in the past or was currently occurring.  These used Pearson’s 
r where parametric assumptions had not been violated, and Spearman’s rho where 
they had. 
There were significant positive correlations between cancer treatment 
expectations and treatment experiences across all subscales and for both those whose 
treatment was currently occurring and those whose treatment was in the past, with 
medium to large effect sizes.  Details of the effect sizes and significance values are 
contained within Table 6.1.  This indicates that the more positive participants’ 
expectations of cancer treatment were, the more positive their experiences were. 
Table 6.1: The Relationships between Expectations and Experiences 
 Past Treatment Current Treatment 
Appearance *r2 = 0.78, p > 0.001 (n= 130) *r2 = 0.65, p > 0.001 (n= 62) 
Pain *r2 = 0.52, p > 0.001 (n= 126) *r2 = 0.47, p > 0.001 (n= 62) 
Fatigue *r2 = 0.27, p = 0.002 (n= 130) *r2 = 0.37, p = 0.003 (n= 62) 
Gastro *r2 = 0.46, p > 0.001 (n= 130) *r2 = 0.45, p > 0.001 (n= 62) 
Total Physical 
Side Effects 
*r2 = 0.56, p > 0.001 (n= 130) r = 0.51, p > 0.001 (n= 62) 
Negative Emotion *r2 = 0.54, p > 0.001 (n= 126) r = 0.58, p > 0.001 (n= 62) 
Positive Outlook *r2 = 0.53, p > 0.001 (n= 130) r = 0.66, p > 0.001 (n= 62) 
Total 
Psychological Side 
Effects 
r = 0.49, p > 0.001 (n= 130) r = 0.69, p > 0.001 (n= 62) 
Self-Care *r2 = 0.66, p > 0.001 (n= 124) *r2 = 0.58, p > 0.001 (n= 62) 
Impact on Daily 
Life 
*r2 = 0.54, p > 0.001 (n= 124) *r2 = 0.27, p = 0.033 (n= 62) 
Social Impact *r2 = 0.49, p > 0.001 (n= 124) r = 0.34, p = 0.007 (n= 62) 
Total Impact r = 0.62, p > 0.001 (n= 124) r = 0.49, p > 0.001 (n= 62) 
Total Treatment 
Consequences 
r = 0.53, p > 0.001 (n= 130) r = 0.50, p > 0.001 (n= 62) 
 *parametric assumptions violated, non-parametric equivalent test used 
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 6.5.1.2 Using total scores 
Further correlational analyses were conducted to explore whether any significant 
relationships existed between expectations and experiences when different groups of 
subscales were compared.  These were conducted at the level of total physical side 
effects, total psychological side effects, and total impact, and were again split by 
treatment status, past or current.  For those who had received treatment in the past, 
there were three significant relationships.   
Firstly, there was a significant positive correlation between total physical side 
effects expectations and total impact experiences with a small to medium effect size 
(r = 0.20, p = 0.025).  This indicates that the more positive participants’ expectations 
of physical side effects were, i.e. they expected fewer of them, the more positive 
their experiences in terms of the impact treatment had, i.e. treatment had less of an 
impact on their self-care, daily life and social life. 
Secondly, there was a significant positive correlation between total impact 
expectations and total physical side effects experiences with a medium effect size (r2 
= 0.32, p > 0.001). This indicates that the more positive participants’ impact 
expectations were, i.e. they expected treatment to have little impact on their self-
care, daily life and social life, the more positive their experiences of physical side 
effects were, i.e. they experienced fewer of them. 
Finally, there was a significant positive correlation between total impact 
expectations and total psychological side effects experiences with a small to medium 
effect size (r = 0.20, p > 0.023).  This indicates that the more positive participants’ 
impact expectations were, the more positive their experiences of psychological side 
effects were, i.e. they experienced more of a positive outlook and fewer negative 
emotions. 
For those currently receiving treatment, there was only one significant 
relationship and this was a positive correlation between total psychological side 
effects expectations and total impact experiences with a small to medium effect size 
(r = 0.26, p > 0.043).  This indicates that the more positive participants’ expectations 
of psychological side effects were, i.e. they expected to have a more positive outlook 
and fewer negative emotions, the more positive their impact experiences, i.e. 
treatment was having less of an impact on self-care, daily life and social life. 
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Full details of all the significance values and effect sizes for these analyses 
are shown in Table 6.2. 
Table 6.2: The Relationships between Expectations and Experiences Across 
Subscales 
 Past Treatment Current Treatment 
Total Physical Side 
Effects Expectations => 
Total Psychological Side 
Effects Experiences 
r = 0.05, p = 0.561 (n= 130) r = 0.17, p = 0.190 (n= 62) 
Total Physical Side 
Effects Expectations => 
Total Impact Experiences 
r = 0.20, p = 0.025 (n= 124) r = 0.14, p = 0.285 (n= 62) 
Total Psychological Side 
Effects Expectations => 
Total Physical Side 
Effects Experiences 
*r2 = 0.17, p = 0.188 (n= 130) r = 0.12, p = 0.370 (n= 62) 
Total Psychological Side 
Effects Expectations => 
Total Impact Experiences 
r = 0.13, p = 0.136 (n= 124) r = 0.26, p > 0.043 (n= 62) 
Total Impact 
Expectations => Total 
Physical Side Effects 
Experiences 
*r2 = 0.32, p > 0.001 (n= 130) r = 0.15, p = 0.256 (n= 62) 
Total Impact 
Expectations => Total 
Psychological Side Effects 
Experiences 
r = 0.20, p > 0.023 (n= 130) r = 0.16, p = 0.206 (n= 62) 
 *parametric assumptions violated, non-parametric equivalent test used 
 6.5.2 Do treatment efficacy expectations relate to expectations and 
experiences? 
Correlational analyses were conducted to explore the relationship between treatment 
efficacy expectations and firstly all other treatment expectations groups (Total 
Physical Side Effects, Total Psychological Side Effects, and Total Impact, and these 
groups combined into Total Treatment Consequences), and secondly, all of the 
equivalent treatment experiences groups.  All analyses were conducted using 
Spearman’s rho as parametric assumptions had been violated.  As with the previous 
analyses, these were split according to treatment status, past or current. 
 6.5.2.1 Treatment expectations 
 6.5.2.1.1 Patients who had received treatment in the past 
There were two significant relationships and two which approached the level of 
significance but that had small or very small effect sizes.  Of these, the first was a 
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positive relationship between treatment efficacy expectations and psychological side 
effects expectations, with a medium-sized effect (r2 = 0.35, p < 0.001).  This 
indicates that the more positive the expectation of treatment efficacy, i.e. a greater 
level of expectation that the treatment will work, the more positive the expectations 
of psychological side effects are, i.e. higher expectations of a positive outlook and 
lower expectation of negative mood. 
The second was a positive relationship between treatment efficacy 
expectations and treatment consequences expectations, with a small-to-medium-
sized effect (r2 = 0.22, p = 0.01).  This indicates that the more positive the 
expectation of treatment efficacy, the more positive the expectation of overall 
treatment consequences, i.e. expecting fewer physical side effects, expecting to have 
a more positive outlook and fewer negative emotions, and expecting treatment to 
have less of an impact on self-care, daily life and social life. 
 6.5.2.1.2 Patients who were currently receiving treatment 
There was only one significant relationship, the rest were far from significant.  The 
significant relationship was between treatment efficacy expectations and 
psychological side effect expectations, in a positive direction, with a small-to-
medium-sized effect (r2 = 0.24, p = 0.05).  This is congruous with the relationship 
between these variables for those who had received treatment in the past, and 
likewise indicates that a more positive treatment efficacy expectation, the more 
positive the expectations of psychological side effects are. 
Full details of all the relationships between treatment efficacy expectations 
and expectations, for both those who had received treatment in the past and those 
who were currently receiving treatment, are shown in Table 6.3. 
Table 6.3: The Relationships between Treatment Efficacy Expectations and 
Expectations 
 Expectations 
Past Current 
Physical Side Effects r2 = 0.05, p = 0.56 (n= 135) r2 = 0.03, p = 0.84 (n= 65) 
Psychological Side 
Effects 
r2 = 0.35, p < 0.001 (n= 135) r2 = 0.24, p = 0.05 (n= 65) 
Impact r2 = 0.17, p = 0.056 (n= 135) r2 = 0.15, p = 0.22 (n= 65) 
Treatment 
Consequences 
r2 = 0.22, p = 0.01 (n= 135) r2 = 0.14, p = 0.27 (n= 65) 
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 6.5.2.2 Treatment experiences 
 6.5.2.2.1 Patients who had received treatment in the past 
Treatment efficacy expectations were significantly correlated with three of the four 
experiences subscale groups.  Firstly, treatment efficacy expectations had a positive 
correlation with physical side effect experiences, with a small effect size (r2 = 0.18, p 
= 0.04).  This indicates that the more positive the expectation regarding treatment 
efficacy, i.e. higher hope that treatment will be effective, the more positive the 
experience of physical side effects, i.e. fewer physical side effects were reported. 
Secondly, treatment efficacy expectations had a positive correlation with 
psychological side effects experiences, with a medium effect size (r2 = 0.36, p < 
0.001).  This indicates that the more positive the expectation regarding treatment 
efficacy, the more positive the experience of psychological side effects, i.e. a greater 
experience of positive outlook and fewer negative emotions. 
Finally, treatment efficacy expectations had a positive correlation with 
treatment consequences experiences, with a medium-sized effect (r2 = 0.30, p = 
0.001).  This indicates that the more positive the expectation regarding treatment 
efficacy, the more positive the experience of the overall treatment consequences, i.e. 
fewer physical side effects, more positive psychological side effects and fewer 
negative ones, and a lesser impact on self-care, daily life, and social life. 
 6.5.2.2.2 Patients who were currently receiving treatment 
There were no significant relationships between treatment efficacy expectations and 
experiences for those who were currently receiving treatment.   
Table 6.4 has the full details of the relationships between treatment efficacy 
expectations and treatment experiences, for both treatment statuses. 
Table 6.4: The Relationships between Treatment Efficacy Expectations and 
Treatment Experiences 
 Experiences 
Past Current 
Physical Side Effects r2 = 0.18, p = 0.04 (n= 130) r2 = -0.14, p = 0.28 (n= 62) 
Psychological Side Effects r2 = 0.36, p < 0.001 (n= 130) r2 = 0.17, p = 0.18 (n= 62) 
Impact r2 = 0.14, p = 0.13 (n= 124) r2 = 0.06, p = 0.64 (n= 62) 
Treatment Consequences r2 = 0.30, p = 0.001 (n= 130) r2 = 0.07, p = 0.57 (n= 62) 
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6.5.3 Do treatment efficacy expectations relate to expectations and 
experiences by treatment type? 
For the variables that had a significant relationship with treatment efficacy 
expectations, further correlational analyses were conducted to explore the 
relationships by treatment type, again using Spearman’s rho as parametric 
assumptions had been violated.  Due to the limited sample size in those who were 
currently receiving treatment, these analyses were conducted only on the sample who 
had received treatment in the past.  Again due to sample sizes, only the three main 
types of treatment were included in the analyses: surgery (n= 36), radiotherapy (n= 
57), and chemotherapy (n= 30). 
 6.5.3.1 Treatment expectations 
Treatment efficacy expectations had a significant positive medium-sized correlation 
with psychological side effects expectations, for surgery (r2 = 0.33, p = 0.049), 
radiotherapy (r2 = 0.34, p = 0.010), and chemotherapy (r2 = 0.35, p = 0.055).  This 
indicates that for all treatment types, the more positive the treatment efficacy 
expectation, the more positive the psychological side effects expectation. 
All other relationships between treatment efficacy expectations and 
expectations were not significant for any treatment type.  Full details of these 
analyses can be found in Table 6.5. 
Table 6.5: The Relationship between Treatment Efficacy Expectations and Treatment 
Expectations, by Treatment Type 
 Expectations 
Surgery Radiotherapy Chemotherapy 
Psychological 
Side Effects 
r2 = 0.33, p = 0.049 
(n= 36) 
r2 = 0.34, p = 0.010 
(n= 57) 
r2 = 0.35, p = 0.055 
(n= 30) 
Impact r2 = 0.22, p = 0.191 
(n= 36) 
r2 = 0.15, p = 0.264 
(n= 57) 
r2 = 0.12, p = 0.520 
(n= 30) 
Treatment 
Consequences 
r2 = 0.21, p = 0.226 
(n= 36) 
r2 = 0.12, p = 0.390 
(n= 57) 
r2 = 0.23, p = 0.225 
(n= 30) 
 
 6.5.3.2 Treatment experiences 
Treatment efficacy expectations had a significant positive medium or large-sized 
correlation with psychological side effect experiences, for surgery (r2 = 0.46, p = 
0.005), and radiotherapy (r2 = 0.30, p = 0.025), but this was not significant for 
chemotherapy (r2 = 0.32, p = 0.097).  This indicates that for surgery and 
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radiotherapy, the more positive the treatment efficacy expectation, the more positive 
the experience of psychological side effects, but not for chemotherapy. 
Treatment efficacy expectations had a significant positive correlation with 
treatment consequences experiences, only for surgery, this had a large effect size (r2 
= 0.48, p = 0.004), this was not significant for radiotherapy (r2 = 0.21, p < 0.122) or 
chemotherapy (r2 = 0.12, p = 0.548).  This indicates that for surgery, the more 
positive the treatment efficacy expectation, the more positive the overall experience 
of treatment consequences, but not for radiotherapy or chemotherapy.  Table 6.6 
contains full details of these analyses. 
Table 6.6: The Relationship between Treatment Efficacy Expectations and Treatment 
Experiences, by Treatment Type 
 Experiences 
Surgery Radiotherapy Chemotherapy 
Physical Side 
Effects 
r2 = 0.24, p = 0.158 
(n= 35) 
r2 = 0.08, p = 0.543 
(n= 56) 
r2 = 0.01, p = 0.966 
(n= 28) 
Psychological 
Side Effects 
r2 = 0.46, p = 0.005 
(n= 35) 
r2 = 0.30, p = 0.025 
(n= 56) 
r2 = 0.32, p = 0.097 
(n= 28) 
Treatment 
Consequences 
r2 = 0.48, p = 0.004 
(n= 35) 
r2 = 0.21, p < 0.122 
(n= 56) 
r2 = 0.12, p = 0.548 
(n= 28) 
 
6.5.4 Calculating the gap between treatment expectations and treatment 
experiences 
To calculate the gap between expectations and experiences, participants’ experiences 
scores were subtracted from their expectations scores, to give a gap score for each 
participant.  A positive gap score indicates that the treatment experience was worse 
than expected.  A negative gap score indicates that the treatment experience was 
better than expected.  The mean gap for each of the total score variables are shown in 
Table 6.7, on the next page.  All mean expectations-experiences gap scores indicated 
that they were well-matched, with the exception of Total Impact for those treated in 
the past, which had a mean gap showing that experiences were slightly worse than 
expected. 
 
 
 
  
137 
 
Table 6.7: Mean Gaps between Expectations and Experiences 
 Expectations-Experiences Mean 
Gaps 
Past Current 
Total Physical Side Effects 0.47 (SD= 1.14) -0.45 (SD= 1.17) 
Total Psychological Side 
Effects 
-0.34 (SD= 1.15) -0.40 (SD= 0.94) 
Total Impact 0.54 (SD= 1.09) 0.12 (SD= 1.17) 
Total Treatment 
Consequences 
0.21 (SD= 0.91) -0.24 (SD= 0.92) 
 
 6.5.5 Do treatment efficacy expectations relate to the gap between 
expectations and experiences? 
Correlational analyses were conducted to explore the relationship between treatment 
efficacy and the gap between expectations and experiences, using Spearman’s rho as 
parametric assumptions had been violated.   
For those whose treatment was in the past, there was a significant negative 
correlation between treatment efficacy expectations and psychological side effects, 
with a small-to-medium-sized effect (r2 = -0.20, p = 0.02).  There was also a 
negative correlation between treatment efficacy expectations and psychological side 
effects and impact combined, with a small effect size, which approached the level of 
significance (r2 = -0.17, p = 0.058).  All other relationships with treatment efficacy 
expectations for those who had received treatment in the past were not significant 
but they were all in a negative direction.  This indicates that those with lower 
treatment efficacy expectations had experiences that were worse than expected and 
those with higher treatment efficacy expectations had experiences that were better 
than expected. 
For those who were currently receiving treatment, no significant relationships 
were found between treatment efficacy and the difference between expectations and 
experiences scores.  This might be explained by the lower sample size available for 
these calculations (n= 62) and ensuing lack of power, particularly as the effect sizes 
were small.  However, all correlations are positive, indicating that the relationship 
may be in the opposite direction than found with those whose treatment was in the 
past.  This indicates that for those currently receiving treatment, those with higher 
treatment efficacy expectations had treatment experiences that were worse than 
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expected and those with lower treatment efficacy expectations had experiences that 
were better than expected. 
Full details of the relationship significance values and effect sizes for both 
treatment statuses can be found in Table 6.8. 
Table 6.8: The Relationships between Treatment Efficacy Expectations and the Gap 
Between Expectations and Experiences 
 Past Current 
Physical Side Effects r2 = -0.10, p = 0.28 
(n= 130) 
r2 = 0.12, p = 0.37 
(n= 62) 
Psychological Side Effects r2 = -0.20, p = 0.02 
(n= 130) 
r2 = 0.06, p = 0.67 
(n= 62) 
Total Side Effects r2 = -0.15, p = 0.09 
(n= 130) 
r2 = 0.13, p = 0.30 
(n= 62) 
Impact r2 = -0.11, p = 0.24 
(n= 124) 
r2 = 0.12, p = 0.35 
(n= 62) 
Impact & Physical Side Effects r2 = -0.09, p = 0.31 
(n= 130) 
r2 = 0.13, p = 0.31 
(n= 62) 
Impact & Psychological Side Effects r2 = -0.17, p = 0.058 
(n= 130) 
r2 = 0.08, p = 0.52 
(n= 62) 
Treatment Consequences r2 = -0.13, p = 0.15 
(n= 130) 
r2 = 0.14, p = 0.29 
(n= 62) 
 
 6.5.6 Does the gap between expectations and experiences relate to 
experiences? 
The final analyses to be conducted explored the relationship between the 
expectations-experiences gap and experiences, to understand whether the gap 
between expectations and experiences was related to experiences.  This would 
indicate whether having more positive or negative experiences than patients 
expected, had a relationship with their treatment experiences. 
 6.5.6.1 Is there a relationship between the expectations-experiences gap 
and experiences? 
These analyses used Pearson’s r where parametric assumptions had not been 
violated, and Spearman’s rho where they had.  The gap scores from the previous 
analysis were used, which were calculated by subtracting participants’ experiences 
scores from their expectations score.  These were then correlated with their original 
experiences score.   These were carried out at the group level and split by treatment 
status, past or current. 
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All the relationships explored were significant negative relationships between 
the expectations-experiences gap and experiences. The effect sizes were almost 
exclusively large, the only exception being for physical side effects, where there was 
a medium-to-large-sized effect (r2 = -0.43).  Full details of the significance values 
and effect sizes can be seen in Table 6.9.  To reiterate the meaning of the difference 
scoring, a positive difference score indicates that the experience was worse than 
expected, whereas a negative difference score indicates that the experience was 
better than expected.  Therefore, the results suggest that the worse an experience was 
than expected, the more negative the experience was overall and the better it was 
than expected, the more positive it was overall. 
Table 6.9: The relationships between the expectations-experiences gap and 
experiences 
 Past Current 
Physical Side Effects *r2 = -0.43, p < 0.001 
(n= 130) 
r = -0.55, p < 0.001 
(n= 62) 
Psychological Side Effects r = -0.74, p < 0.001 
(n= 130) 
r = -0.69, p < 0.001 
(n= 62) 
Impact r = -0.60, p < 0.001 
(n= 124) 
r = -0.62, p < 0.001 
(n= 62) 
Treatment Consequences r = -0.61, p < 0.001 
(n= 130) 
r = -0.73, p < 0.001 
(n= 62) 
 *parametric assumptions violated, non-parametric equivalent test used 
 6.5.6.2 Does the nature of the expectations-experiences gap relate to 
experiences? 
Participants’ gap scores were then used to determine three groups: participants 
whose experiences were better than expected, those whose experiences were worse 
than expected, and those who experiences were well-matched to their expectations.  
These groups were analysed to understand whether group membership had an effect 
on overall experiences scores. 
 6.5.6.2.1 Patients currently receiving treatment 
Physical Side Effects: Results showed that there was a significant, large effect of 
group membership on experience score, F (2,61) = 14.82, p < 0.001, r = 0.58. A 
Gabriel post-hoc test revealed that experiences were significantly more positive for 
those whose experiences were better than expected (M= 4.58, SD= 0.92), than those 
whose experiences were well-matched to their expectations (M= 3.20, SD= 1.19, p< 
0.001) and those whose experiences were worse than their expectations (M= 3.08, 
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SD= 1.05, p< 0.001).  There was no significant difference between the matched 
group and the group with experiences worse than their expectations (p = 0.983). 
Psychological Side Effects: Results showed that there was a significant, very 
large effect of group membership on experience score, F (2,61) = 25.67, p < 0.001, r 
= 0.93. A Gabriel post-hoc test revealed that experiences were significantly more 
positive for those whose experiences were better than expected (M= 4.49, SD= 
0.99), than those whose experiences were well-matched to their expectations (M= 
3.18, SD= 1.03, p < 0.001), and those whose experiences were worse than their 
expectations (M= 2.03, SD= 0.59, p < 0.001).  Experiences were also significantly 
more positive for those whose experiences were well-matched to their expectations 
(M= 3.18, SD= 1.03), than those whose experiences were worse than their 
expectations (M= 2.03, SD= 0.59, p = 0.06). 
Impact: Results showed that there was a significant, large effect of group 
membership on experience score, F (2,61) = 15.17, p < 0.001, r = 0.58. A Gabriel 
post-hoc test revealed that experiences were significantly more negative for those 
whose experiences were worse than their expectations (M= 3.11, SD= 1.17), than 
those whose experiences were well-matched to their expectations (M= 4.26, SD= 
1.08, p = 0.001), and those whose experiences were better than expected (M= 5.01, 
SD= 0.77, p < 0.001).  There was no significant difference between the group with 
experiences better than expected and the matched group (p = 0.068). 
Treatment Consequences: Results showed that there was a significant, large 
effect of group membership on experience score, F (2,61) = 24.53, p < 0.001, r = 
0.67. A Gabriel post-hoc test revealed that experiences were significantly more 
positive for those whose experiences were better than expected (M= 4.65, SD= 
0.78), than those whose experiences were well-matched to their expectations (M= 
3.66, SD= 0.85, p < 0.001), and those whose experiences were worse than their 
expectations (M= 2.78, SD= 0.60, p < 0.001).  Experiences were also significantly 
more positive for those whose experiences were well-matched to their expectations 
(M= 3.66, SD= 0.85), than those whose experiences were worse than their 
expectations (M= 2.78, SD= 0.60, p= 0.004). 
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 6.5.6.2.2 Patients who had received treatment in the past 
Physical Side Effects: Results showed that there was a significant, medium-sized 
effect of group membership on experience score, F (2,53) = 11.91, p < 0.001, r = 
0.35. A Games-Howell post-hoc test revealed that experiences were significantly 
more negative for those whose experiences were worse than their expectations (M= 
2.73, SD= 1.02), than those whose experiences were well-matched to their 
expectations (M= 3.45, SD= 1.44, p = 0.008), and those whose experiences were 
better than expected (M= 4.00, SD= 1.04, p < 0.001).  There was no significant 
difference between the group with experiences better than expected and the matched 
group (p = 0.180). 
Psychological Side Effects: Results showed that there was a significant, large 
effect of group membership on experience score, F (2,129) = 42.44, p < 0.001, r = 
0.63. A Gabriel post-hoc test revealed that experiences were significantly more 
positive for those whose experiences were better than expected (M= 4.60, SD= 
1.15), than those whose experiences were well-matched to their expectations (M= 
3.45, SD= 0.96, p < 0.001), and those whose experiences were worse than their 
expectations (M= 2.40, SD= 0.80, p < 0.001).  Experiences were also significantly 
more positive for those whose experiences were well-matched to their expectations 
(M= 3.45, SD= 0.96), than those whose experiences were worse than their 
expectations (M= 2.40, SD= 0.80, p < 0.001). 
Impact: Results showed that there was a significant, large effect of group 
membership on experience score, F (2,123) = 26.57, p < 0.001, r = 0.55. A Gabriel 
post-hoc test revealed that experiences were significantly more negative for those 
whose experiences were worse than their expectations (M= 2.83, SD= 0.98), than 
those whose experiences were well-matched to their expectations (M= 4.24, SD= 
1.27, p = 0.001), and those whose experiences were better than expected (M= 4.47, 
SD= 1.18, p < 0.001).  There was no significant difference between the group with 
experiences better than expected and the matched group (p = 0.828). 
Treatment Consequences: Results showed that there was a significant, large 
effect of group membership on experience score, F (2,117) = 40.41, p < 0.001, r = 
0.57. A Gabriel post-hoc test revealed that experiences were significantly more 
positive for those whose experiences were better than expected (M= 4.58, SD= 
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0.54), than those whose experiences were well-matched to their expectations (M= 
3.59, SD= 0.94, p < 0.001), and those whose experiences were worse than their 
expectations (M= 2.86, SD= 0.72, p < 0.001).  Experiences were also significantly 
more positive for those whose experiences were well-matched to their expectations 
(M= 3.59, SD= 0.94), than those whose experiences were worse than their 
expectations (M= 2.86, SD= 0.72, p < 0.001). Details of all these analyses are shown 
in Table 6.10. 
Table 6.10: Analysis of the Effect of Expectations-Experiences Gap Group 
Membership on Experiences 
 Past Current 
ANOVA Post-hoc ANOVA Post-hoc 
Physical Side 
Effects 
n for 1 = 19 
n for 2 = 58 
n for 3 = 53 
Games-
Howell 
3 > 2 
3 > 1 
1 = 2 
F (2,61) = 
14.82, p < 
0.001, r = 0.58 
n for 3 = 14 
n for 2 = 19 
n for 1 = 29 
Gabriel 
1 > 2 
1 > 3 
2 = 3 
Psychological Side 
Effects 
n for 1 = 46 
n for 2 = 57 
n for 3 = 27 
Gabriel 
1 > 2 > 3 
n for 3 = 9 
n for 2 = 27 
n for 1 = 26 
Gabriel 
1 > 2 > 3 
Impact n for 1 = 21 
n for 2 = 47 
n for 3 = 56 
Gabriel 
3 > 2 
3 > 1 
1 = 2 
n for 3 = 19 
n for 2 = 27 
n for 1 = 16 
Gabriel 
3 > 2 
3 > 1 
1 = 2 
Treatment 
Consequences 
n for 1 = 21 
n for 2 = 67 
n for 3 = 40 
Games-
Howell 
1 > 2 > 3 
n for 3 = 13 
n for 2 = 27 
n for 1 = 22 
Gabriel 
1 > 2 > 3 
 1= better than expected, 2= well-matched, 3= worse 
6.6 Discussion 
The current chapter explored the relationship between expectations and experiences 
of cancer treatment, in a broader sense than has been included in the previous 
literature.  It also provided evidence to understand the implications of the gap 
between expectations and experiences.  Overall, the results indicate that there are 
significant relationships between expectations and experiences, and that the 
expectations-experiences gap does impact experiences. 
There were significant positive correlations between expectations and 
experiences on all subscales, and when these subscales were grouped into physical 
side effects, psychological side effects and impact.  The relationship remained when 
these groups were combined to study the total treatment consequences, indicating 
that an overall more positive expectation is related to an overall more positive 
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experience.  Effect sizes for all relationships were medium or large and this held 
across those who had received treatment in the past and those currently receiving 
treatment.  This could indicate support for a response expectancy perspective by 
suggesting that expectations and experiences are related, and therefore it may be 
better to have more positive expectations, in order to have more positive experiences 
(Kirsch, 1985).  As results were measured cross-sectionally and expectations data 
were retrospective they could have been contaminated by current or past 
experiences.  However, given the larger effect sizes, it is likely that there is some 
effect of expectations on experiences.  This first attempt at using a broader measure 
of expectations and experiences to examine the relationship between the two 
variables shows that this warrants further attention with prospective longitudinal 
methods. 
To continue this broader examination of the expectations-experiences 
relationship, treatment efficacy expectations were explored in relation to both 
expectations of treatment consequences and experiences thereof.  The results were a 
little more mixed than with the previous analyses but suggested that treatment 
efficacy expectations relate to expectations of psychological side effects, regardless 
of treatment modality or whether patients had received treatment in the past or were 
currently receiving treatment.  This may be likened to the necessary evil findings 
from Chapter 4, as perhaps those who have positive treatment efficacy expectations 
believe that whatever physical side effects and impact the treatment may have will 
not necessarily affect them psychologically because the overall outcome will be 
positive in terms of survival.  This aligns with Koller et al.’s (2000) findings which 
suggest that positive treatment efficacy expectations are protective of QOL in the 
short-term and indicates that this could occur because patients feel that whatever 
treatment entails, they will be able to cope with it because they have confidence that 
they will survive.  These findings could also reflect a generally positive outlook on 
the part of patients who have positive treatment efficacy expectations.  This seems 
unlikely, however, in light of the fact that treatment efficacy expectations were often 
unrelated to other expectations. 
In terms of the relationship between treatment efficacy expectations and 
experiences, the results for those who had received treatment in the past were very 
different than for those currently receiving treatment.  For those who had received 
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treatment in the past, treatment efficacy expectations were related to both physical 
and psychological side effects but not impact.  When these three groups were 
analysed together, there was a significant positive relationship between treatment 
efficacy expectations and overall treatment experiences.  Like the above findings, 
this may be suggestive of the benefits of encouraging positive expectations prior to 
cancer treatment, perhaps suggesting that they may be protective of QOL, like other 
findings (Koller et al., 2000).  Conversely, however, for those currently receiving 
treatment there were no significant relationships.  This difference between past and 
current treatment status indicates that caution should be applied to the interpretation 
of these findings because the relationship may be more a result of when measures 
were presented.  The mixed findings mean that this does warrant further 
consideration but the current results add a breadth of knowledge to the treatment 
efficacy expectations literature, taking this beyond merely exploring physical 
outcomes in terms of survival, or overall QOL. 
The remainder of the results made a first attempt at examining the 
expectations-experiences gap using broader measures of both factors and paving the 
way for further prospective analyses of the relationship.  They do, however, provide 
some interesting findings in their own right.  Firstly, the relationship between 
treatment efficacy expectations and the expectations-experiences gap was examined.  
The most notable finding here was the difference in the direction of relationship 
between those who were currently receiving treatment and those who had received it 
in the past.  The current treatment group relationships were not significant, probably 
due to the small sample size and lack of power but provide an interesting insight 
nonetheless.  For those who received treatment in the past, the higher treatment 
efficacy expectations were, the better experiences were than expected.  The reverse 
was true of those currently receiving treatment.  This could reflect the differences 
between when participants were completing the measures.  In those currently 
receiving treatment, the experiences measured are currently occurring and so they 
are directly experiencing the impact of any expectancy violations.  In line with this 
perspective, therefore, those who are experiencing a negative violation, and feeling 
unprepared, or as evidenced in Chapter 4, feeling shocked at the reality of treatment, 
reported higher treatment efficacy expectations.  Those who are experiencing a 
positive violation, and feeling the relief described in Chapter 4, tended towards lower 
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treatment efficacy expectations.  This may reflect the shifting focus described in 
Chapter 4; when patients experience negative expectancy violations and shock, they 
focus on a positive treatment efficacy expectation to assist them in coping with a 
treatment experience that is worse than they had anticipated.  When patients 
experience positive expectancy violations and relief, they can focus on the treatment 
experience that is not as bad as anticipated and do not need to rely on treatment 
efficacy expectations in order to help them to cope. In this way, the treatment 
efficacy expectations that participants gave may have represented their current 
treatment efficacy expectations rather than retrospective ones, as it was too soon for 
participants to know their actual outcomes, it may have been difficult to differentiate 
between expectations prior to treatment and their current focus.  This does, however, 
lend some support to both an expectancy violations perspective and the previous 
qualitative findings within this thesis, which warrants prospective investigation in a 
larger sample (Burgoon & Hale, 1988; Chapter 4).  The divergent relationship found 
in those whose treatment was in the past was only significant in the relationship 
between treatment efficacy expectations and the psychological side effects 
expectations-experiences gap.  Given that other aspects were not significant, the 
direction is different to the above and not in line with the expectancy violations 
perspective, this may be an artefact of reflection.  This does not detract, however, 
from the findings of interest here that definitely justify further study of the 
relationships in question. 
The final set of analyses concerned the examination of the gap between 
expectations and experiences, in terms of whether experiences were better than, 
worse than, or matched to expectations, and the implications of this gap for how 
positive or negative experiences were.  The findings were very much in line with an 
expectancy violations perspective and again found support for the qualitative 
findings in Chapter 4 (Burgoon & Hale, 1988; Chapter 4).  Those whose experiences 
were better than their expectations, consistently had better experiences overall than 
those whose experiences were worse than their expectations.  In addition, those with 
matched expectations and experiences usually sat right in the middle of these groups 
in terms of their overall experiences.  This was found across subscale groups, and in 
both those who were currently receiving treatment and those who had received 
treatment in the past. 
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6.6.1 Limitations 
There are four significant limitations to this study that should be noted.  These do not 
mean that findings should be dismissed but they should be treated with caution.  The 
first is the sampling method, the use of social media may have led to a younger 
sample of cancer patients than may have been obtained in a clinical environment, if 
older patients are not using such networking sites.  The second, and most significant, 
is the retrospective collection of data on most measures.  Recollections of 
expectations may have been influenced by subsequent experiences and any 
recollections of experiences may have been influenced by eventual treatment 
efficacy-related outcomes.  For example, treatment experiences may have been 
viewed more favourably if the treatment had resulted in good long-term survival 
prospects.  Connected to this is the third limitation and that is the cross-sectional 
measurement of expectations and experiences.  Measuring the factors so close 
together could have led to more contamination of responses between the two factors; 
differentiating between expectations and experiences may be more challenging when 
the questions are presented concurrently.  Finally, potential confounder variables 
were not explored in the analyses, which may have influenced the relationships 
analysed.  For example, demographic factors such as age, gender or socioeconomic 
status may have affected the nature of the expectations-experiences relationship.  
The effect of such variables in this relationship should be explored in future research. 
6.7 Conclusion 
The current study has identified some support for both perspectives of expectations 
by both suggesting that expectations are related to experiences of cancer treatment 
and that the expectations-experiences gap may have implications patients’ overall 
experiences.  It demonstrates that the measures developed in the previous chapter 
can be used in this context, provide a broader means of exploring expectations of 
cancer treatment than have previously been available, and illuminate the 
expectations-experiences gap.  There is also support for some of the qualitative 
findings from Chapter 4.  The retrospective nature of measuring expectations does 
represent a significant methodological limitation within this study and the 
recruitment of participants over social media may mean that the sample were not 
representative of all cancer patients.  The findings, therefore, do not yet provide 
enough evidence to clearly suggest the best approach to managing expectations in 
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cancer care.  In line with some of the previous literature, and the qualitative findings 
from Chapter 4, there is a suggestion that the expectations-experiences gap may be 
important and further, prospective, longitudinal study is definitely warranted. 
6.8 Towards Understanding the Role of Expectations of Cancer Treatment and 
Their Impact on Outcomes 
This chapter has explored the relationship between cancer patients’ expectations and 
experiences using the newly developed measures thereof, thus encompassing a 
broader range of expectations than has previously been the focus of research in this 
area.  Due to methodological limitations, the findings should be treated with caution 
but do suggest that the expectations-experiences gap is important, in line with an 
expectancy violations perspective.  This relationship will be examined further in a 
case study in the next chapter.  
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Chapter 7 
Study 4. The Relationship between Expectations and 
Experiences: A Clinical Case Study 
 
7.1 Overview 
Chapter 4 explored patients’ expectations and experiences of cancer treatment and 
highlighted that they are much broader than has previously been the focus, 
emphasising the need for the new measures of expectations and experiences that 
were developed and validated in Chapter 5.  These measures were operationalised in 
Chapter 6, which compared expectations and experiences, and also studied the 
expectations-experiences gap.  The results suggested that, in line with previous 
research, patients’ expectations of cancer treatment do have the potential to influence 
patients’ experiences of cancer treatment.  The study provided further support for the 
standpoint that suggests there may be implications when patients’ experiences do not 
match their expectations, although conclusions are limited by the retrospective 
nature of the measurement of expectations.  This chapter presents a case study that 
explores the relationship between patients’ expectations of cancer treatment and their 
experiences using the measures developed in Chapter 5 and extending the previous 
chapter into using a prospective design. 
7.2 Introduction 
The relationship between expectations and experiences of cancer treatment in the 
literature prior to this thesis, was explored predominantly in terms of response 
expectancy theory, which suggests that expectations predict experiences and that 
more positive expectations are advantageous, in order that patients’ experiences of 
treatment are positive (Kirsch, 1985).  Differing perspectives to this can be drawn 
from expectancy violations theory and preparation for treatment, both of which 
ultimately suggest that more realistic pre-treatment expectations may be more 
preferential, in order that patients can better cope with their treatment experiences 
and to negate the adverse consequences that may be felt when experiences do not 
live up to expectations (Burgoon & Hale, 1988; Janis, 1958). 
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Findings from the thesis chapters presented thus far, suggest that expectations 
are related to experiences, as suggested by response expectancy theory (Kirsch, 
1985; Chapter 6).  However, there is evidence that the expectations-experiences gap 
deserves more attention than it has previously received and may perhaps be a more 
important determinant of longer-term outcomes (Chapters 4 and 6).  Findings from a 
qualitative study and a quantitative study with retrospective collection of 
expectations data, suggest support for a role of expectancy violations theory by 
showing that those with better experiences than their expectations feel relief and 
have more positive experiences overall, whereas those with worse experiences than 
their expectations feel shock and have more negative experiences overall (Burgoon 
& Hale, 1988; Chapters 4 and 6).  In order to further explore the relationships 
between expectations and experiences suggested in the previous chapters, 
quantitative, prospective, longitudinal study is required, preferably conducted within 
a clinical setting. 
7.3 Aims of the Present Study 
The aim of this study was to explore the longer-term relationship between patients’ 
expectations pre-treatment and their experiences of subsequent treatment.  There 
were, however, a multitude of problems with the original longitudinal clinical based 
study as described below.  This chapter, therefore, instead presents a case study on a 
single patient to explore the link between pre-treatment expectations and experiences 
during treatment. 
7.4 Problems Encountered for this Study 
The original aim of the present study was to carry out a large scale longitudinal study 
in a clinical setting to track the dynamic relationship between expectations and 
experiences of cancer treatment.  To this end NHS ethical and Research and 
Development approval was obtained together with approval and commitment from a 
cancer ward.  This process took about 9 months.  There were, however, two key 
issues that limited recruitment.  First, the ethics committee were unwilling to let the 
researcher approach the patients directly in the waiting room.  This was due to the 
fact that cancer patients meet a lot of new people in the course of their diagnosis and 
treatment which is overwhelming and it was felt that introducing another new face 
for the purposes of research was unethical due to the burden this could place on 
patients.   As a result, it was agreed that clinic staff would be responsible for 
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advertising the study and recruiting patients.  This approach was approved by the 
cancer centre and the CNSs were keen to be involved in this part of the process.  
Second, once set up, there were last minute concerns expressed by management over 
the additional workload that this might create within their teams, which appeared to 
result from structural changes within the department.  This was probably 
compounded by the length of time between the initial agreements for these processes 
being made and their eventual implementation, due to delays experienced in 
obtaining all the necessary ethical and governance approvals.  As a result the 
researcher was advised to use a much more passive advertising method, involving 
placement of leaflets in patient information packs, waiting rooms, and on notice 
boards in the hospital.  The researcher was therefore not permitted into the clinic and 
clinic staff were not permitted to help with recruitment. 
Therefore, although over 1,000 leaflets were distributed using these means 
over the course of around 7 months, only three patients contacted the researcher 
interested in participating.  Of these, one did not respond, one completed just the 
baseline measures and only one completed all measures at baseline and follow-up.  It 
is for this reason that the current chapter reports on a case study of one patient. 
7.5 Method 
 7.5.1 Design 
The study used a repeated measures single case study (n=1) design with measures of 
expectations taken prior to treatment commencement and measures of actual 
experiences taken approximately four weeks after the start of treatment. 
Although not the original aim of the study, and there are limitations in terms 
of generalisability, using a case study design has benefits.  Such an approach 
facilitates focused, in-depth exploration of the perspectives of one patient.  It can 
highlight the nuances of a patient’s experiences, examining them more closely and 
gaining a much more detailed understanding of them than when using larger samples 
(Noor, 2008; Willig, 2008). 
 7.5.2 Case 
The patient was a 59-year-old woman of White British ethnic origin with breast 
cancer.  She had children but they were not dependents.  Upon recruitment, the 
patient was three months post diagnosis.  She was due to receive radiotherapy and 
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her expectations and experiences were therefore measured in relation to this.  The 
patient had never received radiotherapy in the past but had been treated for this 
cancer diagnosis with surgery.  The radiotherapy treatment was of curative intent. 
 7.5.3 Measures 
A background information questionnaire was used to capture the patient’s 
demographic data and that relating to her cancer and its treatment.  At baseline, the 
Expectations of Cancer Treatment Questionnaire (EXPECT-CTQ; Appendix T) was 
used to gather prospective data about the patient’s expectations of her upcoming 
radiotherapy treatment which assesses expectations about treatment efficacy and 
treatment consequences.  Treatment consequences had 3 sub-constructs each divided 
into sub scales made up of individual items: i) expectations about physical side 
effects (subscales: appearance, pain, fatigue, gastro); ii) psychological side effects 
(subscales: negative emotion, positive outlook); iii) impact (subscales: self-care, 
impact on daily life and social impact).  This is a 39-item scale. 
The matched Experiences of Cancer Treatment Questionnaire (EXPER-CTQ; 
Appendix U) was presented at follow up, during the patient’s treatment with 
radiotherapy. This measures experiences of cancer treatment consequences; physical 
side effects, psychological side effects, and impact; and has 36 items.  The two 
measures are matched in relation to treatment consequences subscales and items but 
treatment efficacy is only included in the baseline measure.  Both assess beliefs 
about the physical and psychosocial consequences of treatment. 
 7.5.4 Procedure 
Ethical approval was gained from an NHS Research Ethics Committee prior to 
advertisement and recruitment (Appendix V).  The study was advertised in one 
Oncology Centre in South East England in the form of leaflets and posters that were 
distributed throughout the Oncology Centre, placed in patient information packs and 
also given to patients by Clinical Nurse Specialists working within the Oncology 
Centre (Appendix W). 
Leaflets and posters invited interested individuals to contact the researcher 
for more information.  Upon doing so, interested individuals were provided with 
more details about the study in the form of a Participant Information Sheet 
(Appendix X).  They were encouraged to read this and ask any questions required 
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before signing consent (a copy of the Consent Form is available in Appendix Y).  
The participant was also provided with the background information questionnaire 
and baseline measures at this time and asked to return them by post once complete.  
The researcher contacted the patient once more for the follow up during treatment, 
based on the treatment start date provided by the patient at baseline.  A written 
debrief sheet (Appendix Z) was provided for the participant to read upon completion 
of the study.  Data were collected between April and June 2017. 
 7.5.5 Data analysis 
Scores were calculated for each sub-construct and sub scale of the EXPECT-CTQ 
and the EXPER-CTQ. These scores were then used to produce a series of graphs 
detailing the patient’s baseline and follow up scores on each.  No statistical analyses 
were possible due to there only being one participant, but the contents of the graphs 
have been analysed descriptively. 
7.6 Results 
Only one patient responded to questionnaires presented at both time points and 
therefore no statistical analyses could be conducted. What follows, therefore, is a 
detailed depiction of the results gained from this patient at baseline and follow up. 
 7.6.1 Treatment efficacy expectations (baseline) 
For all items within the treatment efficacy expectations subscale, the patient’s score 
was 6 out of a possible 7.  This indicates a positive expectation of treatment efficacy. 
 7.6.2 Comparing treatment expectations (baseline) and treatment 
experiences (follow up) 
The comparison between baseline expectations and follow up experiences is 
presented using a summary table and a series of graphs, which show the relationship 
between expectations and experiences for this patient at the level of total scores, sub-
constructs, subscales and items.  The first graph presented shows the total treatment 
consequences scores, split by sub-constructs (physical side effects, psychological 
side effects and impact). Graphs are then presented for each of the subscales 
contained within these sub-constructs.  Finally, graphs will be presented for each of 
the items contained within the subscales. 
Table 7.1, on the next page, shows this numerically and summarises the structure of 
the sub-constructs, subscales and the items contained within them. 
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Table 7.1: Mean Scores for Expectations and Experiences: Total Scores, Sub-constructs, Subscales and Items 
 Expectations Experiences  Expectations Experiences  Expectations Experiences  Expectations Experiences 
Treatment 
Consequences 
4.59 2.57 Physical Side 
Effects 
4.38 2.63 Appearance 5.67 1.33 Lose hair - 
head 
7.00 1.00 
Lose hair - 
body 
6.00 1.00 
Weight 
control 
4.00 2.00 
Pain 3.67 3.67 Pain - 
medication 
4.00 2.00 
Pain - 
cancer 
4.00 7.00 
Pain - Tx 
process 
3.00 2.00 
Fatigue 4.00 2.33 Tired 4.00 2.00 
Low energy 4.00 3.00 
Exhausted 4.00 2.00 
Gastro 4.20 3.20 Nausea 4.00 2.00 
Vomiting 6.00 7.00 
Appetite 4.00 5.00 
Constipated 3.00 1.00 
Diarrhoea 4.00 1.00 
Psychological 
Side Effects 
3.93 2.45 Negative 
Emotion 
3.60 3.40 Worried 2.00 1.00 
Irritated 4.00 5.00 
Depressed 4.00 4.00 
Sad 4.00 4.00 
Down 4.00 3.00 
Positive 
Outlook 
4.25 1.50 Stronger 
person 
5.00 2.00 
Content 3.00 1.00 
Kind 4.00 1.00 
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 Expectations Experiences  Expectations Experiences  Expectations Experiences  Expectations Experiences 
Optimistic 5.00 2.00 
Impact 5.47 2.64 Self-Care 6.50 3.83 Walking 6.00 2.00 
Dressing 6.00 1.00 
Feeding 6.00 7.00 
Stairs 7.00 4.00 
Personal 
hygiene 
7.00 4.00 
Toilet 
hygiene 
7.00 5.00 
Impact on 
Daily Life 
4.67 1.33 Work 6.00 1.00 
Housework/ 
gardening 
4.00 2.00 
Pastimes/ 
hobbies 
4.00 1.00 
Social 
Impact 
5.25 2.75 Same 
things 
socially 
6.00 1.00 
More 
dependent 
6.00 2.00 
Care of 
others 
3.00 7.00 
Drive 6.00 1.00 
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 7.6.2.1 Total treatment consequences scores 
All data from the matched questionnaires of treatment expectations and experiences 
that were comparable (i.e. all items except those that related to treatment efficacy 
expectations), are included under the heading ‘Treatment Consequences’. 
The patient’s total score for expectations indicates a slightly positive 
expectation for treatment consequences.  Expectations differed according to the 
different sub-constructs.  The patient’s expectations of the impact of treatment were 
quite positive, so she expected that treatment would not have a big impact on her. 
The patient’s expectations of physical and psychological side effects were more 
neutral, with scores close to the midpoint of 4. 
The patient’s total score for experiences indicates a negative experience of 
treatment consequences.  All three sub-constructs of treatment consequences were 
quite homogenous in this regard. 
It was clear from this that overall, the patient’s treatment expectations were 
somewhat more positive than her experiences, although there were some differences 
between the sub-constructs.  Expectations of impact were more positive than 
experiences, expectations of physical side effects were somewhat more positive than 
experiences and expectations of psychological side effects were reasonably well-
matched to experiences. 
The difference between these expectations scores and experiences scores can 
be viewed in Figure 7.1, on the next page, which is split by physical side effects, 
psychological side effects, and impact. 
Next, this will be presented in more detail by looking at the sub-constructs of 
physical side effects, psychological side effects and impact individually, and the 
relationship between treatment expectations and experiences for each. 
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Figure 7.1: Patient Expectations and Experiences for Treatment Consequences by Physical 
Side Effects, Psychological Side Effects and Impact 
 
 7.6.2.2 Sub-construct 1: physical side effects 
Physical side effects expectations and experiences data can be viewed in Figure 7.2. 
 
Figure 7.2: Patient Expectations and Experiences for Physical Side Effects by Appearance, 
Pain, Fatigue and Gastro Symptoms 
The patient’s expectations of physical side effects were neutral overall.  
Expectations differed according to the different subscales.  The patient’s appearance 
expectations were positive, indicating that she did not expect to experience 
appearance-related side effects but her expectations of pain, fatigue and gastro side 
effects were neutral. 
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The patient’s experiences of physical side effects were slightly negative 
overall.  Experiences also differed according to the different subscales.  The patient’s 
experience of appearance-related side effects was very negative, of fatigue was 
negative, of gastro side effects was slightly negative and pain was neutral. 
Physical side effect expectations were somewhat more positive than 
experiences.  The expectations-experiences gap differed according to the four 
subscales.  Appearance expectations were much more positive than appearance side 
effect experiences.  Fatigue expectations were somewhat more positive than fatigue 
experiences.  Gastro expectations were reasonably well-matched to gastro 
experiences and pain expectations were well-matched to pain experiences. 
 7.6.2.3 Sub-construct 2:  psychological side effects 
Psychological side effects expectations and experiences data can be viewed in Figure 
7.3. 
 
Figure 7.3: Patient Expectations and Experiences for Psychological Side Effects by 
Negative Emotion and Positive Outlook 
The patient’s expectations of psychological side effects were neutral overall 
and for both subscales; negative emotion and positive outlook. 
The patient’s experiences of psychological side effects were negative overall.  
Experiences differed slightly according to the different subscales.  Positive outlook 
experiences were negative and negative emotion experiences were slightly negative. 
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Expectations of psychological side effects were reasonably well-matched to 
experiences overall.  The expectations-experiences gap differed according to the 
different subscales.  For negative emotion, expectations were well-matched to the 
patient’s experiences.  However, for positive outlook, expectations were more 
positive than experiences. 
 7.6.2.4 Sub-construct 3: impact 
Impact expectations and experiences data can be viewed in Figure 7.4. 
The patient’s expectations of impact were slightly positive overall.  
Expectations differed according to the different subscales.  Impact on daily life and 
social impact expectations were both slightly positive but self-care expectations were 
very positive. 
The patient’s experiences of impact were slightly negative overall.  
Experiences also differed according to the different subscales. Experiences of the 
impact on daily life were very negative, experiences of the social impact were 
slightly negative and experiences of self-care were neutral. 
Expectations of impact were more positive than experiences, both overall and 
across the three different subscales. 
 
Figure 7.4: Patient Expectations and Experiences for Impact by Self-Care, Impact on Daily 
Life and Social Impact 
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These will now be explored in even further detail, by presenting data by item, 
relating to the subscales within the above-mentioned sub-constructs of physical side 
effects, psychological side effects, and impact. 
 7.6.2.5 Subscales of physical side effects 
Physical side effects includes subscales of appearance, pain, fatigue and gastro 
symptoms. 
 7.6.2.5.1 Appearance 
Appearance expectations and experiences can be viewed in Figure 7.5. 
 
Figure 7.5: Patient Expectations and Experiences for Appearance by Lose Hair from Head, 
Lose Hair from Body, and Weight Control 
The patient’s expectations of appearance-related side effects were positive 
overall.  Expectations differed according to the different items within the subscale.  
The patient’s expectation of losing hair from her head was very positive (i.e. she did 
not expect to lose her hair), of losing hair from her body was positive, and of her 
weight being out of control was neutral. 
The patient’s experiences of appearance-related side effects were very 
negative overall.  Experiences also differed according to the different items but they 
were more homogenous than expectations.  The patient’s experience of losing hair 
from both her head and her body were very negative, and of her weight being out of 
control was negative. 
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The patient’s expectations were more positive than her experiences both 
overall for appearance and for all three of the items within the appearance subscale.  
For the hair-loss-related items, expectations were tremendously more positive than 
experiences but for the weight control item, the expectation was only somewhat 
more positive than the experience. 
 7.6.2.5.2 Pain 
Expectations and experiences of the second physical side effect subscale, pain, can 
be viewed in Figure 7.6. 
 
Figure 7.6: Patient Expectations and Experiences for Pain by Pain from Medication, Pain 
from Cancer, and Pain from Treatment Process 
The patient’s expectations of pain were neutral overall and on two of the 
three pain-related items (pain from cancer and pain from medication).  They were 
slightly negative on the third item (pain from the treatment process). 
The patient’s experiences of pain were likewise neutral overall.  However, 
experiences differed according to the different items within the subscale.  For two of 
the three pain items (pain from medication and from the treatment process), 
experiences were negative but for the third (pain from cancer), the experience was 
very positive. 
Expectations of pain were well-matched to experiences overall.  The 
expectations-experiences gap differed according to the different items.  For pain 
from the treatment process, expectations were reasonably well-matched to 
experiences.  For pain from medication, expectations were somewhat more positive 
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than experiences.  For pain from the cancer, expectations were more negative than 
experiences. 
 7.6.2.5.3 Fatigue 
The third subscale of physical side effects is fatigue and the patient’s expectations 
and experiences for the items contained within it can be viewed in Figure 7.7.  There 
is no separate line on the graph for tired because tired and exhausted were scored the 
same on both expectations and experiences. 
The patient’s expectations of fatigue were neutral overall and at item level.  
The patient’s experiences of fatigue were negative overall.  Experiences differed 
slightly according to the different items within the subscale.  For tired and exhausted, 
the patient’s experiences were negative, and for low energy, the experience was 
slightly negative. 
Expectations of fatigue were somewhat more positive than experiences, both 
overall and for the items of tired and exhausted.  For the final item in the subscale, 
low energy, the expectation was reasonably well-matched to the experience. 
 
Figure 7.7: Patient Expectations and Experiences for Fatigue by Tired, Low Energy, and 
Exhausted 
  
7.6.2.5.4 Gastro-Intestinal (Gastro) 
Expectations and experiences of the fourth and final physical side effect subscale, 
gastro, can be viewed in Figure 7.8, on the next page. 
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The patient’s gastro expectations indicate a neutral expectation of gastro side 
effects.  With the exception of the vomiting item, other gastro item expectations 
were fairly homogenous.  Items for appetite, nausea, and diarrhoea were all neutral, 
and the item for constipation was slightly negative.  The patient’s expectation of 
vomiting was positive, she did not expect to experience this.   
The patient’s gastro side effect experiences were slightly negative overall.  
Experiences differed according to the different items within the subscale.  
Experiences of constipation and diarrhoea were very negative and nausea was 
negative.  Experiences of appetite were slightly positive and vomiting very positive. 
Expectations of gastro symptoms overall were reasonably well-matched to 
experiences.  The expectation-experience gap differed according to the different 
items.  Vomiting and appetite expectations were reasonably well-matched to 
experiences.  Nausea and constipation expectations were somewhat more positive 
than experiences, and diarrhoea expectations were more positive than experiences. 
 
Figure 7.8: Patient Expectations and Experiences for Gastro by Nausea, Vomiting, Appetite, 
Constipation, and Diarrhoea 
  
7.6.2.6 Subscales of psychological side effects 
Psychological side effects includes negative emotion and positive outlook. 
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 7.6.2.6.1 Negative emotion 
Negative emotion expectations and experiences can be viewed in Figure 7.9, below.  
Depressed and sad had identical scores for both expectations and experiences, 
therefore there is no separate line depicted on the graph for depressed. 
The patient’s expectations of negative emotion were neutral overall.  Four of 
the five negative emotion items indicated a neutral expectation but the fifth, worried, 
indicated a negative expectation. 
The patient’s experiences of negative emotion were slightly negative overall.  
Experiences differed according to the different items within the subscale.  The items 
depressed and sad indicated neutral experiences, worried indicated a very negative 
experience, down a slightly negative experience, and irritated a slightly positive 
experience. 
Expectations were well-matched to experiences for negative emotion overall 
and all five items in the subscale were well-matched or reasonably well-matched. 
 
Figure 7.9: Patient Expectations and Experiences for Negative Emotion by Worried, 
Irritated, Depressed, Sad, and Down 
  
7.6.2.6.2 Positive outlook 
The second, and final, subscale of psychological side effects is positive outlook and 
the expectations and experiences scores from the items within this are shown in 
Figure 7.10, on the next page.  The scores for stronger person and optimistic are 
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identical on both expectations and experiences and there is therefore no separate line 
shown for stronger person.   
The patient’s expectations for positive outlook were neutral overall.  
Expectations differed according to the different items within the subscale.  
Expectations of two items (stronger person and optimistic) were slightly positive, 
one (kind) was neutral, and one (content) was slightly negative. 
The patient’s experiences of positive outlook were negative overall.  
Experiences differed slightly according to the different items within the subscale, all 
experiences were negative but the degree of this differed.  Stronger person and 
optimistic were negative and contend and kind were very negative. 
Expectations were more positive than experiences for positive outlook 
overall, and for the items contained within it.  The degree of this only varied for one 
item, content, for which expectations were only somewhat more positive than 
experiences. 
 
Figure 7.10: Patient Expectations and Experiences for Positive Outlook by Stronger Person, 
Content, Kind and Optimistic 
  
7.6.2.7 Subscales of impact 
Impact includes subscales of self-care, impact on daily life (DL), and social impact. 
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 7.6.2.7.1 Self-care 
Firstly, self-care expectations and experiences can be viewed in Figure 7.11, below.  
Stairs and personal hygiene expectations and experiences scores were identical, 
hence there is no separate line depicted on the graph for stairs. 
The patient’s expectations for self-care were positive overall and the items 
within the subscale were all quite homogenous.  They were all positive or very 
positive; the patient did not expect treatment to impact on her ability to care for 
herself. 
The patient’s experiences for self-care were neutral overall.  Experiences 
differed according to the different items within the subscale.  The patient’s 
experience of feeding was very positive, of toilet hygiene was slightly positive, of 
personal hygiene and stairs was neutral, of walking was negative and of dressing was 
very negative. 
Expectations were more positive than experiences for self-care overall.  The 
expectations-experiences gap differed according to the different items within the 
subscale.  Expectations for dressing were tremendously more positive than 
experiences, for walking they were much more positive than experiences, for 
personal hygiene and stairs they were more positive than experiences and for toilet 
hygiene they were somewhat more positive than experiences.  Finally, expectations 
for feeding were reasonably well-matched to experiences. 
 
Figure 7.11: Patient Expectations and Experiences for Self-Care by Walking, Dressing, 
Feeding, Stairs, Personal Hygiene and Toilet Hygiene 
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 7.6.2.7.2 Impact on daily life 
Expectations and experiences for the second subscale within impact, impact on daily 
life, can be viewed in Figure 7.12, below. 
The patient’s expectations of impact on daily life were slightly positive 
overall.  Expectations differed according to the items within the subscale.  The 
patient’s expectation of the impact on work was positive, indicating that she did not 
think treatment would impact on her ability to work.  For housework or gardening, 
and pastimes or hobbies, the patient’s expectations were neutral. 
The patient’s experiences of impact on daily life were very negative overall.  
All three items within the subscale were experienced negatively but for work and 
pastimes or hobbies, this experience was very negative. 
Expectations of impact on daily life were more positive than experiences.  
The size of the expectations-experiences gap differed according to the items within 
the subscale but expectations were more positive than experiences for all items.  
Expectations for work were tremendously more positive than experiences, for 
pastimes or hobbies they were more positive, and for housework or gardening they 
were somewhat more positive. 
 
Figure 7.12: Patient Expectations and Experiences for Impact on Daily Life by Work, 
Housework/Gardening, and Pastimes/Hobbies 
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 7.6.2.7.3 Social impact 
The third and final subscale of impact is social impact and the expectations and 
experiences scores from the items within this are shown in Figure 7.13, below.  
Same things socially and drive were scored identically for both expectations and 
experiences, which is why there is no separate line depicted for same things socially.  
The patient’s expectations of social impact were slightly positive overall.  
Expectations differed according to the different items within the subscale.  Same 
things socially, more dependent, and drive all had positive expectations but care of 
others had a slightly negative expectation. 
The patient’s experiences of social impact were slightly negative overall.  
Experiences also differed according to the different items within the subscale.  Same 
things socially and drive were experienced very negatively and more dependent 
negatively.  Care of others, however, was experienced very positively. 
Expectations were more positive than experiences for social impact overall.  
The expectations-experiences gap differed according to the items within the 
subscale.  For same things socially and drive expectations were tremendously more 
positive than experiences.  For more dependent expectations were much more 
positive than experiences but for care of others expectations were much more 
negative than experiences. 
 
Figure 7.13: Patient Expectations and Experiences for Social Impact by Same Things 
Socially, More Dependent, Care of Others and Drive 
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7.7 Discussion 
The patient in this case study had quite positive expectations of the overall 
consequences of treatment, and her expectations of treatment efficacy were positive.  
However, her experiences of treatment consequences were negative overall.  The 
similarity between treatment efficacy and treatment consequences expectations is 
congruent with the findings from the previous chapter (Chapter 6) although the 
current relationship could not be analysed statistically.  It lends a little more support 
to the notion discussed in that chapter, that where expectations of treatment efficacy 
are positive, treatment consequences may be anticipated as manageable because 
treatment is necessary for survival, also consistent with the view of treatment as a 
necessary evil found in Chapter 4.  Again, this could be interpreted as a general 
positive outlook on expectations of treatment, but treatment efficacy expectations are 
positive and treatment consequence expectations are only slightly positive.  At the 
sub-construct level, impact expectations are slightly positive but physical and 
psychological side effect expectations are more neutral.  These differences may 
undermine a general positive outlook perspective, as was also the case in the 
previous chapter (Chapter 6). 
Treatment efficacy expectations were positive, and experiences of treatment 
consequences were negative.  This fails to support a protective role of holding 
positive treatment efficacy expectations, that some previous research has evidenced 
(Koller et al., 2000).  Limited conclusions on this can be drawn from a case study, 
but it may indicate that the short-term gains in QOL previously found, do not hold as 
time passes.  As findings from the previous chapter show some support for Koller et 
al.’s (2000) study in this regard, and there are limitations to both studies within this 
thesis that address this, further investigation is needed to clarify this relationship. 
In relation to treatment consequences, there are some interesting implications 
for the consideration of the predictive role of expectations on experiences, and the 
expectations-experiences gap.  In terms of expectations as predictors of experiences, 
the results of this case study find little support for a response expectancy perspective, 
which would suggest that expectations and experiences should be at least reasonably 
well-matched (Kirsch, 1985).  Treatment consequences experiences overall were 
slightly more negative than experiences; at the level of the sub-construct of this, two 
out of three sub-constructs had unmatched expectations and experiences, in the same 
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direction as the overall scale.  Only psychological side effect expectations and 
experiences were reasonably well-matched.  At the subscale level, out of nine 
subscales, only three were at least reasonably well-matched; pain, gastro and 
negative emotion.  All the matched sub-constructs and subscales also had something 
in common with regard to expectations; expectations were neutral, indicating that 
expectations only predicted experiences where expectations were neutral.  Even at 
the item level, of 36 items, only 10 were well-matched; feeding, appetite, vomiting, 
all five negative emotion items, one of the three pain items, and one of the three 
fatigue items.  Of these 10 items, six contained neutral expectations, as seen with the 
matched subscales and sub-constructs.  Four items; the pain item, vomiting, worried, 
and feeding; showed either a positive or negative expectation predicting a matched 
positive or negative experience.  Their small number suggests that perhaps 
expectations for those particular items were just more realistic, rather than their 
having influenced experiences the way response expectancy theory would suggest 
(Kirsch, 1985).  However, it would be premature to conclude that these findings 
refute this perspective, but this does present a thought-provoking challenge that 
would be interesting to explore further with a larger sample. 
In terms of assessing the gap between expectations and experiences, then, 
overall the patient’s experiences were worse than expected, and her experiences were 
negative.  When viewed at the level of the subscales, those where expectations and 
experiences matched had neutral or only slightly negative experiences.  Conversely, 
those where experiences were worse than expectations, almost exclusively saw 
negative experiences; and the degree of this appeared to mirror the size of the 
expectations-experiences gap.  This would therefore appear to lend more support to 
an expectancy violations perspective, which suggests that a negative violation would 
lead to more negative experiences (Burgoon & Hale, 1988).  It is also in line with the 
findings from the previous chapter (Chapter 6), the study from which includes a 
much larger sample but was conducted using retrospective data.  Although both 
studies have their limitations, the fact that findings are congruent between them and 
with the previous literature in the area, shows promise for an expectancy violations 
perspective and the concept of encouraging realistic pre-treatment expectations in 
cancer patients (Maguire et al., 2017; Winterling et al., 2008; Koller et al., 2000; 
Wan et al., 1997).  Conducting research using the new measures of expectations and 
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experiences, addressing the limitations of the research presented thus far in the 
thesis, and within the wider literature, will strengthen the evidence in this area. 
7.8 Conclusion 
Together with the previous chapters (Chapters 4 and 6), the exploration of this 
expectations-experiences relationship does tend to provide more support for the 
perspective that suggests that more realistic expectations are optimal.  There are 
limitations of the current and previous studies of this within this thesis, including the 
case study nature of the current study, and retrospective data collection in the 
previous chapter.  Therefore, these findings would benefit from further investigation.  
By conducting more research using the methods described in this chapter, evidence 
can be gathered to further confirm this in larger, prospective samples.  Such research 
would also facilitate the confirmatory validation of the EXPECT-CTQ measure.  The 
findings from expectations research could help inform HCPs about how best to 
manage expectations.  Due to their involvement in this process, it is important to 
understand HCPs’ perspectives of patients’ expectations and experiences, which will 
be explored in the next chapter. 
7.9 Towards Understanding the Role of Expectations of Cancer Treatment and 
Their Impact on Outcomes 
This chapter has described a case study of a patient, measuring expectations prior to 
treatment commencement and experiences during treatment.  This highlights further 
support for the importance of the expectations-experiences gap and when taken 
together with findings from the previous chapters, could cautiously be suggested to 
conclude that it may be preferential for patients to have more realistic expectations 
of cancer treatment, in line with expectancy violations theory and preparation for 
treatment perspectives.  Further work would help to strengthen the evidence in this 
area and this chapter also describes the methodology that could be used to conduct 
such research in a larger clinical sample.  Healthcare professionals could help to 
manage expectations and therefore their perspectives on patients’ expectations and 
experiences of cancer treatment are important and will be explored in the next 
chapter. 
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Chapter Eight 
Study 5. Healthcare Professionals’ Beliefs about Patients’ 
Expectations and Experiences of Cancer Treatment:  
A Qualitative Study 
 
8.1 Overview 
Existing literature suggests a role for expectations in influencing experiences of 
cancer treatment.  The previous chapters (4-7) have extended this by studying 
expectations more broadly and comprehensively, developing, validating and utilising 
new measures that capture this wider approach to understanding expectations.  The 
results suggest that a broad range of expectations can influence patients’ experiences 
of cancer treatment and highlight the importance of the expectations-experiences 
gap.  Although no firm conclusions can be drawn due to methodological limitations, 
there is some support for the standpoint that patients should be encouraged to hold 
more realistic expectations about an upcoming treatment.  Whilst work continues in 
this area, it is additionally important to consider the perspectives of healthcare 
professionals, as the literature suggests they have a role in managing patients’ 
expectations.  Understanding their beliefs about patients’ expectations and 
experiences of cancer treatment is therefore the focus of the present chapter. 
8.2 Introduction 
Within cancer care, patients encounter a number of different healthcare professionals 
(HCPs) throughout their treatment pathway.  HCPs have a role in providing support, 
developing good-quality relationships with patients and demonstrating to them that 
they care, which can impact on patients’ experiences of cancer treatment (Oakley, et 
al., 2017; Lelorain et al., 2012; Kristiansen et al., 2010).  The multidisciplinary team 
(MDT) has emerged as an effective way of managing cancer care, with clinical nurse 
specialists (CNSs) seen as an integral part of this team and vital in providing holistic 
care in line with a biopsychosocial model of health (McPhillips et al., 2015; Tarrant 
et al., 2008).  It is now a recommendation that all cancer patients should be 
introduced to a CNS at the point of diagnosis, and there is much support for the role 
from other HCPs and patients (Ling et al., 2017; Dempsey et al., 2016; Droog et al., 
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2014; Ling et al., 2013; Hardie & Leary, 2010; Ream et al., 2009; Wells et al., 2008; 
Jack et al., 2003).  There is also evidence to suggest that the provision of a CNS can 
have a range of positive health outcomes, such as reduced mortality and length of 
hospital stay (Bryant-Lukosius et al., 2015).  It is therefore understandable that CNSs 
have become a valued and integral part of caring for cancer patients and optimising 
patient experiences of cancer treatment. 
Within the context of patients’ expectations of cancer treatment, the focus of 
the thesis, the relationship developed between the CNS and the patient, and the 
support they offer, provides another opportunity for the CNS to influence patients’ 
treatment experiences.  This is through the ways in which they manage patients’ 
expectations.  The way information is framed in healthcare communications has long 
been established to influence how treatments are perceived by patients (Tversky & 
Kahneman, 1981).  Therefore, the CNS’s framing of information has the potential to 
impact upon patients’ expectations of cancer treatment.  The information received 
and retained from HCPs has been shown to have a significant influence on patients’ 
expectations of cancer treatment (Llewellyn et al., 2005). 
There tends to be a focus on positive expectations in cancer care and HCPs 
play an active part in creating this positive outlook, especially in relation to treatment 
efficacy (Taylor et al., 2016).  Considering the previous literature and the findings 
from the earlier thesis chapters (Chapters 4-7), this could be problematic because the 
more positive patients’ expectations are, the more likelihood there is of negative 
expectancy violations, which there is emerging evidence to suggest could impact 
negatively on patients’ experiences of cancer treatment. 
It is important, therefore, to understand what CNSs believe regarding 
patients’ expectations and experiences of cancer treatment, as these may influence 
the management of patient expectations. 
8.3 Aims of the Present Study 
The current study aimed to understand CNSs beliefs about the role of patients’ 
expectations in their subsequent experiences of cancer treatment. 
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8.4 Method 
 8.4.1 Design 
Qualitative methods were used to gain a detailed understanding of what CNSs 
believe makes a difference to patients’ experiences of cancer treatment.  One-to-one 
interviews were conducted in order that professionals felt they could be open about 
their opinions and not feel restricted in what they could say in the presence of a 
colleague or guided by others’ views. These were semi-structured so that specific 
aspects of CNSs' beliefs could be explored but without restricting the disclosure of 
other related information. 
 8.4.2 Sample 
Eight female CNSs with between 5 and 26 years of experience working with cancer 
patients (M= 15.25 years) were interviewed.  They were aged between 39 and 65, 
were White British (n= 7) or White Irish (n= 1), and educated to at least A-level 
standard, with most having a Degree or Postgraduate Degree.  Nurses had experience 
of working within different cancer specialities, including breast, gynaecological, 
colorectal, and upper gastrointestinal. 
 8.4.3 Interview schedule 
The semi-structured interview scheduled (Appendix AA) was designed to explore 
nurses’ beliefs about what makes a difference to patients’ experiences of cancer 
treatment, what expectations patients focus on before starting their treatment and 
how these expectations are perceived to impact on experiences of cancer treatment. 
At the beginning of the schedule, nurses were asked about what makes a 
difference to patients’ experiences of cancer treatment, with a focus on factors that 
can be both helpful and unhelpful. The key question here was ‘What factors 
influence how patients experience treatment for cancer?’.  Next, the focus was on 
CNS’s beliefs about patients’ expectations of treatment, before beginning their 
treatment.  This explored treatment efficacy, side effects, and the impact treatment 
would have on daily life but the core question was ‘What kind of expectations do 
patients have of their treatment before treatment has started?’.  Then, the schedule 
focused on whether and how nurses felt these expectations could influence treatment 
experiences with the central question of ‘How, if at all, do you think these 
expectations influence their experiences of their treatment?’.  Finally, nurses were 
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asked what they thought could be done to improve patients’ experiences of cancer 
treatment, before providing the opportunity to add any further comments that had not 
been covered by the rest of the schedule. 
The schedule was generally very effective at eliciting the required detail.  
During the first part concerned with what makes a difference to patients’ 
experiences, however, there was a tendency for nurses to focus on their role and 
what they can do to make a difference, rather than the patients’ experience and 
circumstances as a whole.  It was therefore necessary to add further prompts to 
ensure nurses were broader with their answers, which was successful. 
 8.4.4 Procedure 
A favourable ethical opinion was gained from the University Ethics Committee and 
the necessary approvals were gained from the NHS Research and Development 
department for the Trust where nurses worked (Appendix AB). 
Advertisement was via email, with the initial email (Appendix AC) and one 
reminder being sent by the Lead Cancer Nurse to all CNSs in the Trust.  Follow up 
emails were also sent by the researcher to remind CNSs of the opportunity to 
participate.  Interested individuals were invited to contact the researcher for more 
information.  Anyone who did was sent an information sheet (Appendix AD) and 
encouraged to read it before considering whether they would like to participate, with 
no time restriction being applied to this decision process. 
For those who wished to participate, a suitable date was arranged to conduct 
the interview, either at the oncology centre or on the telephone, where it was more 
convenient for the participant.  Written consent was obtained prior to interview 
commencement, either on paper or via email (see Appendix AE for Consent Form).  
Background information was collected shortly after consent.  The researcher 
conducted all of the interviews, in the interest of being consistent. 
A short general conversation was held prior to the start of the interview, to 
make nurses feel more comfortable speaking to the interviewer, then the study aims 
were reiterated, as was the right to withdraw or refuse to answer questions.  
Although it was included in the written consent, further verbal consent was gained 
before starting the audio recording equipment.  The interviewer followed the semi-
structured interview schedule, after which nurses were debriefed (Appendix AF).  
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The mean interview length was 41 minutes and interviews were conducted between 
January and October 2017. 
 8.4.5 Data analysis 
Thematic analysis was used for data analysis because of the flexibility it offers to 
ground analyses in the data (Braun & Clarke, 2006).  All nurses agreed to the audio 
recording of interviews and these were transcribed verbatim, using pseudonyms and 
taking other necessary steps to anonymise the data.  These transcripts were coded for 
key points raised, which were then collated and synthesised into theme and subtheme 
suggestions, which were reviewed and discussed further before being adjusted into 
the initial themes and subthemes.  These were then reviewed again in conjunction 
with the coded transcripts, to understand the suitability of the themes and to select 
quotations that would illustrate the points to be made within the themes.  Only minor 
adjustments to the themes were necessary at this stage, as they reflected the data well 
but these were made before the final themes and subthemes, as shown in Table 8.1, 
were reached. 
Table 8.1: Themes and Subthemes 
Themes Subthemes Transcending 
Theme: 
1. The Role of the 
CNS 
i. Information giving 
ii. Listening to the patient 
iii. Checking understanding 
iv. Providing support 
v. Managing emotion 
Balancing Hope and 
Honesty 
2. Following Best 
Practice 
i. Timing of information, support and care 
ii. Matching of information, support and care 
3. Being a 
Companion 
i. Building and maintaining trust 
ii. Promoting patient control 
 
8.5 Results 
Nurses described their beliefs about what makes a difference to patients’ experiences 
of cancer treatment in relation to the role of the CNS, best practice and being a 
companion.  There was a transcending theme of balancing hope and honesty 
apparent throughout these aspects of nurses’ accounts.  These will be now be 
  
176 
 
described under themes titled as such, with appropriate, detailed subthemes and 
using supporting quotations. 
 8.5.1 Theme 1: the role of the CNS 
The CNS undertakes a vary varied role, which nurses discussed in detail.  The key 
functions nurses identified within their role, that are important aspects of patient care 
and can make a difference to patients’ experiences of cancer treatment, were 
information giving, listening to the patient, checking understanding, providing 
support and managing emotion.  These will now be described in detail. 
 8.5.1.1 Information giving 
One of the most important jobs the CNS has is to convey accurate and appropriate 
information to patients about their cancer and its treatment.  This was mentioned by 
all nurses as a vital part of what they do: ‘I think information giving obviously is 
crucial’ (Olivia); ‘it is all about information giving, getting the right information’ 
(Georgina).   
This included information about the medical side of patients’ cancer and its 
treatment, such as treatment pathways and potential side effects, and ways of 
managing those side effects both psychologically, by managing expectations, and 
medically, by providing drugs to help reduce their severity.  This is illustrated by 
Lynda who said: 
They ask all the time the side effects are […] we go through all of 
that, talk them all through, give them the printed off resources so they 
know exactly what they could potentially face. But also warn them 
that they may get none of these side effects […] but if they do get it, 
don’t ignore it because we can help lessen the impact of it. Which has 
a better outcome for them in the long term. (Lynda) 
It also includes information about psychosocial aspects of patients’ cancer and its 
treatment, such as ‘useful contacts’; ‘websites where they can go for support and 
resource information’; ‘social type of support’; ‘financial grants and benefits’ 
(Hazel). 
The qualities of the CNS were also perceived as having a part in information 
giving, as described by Mary who said that patients need ‘somebody that they feel 
they can get information from that is knowledgeable, an expert in their cancer’.  The 
source of the CNS’ information was also mentioned: ‘we tell them all our 
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information is totally research based’ (Dawn).  Both of which were seen as enabling 
patients to feel confident in the information being given. 
Information giving was seen by nurses as a means to help patients prepare for 
upcoming treatments and ameliorate some of their concerns.  For example, Tina 
described the following: 
Correct information and keeping them informed all the way through, 
reduces their anxiety and [manages] their expectations, you know, 
how long it’ll take for tests, investigations, what’s the next step, 
what’s the plan. I find they get more anxious if they don’t have a 
plan, they don’t know what’s happening. (Tina) 
This could include preparing patients for different eventualities by mentioning 
different treatment options: 
when they’re diagnosed you just tell them what the diagnosis is, you 
won’t know what the actual treatment plan- you’ll have a vague idea. 
And it’s better from the outset to sort of give them a general treatment 
plan […] And then when they do get the histology report they have an 
idea where they’re going from there you know it’s not a shock when 
you mention chemotherapy and radiotherapy and things like that. And 
it gives them a chance to sort of just know that that might come their 
way and then confirm it and it’s never too much of a shock to them. 
(Dawn) 
However, it was also seen as important not to overload patients with information by 
giving them too many details about treatments and pathways that they may not 
eventually even experience.  The is exemplified in this quotation from Mary, who 
spoke about this in the context of secondary cancers: 
the pathway unfortunately is that patients will have a set amount of 
treatment and I can’t predict on any individual level how long that 
treatment will work but at some point the treatment will stop working 
and then you have to stop that treatment and start something else so 
that becomes a lifelong sequential treatment and obviously trying to 
tell somebody that at the beginning of a diagnosis is so overwhelming 
in secondary disease.  
Giving adequate information can therefore be a challenge because there is a lot for 
patients to process, which limits how prepared the CNS can help the patient to feel.  
This can also be problematic because sometimes the CNS does not have definite 
information to give.  There will be aspects of the cancer and treatment pathway that 
are uncertain, such as the patient’s response to treatment and their experiences of 
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side effects.  Wendy used examples from her practice to describe the difficulties that 
she can face: 
they need to know what’s likely to happen in the future and that’s 
really difficult because we don’t know what’s likely to happen in the 
future. We can indicate what we think the pathway will be and how 
things will go but sometimes things happen that you’re not expecting. 
[…] So I think it’s just you have to talk to patients all the way through 
about that’s what’s happening and why it’s happening and what’s 
changed and why we now can’t do what we thought we would be able 
to do. Or why now we can do what we didn’t think we were going to 
be able to. (Wendy) 
It was mentioned by some nurses that the majority of complaints from patients 
related to communication, or lack of information in some way, whether this be a 
failure to keep the patient as informed as they would have liked or insufficient 
internal communications: 
most complaints that come in basically boil down to lack of 
communication you know that something hasn’t been explained fully 
or […] they haven’t been told about appointments or haven’t been 
communication between departments. (Wendy) 
This shows how important this aspect of the role of the CNS is to patient 
experiences. 
 8.5.1.2 Listening to the patient 
As well as providing patients with information, nurses stressed the importance of 
listening to the patient.  Patient outcomes were thought to be improved if healthcare 
professionals listened to them: ‘people do come through it less traumatised because 
if they’re listened to and they’re heard’ (Georgina).  Conversely, if healthcare 
professionals fail to listen to patients, it is a leading cause of patient complaints: 
‘When you look at patient satisfaction studies that we do internally and if you look 
externally as well, the main thing that seems to come out is not being heard, actions 
not being taken on things that have been asked for.’ (Georgina) 
Healthcare professionals also identified listening as vital to understanding the 
patient’s concerns, as assumptions cannot be made about what is worrying a patient 
because reactions are varied, the obvious trauma of diagnosis is not always the most 
pressing concern and this can be very difficult to predict.  As Hazel said: ‘It’s not, 
it’s not ever what you think it’s going to be’. 
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Often, this is directly related to the diagnosis and the fear of cancer or a 
specific treatment but nurses still expressed the importance of listening to understand 
where the concerns were directed and from where they were coming.  Treatment-
wise, patients’ perceptions of chemotherapy were often described as being amongst 
the most negative in terms of its side effects, impact, and what receiving it meant 
with regards to the severity of the cancer.  Dawn spoke of this, for example: 
Very very fearful of the word chemotherapy. The minute you mention 
chemo, I don’t want chemo I’m going to lose my hair I’m going to be 
sick, I can’t cope with that I’ve got a young family. […] They have 
sometimes expectations because they’ve seen somebody else on 
chemotherapy but it might be a completely different treatment that 
they’re going to have so not all chemotherapies are the same. So you 
have to find out about that. (Dawn) 
Frequently, however, it is not the diagnosis or treatment that is causing the most 
distress.  For example, Hazel spoke of an experience she had with one patient: 
you don’t ever know what that support is going to be or where it’s 
going to be needed, it varies so much. I can have someone who we’ve 
just told has got- we’ve literally just told her she’s got a horrendous 
cancer diagnosis, she bursts into tears but actually when you explore 
that, unpick that, you find out that her husband walked out on her two 
days before and actually the cancer diagnosis is not at the forefront of 
her mind.  
Similarly, even when a patient has a good prognosis, there is still a need to listen to 
them and understand their reactions because there may be other circumstances in 
their life that treatment could disrupt.  Another account of a patient interaction from 
Hazel exemplifies this: 
you’ll get a lady who is, you tell her that she needs to have a 
hysterectomy because she’s got an endometrial cancer that is very 
easy to cure and actually when you unpick her emotions around it, 
you found out that she’s got a grandson who’s got leukaemia who is 
not going to do as well and she likes looking after him one day a 
week to give her daughter some respite and how is she going to do 
that if she has an operation.  
As well as involving other people in their lives, patients were identified as having 
concerns about their companion animals and leaving them at home: ‘Another lady 
who her life was her dog and she was on her own and she didn’t want to have an 
operation because she didn’t want to be separated from her dog’ (Hazel). 
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Nurses therefore stressed how vital listening to patients was to be able to understand 
their very individual circumstances and concerns. 
 8.5.1.3 Checking understanding 
Listening was also a vital tool in checking patients’ understanding of the information 
that has been given to them.  Nurses described checking understanding as a central in 
the role of the CNS, whether it be information relating to the diagnosis, prognosis or 
treatment.  Patients may not process the information given to them or may interpret it 
in a different way than the healthcare professional communicating it intended and so 
listening to them facilitates the CNS to uncover any false beliefs the patient may 
hold:  
people’s perceptions of what’s happening and where they’re going 
can be different to what you’ve actually explained. And sometimes 
later in the conversation you might pick up on something that you’re 
like mm OK I’m not quite sure that you’re understanding so then you 
have to go back and revisit and sometimes that can be quite difficult. 
(Wendy) 
The language used by the healthcare professional when trying to communicate the 
information was felt to contribute to this in some consultations.  Nurses described 
this in terms of the phrasing that is chosen, for example, Georgina spoke about the 
conveying of prognostic information: 
often doctors talk to patients in terms of five and ten years and they’re 
talking like that because that’s what the studies show – five or ten 
years because they always measure it in blocks but a patient could 
come away- and has come away and rung me up and said oh my god 
I’ve been told I’ve got five to ten years. 
Certain terms such as ‘cure’ and ‘palliative’ in particular were also often 
misunderstood by patients: 
A lot of times patients don’t understand the terminology, they don’t 
understand what palliative means, they say is palliative terminal, does 
it mean that I’m terminal now so again it’s explaining all the 
terminology to them so they understand exactly where they are. 
(Wendy) 
Use of medical terminology was also widely felt to contribute to a complete lack of 
understanding of the information conveyed in a consultation and nurses thought it 
was a crucial part of the role of the CNS to have time with the patient following the 
consultation, to check their understanding and explain anything required in more 
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accessible language: ‘normally we have the chat afterwards and you know just go 
through it, explain it in a bit more of dare I say a humanised way or layman’s terms 
for them so that they understand it’ (Lynda). 
Nurses would also intervene during a consultation to check patient understanding, 
particularly if the consultant is communicating at a fast pace: ‘if we think the 
consultant’s rushing a little bit [we stop them] and say can you just wait a minute, 
did you understand that?’ (Dawn). 
 8.5.1.4 Providing support 
Another key aspect of the role of the CNS is to provide patients with support.  This 
was described both in terms of the sort of support the CNS can give a patient 
themselves and the other support services that patients could be referred to. 
With regards to outside support, there were a variety of services available, 
both within the hospital and outside of the hospital, such as: ‘welfare benefits 
advisor[s]’ (Lynda), ‘Macmillan grants’ (Lynda), a ‘counselling service’ (Tina), 
‘community hospice teams’ (Tina), ‘community palliative care’ (Wendy), 
‘Macmillan do a befriending service’ (Wendy), ‘online internet blogs’ (Wendy), and 
‘Macmillan [have] got a very good website and they have internet patient support on 
there’ (Wendy). 
Nurses saw it as a key part of their role to make patients aware of these 
support services and encourage their use where appropriate.  They acknowledged 
that they could not support the patient on their own and needed these services: ‘in 
my practice I’m very heavily reliant on practitioners, external organisations, charities 
that collectively will collaborate to provide as much support for the patients to 
improve their patient experience’ (Mary). 
Within these services and throughout their cancer pathway, a key aspect of 
the support the CNS provides is to help coordinate the patient’s experience.  Nurses 
described supporting patients through the complex cancer pathway: ‘a lot of the 
patient bewilderment that can happen when they go through something like this is 
about not knowing how to navigate the system and that’s what we do, we act as that 
navigator if you like’ (Hazel). The CNS will provide support by being a point of 
contact that remains constant throughout this pathway.  This was seen by nurses as a 
pivotal part of their role: 
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I think that all patients need to have access to someone to support 
them. […] to communicate with other professionals about their 
pathway, what needs to happen, make sure things are put in place at 
the right time, cancel things that need to be cancelled. (Wendy) 
In addition to this, there were various ways in which nurses described their role as a 
CNS in providing support to patients.  Making people feel cared for was seen as 
central to the support the CNS provides: ‘you just want to make sure people don’t 
feel like they’re a number, they’re on this sort of conveyor belt’ (Georgina); ‘Care, 
compassion, support and empathy really. All of those things are crucial I think to the 
patients’ experience. You’ve got somebody that’s dismissive and makes you feel 
non-valued then your experience is going to be awful’ (Olivia). 
Nurses described the importance of knowing someone was available for the 
patient: ‘I think for patients you know they just need to know that someone’s there. 
And that’s our job’ (Hazel).  This should be ‘somebody that they [patients] can 
access quite easily’ (Mary), and someone who is approachable:  
you know what it’s like you’re driving home and you’re like oh I 
didn’t ask that question, or you’re making a cup of tea, making sure 
that they feel comfortable and that they can phone and call if they’ve 
got a question. (Lynda) 
you get people apologise and say I’m sorry to keep asking you but I 
don’t understand that, making them realise and comfortable to ask. 
(Mary) 
The benefit of having a constant in patients’ care was also highlighted here: 
they’re comforted by the fact that they know there’s someone on the 
end of the phone who knows them, who knows what’s going on with 
them, and knows their whole pathway not just that little bit of what’s 
going on, and can advise them (Wendy) 
Providing support may involve no more than giving patients someone to talk to: 
‘sometimes patients ring up and say I just need a chat. I just need a chat. And that’s 
all they need’ (Tina).  This may involve some form of catharsis: ‘even if [patients] 
just want to have a cry or just go ra ra ra ra ra ra ra down the telephone, just to vent’ 
(Lynda).  It may also be supportive in helping patients to feel like their normal selves 
and maintain their identity outside of their cancer: 
I was talking to a lady the other day and we was just having a chat 
and she said do you know what that’s absolutely made my day. She 
said my treatment and diagnosis is what it is but it doesn’t define me, 
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who I am and she thanked me just for taking the time to chat and just 
make sure that she was alright. (Lynda) 
Nurses also spoke of providing support in a range of other ways, including some 
quite practical things, and so this availability extended to being flexible and helping 
wherever they could.  For example, Hazel spoke of providing support surrounding 
holiday plans: 
I will always say to people if they’ve got a holiday booked that they 
then can’t go on because they’re in treatment, loads of insurance 
companies don’t make it particularly easy to cancel a holiday in that 
situation and I’ll say if they need something from someone vaguely 
medical as long as you’re happy, I’m happy to speak to them 
Mostly, there was a psychological focus to the support provided by the CNS, as 
explained by Mary: ‘it’s very easy in clinic to maybe look at the physicality of things 
but it’s not about the physicality necessarily, I would say most of my care is taken up 
with the emotional and mental wellbeing’ (Mary). 
Providing support entailed not only focusing on the patient themselves, their 
pathway and their needs, but also those around the patient, such as family, for 
example: ‘You can’t just deal with one person you’ve got to look at the whole 
family'(Dawn). 
Nurses also stressed that the aim of this support was to foster better outcomes 
for patients, and they were fairly confident that the support the CNS provides can 
make a difference: 
No one wants a cancer diagnosis, no one ever wants it to happen, our 
job is to facilitate their experience and make it as positive a one as it 
can be and as I say most of the time, we get that right I think. (Hazel) 
Although they are making a difference to patients in their cancer treatment 
experiences in providing this support, nurses unanimously wanted to be able to do 
more.  This centred around having more resources and was usually directly linked to 
giving patients more time.  Georgina’s sentiment, ‘more hours for us would be great’ 
was widely echoed and seemed to be at the heart of this.  There was also a call for 
greater provision of psychological services: 'the resources to be able to fix for want 
of a better word stuff holistically that’s not medical or physical is wanting' (Hazel). 
The CNS therefore has a role in directly providing support and navigating 
complex cancer treatment pathways, as well as signposting to other support services.  
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This support can make a real difference to patients’ experiences of cancer treatment 
but with more resources, there is more that could be done. 
 8.5.1.5 Managing emotion 
The final aspect of the role of the CNS that nurses focused on was managing 
patients’ emotions.  Cancer and its treatment produce a lot of uncertainty and fear, 
which leads to high levels of emotion in a cancer setting as described by Georgina: 
‘We’re dealing with a very charged emotional environment’ (Georgina). 
Patients can display a range of emotional reactions, largely in response to the 
potentially life-limiting nature of the diagnosis.  Cancer evokes a huge fear of 
mortality for many patients: ‘the main thing that people say to us or that my 
experience tells me is that as soon as they hear that word cancer, they still equate it 
to death sentence’ (Olivia).  This may be exacerbated by previous experiences of 
cancer, particularly within the family: ‘They might have a mother, a sister all 
diagnosed with cancer and deceased and they’re looking at themselves now, that 
could be me’ (Dawn). 
There exist a lot of misconceptions about cancer, which add to the emotions 
patients may be experiencing, as explained by Georgina: ‘people describe feeling 
dirty when they have cancer, they feel infected, they feel like it’s going to be running 
away with legs around their body as soon as they put a name to it.’ 
The CNS has a big role in helping the manage the fears and anxieties created 
by diagnosis.  This begins prior to the diagnosis being given; preparing patients for 
the news can help to lessen its impact, as Lynda explained: 
you need to prep them so that when you do deliver that diagnosis it’s 
not come out of the blue they’ve got this little warning bell that’s 
been starting to go off in their heads and do you know what I actually 
thought you know was going to say that 
The aforementioned role of information giving can also play a part here, by 
providing accurate information the CNS can correct misconceptions and generally 
help to manage the patient’s emotions: ‘it is about again giving them the right 
information so that you’re taking away some of that anxiety for them’ (Olivia).  This 
may include reassurances about the prognosis and the efficacy of modern medical 
treatments: 
  
185 
 
you’re able to tell them that this is what happens and then you give 
them percentages of how many people are still living and how good 
our treatments are nowadays. And there’s clinical trials they can go 
into you know there’s lots of, lots of add-on treatments that we never 
had. And that helps them. It’s not like somebody fifteen years ago and 
even as we speak sometimes I will say look if it did come back in five 
years’ time we’ll be five years on, there’ll be something else. (Dawn) 
Providing support as part of the role of the CNS, is also heavily linked to managing 
emotions.  In order to help manage patients’ emotions, the CNS may provide support 
and help the patient to adjust to the diagnosis, as stated by Lynda, for example: 
‘helping them to put things into perspective and rationalise things even though 
you’ve just given them the news that they never wanted to hear, just help them make 
sense of it’ (Lynda). 
The role of the CNS in managing emotions surrounding diagnosis may also 
involve the adoption of a particular approach to communicate with patients.  For 
example, Georgina spoke of managing patient anger: 
it’s very rare that someone gets cross and if they do it’s because 
they’re scared.  They’re scared, they’re fearful, they’re worried and 
that is unusual but again that’s a reaction, that’s a response and it’s 
fine, it’s not a problem.  Just stay calm, focus, and look at why that’s 
happening, look at the root cause and realise it’s not personal and it’s 
something that needs dealing with in a nice, kind, gentle way. 
(Georgina) 
Treatment itself can cause a lot of patient emotion, a large part of which centres 
around the physical side effects that the patient may experience.  This may be the 
case whether patients are currently feeling quite well, or if they are feeling unwell as 
a result of their cancer: 
for the patients that are well I think it’s really hard for them to know 
they’re going to start a treatment that they feel’s going to make them 
unwell. For the patients that are quite sick, they think, how are they 
going to cope being sicker because they think that the treatments are 
going to make them ill.  […] How can they cope because when you 
say I’m going to be tired, I’m already tired, if you say I’m going to be 
sick I’m already sick. (Tina) 
Patients may have experienced treatment in the past themselves and so therefore may 
be quite fearful of the side effects based on their own past experiences.  They may 
also know friends or relatives who have had experiences of cancer treatment side 
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effects, which may affect their emotions in expectation of treatment. As Olivia and 
Tina, for example, explained: 
you’ll find people come to us with a new diagnosis but they know sort 
of Great Aunty Flo from twenty years ago that had chemo and she 
really struggled and you hear horror stories like all her nails fell off 
and things like that. (Olivia) 
if people have had friends that have gone through treatment that have 
had good experiences you find that they’re more- not relaxed in clinic 
but they’re a bit more matter of fact, they know what to expect a bit 
more and they don’t see it as hard treatment. (Tina) 
Media representations of cancer can also influence patients’ perceptions of the 
treatment they are due to receive and therefore their emotions regarding this.  Nurses 
particularly mentioned this with reference to chemotherapy, such as Wendy: ‘a lot of 
the time, patients’ expectations of chemotherapy are what they’ve read about in the 
papers and they’ve read all the horror stories and they’ve read all the terrible things 
that can happen to you on chemotherapy’. 
Nurses described various techniques that they used in their role as a CNS, to 
manage these emotions associated with physical side effects.  Firstly, the CNS will 
provide information that can help to reassure the patient and provide a ‘balanced 
picture’ (Wendy) of treatment, particularly if they have inaccurate perceptions of 
what treatment side effects might entail.  For example, Olivia spoke about this in 
relation to chemotherapy: 
you kind of need to explain that well things have moved on, chemo’s 
very different now and- so we have to do a lot of – not squashing of 
rumours as such but just readjusting the balance from what they’ve 
heard or what they’ve read in the media, things like that. (Olivia) 
This may include simply informing patients that there are medications that can be 
given and strategies that can be used to help manage physical side effects, which can 
help to manage patients’ fears about how they will respond to treatment: 
there’s always something you can give or you can manage with side 
effects of chemotherapy and that may be further medications to 
manage their sickness, it may be dose reduction, it may be dose delay 
to try and make that the physical side effects of treatment more 
tolerable (Mary) 
In managing emotions surrounding the physical side effects of treatment, nurses also 
stressed their role in encouraging effective coping with the prospect of these effects.  
  
187 
 
For example, Lynda: ‘I try to say to them just try and be relaxed and have an open 
mind about it and if you do get the side effects, you get the side effects’.  Also, 
coping with the manifestation of side effects: ‘if something does happen not to be 
frightened of it, it’s only a temporary thing, it will resolve but don’t be frightened 
and shut yourself away at home from it’ (Lynda). 
In general, patients will have an idea of what they expect from their cancer 
and its treatment before the CNS sees them.  These will be formed based on 
information from multiple sources, of varying quality, as Mary, for example, 
explained: 
we are in an era whereby patients will identify information from lots 
of different sources, and some of them shockingly awful like the 
Daily Mail but some of them may have been on websites in their like 
Breast Cancer Care for example in my practice which are reputable, 
Macmillan websites for patients to go on. But if you have patients 
who have been Googling or researching then again they come to you 
with an expectation of what they’ve read as the norm. 
This can sometimes lead the patient to possess inaccurate information, which can 
lead to negative emotions, which the CNS then has a role in managing.  For 
example, Dawn spoke of the consequences of searching for information on the 
internet, when the staging of cancers is not properly understood by the patient: 
to try and untangle that can be a big issue because they’ve come with 
those expectations in their head and they know they’re going to need 
chemo because it’s a stage this – no you don’t, we don’t know that 
yet. So, I try personally to say please just take it one step at a time, 
don’t Google. There are sites out there that are quite scary.  You 
know very scary for people. (Dawn) 
This can therefore lead patients to have inaccurate expectations and associated 
emotions, relating to their cancer treatment.  It is part of the role of the CNS to assess 
and manage these, as explained by Mary: ‘it comes down to good dialogue between 
the patient and the oncologist or myself or another similar specialist nurse, to find 
out what their expectation is and manage that accordingly’. 
Providing accurate information early in the treatment pathway can help to 
mitigate some of these problems.  It can also help patients to feel more prepared and 
further manage their emotions, by ameliorating any shock they may feel by being 
unexpectedly told later in the pathway that they need a further treatment.  As 
Georgina explained: 
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what we do is set out quite early on what we’re expecting the 
treatments to be so they have time to think about that and get used to 
the names, the words and at least it’s not a huge shock at the end of 
the surgery or whatever we’re doing 
By managing information and providing support to patients, the CNS can help to 
manage patient emotions and promote better outcomes. 
Therefore, this first theme highlights the key role of the CNS in giving 
accurate information, but also listening to the patient and checking their 
understanding of the information they have been given.  It also emphasises their role 
in providing support to patients, both directly by being caring and consistent, and 
indirectly by referring to other services, and in managing patient emotion throughout 
their cancer pathway. 
 8.5.2 Theme 2: following best practice 
Within their roles and these various functions, there were also two sub-themes of 
following best practice that nurses highlighted as being particularly important to 
patients’ experiences of cancer treatment.  The first of these was timing, especially 
timing of the information and support provided.  The second related to matching the 
information, support and care given to patients according to the individual patient 
and their needs and wishes. 
 8.5.2.1 Timing of information, support and care 
Timing is an important part of best practice because patients’ needs, requirements 
and psychological state can vary, depending on where they are on their treatment 
pathway.  A newly diagnosed patient will be dealing with the idea that they have 
cancer:  
when they first come to clinic, obviously it’s a huge shock, most 
patients have been pretty well all their lives, haven’t had many 
problems and then all of a sudden they’ve got a disease that a lot of 
people didn’t even know they had until very recently because the 
symptoms have been quite slow and can be overlooked and explained 
by other things for a lot of the time and then all of a sudden they’ve 
got this diagnosis that they’ve got cancer (Wendy). 
They may be very focused on the treatment outcome: ‘generally everybody first 
walks through the door going I’ve got cancer, get rid of it. And so they’re prepared 
to have surgery, to do whatever because they don’t want cancer, they want to get rid 
of it.’ (Lynda). 
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At this stage, when they focus on the treatment and its side effects and impact 
on daily life, patients tended to be described as being very anxious: ‘I think that 
initially they’re very scared about starting treatment because it’s fear of the 
unknown’ (Wendy). 
Later in the pathway, when patients have started receiving treatment, 
experiences depended a lot more on responses to treatment and side effects.  Often 
nurses suggested that a lot of patients have a greater ability to cope with treatment 
once they are used to its effects: 
their expectation of treatment can be worse before they start and 
better after they actually start because it’s not as bad as they thought it 
was. And so then with each subsequent cycle they get a bit more 
confident and a bit more able to cope […] they become familiar with 
the side effects that they expect because most people sort of settle into 
a pattern. (Wendy) 
Conversely, for some patients, things do not go as well as they had anticipated and 
this can result in a completely different psychological response: 
Then after that initial process they then have the after effects of 
surgery, it’s not quite what they expected, they thought that they 
would be getting up, bouncing back straight away, they don’t quite 
realise the effect that it has on them from a physical point of view 
(Lynda) 
Therefore, various aspects of care need to be timed according to when they are most 
appropriate.  Timing of support provided, whether directly or indirectly was 
mentioned as being important for best practice. For example, Mary spoke of 
directing patients to timely support within and outside of the department: 
‘signposting the right dream team at that time for that patient.’ 
More of a focus for nurses, however, was the timing of the information 
provided to patients.  As well as acknowledging that accurate information was vital, 
nurses stressed that it was important to ensure that this be communicated at an 
appropriate time for the patient and not all given at once: ‘giving them the right bit of 
information at a point that’s appropriate without overwhelming them. […] So they 
tend to get information drip fed all the way through, at various points’ (Olivia). 
This could also be for quite practical reasons, in the sense that a patient has a 
limited capacity to retain information and so providing details that are not time-
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sensitive may lead to more immediately pertinent facts being forgotten, such as is 
described by Tina: 
bite size chunks I think is always really important because you start 
talking about what could happen six months down the line although a 
lot of them want to know, they forget the key information beforehand 
and then they’ve forgotten what you’ve said about how long tests and 
investigations are going to take. 
Timing of information also involved an element of waiting for accurate information, 
rather than having an educated guess.  This was mostly described in terms of 
delivering prognoses, such as is exemplified by Hazel: 
sometimes it’s about the right time to ask. And very often at the 
beginning of treatment, [...] is not the right time to ask because we 
actually don’t know what the effect of the treatment’s going to be 
until they’ve had some and we know how they’re going to react. And 
again you know sometimes your kneejerk reaction when you get 
given that diagnosis is what’s my prognosis but if you were to answer 
that question in terms of a timeframe at that time anything you say 
would be wrong. 
Further to this, nurses described the importance of allowing patients time to process 
the information that had been delivered.  This was generally discussed with reference 
to the delivery of bad news, this could be at the point of diagnosis, as is seen in these 
quotations from Dawn and Mary: 
sometimes you know I’ll see somebody who’s so shocked, if they’re 
with their partners and I know that I need to leave them be then I will 
say I am going to leave you alone for a little while, I offer them a 
drink, I might go back ten minutes later when I know that they’ve 
chatted and calmed down a little bit. That’s hugely important. (Dawn) 
it’s just about time for these patients to digest this life limiting 
diagnosis (Mary) 
Timing was also important for nurses in terms of waiting times.  This was firstly 
described in terms of waiting for test results, which was said to be an extremely 
anxious time for patients, as time can seem protracted: 'most are done within a timely 
fashion anyway but again it’s too long for the patients that have got cancer, they 
don’t want to wait two weeks for that scan' (Tina). 
Any delays were perceived as being quite difficult because of fears over what 
the cancer might be doing in the meantime: 
  
191 
 
whether there isn’t a delay, if their perception is then in their world 
there is. And frustration over if they need certain tests and imaging 
and things like that, there’s always this perception that the cancer’s 
going to do something more while they might be waiting for a CT 
scan. (Olivia) 
This may be in relation to waiting for diagnostic tests: 
I think waiting around, waiting times so things like biopsy results, not 
having to wait a week for those- that week is terrible for patients 
waiting when we’ve muted they might have cancer and they have to 
come back in a week’s time.  (Georgia) 
It could also relate to tests to understand the effects of treatment: 
'scans are timepoints that significantly raise anxiety because it’s 
what’s the cancer doing, is the cancer stable, is it responding, is it 
getting worse' (Mary). 
Scans were described as being a huge focus for patients, when they were awaiting 
results, as Tina described: 
when they come into clinics and they’ve had scans, they just want to 
know about the scan, they don’t want to know anything else, it 
doesn’t matter if their symptoms are really good or really bad, they 
just want to know about that scan.  
Appointment waiting times were also a focus for nurses and were thought to be a key 
cause for patient complaints: ‘When you look at patient satisfaction studies that we 
do internally and if you look externally as well, the main thing that seems to come 
out is […] waiting times’ (Georgina).  Waiting for a consultation can create a lot of 
anxiety in patients, which perhaps explains why it is often cited in patient feedback.  
It means that healthcare professionals must spend more time managing patients’ 
emotions: 
I think it can unhelpful sometimes in a really busy clinic when 
they’ve been kept waiting, they’re hugely anxious when they come 
into that room and you have to sort of bring them back from the 
anxiety of just waiting to come into the appointment to just say look, 
we’re here now, this is where we’re at, we’ll start at the beginning 
again, and just calming everything down. (Dawn) 
However, nurses also said that if patients were satisfied with the consultation once 
they had it, then this helped to ameliorate their anxieties and any negative feelings 
held towards the practitioners present.  Clinics were described as being frequently 
behind schedule, so the above would seem to be a common occurrence, but this was 
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mostly seen to be fuelled by a desire to give each patient all the time that they 
needed, as was all described by Georgina: 
what we’ve found is that a patient doesn’t mind waiting if when they 
get the consultation it is a thorough consultation, that they leave 
feeling that they know what’s going on and feeling cared about and 
listened to. So when we see a patient, there is no time limit, and this 
goes for the consultants as well who get 10 minutes regardless of 
whether they’re breaking bad news or whatever they’re doing.  We 
spend as long as we need with patients, which is why we do run 
behind but […] if we rushed it they would go away feeling 
traumatised, not listened to, very upset, probably make them angry, 
sad, whatever and we don’t want them feeling like that, going away 
feeling like that. 
Even though nurses were already dedicated to patients, when asked what could be 
done to improve patients’ experiences of cancer treatment, all nurses stated that they 
would like more resources so that they could have more time for patients, either face 
to face or on the telephone: 'From our point of view it would be really lovely if we 
had more time to spend with patients.' (Georgina); 'I’d love to ring all of my patients 
every week and find out how they’re doing but that doesn’t happen, you know I’ve 
got 700 people plus I can’t ring 700 people every week it just- it’s not feasible' 
(Hazel). 
 8.5.2.2 Matching of information, support and care 
As well as timing, matching the approach taken to the patient as an individual was 
central to best practice for all nurses.  A certain amount of this was described in 
relation to physical factors, such as the tumour type, treatment type, prognosis, 
previous cancer history and comorbidities.  However, the main focus was on 
psychosocial factors, and these will be detailed below with supporting quotations. 
Nurses acknowledged that research evidence can help to understand patients, 
their reactions, and their needs but when they applied this within best practice, they 
also felt it important to recognise that ‘every patient is very different’ (Tina).  They 
stressed the value of treating patients ‘individually’ and ‘completely holistically’ 
(Hazel): ‘I don’t believe in oncology any more that it’s a one model fits all, very 
much it’s a very much person-centred, individualised care’ (Mary).   
Personal characteristics such as gender and age can make a difference to how 
patients experience their cancer treatment and the approach that may be required by 
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the CNS.  Georgina, for example, spoke of gender differences in the information and 
support required: ‘men deal with things often very differently to women. They want, 
what do we do about it, what is it, what do we do about it, how can we achieve it, 
and we did try inviting them to support groups and […] they didn’t feel it was 
something they wanted’ (Georgina). 
Olivia and Wendy discussed some of the different challenges faced by the 
older and younger patients, highlighting that it is not necessarily easier or more 
difficult for one or the other, just that there are different challenges faced that the 
CNS must match their approach to.  Firstly, Olivia spoke of older patients: 
age has a lot to do with it as well because the older you are quite often 
you have a lot more health problems going on as well and so the 
practicalities that that brings with it probably has a lot to do with it. 
When speaking about young patients, Wendy stated: 
certainly for them we try to find support that works better for them 
because some aspects of their situation is going to be completely 
different to the patients who are diagnosed in their sixties and 
seventies, eighties, which is our usual group. So we have counsellors 
here that we can refer to, we have a local support group for under 40s, 
and we refer to that. 
Another reason for the variation in patients’ needs is the patient’s own personal 
circumstances and what is happening in their life at the point of diagnosis and as 
they progress through their treatment pathway: ‘the other challenges people have, 
they’ll vary’ (Olivia).  Communicating with the patient and understanding these 
circumstances was felt to assist in matching the care given: 
I always feel that people come with their own problems, they’re 
human, they’ve already got problems, they might be going through a 
divorce, they might be worried about their children, the husband 
might be working away and they’re there on their own. It’s hugely 
important that you encompass all that from the outset, sort of get to 
know them a little bit from the outset. Some people won’t, they’ll just 
clam up and that’s fine you have to acknowledge that and be 
respectful. But usually they come back once they’ve just got it into 
their own heads and understood it. (Dawn) 
The patient’s social situation can also make a difference to the amount of support 
and care required from the CNS.  Some patients do not have a lot of social support in 
their life and therefore may need more input from the CNS: ‘we know that we need 
to keep an eye on someone if they are socially isolated, you know they’re living on 
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their own, they’re going through a particularly tricky treatment regime’ (Hazel).  
Conversely, others may have a good social network and require less from the CNS ‘a 
lot of patients say to me I don’t need support from other people, I’ve got my family, 
I’ve got my friends, that’s all I need’ (Wendy). 
Patients’ approaches to coping can also vary hugely.  Nurses again 
acknowledged the coping literature but stressed the individuality of utilising coping 
strategies and the need to adapt their approach accordingly: 
everybody has their own coping mechanism and no two people are 
the same. We all cope differently. If we were all given ten situations 
to deal with, we’d all do it differently. We’d all come out with maybe 
the same answer but we’d all approach it very differently. And I say 
to every person, I don’t know you, you know yourself. You need to 
tell me how I can help you. (Dawn) 
Associated with this is the amount and type of information that patients require, 
which can again be variable.  Nurses expressed the need to understand individual 
information needs and match these with the information given, wherever possible: 
You’ve got the people that want to know absolutely everything, the 
people that want to go into denial, which is totally fine cause that’s a 
very good coping mechanism as long as they are informed and they 
have information to make informed choices, it’s all about gauging 
that person and what they want to know (Georgina) 
From both research evidence and her own practice, Dawn raised an important 
additional point about information giving and matching this to the individual, and the 
need to consider what information is given and when, based on the patient’s ability 
to process it: ‘people sit there and you know full well you’re talking but there’s 
nothing going in. And you know there’s a lot of proof there that they only hear part 
of what’s being said anyway’. 
Nurses would also match their approach accordingly and be led by the patient 
when it came to the support they provided.  For example, Tina spoke of the amount 
of telephone support given to patients: 
Some people don’t want a call at home, they don’t want you to 
contact them, they don’t like you reminding them that they’ve got a 
disease or whatever, whereas others, I’ve got patients that when 
they’re unwell I ring them every other day, I ring them weekly. 
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It was evident through all of this that in order to be able to effectively match their 
approach to the individual patient, the CNS must be adaptable.  For example, Lynda 
discussed this in the context of communication: 
being able to adapt yourself, being a little bit like a chameleon and 
[…] adapt how I deliver the consultation depending on who’s in front 
of me, I deliver it in the style that I know that they’re going to take it 
in, understand what’s being said to them 
For the CNS who sees a lot of patients, individualising care can be difficult, as 
highlighted by Wendy: 
we come into work every day and we do this every day with hundreds 
of people but for them they’re the only one that’s involved, or it’s 
their mum that’s involved, or it’s their dad that’s involved and so you 
very much have to individualise what you do. 
Patients are therefore very individual and a big part of best practice for the CNS is 
matching the information, support and care they provide to the patient, in order to 
meet their individual needs. 
This second theme highlighted the role of best practice in terms of matching 
and timing of information and support provided to patients, according to their 
individual characteristics and needs, and the point they are at along their cancer 
treatment pathway. 
 8.5.3 Theme 3: being a companion 
The third theme reflects how nurses were also a companion, guiding patients through 
their treatment to make a difference to their experiences.  Nurses described being a 
companion in relation to two subthemes ‘building and maintaining trust’ and 
‘promoting patient control’, which will now be detailed. 
 8.5.3.1 Building and maintaining trust 
It was evident that building trust with the patient was a vital part of the role of the 
CNS in being a companion and in developing a relationship with patients:  
you become almost their friend really for a short time. You’re part of 
them for a while. And you create a bond together a closeness and they 
trust you. Trust is hugely important if they don’t trust you, they won’t 
come back. […] Or open up to you and tell you their fears and their 
concerns. (Dawn) 
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This was often recognised by nurses, for example, Hazel: ‘in my job, if you haven’t 
got that rapport and that trust with the patient it’s not going to work.’; and Dawn 
‘Honest and respectful. I think those are the two most important things really’.  As 
was the importance of building this trust right from the start of the relationship with 
the patient: ‘if you don’t get that trust from the beginning I think you’re lost’ 
(Dawn). 
Trust was formed and maintained on the basis of honesty on the part of the 
CNS, something that was cited by all nurses as being vital: ‘my biggest role to be 
honest’ (Hazel).  This was particularly the case in the face of bad news: 'you can’t 
take away the bad news if it is bad news, however uncomfortable a person may feel 
about breaking it, we’ve got to get over that because it is what it is and it needs 
addressing' (Georgina).  This was particularly pertinent as bad news was seen as 
being better than no news, as described by Olivia: 
I think it’s the not knowing sometimes that’s even worse than actually 
knowing, even if it is bad news. Yeah because they can start to 
assimilate it and process it, where when it’s not known, I think people 
imagine so much worse. Is my experience of it really. Honesty 
definitely is the best policy. (Olivia) 
Withholding such information could ultimately prove damaging to the trust 
relationship, especially as nurses felt that patients valued trust: ‘all people want at the 
end of the day is for you to be honest with them.’ (Hazel).  It may also have 
connotations for patients’ experiences of their cancer treatment: ‘For me personally I 
think patients have a better experience if people are open and honest to them no 
matter how difficult it is’ (Lynda). 
Even if they did not seem to want to accept the bad news, patients were still 
seen to remember when the CNS was honest with them, as shown in this example 
from Wendy: 
I had a lady who, I only came into her pathway late and she’s had all 
the treatments we can offer and she really could not accept that. 
Really couldn’t accept it that now we were at the end of treatment, 
even though I’ve had conversations with her over the past few months 
trying to prepare her for this. And when we were in clinic and the 
doctors told her that we have no further treatment options, she turned 
to me and she said so you were right, you told me the truth. You scare 
me but you told me the truth. (Wendy) 
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Being honest also allowed patients to make better informed decisions, which again 
helped them to trust the CNS, knowing that they had their best interests and their 
wishes at heart: 
informing the patient, allowing the patient to understand when they 
get new symptoms, which may mean again that the disease is getting 
worse, again it goes back to the patient experience of understanding 
that patients get to a point when they are less well to receive treatment 
or the disease becomes I suppose, less sensitive to treatment and then 
those are the very difficult and emotionally challenging conversations 
then that you’re having with patients about what further expectations 
treatment will offer you (Mary) 
Sometimes patients don’t want to accept that maybe things aren’t 
going so well and that we’re running out of treatment options […] 
and that’s hard because you have to be honest with people so that they 
know what’s going on and if we’re now talking about a much 
shortened lifespan that they have the time to make decisions about 
what they want. (Wendy) 
Trust can also be broken, particularly if treatment had not occurred as the patient 
perceived they have been informed it would, so the CNS must maintain the trust in a 
relationship and also re-build it, if confidences are lost.  For example, when trust was 
knocked with one patient, Wendy spoke of having ‘to do some bridge building to try 
and regain trust and confidence’ (Wendy).  However, it was also evident that nurses 
had frequently built lasting trust relationships with their patients, making them a 
reliable contact, even after patients had left their care: 
we’ve built up a good relationship with people and they often do want 
us to follow them through […] So we don’t just sort of bin them, it’s 
not a case of just right that’s it your pathway’s ended with us and to 
be fair we have people ringing us 10 years down the line because 
they’re not sure who to turn to and they remember us and we’re the 
port of call. (Georgina) 
Building and maintaining trust is therefore central to being a companion to patients 
throughout their treatment pathway and being honest is integral to this. 
 8.5.3.2 Promoting patient control 
Cancer and its treatment can lead patients to feel a loss of control: 
they feel like they’re on a rollercoaster and like stop the world I want 
to get off for a second. But once you’re in the two week wait pathway 
and you’re in the motions of treatment, it rolls away, it carries on, 
chemo’s cyclical you have a cycle then you have bloods then you 
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have the next cycle and you’re there and things happen and that can 
make you feel quite out of control. (Olivia) 
Part of the role of the CNS in being a companion is to help patients to regain some of 
this control: ‘empowerment is incredibly important, [for] people all through their 
cancer journey but particularly when you’re talking about treatment’ (Hazel).  Loss 
of control is even more marked for those whose cancer cannot be treated with 
curative intent and nurses also described control and their role in this context 
specifically. For example, Lynda:  
[if] they know that we can’t cure them it’s trying to help them 
internalise what’s going on, what’s happening to them and not make 
light of their diagnosis but let them be in charge of it rather than it 
controlling them. (Lynda) 
Providing information to patients is one way in which nurses described that they 
could make them feel more in control, by reducing uncertainty: 
people are quite pragmatic I think when they know what they’re 
dealing [with], you can start to problem solve and start to think right 
OK, best case scenario is this, worst case scenario is this therefore 
I’ve got a plan A, B, C, and D. […] I think it empowers them in a 
sense of they’ve got a bit of control over what’s going on. (Olivia) 
Information provision also affords patients more control by giving them the details 
they need to be able to make decisions or at least share decisions with healthcare 
professionals with regards to their treatment, as stated by Mary: ‘providing that 
information to the patient so that then they can make that shared decision’.  Nurses 
positively described how ‘patients are becoming more involved in decisions about 
their treatment’ (Wendy).  It was noted that often patients would be led by what the 
healthcare professionals advised but in such cases control was given by providing 
information and allowing the patient to feel part of the decision. 
Less common, but often very memorable for nurses, were those patients who 
made the decision to refuse treatment: ‘it’s not many but I’ve certainly had some 
people – three come to my mind immediately and they’re not with us now’ (Dawn).  
The CNS must respect the patient’s decision, even if that involves refusing 
treatment.  If the CNS knows that the patient is making an informed choice, whether 
they believe it is the right decision or not, they must allow the patient the control 
over their own pathway: 
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Our job is not to force people into having treatment and that’s what I 
mean, if they have mental capacity then they have the right to do with 
their body what they want to do, we are there to offer the information 
to the best of our knowledge about what is the right thing to do, it’s 
up to them whether they choose to accept it. (Hazel) 
tell them you know that the cancer is not going to go away, it’s going 
to get bigger, and eventually it could travel elsewhere.  You have to 
tell them what our experience is with treating […] cancer but if they 
don’t want the treatment you can’t force them. (Dawn) 
The refusal of treatment can be a consequence of patients’ beliefs about treating 
cancer and alternative treatments that are inaccurately purported to be effective.  
Whilst the CNS can provide evidence-based information, they cannot remove the 
patient’s control and force them to accept medical treatment.  Respecting these 
beliefs, however misconceived they appear, is an important aspect of allowing 
patients to retain some control.  For example, Dawn spoke of this when she had 
recalled a patient who had chosen to treat her cancer with a juicing diet: ‘that’s their 
ideal in their heads that this is how you treat cancers. There are some people that 
have come with this ideal and you can’t dispel it.  You just can’t. You know you 
can’t’ (Dawn).  It was evident that this was a very difficult but necessary part of the 
role of the CNS in being a companion and allowing patients to have as much control 
as possible. 
Another reason that nurses discussed for refusal of treatment, is that patients 
have their own priorities, and may place a higher value on things other than 
longevity: ‘it is all about what’s important to them at that time, it’s not necessarily 
about living longer with their disease, it’s about improved quality of life’ (Mary).  
For example, Hazel spoke of a particularly poignant example from her practice: 
we’ve had a relatively young woman who’s decided that because the 
treatment to cure her cancer – and the hope would have been that it 
would have cured her cancer – that it would interrupt or withdraw her 
fertility status because it would have meant removing her womb, she 
decided that she didn’t want that to happen so she refused all 
treatment knowing you know we were very frank with her – knowing 
that that would mean the cancer she had would spread and it would 
compromise her life, whereas she was in a position at the beginning 
that she would have 98% chance of cure and she opted not to do that 
because she wanted to try and have a baby. 
Again, this could be difficult for the CNS but they must allow patients 
control over their decisions and respect individual priorities.  Within 
this, it is also important for the CNS to retain a focus on the whole 
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patient and remember that ‘the goals of care and the goals of 
treatment are two totally different things’ (Mary). 
What was particularly important throughout was adapting to the individual patient 
and allowing them control over the decision process.  Whilst some patients place 
higher value on things other than longevity, for others, living as long as possible is 
the most important factor.  Facilitating this decision process and encouraging 
patients to think about their priorities is an important aspect of promoting patient 
control.  Wendy spoke about this in the context of palliative care: 
I try to encourage patients to think about what it means to them to 
have that treatment and actually do they want to carry on having 
treatment right up to the point that they die. And some patients do. Or 
do they […] want to have quality of life without the side effects of 
treatment. So you know and families are involved in this as well. And 
I always say to them, go home have a chat with your family, talk it 
through, see what they feel, see what you feel. 
Even in the support that is provided, the CNS allows patients to maintain control 
over whether or not they choose to engage with this: 
there will be people who even though we give them our support group 
leaflet in their information at the beginning and we give them the 
Macmillan information, they will readily admit that they haven’t read 
it and they won’t engage and again that’s patient choice we have to 
respect that. (Hazel) 
As a supportive companion, the CNS will also allow patients as much control as 
possible over the information they receive.  There are, however, limits to this, as 
Lynda described: 
respect their wishes so if they don’t want to know something you 
don’t tell them or if you have to tell them you tell them in such a way 
that you say look I’m really sorry but I have to tell you, I can’t not tell 
you but deliver it in such a way that […] you’re going to limit the 
impact that it has on them. 
In this role, the CNS may also advise patients about what they think is the right 
approach but they will not dictate to them and tell them what to do.  This extends to 
patients’ communications with others and what they decide to tell their loved ones, 
including any children they have, as in this example from Dawn: 
They know how they cope, they know their own children. No good 
sitting there and saying you’ve got to tell your kids. They know their 
children, they might be able to tell one because they know they’ll deal 
with it, they might not be able to tell the other one.  Or, they might 
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have already decided in their heads if anything ever happened to me I 
would never tell my children. So that’s how they come, I’m not going 
to tell them. 
This third theme therefore highlights how the CNS has the difficult task within the 
role of being a companion to patients, of helping patients to feel more in control by 
providing information and allowing them to share decisions or make decisions for 
themselves. 
These three themes emphasise the varied and important role of the CNS in 
giving information, listening to the patient and checking their understanding, 
providing support, and managing emotion, and how within this role there are areas of 
best practice that can make a difference to patients’ experiences of cancer treatment, 
namely the matching and timing of information and support.  The role also involves 
being a companion to patients, building and maintaining trust by providing accurate 
information, and allowing patients to have control over their treatment decisions, 
both of which can be difficult tasks. 
 8.5.4 Transcending theme: balancing hope and honesty 
Transcending all the three themes of ‘The Role of the CNS’, ‘Best Practice’ and 
‘Being a Companion’ was a need to balance hope and honesty.  The role of the CNS 
includes giving accurate information, providing support and managing emotion, 
which can present competing demands.  Accurate information may be negative 
information for the patient to hear and so although providing it is honest, it will 
likely be damaging to any hope the patient holds.  This was particularly discussed in 
relation to treatment intent, whether this was curative or palliative, as this is a big 
focus for most patients. For example, Tina stated: 
And often we discuss at the beginning of treatment whether the 
treatment is for a curative intent or actually it’s a symptom control 
palliative treatment. And we find it’s important to say that in the 
conversation at the beginning, otherwise expectations are different 
without I suppose inhibiting somebody’s future and their positivity. 
By using the best practice measures of timing and matching information and support, 
the CNS is managing the information the patient receives and ensuring it suits the 
individual patient at the specific point they are at in their pathway. By presenting 
relevant information and not dwelling on uncertain future possibilities, the CNS can 
often provide patients with an honest and manageable picture of the present 
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situation, whilst allowing them to maintain hope.  This can be an especially difficult 
task within secondary cancer because these cancers are usually managed palliatively 
rather than with curative intent and are usually life-limiting.  However, nurses were 
able to be honest about this and give patients something to hope for, as exemplified 
in this quotation from Mary: 
giving hope at the beginning of somebody’s diagnosis of secondary 
disease and to say OK this isn’t curable but it is treatable, we are 
aiming for as long as life as possible as well as a symptom free so 
improved quality of life whilst you’re going through oncology 
treatment because you’re going to need lifelong treatment. And 
inevitably what does happen as the disease progresses – because it 
will progress very sadly, the symptoms of the disease will start to 
affect the wellbeing of the patient.  
In being a companion, building and maintaining trust is central, and therefore so is 
being honest.  Honesty is also important in order that patients can maintain control 
over the decisions that are made over their care.  Without accurate information, 
patients would not be able to make a suitably informed decision about, for example, 
if they would like to receive further treatment or not.  However, balancing this with 
allowing the patient to maintain hope also serves to strengthen the relationship. 
8.6 Discussion 
Nurses described their beliefs about patients’ expectations and experiences of cancer 
treatment in relation to three themes: ‘the role of the CNS’, ‘best practice’, and 
‘being a companion’.  Transcending these was the theme of ‘balancing hope and 
honesty’.  Nurses clearly have a varied role in providing support and care to patients.  
They believe in a focus on distinct areas of best practice, in particular the timing and 
matching of information to the individual patient and treating them as an individual.  
Being a companion to patients is also clearly important to them with a vital focus on 
building and maintaining a trusting relationship with them.  Whilst being a constant 
source of support for patients, nurses also described a necessity to allow patients to 
maintain control over their decisions and their futures, even where their actions may 
not be perceived by nurses to be in their best interest. 
The transcending theme of the need to balance hope and honesty is 
interesting when discussed in terms of expectations.  Hope could be understood as 
representing positive expectations, therefore a need to maintain hope provides 
support for the response expectancy perspective that positive expectations lead to 
  
203 
 
positive experiences (Koller et al., 2000; Kirsch, 1985).  This is in line with previous 
research which suggests that positivity is a focus for HCPs in cancer care, that they 
have a role in promoting it and a desire to do so (Taylor et al., 2016). 
Honesty is important for the nurse-patient relationship because it helps in 
building and maintaining the trusting relationship that nurses believe is a vital part of 
the care they provide.  It also assists in promoting patient control because without 
accurate information, patients would also not be properly informed about the 
treatment process, which also has implications for their decision making and 
provision of informed consent.  This highlights other important practical clinical and 
ethical considerations when managing expectations that should not be taken lightly.  
If the recommendation from research were that positive expectations were best, then 
nurses still would not simply be able to paint upcoming treatments in a very 
favourable light when managing patients’ expectations, they would still need to 
maintain honesty. 
This seems to represent the current view of nurses on expectations; that they 
want to promote positive expectations but must maintain a degree of honesty for the 
sake of a trusting relationship, allowing patients control over their decisions, and 
facilitating informed consent.  Honesty could also be seen as representative of 
fostering more realistic expectations.  From this perspective, being honest is in line 
with a preparation for treatment standpoint, which suggests that realistic expectations 
allow patients to prepare for treatment better and therefore cope more effectively 
(Janis, 1958).  In addition, it supports an expectancy violations theory perspective, 
which favours realistic expectations because they are less likely to be violated, and 
negative violations lead to more negative outcomes than unviolated expectations 
(Burgoon & Hale, 1988). 
Nurses, however, do not appear to view it in this way.  They seem to focus on 
honesty in terms of the aforementioned clinical and ethical considerations but not 
that this could actually benefit patients’ experiences of cancer treatment more 
directly.  It may be that incidentally there are some good practices occurring with 
regards to managing expectations though.  The evidence to date, discussed and 
provided in the previous chapters, does seem to indicate overall that there are 
advantages to both positive and realistic expectations, with not enough data yet to 
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conclude whether one stance is best overall than the other.  Nurses may therefore 
have adopted the best approach to managing expectations in practice, having a 
balance of the positive and realistic expectations, that current evidence could 
support, even if the basis for this does not include all the evidence. 
8.7 Conclusion 
It is clear that nurses believe they can make a difference to patients’ experiences of 
cancer treatment and that part of their job is to balance hope for the future with 
honest depictions of the realities of treatment and its outcomes.  In this way, they 
acknowledge their part in managing patients’ expectations and suggest that a balance 
between positive and realistic expectations is their preferred approach to this.  This is 
an interesting perspective that should also be considered in light findings from the 
previous literature and the preceding chapters.  If positive and realistic expectations 
have both been shown to have a positive effect on patients’ expectations, then 
perhaps balancing the two perspectives is the right approach to take with patients.  
However, the expectations-experiences relationship still needs further attention with 
patients and it is too soon to draw any firm conclusions.  What is clear though, is that 
nurses have an integral role in managing expectations and their position should be 
considered in future research, particularly in terms of implementing expectation-
based interventions. 
8.8 Towards Understanding the Role of Expectations of Cancer Treatment and 
Their Impact on Outcomes 
This chapter has described an in-depth qualitative study of CNS’ beliefs about 
patients’ expectations and experiences of cancer treatment.  It highlights that CNSs 
have an important role in managing patients’ expectations and feel there is a need to 
balance positive expectations with more realistic ones for the best patient outcomes.  
The results also illustrate the impact on the nurse of providing this care which is the 
focus of the next chapter. 
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Chapter Nine 
Study 6. The Impact on Clinical Nurse Specialists of Caring 
for Cancer Patients: A Qualitative Study 
 
9.1 Overview 
The previous chapter illustrates the value of the CNS and their ability to improve 
patients’ experiences of cancer treatment.  Providing this level of support must 
inevitably have an impact upon the CNS.  This chapter provides an in-depth 
exploration of this impact. 
9.2 Introduction 
High levels of stress, burnout and fatigue have been found to exist in oncology HCPs 
more generally (eg. Eelen et al., 2014; Jones et al., 2013; Girgis et al., 2009).  A 
systematic review concluded that the emotional responses from HCPs to the 
suffering and decline of patients were largely left unmanaged, potentially leading to 
high levels of distress, which could impact patients’ experiences of cancer treatment 
as distressed HCPs make poorer decisions and have poorer communication skills 
(Turner et al., 2011).  Further to this, in a different systematic review, De Vries et al. 
(2014) found that increased levels of fatigue and burnout amongst oncology HCPs 
were associated with lower quality communications with patients, poorer patient 
outcomes and lower patient-perceived empathy.   
The CNS plays a central role in the management of cancer patients.  It is 
therefore likely, that there may also be a negative impact to the CNS of working 
directly with cancer patients, which, if left unmanaged, could have an impact on 
patients’ experiences of cancer treatment.  In line with this, limited research suggests 
that CNSs also show high levels of stress, distress and burnout, resulting largely 
from the demands of the role, lack of support for themselves, and caring for suffering 
and dying patients (Wahlberg et al., 2016; Sharma et al., 2008). 
To date, however, much of the research to date has focused on the physician 
or oncologist and less attention has been given to the CNS.  Furthermore, many 
studies have been conducted outside of the NHS setting which itself brings with it 
additional demands.  Further, those studies that have been UK-based have largely 
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been quantitative so a detailed understanding of the role of the CNS is lacking.  
There is a need for an in-depth exploration of the experiences of CNSs caring for 
cancer patients within the context of the present UK NHS. 
9.3 Aims of the Present Study 
This chapter will therefore aim to qualitatively explore oncology CNSs’ experiences 
of caring for cancer patients within the NHS in the UK. 
9.4 Method 
The data in the present chapter was generated through the interviews used in the 
previous chapter.  Therefore, the design, sample and procedure followed were the 
same as was outlined in the previous chapter.  However, the focus here was on 
understanding the CNS’s experiences of caring for cancer patients.  A secondary 
analysis was conducted of the data collected in the previous chapter. 
 9.4.1 Data analysis 
Thematic analysis was selected for data analysis due to the flexibility it affords to 
ground analyses in the data (Braun & Clarke, 2006).  All interviews were audio 
recorded with participants’ consent, these were transcribed verbatim using 
pseudonyms and removing any other identifiable information.  Transcripts were then 
coded according to key points raised in relation to the impact of caring for cancer 
patients.  These were used to generate theme and subtheme suggestions, which were 
reviewed and discussed to ascertain their suitability.  No changes were made at this 
stage, but when these were compared again to the coded transcripts, some small 
adjustments were made to ensure the themes and subthemes better fit the data.  
Quotations were selected to illustrate the themes and subthemes.  The final themes 
and subthemes are shown in Table 9.1, on the following page. 
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Table 9.1: Themes and Subthemes 
Themes Subthemes Transcending 
Theme: 
1. Working in a 
Multifaceted Role 
i. Having varied job demands 
ii. Having unpredictable job demands 
Finding Rewards in 
the Job 
2. Working within 
the Constraints of 
the NHS 
i. Having limited resources 
ii. Lacking appropriate spaces 
iii. Not having enough time for patients 
iv. Wanting to do more for patients 
3. Managing Own 
and Others’ 
Emotions 
i. Working in an emotional setting 
ii. Being careful about what is 
communicated 
iii. Balancing hope and honesty 
iv. Witnessing death and decline 
 
9.5 Results 
Nurses described their experiences of caring for cancer patients in terms of working 
in a multifaceted role, working within the constraints of the NHS, and managing 
their own and others’ emotions.  Transcending these themes was a drive to find 
rewards in a challenging role.  These themes will be expanded under appropriate 
headings with detailed subthemes and using supporting quotations. 
 9.5.1 Theme 1: working in a multifaceted role 
Nurses clearly described their roles and the multifaceted nature of them, with varied 
aspects that they were responsible for when caring for patients.  These job demands 
will now be detailed as subthemes under the headings: ‘having varied job demands’ 
and ‘having unpredictable job demands’. 
 9.5.1.1 Having varied job demands 
Working in a multifaceted role meant that the nurses had very varied job demands.  
These centred on supporting the patient, which was undoubtedly the most important 
focus: ‘for patients, they just need to know that someone’s there. And that’s our job’ 
(Hazel); ‘all patients need to have access to someone to support them’ (Wendy). 
Providing reliable, consistent support was discussed as being a large part of 
this: ‘one of the benefits of this role, and again going back to the patient experience, 
is about the continuum of somebody who advocates for them through their cancer 
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pathway’ (Mary).  Demonstrating that the CNS cares was also key: ‘it is about 
people being caring, people actually showing they care, not feeling like a conveyor 
belt or being on a hamster wheel with no one really helping you’ (Georgina). 
Another important aspect of the role that was highlighted was 
communicating with patients.  This involved providing patients with information, 
which was seen as a core component of the job: ‘information giving obviously is 
crucial’ (Olivia); ‘giving them the correct understanding and the information from 
the outset’ (Dawn).  However, nurses also stressed that listening to patients and 
checking they understood the information being communicated was also an 
important part of their job, in promoting better patient outcomes: ‘people do come 
through it less traumatised because if they’re listened to and they’re heard’ 
(Georgina). 
As well as communicating with patients, it was clear that nurses had a role in 
dealing with other healthcare professionals within and outside of their team or 
‘liaising with other hospitals’ (Wendy).  This would involve coordinating and 
helping patients to ‘navigate’ (Hazel) the ‘huge maze of complexity’ (Mary) of 
cancer care.  For example, Georgina illustrated this navigation process in the context 
of the immediate team: 
We’re in the know, we work with whole team, we liaise with all of 
the team so if a patient rings me with a query I can go straight by 
email, text or see the consultant in clinic direct and talk to them about 
it (Georgina) 
Additionally, Wendy gave an example of how she would coordinate with another 
department within the same hospital: 
liaising with the medical team to make sure that they’re getting the 
best care and that we’re aware of what’s going on and that we will 
cancel their chemotherapy appointments and-- because that’s always 
their concerns oh I’m supposed to be coming for this today, no it’s 
fine I’ve already looked at that you know and we’re going to delay 
that by a week. (Wendy) 
Working in a multifaceted role therefore involved nurses having varied role 
demands, which focused on supporting patients but included communicating with 
patients and healthcare professionals alike, both within and outside of their own 
team. 
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 9.5.1.2 Having unpredictable job demands 
Job demands, however, were not just varied but also unpredictable.  Patient needs 
and desires were described as being ‘not ever what you think it’s going to be’ 
(Hazel).  This unpredictability was seen as a result of both physical and 
psychological factors. 
Physical differences could arise as a result of the specific cancer type, 
treatment type and due to individual physiological differences, as explained by Tina: 
‘cancer treatment’s always different for every part of the body, every type of cancer 
and everybody even if somebody had the same cancer as you, you don’t know how 
you’re going to react to treatment’ (Tina). 
From a psychological perspective, reactions to cancer and its treatment were 
described as unpredictable and specific to each individual, as were approaches to 
coping, as Lynda summarised: ‘You see all sorts they all take it differently’ (Lynda).  
This, again, can add to the unpredictable nature of the job: ‘you can’t ever predict it’ 
(Hazel).  It also made it difficult for nurses to predict how a patient might react when 
communicating information to them: ‘you don’t know when you’re talking to 
someone, how they’re going to view something, perceive something, you don’t 
know how they feel about it’ (Georgina). 
The unpredictable nature of patient needs, and the demands this placed upon 
the nurses meant that they stressed the need for them to be able to adapt to the 
individual patient: ‘from our point of view we just have to be able to support them 
whatever their situation is’ (Hazel). 
In summary, this first theme illustrates how nurses described working in a 
multifaceted role in terms of the having varied and unpredictable job demands, that 
could prove challenging. 
 9.5.2 Theme 2: working within the constraints of the NHS 
Compounding the challenge of these varied and unpredictable job demands in their 
multifaceted role was the context: working within the constraints of the NHS.  This 
was described by nurses in terms of the subthemes: having limited resources, lacking 
appropriate spaces, not having enough time for patients, and wanting to do more for 
patients. 
  
210 
 
 9.5.2.1 Having limited resources 
The main constraint of working within the NHS was the available resources: ‘I think 
our resources are limited.  Without a doubt they are limited’ (Mary).  There was a 
widespread acknowledgement amongst nurses of the ‘plight in the NHS’ (Georgina), 
the financial constraints and the resulting resource issues, which raised a lot of 
concern: ‘we are really getting quite, if we’re not already there, a broken NHS’ 
(Mary).  It was also suggested that this was understood by patients: ‘I think people 
sometimes had the perception that the NHS generally is struggling and finances – 
which they’re quite right – is an issue’ (Olivia). 
Central to this was a lack of staff both within their own teams: ‘the team is 
under-resourced, is overworked, is overburdened’ (Mary) and beyond: ‘it’s not just 
about what’s going on in the health- in the acute hospital trust with oncology, it’s 
about the whole health and social care structure’ (Mary). 
It was evident that nurses were seeing high volumes of patients and that 
‘unfortunately the demand for the service is increasing’ (Lynda), which was clearly 
placing a strain on the resources available.  To an extent there seemed also to be 
higher patient standards about what they should expect from their care, which further 
impacted this: ‘patient demand as well, they are seeking more things to improve their 
patient experience and things that aren’t necessarily available’ (Mary). 
Having limited resources, particularly staff within their own team, presented 
challenges for nurses when carrying out their multifaceted role and placed a lot of 
burden on them: ‘as with every NHS service we’re all pushed, we’re all stretched’ 
(Tina).  Despite having limited resources, they clearly tried to do as much as they 
could for patients but perhaps at their own expense: ‘you have to look at the bigger 
picture about what staff are having to do to achieve things for patients and the toll on 
them as well as individuals’ (Georgina).  There was widespread acknowledgement of 
these challenges and how they are increasing: ‘I salute anyone that does it really 
because it’s yeah it’s becoming evermore difficult’ (Hazel). 
Nurses knew how to handle themselves professionally in this regard but 
Georgina particularly discussed the necessity of this because support was not 
available elsewhere: 
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I think we’re all professional enough not to feel angry or frustrated 
with all the things that come with being working long hours and we 
know how to manage ourselves but it would be quite nice to- for that 
to be considered more in the scheme of things […] but you have to 
self-manage because that’s not going to happen because it’s the NHS, 
we’ve got a financial crisis all the time, you just have to look at self-
management and where you get your support as a worker as well in 
these types of environments. (Georgina) 
Working within the constraints of the NHS, having limited resources, particularly 
limited staffing resources, clearly presented a challenge for nurses. 
 9.5.2.2 Lacking appropriate spaces 
Part of working within the constraints of the NHS was sometimes lacking 
appropriate spaces for patients.  This was discussed in terms of the amount of space 
available for oncology services in light of the growing number of patients entering 
into the service: ‘we’ve already outgrown our unit. It was built 10 years ago and 
we’re struggling for space and you know the capacity is exponential to be fair’ 
(Georgina).  Also in terms of specific concerns about the location of some clinics: 
on a Wednesday our clinics are in the middle of the fertility clinic or 
all our patients have to walk past all the pregnant ladies waiting for 
their ultrasounds and it’s OK if it’s an older lady that’s had her 
children and things but when you’ve got young patients that don’t 
have children and you’re potentially taking away their fertility, that’s 
not good (Lynda) 
Lynda also stressed that it would be better if patients were ‘in place with other 
people going through similar things’, and other nurses suggested the same.  There 
were clearly attempts to do this being made by nurses: ‘you try with the best 
intention to keep all like-minded patients together’ (Lynda).  There was also an 
acknowledgement of the constraints of the NHS and having space for all patients: ‘I 
understand with the bed situation and everything, a bed’s a bed at the end of a day’ 
(Lynda). 
One idea, from Georgina, to improve patients’ experiences of cancer treatment 
involved being able to provide them with space and resources for information 
seeking: 
Somewhere where they have a library where they could go and sit and 
look things up would be lovely, I know a lot of the London hospitals 
I’ve been to, they’ve got that, where they’ve got a whole foyer full of 
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literature, books, IT equipment, where people can actually go like a 
library and sit, just find stuff out. 
However, it was also clear that staff attitudes could ameliorate some potential 
problems with the spaces available.  Dawn discussed the need for ‘a quiet area 
undisturbed’ when speaking with patients, and how the actions of staff can help 
ensure this is possible: 
People knocking on doors and coming in, you’ve lost them basically, 
we lose the thread of what we’re saying if people keep knocking on 
the door so we don’t encourage that and the staff here are very very 
good in not doing it. So we’re lucky. 
It was therefore clear that appropriate spaces were important to nurses but were 
sometimes lacking due to resource constraints within the NHS.  This could be 
frustrating for nurses who would like more for their patients but they were also quite 
understanding of the limited resources available and acknowledged a role for staff in 
best utilising the available space. 
 9.5.2.3 Not having enough time for patients 
Another frustration of working within the constraints of the NHS and having limited 
resources for nurses was that there are not enough CNSs in comparison to the 
number of patients.  Tina’s statement: ‘it would be nice if there was more of us’ is 
just one example of a sentiment that was common to all nurses in the study. 
Wanting to have more CNSs in post was occasionally the result of a desire to 
be able to ‘see more patients’ (Lynda). However, in clinic, it was mostly about being 
able to spend more time with patients: ‘if there was more of us, we’d have less 
patients each so you’d have more time to spend with each patient’ (Tina); ‘more time 
to give everybody the time they needed’ (Tina). 
Most nurses did state that they aim to spend as much time with the patient as 
possible to try and address their concerns but this results in clinics running behind 
schedule and consequently increased waiting times for patients.  With the potential 
reaction of the patient in mind, it was clear that the knowledge of being behind 
schedule and having patients waiting was challenging for the CNS: ‘try not to be 
distracted by knowing you’ve got people queuing up, trying not to feel that pressure’ 
(Georgina). 
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There was also a limit to this and sometimes the time appeared to be lacking 
to go into as much depth as nurses would like with some of the more challenging 
conversations: 
what my value of care may be for somebody- or the goals of 
treatment maybe – may be very different for that patient, our value 
systems may be very very different and I think again that’s one thing 
that sadly we do lack in the NHS just purely because of the volume of 
patients that are coming through, is the time sometimes to be able to 
discuss that in more detail (Mary) 
In addition to their workloads within the clinic itself, nurses spoke of the extra work 
required when they were in the office and the additional hours that they may do in 
order to respond to patient queries on the telephone.  This was particularly 
highlighted by Georgina, who mostly stressed this in reference to the implications 
for the patient but there are clear implications for the CNS too: 
we’re often coming up after clinics and then answering thirty phone 
calls so the phone call is like a clinic in itself and we’ve left patients 
waiting all day because there’s not enough staff to man the office and 
do that side of things while we’re in clinic. And that’s frustrating for 
patients when they’ve left a call at 9 and we’re often in clinic until 6 
or 7 then they’ll think we’ve forgotten them because it’s after five 
o’clock and most people go home so then we are answering calls at 7 
o’clock plus in the evening. 
Even with all of this extra effort on the part of the CNS, it was clear that nurses still 
want to be able to have more time for telephone conversations with patients: 
I’d love to ring all of my patients every week and find out how 
they’re doing but that doesn’t happen.  I’ve got 700 people plus I 
can’t ring 700 people every week, it’s not feasible. So there is always 
more that we could do but again we have to be very realistic about 
what it is safe and achievable to do. (Hazel) 
It was therefore apparent that nurses wanted to be able to have more time for their 
patients but as professionals they realised their own limitations and recognised the 
constraints of the NHS and the resources available. 
 9.5.2.4 Wanting to do more for patients 
As well as wanting more time for patients, nurses wanted to be able to do more for 
patients more generally.  This was discussed in reference to things that nurses would 
like to improve, like providing more support to patients, and processes and 
procedures; the limits of the CNS in what they can do; and the ways in which nurses 
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are continually developing themselves in order to be able to better support their 
patients. 
Nurses wanted to be able to improve the support that was available to 
patients.  They wanted, for example, more ‘support groups’ (Georgina), better access 
to ‘psychological support’ (Wendy) and ‘a treatment centre that offered 
complimentary therapies’ (Georgina).  Further, as well as wanting to give the 
patients they already saw more time, there was a desire to be able to help greater 
numbers of patients in different circumstances.  An example of this was explained by 
Lynda: 
one thing I would really love to be able to do – and it just would not 
be possible – is  this area doesn’t get the opportunity of a nurse 
specialist at the breaking bad news point, which would make things a 
lot easier because then the patients would be supported right from 
when they needed it rather than when they’ve got here 
There was also a strong desire to improve processes and procedures to be able to do 
more for patients and provide better care.  Communication was central to this, both 
in regards to the information given to patients by outside departments, which was at 
times described as being inaccurate, but also between healthcare professionals within 
the hospital.  The frustration that lack of communication could cause nurses was 
especially noticeable in this example from Dawn: 
You might have somebody who’s been in here for I don’t know six or 
seven days and then they might have been transferred to the hospice 
and we haven’t been told, we could have easily made a phone call to 
the family even. Just say how sorry we are to hear that this has 
happened but we don’t know about it, that’s really hard. I get a bit 
angry sometimes. I just think you’ve done all that lovely work and 
trust and then the very end is broken down for the sake of one phone 
call or one email. But everybody’s busy. 
Nurses also acknowledged that although they would often like to be able to do more 
for the patient, this is not always possible: ‘as a healthcare professional you have to 
balance your duty of care with knowing that there is only so much you can do’ 
(Hazel).  The circumstances in which nurses see patients, in that they have cancer, 
mean that it will not be the most positive experience for the patient, however hard 
the CNS tries: ‘recognising that actually this is not a good situation for anyone so 
you’re never going to be able to make it […] roses, are you?’ (Wendy).  There was 
also a recognition that within the constraints of the NHS and with the limited 
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resources available, the CNS should not place too much pressure on themselves or 
ask too much of themselves: 
as a nurse, of course you want to make the patient experience as best 
as you possibly can do and as easy for them as you possibly can do, 
but you can’t sacrifice yourself for that […] That is very hard when 
you’re a nurse and I still struggle with that twenty odd years in 
practice. (Mary) 
Another limit to what nurses were able to do for patients was evident when patients 
refused treatment.  Nurses expressed the desire to do more for patients than the 
patients wanted to accept, which created a conflict between wanting to help the 
patient and respecting their wishes.  The overriding factor was patient choice but it 
was obviously challenging for nurses when patients were not perceived to be acting 
in their own best interests: 
Our job is not to force people into having treatment, […] if they have 
mental capacity then they have the right to do with their body what 
they want to do, we are there to offer the information to the best of 
our knowledge about what is the right thing to do, it’s up to them 
whether they choose to accept it. (Hazel) 
it can be hard when you get patients like that. But they come with 
their set ideas, no matter what you tell them. (Dawn) 
The desire to do more for patients was so strong that nurses were evidently 
‘constantly looking at different ways of supporting patients and providing things that 
will help them’ (Wendy).  A big part of this was learning new skills and professional 
development: ‘I’m still learning and I think if anyone says they’re still learning then 
that’s OK, I think the day I feel I’ve stopped learning shall be the day that I won’t be 
doing the job’ (Mary). 
In summary, this second theme illustrates how working within the constraints 
of the NHS therefore meant for nurses that there were limited resources, which 
impacted on the spaces available for patients but largely centred on having fewer 
CNS hours than nurses would like.  Nurses expressed desires to both be able to give 
patients more time, and more generally to be able to do more to support them.  This 
was not always possible, largely due to resource constraints. 
 9.5.3 Theme 3: managing own and others’ emotions 
A further challenge described by nurses was managing emotions; both their own and 
others’, particularly patients’ emotions.  Nurses described managing emotions in 
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relation to four subthemes: ‘working in an emotional setting’, ‘being careful about 
what is communicated’, ‘balancing hope and honesty’, and ‘witnessing death and 
decline’, which will now be detailed. 
 9.5.3.1 Working in an emotional setting 
It was clear from nurses that they were very aware of the fact that they are working 
within an emotional setting: ‘We’re dealing with a very charged emotional 
environment’ (Georgina).  Patients were described as being ‘vulnerable’ (Mary, 
Olivia) and nurses often witnessed a variety of strong emotional reactions, such as 
‘the shock, the anger, the acceptance, all that sort of thing, the denial. All those sort 
of reactions – none of which are right or wrong, they can jump backwards and 
forwards between them’ (Georgina).  Nurses described the need to understand these 
reactions and to adapt their approach according to try and manage the situation.  For 
example, Georgina spoke of her response to fear in patients: 
it’s very rare that someone gets cross and if they do it’s because 
they’re scared […] but again that’s a reaction, that’s a response and 
it’s fine, it’s not a problem.  Just stay calm, focus, and look at why 
that’s happening, look at the root cause and realise it’s not personal 
and it’s something that needs dealing with in a nice, kind, gentle way. 
Aside from the initial reaction to diagnosis, there were certain aspects of patients’ 
experiences, which might lead these emotions to be heightened.  Nurses gave various 
examples of this, including waiting for appointments in the clinic: 
when people come to clinic they’ve often had to wait 2 hours to be 
seen because we never run to time and that creates huge anxiety and 
then you know they’re trying to deal with all that emotion they’ve got 
on board as well. (Georgina) 
Another example commonly mentioned was waiting for test results and the role of 
the CNS in managing the associated emotions: ‘they’re waiting for results, they’re 
very anxious they want to know’ (Tina); ‘CT scans […] significantly raise anxiety 
because it’s what’s the cancer doing, is the cancer stable, is it responding, is it 
getting worse, and that’s very much about managing the psychological impact of 
treatment and the outcome of treatment’ (Mary). 
As well as the delays to clinic appointments increasing emotion, the same 
was also said for delays to these test results: 
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the other thing patients mention a lot is perceived delays. Now 
whether there isn’t a delay, if their perception is then in their world 
there is. And frustration over if they need certain tests and imaging 
and things like that, there’s always this perception that the cancer’s 
going to do something more while they might be waiting for a CT 
scan (Olivia) 
The prospect of treatment was another area of concern that raised emotion levels: 
‘They’re obviously worried about the treatment’ (Tina), and at the other end of the 
spectrum, if treatment has not worked or the patient is out of treatment options, it can 
be an especially emotive time for patients, that nurses discussed helping them 
through: 
understanding that patients get to a point when they are less well to 
receive treatment or the disease becomes I suppose, less sensitive to 
treatment and then those are the very difficult and emotionally 
challenging conversations then that you’re having with patients about 
what further expectations treatment will offer you (Mary) 
there’s lots of twists and turns along the pathway and I think it gets 
especially difficult when we get to the point where we haven’t got any 
further treatment that we can offer to patients. (Wendy) 
In addition to managing this emotion in patients by helping them to cope with it, 
nurses also described managing this emotional setting by following procedures 
which enabled them to have a record of the conversations they had with patients, for 
future reference: 
we tick boxes of when we’ve given information and we date and time 
it so if a person has got very cross because they weren’t told 
something we could say well do you remember last time we spoke 
and we mentioned x, y and z, you might not have because you had a 
lot to take on board at that time but we’ve got the confidence that we 
did talk about these things as well for a litigation point of view and 
also informed choices. (Georgina) 
Therefore, the emotional nature of the setting can lead to negative feedback and 
nurses may need to tackle patients’ concerns using evidence they have collected.  
When this feedback is founded, however, nurses were open to learning from it in 
order to improve practice: ‘you don’t take it on the chin but you learn from it and 
adapt for future practice’ (Lynda). 
Nurses, therefore, have a responsibility to respond appropriately to criticism, 
which may be more common in this emotional setting.  It may be unfounded because 
it is emotionally driven and so it is important for nurses to judge whether this is 
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founded or not and either tackle it or adapt practice accordingly.  This could prove a 
challenging aspect of the role. 
Nurses also felt pressure in this emotional setting, not to add to the patient’s 
concerns, only to support and help them: ‘this person’s going through enough, you 
don’t need to add to their burden’ (Olivia). 
Working in what is clearly an emotional setting presents nurses with the 
challenge of managing these emotions appropriately, whilst maintaining their own 
professional approach and responding appropriately to criticism. 
 9.5.3.2 Being careful about what is communicated 
Working in this emotional setting also meant that nurses had to be careful about what 
is being communicated, in order to appropriately manage emotions.  The emotional 
setting can mean patients are quite sensitive to phraseology and can misunderstand 
or misinterpret the true meaning of what the CNS is saying, as was evident in this 
example from Wendy: 
we have to be aware that even the slightest word, the slightest 
inflection, can be taken in a way other than you mean it. For example, 
I had a lady on the phone the other day, […] and I said to her hello, 
what can I do for you? Just meaning hello, what can I do for you 
today? Well she took that as a negative and was like well what do you 
mean what can you do for me, you know what’s going on, you know 
what’s happening, you know what my anxieties are and you’re saying 
what can I do for you? 
The phrasing of communications is therefore important, something which was seen 
throughout nurses’ accounts of their interactions with patients.  Of particular focus 
was the phrasing of information surrounding treatment intent and treatment efficacy: 
what I say to my patients is that everything that we do is designed to 
reduce the risk for you and it is individualised ‘cause we look at you, 
look at the cancer you’ve had, and then make a plan about the best 
treatments for you in light of all that information. So they are aware 
that it’s to reduce the risk of any problems in the future, we can’t 
eliminate the risk but that’s why they’re being offered these 
treatments. (Georgina) 
Similarly, the language used was carefully selected when speaking about treatment 
efficacy: ‘we don’t use the word cure because I think that’s extremely loaded 
because you can’t promise to cure anybody and what does cure mean?’ (Georgina).  
Avoiding complex medical language was also seen as an important aspect of 
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communicating with patients, in order to avoid undue anxieties and confusion 
arising: ‘explain it in a bit more of dare I say a humanised way or layman’s terms for 
them so that they understand it’ (Lynda). 
How information is delivered is therefore quite central to managing patient 
emotions in cancer care.  This can also help to ameliorate some of the impact that 
information communicated may have on patients: ‘we do deliver it in such a way that 
it’s not up against a brick wall’ (Lynda), which further helps to manage the 
emotional reaction that may occur, particularly in cases of bad news. 
It was clear that helping to manage patients’ emotions by being careful about 
what is being communicated, presented a challenge for nurses.  This is apparent, for 
example, in Wendy’s account of when a patient had misunderstood something she 
had said to them: 
sometimes even though we’re very experienced and we think about 
the language we use, sometimes we’re human, and you just don’t 
think – well  actually that was taken the wrong way and I didn’t mean 
it in that way at all – so  then it’s repairing the damage that even that 
slight thing can make. […] It’s a hard road. 
This may be made more difficult when patients have inaccurate beliefs about treating 
their cancer, or beliefs that conflict with nurses’ own views of what would be best 
for the patient.  The need to maintain patient choice whilst communicating evidence-
based information presented conflicts for nurses.  Dawn, for example, discussed a 
patient who decided to treat their cancer using juicing, rather than medical 
treatments: 
they’ve read something about taking this juice or whatever. And you 
have to tell them that you respect it but you can’t force them, but you 
know they’re not going to do well you know they’re going to be back 
sometime. But how do you tell them that?  It’s very difficult, very 
difficult. 
Being careful about what is being communicated by selecting appropriate language 
and phrases is therefore an important part of managing emotions for the CNS, that 
can be challenging. 
 9.5.3.3 Balancing hope and honesty 
Another aspect of managing emotions is the need to balance hope and honesty for 
patients.  ‘Being as honest as you can from the beginning’ (Dawn) was integral to 
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building trust and developing patient relationships.  Having honest conversations 
was felt to impact patient experiences, as explained by Lynda: ‘For me personally I 
think patients have a better experience if people are open and honest to them no 
matter how difficult it is’.  Particularly as no news is often seen as being worse than 
bad news: 
I think it’s the not knowing sometimes that’s even worse than actually 
knowing, even if it is bad news. Yeah because they can start to 
assimilate it and process it, where when it’s not known, I think people 
imagine so much worse. Is my experience of it really. Honesty 
definitely is the best policy. (Olivia) 
Nurses also described how being honest also helped patients to make the best-
informed decisions that they could: 
Sometimes patients don’t want to accept that maybe things aren’t 
going so well and that we’re running out of treatment options […] 
and that’s hard because you have to be honest with people so that they 
know what’s going on and if we’re now talking about a much-
shortened lifespan that they have the time to make decisions about 
what they want. (Wendy) 
However, hope was also seen as ‘hugely important’ (Dawn) and nurses felt it a 
necessary part of coping with cancer and its treatment.  Nurses sometimes managed 
the patient’s outlook in order to promote hope: 
giving hope at the beginning of somebody’s diagnosis of secondary 
disease and to say OK this isn’t curable but it is treatable, we are 
aiming for as long as life as possible as well as a symptom free so 
improved quality of life whilst you’re going through oncology 
treatment because you’re going to need lifelong treatment. (Mary) 
There was therefore a need to balance hope and honesty, in order to promote the best 
possible psychological outcomes for patients, as explained by Tina: 
we discuss at the beginning of treatment whether the treatment is for a 
curative intent or actually it’s a symptom control palliative treatment. 
And we find it’s important to say that in the conversation at the 
beginning, otherwise expectations are different without I suppose 
inhibiting somebody’s future and their positivity. 
It was evident that this was a challenge for nurses: 
trying to sort of prepare patients for the fact that yeah we will be 
getting more information and we don’t know yet the extent of what 
we’re looking at but also trying to stay or promote positivity can be 
quite difficult sometimes. (Olivia) 
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Balancing hope and honesty was therefore a challenging but important part of 
nurses’ roles in managing patients’ emotions. 
 9.5.3.4 Witnessing death and decline 
Nurses often discussed witnessing death, or at least having the knowledge that a 
patient had died, and patient decline.  This was particularly apparent with, but not 
limited to, those nurses working within secondary care.  There were difficult 
conversations to have with patients, particularly those ‘potentially with a life-
limiting diagnosis’ (Mary). 
There was a need to discuss matters relating to end of life care.  For example, 
when to stop treatment: ‘I try to encourage patients to think about what it means to 
them to have that treatment and actually do they want to carry on having treatment 
right up to the point that they die’ (Wendy). 
Nurses also had difficult conversations with patients about getting 
community support and deciding where they would like to die: 
at some point they are going to need the support of the community, 
either to die at home or maybe to die in the hospice. I think less and 
less patients are dying in hospital because we are more in tune with 
their wishes. (Wendy) 
Providing support to those patients with poor prognoses was a big part of the role of 
the CNS in this context.  This could be directly, by helping patients come to terms 
with a life-limiting diagnosis and receive good care, as discussed by Lynda, for 
example: 
unfortunately we have the cases where we’re in a very dire situation 
where there is very little that we can do so it’s just trying to offer 
support and advice to just make whatever time and treatment they 
have as smooth as possible for them 
It could also be indirectly, by referring to the appropriate outside services: ‘we try 
and offer people that aren’t going to be cured by their treatment, we offer them 
obviously the community hospice teams for psychological support as well as 
symptom control’ (Tina). 
In those with a poor prognosis, as well as discussing matters relating to death, 
nurses also witnessed patient decline.  This is exemplified by the following quotation 
from Mary, in which is evident the potential emotional impact that witnessing this 
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decline could have on the CNS: ‘inevitably what does happen as the disease 
progresses – because it will progress very sadly, the symptoms of the disease will 
start to affect the wellbeing of the patient’. 
Another difficult aspect for nurses of witnessing death and decline was 
seeing patients make decisions that would lead to this outcome.  This was 
particularly discussed in the context of treatment refusal, where nurses must respect 
patients’ wishes but knowing full well that the patient’s decision would lead to their 
decline and eventual death.  Although this was usually mentioned in regard to 
patients with false beliefs about alternative therapies, Dawn spoke of one example of 
a patient who was refusing treatment because she actually wanted to die: ‘we’ve got 
a lady recently she believes that she doesn’t want treatment. Her husband died very 
sadly, not very long ago and she wants to be with him’ (Dawn). 
It was apparent that these kinds of circumstances were difficult for nurses and 
potentially emotive.  There were also times when other aspects of patients’ lives 
made it difficult for them to receive treatment.  This was spoken about in terms of 
practicalities, such as travelling to appointments, and in terms of comorbidities.  
Hazel gave a striking example of how a patient’s mental health might have an impact 
on their treatment and how this could affect the nurse: 
we’ve had a lady who has actually not even got to the point of being 
able to receive treatment yet because she’s so severely agoraphobic, 
claustrophobic and her mental health needs are such that she can’t 
bring herself to be at the point where she’s willing to accept 
treatment. And that’s very difficult when you know that that’s 
potentially going to have an impact on her life (Hazel) 
These aspects of death and decline have an emotional element and may be difficult 
for patients and nurses alike.  In particular, the discussions they have with patients 
about death seemed to have the most impact on nurses.  Wendy gave an example of a 
conversation with one patient that had clearly stayed with her: ‘she got married in 
April and back in January we had a very emotive discussion about whether or not 
she would be here for her wedding’ (Wendy). 
Witnessing death and decline invariably meant for nurses, handling patient 
emotions, particularly relating to life-limiting prognoses.  Working within such an 
environment, however, brought death to the fore and may have served as a reminder 
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of their own mortality.  It was clear that nurses must also manage their own emotions 
whilst working in this setting. 
This third theme illustrates that within their multifaceted role and the 
constraints of the NHS, a further challenge was apparent for nurses, is managing 
emotions; mostly patients’ emotions but also their own. 
 9.5.4 Transcending theme: finding rewards in the job 
The nurses therefore described the experience of working with patients with cancer 
in terms of working in a multifaceted role and having varied and unpredictable job 
demands, struggling within the constraints of the NHS with limited time and space 
and the tensions created by managing their own and others’ emotions, as detailed 
within the three themes above.  These themes illustrate a wide range of challenges 
faced by the nurses.  Transcending these themes was a strong sense of the nurses still 
finding rewards in their work even though it was clearly challenging.  In particular, 
the nurses found rewards through their sense of altruism as well as by feeling that 
there were staying on top of a difficult job. 
Feeling that they were able to stay on top of this challenging job gave nurses 
a sense of achievement and job satisfaction.  This was threaded throughout the 
nurses’ accounts of their experiences of caring for cancer patients and rarely stated 
explicitly.  Hazel, however, exemplified this by describing two sets of circumstances 
that demonstrate this.  The first was when Hazel spoke about the unpredictable 
nature of the role: ‘which is part of the reason I love the job because you never ever 
know what you’re going to walk into’.  The second was in handling difficult 
conversations: ‘it’s the really challenging discussions, the really in-depth 
discussions, they’re the ones I love, they’re the ones I relish’. 
Central to finding rewards in the job for nurses was being rewarded by 
altruism.  Helping patients and making a difference to their experiences of cancer 
care was the focus.  Within their multifaceted role as a CNS, there were various 
ways in which nurses described this altruistic reward.  The first related to the support 
provided to patients in their role.  For example, Georgina described the added value 
to patients of nurses showing that they care: 
I think the main thing for me, for patients is that they need to know 
you care and that you are genuinely concerned about them and that 
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you will listen to them. And that I think is absolutely key.  I think that 
makes a huge difference to patients, that feeling- it makes people feel 
valued, like they matter. (Georgina) 
In this supportive role, there were other benefits described by Mary: 
I’m very lucky in oncology. Oncology is a speciality that- and in 
secondary disease you really are able to build a relationship, you 
don’t have that in other areas sometimes with clinical practice. You 
know the individual, you know their husband, their partner, you know 
the kids, you know when they’ve got a key birthday coming up or 
things like that you’re in a very privileged position to be able to 
access somebody’s life when you’re caring for them. 
Managing patients’ emotions was another area in which nurses were able to help 
patients and therefore find an altruistic reward.  By being careful about what was 
communicated to patients, nurses were rewarded by being able to make a difference, 
for example, to the way patients understand their situation: 
we can talk to patients in that way and that is hugely reassuring for 
patients, they come with all sorts of worries and concerns, a lot of 
which are not true so at least if we can demystify it and then take 
away that because it’s actually not even correct then that’s great 
(Georgina) 
Nurses also described findings rewards through their attempts to balance hope and 
honesty as this made a difference to patients.  Hazel, for example, spoke about 
having challenging but honest conversations about the appropriate time to stop 
treatment: 
sometimes if you have a frank conversation with people and say the 
chances of it working versus your quality of life, they will actually be 
very appreciative of the fact that you’ve had that kind of conversation 
with them and they’ll say fair enough I understand now, I’m not 
going to have any more treatment and then they can live the rest of 
their life with appropriate palliative care support and community 
support but with a better quality of life than if they’d continued 
having treatment and those kind of conversations – as difficult as they 
are – for a healthcare professional to have, you go home thinking that 
you’ve- that’s when you make a real difference because you think 
actually if I hadn’t had that conversation they would have had a very 
different end to their life. 
Another of the altruistically rewarding aspects of caring for cancer patients that 
nurses discussed was seeing happy patients post-treatment, knowing that they had 
contributed in some way to that: 
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That makes our job very happy when we see them come out the other 
end. That’s the bit of my job I love. […]  Finished treatment, they’re 
looking happy and well and you see them the next year and they’re 
happy and well and you see them the year after. That’s lovely to do, 
lovely to see. (Dawn) 
The difference that nurses make to patients’ experiences of cancer treatment was 
affirmed by positive feedback from patients, which some nurses described as having 
received.  For example, Dawn and Wendy: 
when they’re diagnosed. And I’m talking about here. We are very – 
and this is from feedback as well and what we get in cards and thank 
yous and whatnot – they feel very secure and looked after. (Dawn) 
we’ve had a lot of positive feedback from patients in the form of 
cards, letters, saying how much they appreciate the support, […] that 
they’re comforted by the fact that they know there’s someone on the 
end of the phone who knows them, who knows what’s going on with 
them, and knows their whole pathway not just that little bit of what’s 
going on, and can advise them (Wendy) 
Nurses occasionally also drew on research evidence to assert the value of their role 
in helping patients: 
I’d like to think that we in some way help them cope and then come 
out of the other end more stable than they would have done if they 
hadn’t had that input. And I think that is borne and backed up by a lot 
of literature as well about specialist nurses. (Georgina) 
The biggest rewards that nurses found in caring for cancer patients were the altruistic 
ones; being able to help patients and make a difference to their lives and seeing them 
happy at the end of treatment and beyond. 
Therefore, although the multifaceted role, working within the constraints of 
the NHS and managing one’s own and others’ emotions meant that nurses faced 
huge challenges, they found rewards in these challenges and staying on top of the 
job, and were very rewarded by altruism, by really being able to help and support 
patients throughout their cancer pathway and promote the best possible outcomes. 
9.6 Discussion 
The findings from this study provide a detailed understanding of the nature of CNSs’ 
work, and their daily experiences of caring for cancer patients.  They provide a more 
in-depth exploration of the challenges faced by CNSs in this role.  The results also 
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illustrate that despite these challenges the CNSs find rewards in their work which 
will now be discussed.  
Working in a multifaceted role with varied and unpredictable job demands 
was one area of challenge nurses discussed.  A variety of skills are necessary when 
working within this role.  Central to this is an ability to be supportive and caring to 
patients, but this also includes being able to communicate effectively with patients 
and professionals alike and being flexible and adaptable to situations as they arise.  
The skill involved in the role is clear, as is the challenge of working within it.  The 
sorts of difficulties are likely similar to those faced within different healthcare 
systems as this is more about the nature of the role than the wider context.  When 
considering the nature of this role, it is understandable why previous research has 
found high levels of stress, distress and burnout in oncology CNSs, and why the 
demands of the role have a been found to contribute (Wahlberg et al., 2016; Sharma 
et al., 2008).  The current research illuminates what it is about these role demands 
that make them so challenging. 
In addition, it highlights the additional challenges perceived by CNSs of 
working within the constraints of the NHS, which no previous research has explored.  
These mostly stem from financial limits and the resulting lack of resources, 
including fewer staff than would be ideal.  Nurses’ concerns about the limited 
resources centred on the care they were able to provide to patients, and any 
frustrations with this situation seemed to be levelled at the inability to spend more 
time with them or do more for them. 
Previous research cites caring for suffering and dying patients as one 
contributor to stress, distress and burnout in oncology CNSs (Wahlberg et al., 2016).  
Findings from the current study suggest that this is just one part of the challenges for 
CNSs of managing their own and others’ emotions.  Witnessing death and decline is 
difficult for CNSs, this and the care provision to those who are suffering described 
by previous research, contributes to producing the emotional setting that the 
experience of being a CNS in cancer involves working within.  This setting also 
necessitates being careful about what is communicated to patients, which places 
pressure on the CNS as they must constantly plan what they are going to say and 
how, and try not to say the wrong thing.  In addition to this, the findings from the 
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previous chapter (Chapter 8) are also relevant here because the discussed need to 
balance hope and honesty, and therefore manage patients’ expectations, is 
challenging.  CNSs want to be able to give hope and being honest is very difficult 
when there is bad news, delivering it well takes skill but can also be emotionally 
draining. 
The results also show, however, that not only do CNSs find their role 
challenging they also managed to identify rewards.  Previous research indicates that 
oncology nurses have good overall job satisfaction (Dias et al., 2017) and the present 
study indicates that this might be due to their ability to find rewards in their role 
despite the challenges they face.  In particular, the findings indicate overcoming the 
challenges is part of the reward but also they find satisfaction for more altruistic 
reasons.  However, this does highlight a limitation of both this study and previous 
research, in that study samples may represent more engaged and satisfied CNSs.  
Willingness to participate in research may be a characteristic of those who are not 
having the worst experiences in their role; taking time out of their day to participate 
may seem unmanageable for a CNS who is already struggling with their workload, 
for example.  This may be further exacerbated by an interview setting, as this may 
take more time and be seen as more personal than completing a questionnaire, 
particularly if the interviewer is an outsider to the team, as was the case here.  
However, participating in research could also be perceived as a chance to complain 
for those who are very dissatisfied, and no participants spoke from this perspective. 
Previous research has suggested that there can be a lack of support available 
to oncology HCPs (Wahlberg et al., 2016).  The findings here underline the 
challenging nature of the role of the CNS, which further justifies a need for this 
support.  It could also help to inform the support provision by illuminating some of 
the issues faced by the CNS and therefore potential vulnerabilities.  Perhaps more 
importantly, that the CNS can find rewards despite adversity in this challenging role, 
should be celebrated.  Maximising these rewards of the role could be the focus for 
supporting CNSs, rather than trying to combat the challenges.  Many of the 
challenges are an integral part of the role, they come with the territory, and cannot be 
altered.  For example, the emotive nature of cancer care is driven by patients’ 
understandable responses to their diagnosis and so the need to manage the emotions 
surrounding this cannot be changed.  The context of the NHS and the constraints 
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working in this setting entails are also very difficult to solve, as they would require a 
huge financial commitment.  As far as challenges go, providing support during the 
difficult times would definitely be advantageous but there is also room for 
intervention with a focus on the rewards of the role.  CNSs deserve recognition for 
the difference that they can make to patients’ experiences of cancer treatment.  
Altruism is the biggest reward for them within this challenging role and so anything 
that could highlight the benefit to the patient of their work could serve to bolster 
CNS perceptions of the rewards.  Acknowledging their triumph in adversity could 
further this, because overcoming the challenges faced in the role was another aspect 
that CNSs found rewarding.  Therefore, an integral part of supporting the CNS 
should be to underline these two aspects of the achievements that CNSs accomplish 
whilst in their everyday working roles. 
9.7 Conclusion 
The role of multifaceted role of the CNS is challenging, with varied and 
unpredictable job demands, which is further exacerbated by working within the 
constraints of the NHS.  A further challenge of the role is in managing their own and 
others’ emotions in the emotive cancer setting, needing to be careful what is said, to 
balance hope and honesty, and in witnessing death and decline.  Despite all these 
challenges, there are rewards to be found in the role, largely centred on altruism; 
being able to make a difference to patients’ experiences of cancer treatment was 
cited as highly rewarding.  There is also evidence to suggest that the challenges of 
the role are reward in themselves, overcoming adversity to help their patients is 
hugely satisfying for CNSs.  The challenges do highlight a need to ensure support is 
available to CNSs when they need it, from a perspective of maintaining their own 
personal wellbeing but also in regard of the evidence that when HCPs are stressed, 
distressed or burnt out, it can have detrimental effects on patients’ experiences of 
cancer treatment.  The findings can also be used to help inform providers about 
where to target support interventions for CNSs. 
9.8 Towards Understanding the Role of Expectations of Cancer Treatment and 
Their Impact on Outcomes 
Patient expectations have to be linked to their experiences.  Studies 1-4 explored 
these expectations, developed a new quantitative measure and assessed the link 
between expectations and experiences.  Experiences, however, are also influenced by 
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interactions with HCPs, particularly the CNS.   The previous chapter illustrated 
CNSs beliefs about patient expectations and indicated that they endorse a balance 
between hope and honesty.  This chapter has explored the impact of their role and 
illustrates that the role of the CNS is varied and challenging and that both despite 
and because of these challenges, CNSs find rewards in their roles.  This is the last 
empirical chapter and therefore the next chapter contains the discussion of the thesis.  
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Chapter Ten 
General Discussion 
 
10.1 Introduction 
The healthcare expectations literature contains conflicting perspectives on whether it 
is preferential for patients’ pre-treatment expectations to be positive or more 
realistic.  A response expectancy standpoint suggests that expectations can predict 
experiences and therefore promoting positive expectations would foster positive 
treatment experiences (Kirsch, 1985).  Conversely, expectancy violations theory 
suggests that where experiences are worse than expected, they could be experienced 
more negatively than if they better matched pre-treatment expectations, thus 
advocating more realistic pre-treatment expectations (Burgoon & Hale, 1988).  In 
line with this, a preparation for treatment perspective suggests that receiving 
adequate, accurate information about treatment allows patients to psychologically 
prepare, helping them to cope with treatment, which also supports setting more 
realistic expectations (Janis, 1958).   
Both response expectancies and preparation for treatment approaches have 
received a lot of research attention within the context of cancer care and their 
opposing views therefore do not answer the question of which perspective it is best 
for patients to adopt when facing an upcoming cancer treatment.  Expectancy 
violations theory highlights the need to consider the gap between expectations and 
experiences but has been the focus of little research in a healthcare context.  
Although the previous literature does not highlight the best approach to take, 
healthcare professionals, particularly Clinical Nurse Specialists (CNSs) have a role 
in managing patients’ expectations, and therefore their beliefs and experiences 
surrounding patient care are additionally important to consider.  Common to the 
perspectives on expectations is the lack of an in-depth exploration of patients’ 
expectations of cancer treatment and they often have a narrow focus.  No broad, 
robust measure of patients’ expectations of cancer treatment previously existed. 
10.2 Aims of the Thesis 
The aims of the thesis were therefore to provide a broader exploration of patients’ 
expectations of cancer treatment, to develop new measures of patient expectations 
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and experiences, to quantitatively evaluate the link between expectations and 
experiences and to understand more about the beliefs and experiences of Clinical 
Nurse Specialists (CNSs) in a cancer setting. 
10.3 Overview 
This final discussion will first provide a summary of the findings for each empirical 
study in the context of the literature.  It will then explore links between the studies 
and develop an overall thesis.  The chapter will then describe methodological 
limitations and future directions for research. 
10.4 Summary of Findings 
 10.4.1 Study 1. Patients’ expectations of cancer treatment: a qualitative 
study 
Firstly, a qualitive study explored patients’ expectations of cancer treatment and their 
relation to experiences of treatment.  This found that patients focus on a broad array 
of expectations before treatment and that these did appear to impact on experiences.  
Patients were presented with the challenges of facing their own mortality and the 
uncertainties of treatment, both from an efficacy perspective and a treatment 
experience perspective, and the challenge of a changing identity.  There were very 
often differences between what they expected and what they experienced, for the 
better or for the worse, even when they felt they had known what to expect.  Patients 
invested in healthcare professionals and treatment, putting a lot of trust in both and 
viewing treatment as a necessary evil.  In this way, treatment efficacy expectations 
were viewed as necessarily positive in order to assist coping with what treatment 
would entail.  There was some support for the preparation for treatment perspective, 
as patients felt that experiences were easier to cope with when they felt prepared and 
less so when they were unprepared (Janis, 1958).  In addition, there appeared to be 
three groups of patients: those whose pre-treatment expectations were negative, who 
then experienced relief when treatment was better than they had expected; those 
whose pre-treatment expectations were more positive, who experienced shock when 
treatment was worse than they had expected; and those whose pre-treatment 
expectations and treatment experiences were reasonably well-matched, who 
experienced neither shock nor relief but whose experiences were described neither 
particularly negatively, nor particularly positively.  These groupings are very much 
in line with what would be anticipated by expectancy violations theory (Burgoon & 
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Hale, 1988).  Thus, this tends to reject the predictive nature of expectations on 
experiences and provides no support for a response expectancies perspective in this 
regard (Kirsch, 1985).  There is some support, however, for Koller et al.’s (2000) 
findings which suggest that positive treatment efficacy expectations are protective of 
QOL in the short-term; patients here maintained positive expectations in this regard, 
in order to assist them to cope with the prospects of what treatment might entail.  
Although interesting, the findings here required further study using quantitative 
methods, to understand whether the suggested patterns would be found in a larger, 
more generalisable sample. 
 10.4.2 Study 2. The development and validation of the expectations of 
cancer treatment questionnaire and the experiences of cancer treatment 
questionnaire 
Secondly, new, matched measures of expectations of cancer treatment and 
experiences of cancer treatment, the EXPECT-CTQ and the EXPER-CTQ were 
developed and validated in order to directly compare patients’ expectations before 
cancer treatment, with their experiences during treatment for a broad range of 
expectations and experiences.  The measures were based on the above qualitative 
data and the previous literature and measures.  Any measures that previously existed 
had limitations.  The first of these were that some focused only on a particular aspect 
of expectations, such as treatment efficacy, which neglects the broader range of 
expectations that exist, and any interaction that may occur between them.  Secondly, 
some measured an expectations-experiences gap retrospectively, i.e. asking whether 
experiences were better, worse or the same as expected, which means that 
perspectives on expectations could be altered by the experiences that have ensued.  
Thirdly, some lack rigour in their development and suffer, for example, from item 
generation processes that include only the previous literature on experiences and not 
an in-depth focus on expectations.  Finally, where measures exist in other conditions, 
they are very specific and not suited to adaptation for use in a cancer setting.  This is 
the first time it has been possible to prospectively study a broad range of patients’ 
expectations to understand their direct impact on patients’ experiences of cancer 
treatment.  The EXPECT-CTQ includes expectations of treatment efficacy, 
measuring trust in the treatment and the HCP regarding the treatment outcome; 
physical side effects, with subscales of fatigue, pain, gastro-intestinal, and 
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appearance; psychological side effects, with subscales of negative emotion and 
positive outlook; and impact, with subscales of impact on daily life, social impact, 
and self-care.  The measures also allow the gap between expectations and 
experiences to be calculated, thus making them additionally useful for researching an 
expectancy violations theory perspective.  Exploratory validation was conducted on 
the EXPECT-CTQ but confirmatory analyses will be necessary to ensure the validity 
of the measure.  Both EXPECT-CTQ and EXPER-CTQ were reliable, with good 
internal consistency on all subscales. 
 10.4.3 Study 3. A cross-sectional study of the relationship between 
expectations and experiences 
Thirdly, the relationship between expectations and experiences of cancer treatment 
was quantitatively explored using the EXPECT-CTQ and the EXPER-CTQ.  Due to 
the nature of the new measures, this provided a broader exploration of this 
relationship than has been conducted in the past.  Within this context, expectations 
correlated with experiences in terms of overall treatment consequences, the 
groupings of physical side effects, psychological side effects, and impact, and all 
subscales within them.  All relationships had significant medium or large effect 
sizes.  There was therefore some support for a response expectancy perspective that 
expectations can predict experiences of cancer treatment (Kirsch, 1985).  However, 
the data were collected cross-sectionally so it is unclear what the effect of presenting 
the measures concurrently has been.  This method may have made it more difficult to 
distinguish between the two variables when responding.  The measures were also 
presented during or after treatment and so expectations may have been influenced by 
experiences currently occurring, or which had occurred in the past.  Therefore, their 
situation at the time of participation may have had implications for the results.   
Evidence that this might have been the case was found when considering the 
relationship between treatment efficacy expectations and the treatment consequence 
expectations-experiences gap.  There was a difference in the direction of the 
relationship according to whether participants were currently receiving treatment or 
had done so in the past.  For those who received treatment in the past, the more 
positive treatment efficacy expectations were, the better experiences were than 
expected.  However, for those who were currently receiving treatment the 
relationship was in the opposite direction.  It must be noted that the relationships for 
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those currently receiving treatment were not significant, probably due to an 
insufficient sample size and resulting lack of statistical power.  Nonetheless, that the 
relationships are in opposing directions is of interest.  Perhaps those currently 
receiving treatment are holding on to positive treatment efficacy expectations in the 
face of experiences that are worse than expected, rather than reflecting on their true 
pre-treatment expectations in this sense, and those whose experiences are better than 
expected have no such need to focus on positive treatment efficacy outcomes.  This 
reflects another aspect of the qualitative findings from this thesis, as it could 
represent the shifting of focus also found within this study.  In the qualitative study, 
participants were found to focus on treatment outcomes, finishing treatment, and 
being well again, when treatment experiences were particularly negative.  When they 
were more positive, participants focused on the here and now, taking one step at a 
time, and leaving concerns about treatment outcomes aside until later.  These 
findings could explain what is occurring with patients who were currently receiving 
treatment.  For those whose treatment was in the past, to be able to participate, they 
have survived, so there may be more positive reflections on experiences because 
whatever treatment entailed, it had been worth it to get the outcome they desired.  
However, this did not appear to be the case in the aforementioned qualitative study 
and the relationship was only significant with the psychological side effects 
comparison.  The contrasting findings provide inspiration for an area for future 
investigation.   
Analyses of the gap between expectations and experiences of treatment 
consequences show that where patients’ experiences of treatment were better than 
expected, their experiences were more positive overall; where patients’ experiences 
of treatment were worse than expected, their experiences were more negative 
overall; and where patients’ expectations and experiences were well-matched, their 
experiences were somewhere in the middle overall.  This is in line with the 
qualitative findings from the thesis mentioned above that suggested this same 
relationship.  It also provides support for expectancy violations theory, which 
suggests relationships would be just as the study has found (Burgoon & Hale, 1988).  
Again, the cross-sectional nature of the work presents a limitation, and the 
retrospective accounts of expectations may have influenced their recall.  However, 
that the findings are congruent with the qualitative findings in this thesis, expectancy 
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violations theory, and the previous expectancy violations research, suggests that 
there may be some merit in the findings (Burgoon & Hale, 1988).  This study 
provides some promising evidence, particularly for an expectancy violations theory 
perspective. 
 10.4.4 Study 4. The relationship between expectations and experiences: a 
clinical case study 
Fourthly, a case study was outlined that used the newly devised EXPECT-CTQ and 
EXPER-CTQ using prospective methodology.  The intent of this study was to recruit 
enough participants to conduct statistical analyses on this sample but there were 
various ethical and practical limitations imposed that made advertisement very 
passive, entailing the placement of leaflets in patient information packs, in waiting 
rooms, and on notice boards in the oncology centre.  With no direct conversation 
occurring with patients regarding the study, recruitment therefore struggled.  Only 
three patients approached the researcher interested in participating; one completing 
no measures, another completing only the baseline measures, and the third 
completing all measures and thus becoming the case study.  Although limited 
conclusions can be drawn from a case study, the results are interesting as they do 
appear to support the findings from the rest of the thesis with regard to the 
expectations-experiences gap.  Much like the qualitative study described above, there 
was little evidence of support for a response expectancies perspective, as 
expectations did not generally appear to predict experiences (Kirsch, 1985).  Where 
they did, most often the experiences were near to the neutral point, suggesting more 
support for regarding this from an expectations-experiences gap and expectancy 
violations perspective than for response expectancies.  If patients begin with neutral 
expectations and ends with neutral experiences, they have not experienced an 
expectancy violation, which, from an expectancy violations theory perspective, 
would lead to more neutral experiences overall, which is what is seen here (Burgoon 
& Hale, 1988).  In general, positive expectations led to negative experiences and 
negative expectations led to positive experiences for the different subscales and 
groupings of the EXPECT-CTQ and EXPER-CTQ.  The degree of the gap also 
seemed to mirror the degree of negativity or positivity of the overall experience.  
Again, this is as would be expected with expectancy violations theory but not what 
response expectancy theory would predict (Burgoon & Hale, 1988; Kirsch, 1985).  It 
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would be very interesting to explore this further in a larger sample.  However, that 
the findings presented within the thesis agree, is very promising for an expectancy 
violations perspective. 
 10.4.5 Study 5. Healthcare professionals' beliefs about patients' 
expectations and experiences of cancer treatment: a qualitative study 
There was also a focus on HCPs’ perspectives of patients’ expectations and 
experiences of cancer treatment, with a focus on the CNS, as an integral part of the 
multi-disciplinary team providing cancer care to patients.  Exploring this is important 
because the way that CNSs communicate with patients can influence their 
understanding of the situation they face (Tversky & Kahneman, 1981).  CNSs 
therefore have a role in managing patients’ expectations of cancer treatment.  What 
they believe makes a difference to experiences, and what they think patients should 
expect from treatment could therefore influence patients’ experiences of cancer 
treatment.  The qualitative study within the thesis that explored this found that CNSs 
believed they had a varied role that could support patients and make a difference to 
their experiences.  They highlighted areas of best practice within this role that make 
a difference to patients’ experiences, namely that timing should be considered when 
providing information and support, such that where the patient is on their treatment 
pathway is important in this type of care provision.  They also discussed that this 
information and support should be matched to the individual patient, their needs and 
wishes, in order that the patient feels cared for and does not feel de-individualised. 
CNSs also had a role in being a companion, building and maintaining a trusting 
relationship with patients and providing support whilst promoting patient control.  
Transcending all of this was a need to balance hope and honesty.  In relation to 
expectations, this means that CNSs believed there was a need to balance positivity 
(hope) with realism (honesty), perhaps therefore promoting the adoption of a positive 
realist stance in relation to expectations.  This study provided an understanding of 
the ways in which CNSs believe patients’ expectations should be managed.  Given 
the findings to date on patients’ expectations of cancer treatment, it appears that the 
position adopted by CNSs may actually be the best to take.  Although it is 
conflicting, there are evidenced benefits of both positive and realistic expectations, 
and so therefore at this juncture, perhaps a balance of these is the best approach to 
adopt until further research has been conducted. 
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 10.4.6 Study 6. The impact on Clinical Nurse Specialists of caring for 
cancer patients: a qualitative study 
The final area of exploration in the thesis was of CNSs’ experiences of providing 
care to patients.  The reason for its inclusion was the previous evidence that 
oncology HCPs experience high levels of stress, distress and burnout but with lesser 
focus on CNSs specifically, more on physicians and oncologists (e.g. Eelen et al., 
2014).  Therefore, there is a potential strain on the CNS of providing care to cancer 
patients, that had not been fully explored.  This is an important area because when 
HCPs are suffering from these afflictions, various aspects of their care provision 
suffer, including their communication skills, with an associated impact on patients’ 
experiences of cancer treatment (Turner et al., 2011).  Therefore, the abilities of 
CNSs to manage patients’ expectations of cancer treatment depend upon the impact 
that providing care has had on them.  The qualitative study in the thesis that explored 
this found that the role of the CNS was varied and unpredictable, thus presenting 
them with a challenge.  This was further compounded by working within the 
constraints of the NHS, and the associated restriction on resources available, such as 
appropriate spaces for patient consultations, and staff, meaning that CNSs were left 
wanting to be able to spend more time on patients and do more for them.  The 
emotive context of cancer care necessitated the management of both their own and 
others’ emotions, with being careful about what is communicated to patients, and 
being able to balance hope and honesty cited as being particularly challenging.  
CNSs were also witness to death and decline, which could have emotional 
consequences for themselves as well as the patients and their social networks.  CNS, 
however, were able to find rewards in this challenging role, mostly for altruistic 
reasons, by being able to make a difference to patients’ experiences of cancer 
treatment and seeing patients who have finished treatment and are well. The 
challenge of the role was also viewed as a reward; being able to provide the above 
positive outcomes for patients despite adversity, overcoming hurdles and 
successfully handling difficult conversations were all discussed as being rewarding.  
It was therefore clear that in spite of the challenges, CNSs found great rewards in 
their role.  The main limitation to this, however, is that CNSs who would volunteer 
for research participation, especially with interview methods, may be more positive 
about their role than CNSs generally are.  The majority of CNSs in the study also 
had a lot of experience of working with cancer patients, and so may be more 
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confident and comfortable in their roles.  This has the advantage that they had a 
wealth of experience to draw upon and they were able to reflect on this in a lot of 
detail.  However, understanding whether the same would be found in less 
experienced CNSs would be beneficial. 
10.5 Pulling the Thesis Together 
This thesis has therefore explored expectations of cancer treatment and the impact 
these can have on experiences of cancer treatment, largely from the perspective of 
the patient but also considering the beliefs of the HCP.  It has qualitatively 
uncovered that a broader range of expectations are important to patients than had 
previously been the focus of research in this area, providing support for the notion of 
exploring expectations with a wider view.  In particular, it highlights a role for 
expectations relating to psychological side effects and the impact on daily life, in 
addition to the previous focus on physical side effects and treatment efficacy.  
Measures of expectations and experiences of cancer treatment have been developed 
on the basis of these qualitative findings and the previous literature that allow direct 
comparisons to be made between a wide range of expectations and experiences.  
These measures have been operationalised to provide a little further understanding of 
the relationship between expectations and experiences, which suggests that where 
experiences are worse than expected, experiences are more negative overall; where 
they are better than expected, experiences are more positive overall; and where they 
are reasonably well-matched to expectations, experiences are more neutral. 
With regards to patients’ expectations of cancer treatment and their impact on 
experiences of treatment, the current findings have extended the previous literature 
by providing further support for preparation for treatment in a cancer treatment 
setting.  They have illuminated the importance of studying expectations from an 
expectancy violations perspective, identifying that the gap between expectations and 
experiences is worthy of further consideration in a cancer setting.  The results have 
also challenged the role of response expectancy theory within the wider context of 
patients’ expectations and their experiences as a whole.  There is more support 
overall for setting realistic expectations.  The findings from this thesis and the 
measures developed therein, lay the foundations for further work to be conducted in 
this area, to better understand the relationship between expectations and experiences, 
considering the whole range of patients’ experiences and not just one particular 
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aspect, such as treatment efficacy or particular side effects.  Central to this is 
considering the gap between expectations and experiences. 
In addition to exploring the relationships between expectations and 
experiences, the studies in this thesis have presented the first practical application of 
the newly developed EXPECT-CTQ and the EXPER-CTQ.  The scales performed 
well, facilitating both the measurement of overall expectations and experiences, and 
the subscales thereof.  Items also appear to have been clear to participants.  If 
particular items were consistently missed then it may have indicated ambiguity of 
wording or participant difficulty in responding to that item, but this was not the case, 
all missing data was missing completely at random.  The scales therefore appear to 
have practical utility and are considered suitable for future use. 
From the perspective of HCPs, the thesis has understood that managing 
expectations is believed to consist of balancing positivity (hope) with reality 
(honesty), and that the HCP has a key role in this.  The difficulty of creating such a 
balance and managing patients’ emotions more generally was described in the 
findings, alongside the other challenges faced by CNSs: working in varied and 
unpredictable role and within the constraints of the NHS.  This supports the previous 
literature which suggests that working in an oncology healthcare role can be 
demanding and provides an in-depth exploration of the aspects of the CNS role that 
contribute to this.  Previous research has also suggested that negative implications 
for HCPs could additionally impact on patients’ experiences of cancer treatment as 
HCP communication skills suffer, thus having an effect on their ability to manage 
patients’ expectations.  The findings from this thesis indicated, however, that despite, 
and even due to, the challenges, the role was rewarding. 
In summary, patients hold a breadth of expectations about their treatment 
which are often different to their actual treatment experiences.  This gap between 
expectations and experiences may be detrimental to their wellbeing.  CNS are key to 
the management of cancer patients and they believe that a balance between reality 
and positivity is best.  They find their job challenging but also find rewards mostly 
due to the development of relationships with their patients. 
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10.6 Methodological Limitations 
The main methodological limitation found within the thesis is that much of the data 
was collected retrospectively.  Recall of previous expectations may have been 
influenced by patients’ subsequent experiences and therefore findings should be 
treated with caution.  Study 1 (Chapter 4) found that there may be some support for 
expectancy violations theory, but its qualitative nature meant that the relationship 
between expectations and experiences was not measured directly and the sample size 
was too limited to be able to draw any firm conclusions.  When this relationship was 
measured quantitatively in a larger sample, in Study 3 (Chapter 6), the limitations 
were that measurement was cross-sectional with the retrospective measurement of 
expectations.  Where a prospective, longitudinal design was used to examine the 
relationship between expectations and experiences (Study 4, Chapter 7), a single 
case study is presented, which limits the conclusions that can be drawn.  However, 
that findings about the expectations-experiences relationship appear to be congruent 
throughout the thesis, is promising. 
Studies 5 and 6, the two studies of CNSs (Chapters 8 and 9), have some 
limitations also.  Due to the voluntary nature of research, participants are self-
selected and so may represent the most engaged and satisfied professionals.  If CNSs 
were feeling overworked and overwhelmed, they may not have opted to take part.  
This may have resulted in a more positive view of the experiences of CNSs.  
However, research can also be an opportunity to air grievances and participants did 
discuss the challenges but none were negative about the role overall.  Similarly, most 
participants had a lot of experience of working with cancer patients and thus were 
confident and comfortable in their roles.  This may have meant that they were able to 
find more rewards than less experienced professionals.  However, there did not 
appear to be differences between the least and the most experienced CNSs in the 
studies, in the rewards found. 
In addition, the sample in the CNS studies was obtained from one cancer 
centre in the South East of England.  This has several potential limitations.  Firstly, 
this was a specialist cancer centre and so perhaps there was more collegiality and 
support available to the CNSs than there would be for HCPs working with cancer 
patients in a district general hospital.  Secondly, the experiences and beliefs explored 
could have resulted from working within that particular centre and with the 
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colleagues they had, rather than reflecting wider perspectives.  Thirdly, there is a 
lack of geographical and cultural diversity.  The studies provide interesting in-depth 
insights into this specific population but lack generalisability, as is often the nature 
of qualitative research. 
10.7 Future Directions 
That this line of research into expectations of cancer treatment warrants further 
investigation has been noted throughout the discussion.  More specific suggestions 
for the directions this could go in will now be included.  The most pressing next step 
is to perform confirmatory factor analysis on the EXPECT-CTQ measure to ensure 
that it is suitable for future use.  To do so would require a minimum sample of 117 
cancer patients, to provide three respondents per item (39 items multiplied by 3).  
Participants for this study should be recruited prior to treatment commencement and 
complete the EXPECT-CTQ immediately before their treatment begins to measure 
their expectations of said cancer treatment.  The same participants could then also be 
presented with the EXPER-CTQ during their treatment to measure their treatment 
experiences.  This would allow further analysis of the predictive validity of the 
EXPECT-CTQ but also allow the comparison of expectations and experiences, 
extending the quantitative research contained within this thesis in a clinical sample, 
with a prospective design.  The aim of such a study would therefore also be to 
understand whether findings from this thesis regarding the expectations-experiences 
gap hold in a larger sample and when expectations are not measured retrospectively.  
Such explorations could be furthered by understanding how expectations change 
over time, and by measuring longer-term experiences and psychological outcomes 
following treatment. 
Once more evidence for the relationship between expectations and 
experiences had been gathered, this area of research could be extended to understand 
the relationship between expectations and other variables.  One such variable is 
psychological coping.  As discussed at the start of the thesis, expectations may 
influence coping with treatment, and coping with a diagnosis may influence patients’ 
expectations of cancer treatment.  Exploring the relationship between expectations 
and coping would therefore be interesting and could perhaps also help to clarify 
some of the divergent findings in the study of the relationship between coping and 
QOL or wellbeing. 
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This thesis has also explored the beliefs and experiences of CNSs, as key 
members of patients’ care teams.  The inclusion of this element was an 
acknowledgement of the role HCPs have in managing patients’ expectations and 
there is further study that could be conducted from this perspective.  Once it is better 
established what patients’ expectations of an upcoming treatment should entail; 
positivity or realism, or a mixture of both; further work should be carried out to 
understand how to manage these expectations.  Good quality intervention studies 
would not only provide stronger evidence to support the findings around the 
expectations-experiences relationship but in terms of clinical utility, they would 
create the framework within which HCPs could promote the best pre-treatment 
expectations. 
Aside from HCPs, there are many sources of information available to cancer 
patients prior to the start of their treatment, and even prior to diagnosis.  It would be 
impossible within our society to completely avoid hearing any cancer-related 
information.  Such information has the potential to influence expectations of cancer 
treatment.  Firstly, cancer’s common prevalence means that many patients will have 
known someone affected by it, prior to their own diagnosis.  The outcomes for the 
individual or individuals known to the patient may influence their own expectations 
of cancer treatment.  In cases of recurrence, the patient has their own previous 
experience to draw upon, which will also likely influence their expectations.  
Secondly, related to this there may be additional messages from the patient’s social 
network, particularly once they have been diagnosed, such as secondary data like 
someone recalling an experience of an individual known to them.  Individuals will 
share their own beliefs about cancer treatment with the patient, which may or may 
not influence their expectations.  Thirdly, there is very frequently information in the 
media about cancer treatment, in the news, on social media, on television, and 
through advertisements from charities such as Cancer Research UK.  The different 
messages contained within these may be taken on board by individuals prior to 
diagnosis and form part of the beliefs patients then have when they are diagnosed 
and could similarly impact on patients post-diagnosis.  Thus, such messages also 
have the potential to impact upon patients’ expectations of cancer treatment.  By 
studying sources of information, research could understand what has an influence on 
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patients’ expectations of cancer treatment, and whether there are any other avenues 
for managing these expectations, aside from via HCPs. 
As well as information, there may be other factors that could influence 
patients’ expectations of cancer treatment.  Perhaps the treatment environment could 
affect expectations, maybe a newer hospital environment would instil more 
confidence than an older one, for example.  Alternatively, perhaps feeling cared for 
is more important.  There may be many other factors that influence patients’ 
expectations of cancer treatment that could be explored in order to better understand 
how they can be manipulated to promote the best kind of pre-treatment expectations, 
and therefore promote better patient experiences of cancer treatment.  There is 
therefore much scope for further research in this area, that is warranted by its 
potential influence on patients’ experiences of cancer treatment and beyond. 
10.8 Conclusion 
This thesis has contributed to the understanding of patients’ expectations and 
experiences of cancer treatment by providing an in-depth exploration of patients’ 
expectations and experiences, highlighting that a broader range of expectations are 
important to patients.  The development of a new measure of patients’ expectations 
of cancer treatment that includes a broader range of expectations facilitates 
prospective exploration and has done the groundwork for more thorough 
examinations in this area.  In addition, the development of this alongside a matched 
measure of patients’ experiences of cancer treatment will allow this exploration to 
include both direct comparisons of expectations and experiences, and analysis of the 
gap between them.  Findings from the thesis suggest that the gap between 
expectations and experiences may be particularly important, as this tends to show a 
relationship to patients’ experiences of cancer treatment.  The thesis has also 
considered the HCP’s perspective due to their ability to manage patients’ 
expectations of cancer treatment.  This research has explored CNSs’ beliefs and 
experiences of providing cancer care and suggests that they currently balance 
positive expectations with realistic ones, which may be the most optimal stance, 
given the available evidence.  The role of the CNS is challenging but not without its 
rewards.  Overall, findings from the thesis indicate that the expectations-experiences 
gap is important and therefore the need to set more realistic expectations should be 
considered. 
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Appendices 
Appendix A: Study 1 Interview Schedule 
 
Before Treatment 
• If it’s OK, I’d like to start by asking a bit about the time before you started your 
treatment, after you had been diagnosed.  Thinking back to this time, could you tell me a 
bit about what things were like? 
➢ What were your main concerns? 
➢ What sort of information were you receiving? 
➢ Where were you getting information from? 
 
• What sorts of things were you told about the treatment? 
➢ What were you told about how new or up to date the treatment was? 
➢ What were you told about how effective the treatment might be? 
➢ What were you told about side effects? 
➢ How was the information presented? 
➢ What can you recall about the sort of language used? 
 
• What did you expect from the treatment before you started it? 
➢ Did you think it would impact upon your daily life, and if so, how? 
➢ Did you envisage any side effects, and if so what? 
➢ Did you have any thoughts about your treatment’s chances of success? 
 
Expectations during Treatment 
• How, if at all, did your expectations for future treatment sessions change once you had 
started treatment? 
➢ How much more, or less, prepared did you feel? 
➢ How much more, or less, predictable were side effects? 
➢ How much, if at all, was this influenced by your previous treatment experience? 
 
• How, if at all, was this different when you received a different type of treatment? 
➢ How much more, or less, prepared for this next type of treatment did you feel? 
➢ How much more, or less, did you feel you would know what side effects to 
expect? 
 
Expectations => Experiences 
• How, if at all, do you think the expectations you had before treatment influenced your 
experiences during treatment? 
➢ What about in relation to your side effects? 
➢ What about in relation to the impact on daily life? 
➢ What about in relation to the chances of treatment having a good outcome? 
 
Evaluation/Wrap Up 
• As you know, this study aims to find out more about the expectations you had before 
receiving cancer treatment and the subsequent experiences of treatment.  Is there 
anything you feel you would like to add here, anything we may have missed? 
 
• Thank you very much for your time. 
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Appendix B: Study 1 University Ethics Committee Favourable Ethical Opinion 
Letter 
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Appendix C: Study 1 NHS Research Ethics Committee Favourable Ethical 
Opinion Letter 
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Appendix D: Study 1 University Advertisement 
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Appendix E: Study 1 Clinic Advertisement 
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Appendix F: Study 1 Participant Information Sheet 
 
 
Sam Cockle 
PhD Researcher  
& Trainee Health Psychologist 
School of Psychology 
University of Surrey 
Guildford, GU2 7XH 
E-mail: s.cockle@surrey.ac.uk 
Work Tel: 07497 763887 
Hours: Mon-Fri, 9am-5pm 
 
Participant Information Sheet [version 2, 29/10/2015] 
Expectations and Experiences of Cancer Treatment 
Former Cancer Patients 
Expectations and Experiences of Cancer Treatment 
Introduction 
My name is Sam Cockle and I would like to invite you to take part in a research 
project.  This research will form part of my PhD studies in Health Psychology at the 
University of Surrey.  Before you decide you need to understand why the research is 
being done and what it will involve for you. Please take the time to read the 
following information carefully and ask questions about anything you do not 
understand. Talk to others about this study if you wish. 
What is the purpose of the study? 
The study aims to help us understand more about the expectations people had before 
starting their treatment for cancer, how these changed over time, and the ways in 
which expectations can influence experiences of cancer treatment. 
Why have I been invited to take part in the study? 
You have been invited to take part in this study because you have received treatment 
for cancer. 
To be eligible to take part in the study, you must meet the following criteria: 
• You must have received treatment for cancer within the last two years 
• You must be 18 years of age or older 
About 20 participants will take part in this study. 
Do I have to take part? 
No, you do not have to participate. There will be no adverse consequences in terms 
of your employment and/or education or your legal rights if you decide not to 
participate or to withdraw at a later stage. You can withdraw your participation at 
any time. You can request for your data to be withdrawn until the study is complete, 
which is anticipated to be in March 2016 without giving a reason and without 
prejudice. 
What will my involvement require? 
If you agree to take part, I will then ask you to sign a consent form and you will be 
given this information sheet to keep along with a copy of your signed consent form. 
Your participation will involve a one-off interview lasting approximately 30-40 
minutes (and usually no longer than one hour). 
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What will I have to do? 
You will have to take part in an interview in which I will ask you some questions 
about your expectations and experiences of your treatment.  I will have questions 
prepared but the interview will be fairly informal and you will be able to expand on 
points you feel are relevant.  If anything is unclear at any time, you can ask me to 
explain.  You are asked to talk about this in as much detail as you feel comfortable 
with and if there is anything that you would prefer not to answer then you do not 
have to do so. With your consent, the interview will be audio recorded. 
What will happen to data that I provide? 
Research data are stored securely for at least 10 years following their last access and 
project data (related to the administration of the project, e.g. your consent form) for 
at least 6 years in line with the University of Surrey policies.  
Personal data will be handled in accordance with the UK Data Protection Act (1998). 
With your consent, to make the most of your participation and support efficient 
advancements in science, any data that has been made anonymous may be used for 
future research. We cannot tell you at this moment in time what this research will 
entail or what analyses will be carried out but we can ensure you that all appropriate 
legal, ethical and other approvals will be in place. For practical reasons your consent 
will not be sought again. Your data will not be used for commercial purposes. 
What are the possible disadvantages or risks of taking part? 
It may be an upsetting topic to talk about and although you are encouraged to speak 
only about things you feel comfortable with, you may find you become upset during 
the interview. Please carefully consider this when deciding whether or not to take 
part. 
What are the possible benefits of taking part? 
There are no financial incentives to take part in this study. However, you may benefit 
from being able to talk in confidence with someone about your experiences. You 
may also find benefit in assisting with research, which could be used to help patients 
in future. 
 
What happens when the research study stops? 
At the end of the study you will be debriefed which will include being provided with 
further information about the study and future directions, should you be interested. 
You will also be provided with support information in case you need it. 
What if there is a problem? 
Any complaint or concern about any aspect of the way you have been dealt with 
during the course of the study will be addressed; please contact the Principal 
Investigator, Sam Cockle, on 07497 763887 or s.cockle@surrey.ac.uk in the first 
instance or her Supervisor, Professor Jane Ogden on 01483 686929 or 
j.ogden@surrey.ac.uk. You may also contact Professor Derek Moore, Head of the 
School of Psychology, University of Surrey as someone who is independent of the 
research team on d.g.moore@surrey.ac.uk. 
The University of Surrey holds insurance policies that apply to this study.  If you 
experience harm or injury as a result of taking part in this study, you will be eligible 
to claim compensation. This does not affect your legal rights to seek compensation. 
Will my taking part in the study be kept confidential? 
Yes. Your details will be held in complete confidence and we will follow ethical and 
legal practice in relation to all study procedures. Personal data (name, contact details, 
audio recordings) will be handled in accordance with the UK Data Protection Act 
1998 so that unauthorised individuals will not have access to them. 
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Your personal data will be accessed, processed and securely destroyed by members 
of the research team only: the Principal Investigator Sam Cockle and her Supervisor, 
Professor Jane Ogden. In order to check that this research is carried out in line with 
the law and good research and clinical practice, monitoring and auditing can be 
carried out by independent authorised individuals. Data collected during the study, 
may be looked at by authorised individuals from the University of Surrey or from 
regulatory authorities, where it is relevant to your taking part in this research. All 
will have a duty of confidentiality to you as a participant and we will do our best to 
meet this duty.  
The data you provide will be anonymised and your personal data will be stored 
securely, separately from those anonymised data. You will not be identified in any 
reports or publications resulting from this research and those reading them will not 
know who has contributed to it.  With your permission we would like to use 
anonymous verbatim quotations in reports and publications. 
In certain exceptional circumstances where you or others may be at significant risk 
of harm, the researcher may need to report this to an appropriate authority, in 
accordance with the UK Data Protection Act 1998. This would usually be discussed 
with you first. 
Examples of those exceptional circumstances when confidential information may 
have to be disclosed are: 
- The researcher believes you are at serious risk of harm, either from yourself 
or others 
- The researcher suspects a child may be at risk of harm 
- You pose a serious risk of harm to, or threaten or abuse others 
- As a statutory requirement e.g. reporting certain infectious diseases 
- Under a court order requiring the University to divulge information 
- We are passed information relating to an act of terrorism 
Full Contact details of researcher and supervisor 
Sam Cockle, PhD Researcher & Trainee Health Psychologist 
School of Psychology 
University of Surrey 
Guildford, GU2 7XH 
Email: s.cockle@surrey.ac.uk 
Phone: 07497 763887 (Mon-Fri 9am-5pm) 
 
Professor Jane Ogden, Academic Supervisor & Director of the Psychology PhD 
Programme, School of Psychology 
University of Surrey 
Guildford, GU2 7XH 
Email: j.ogden@surrey.ac.uk 
Phone: 01483 686929 
 Who is organising and funding the research? 
This research is organised by the University of Surrey and funded by the Economic 
and Social Research Council (ESRC). The funder is has no conflict of interest. 
Who has reviewed the project? 
All research from the University of Surrey is looked at by an independent group of 
people, called a Research Ethics Committee, to protect your interests. This study has 
been reviewed and received a favourable ethical opinion from the University of 
Surrey Ethics Committee. 
Thank you for taking the time to read this Information Sheet.  
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Appendix G: Study 1 Consent Form 
Consent Form [version 1, 08/10/2015] Former Cancer Patients 
Expectations and Experiences of Cancer Treatment 
Please initial each box                           
• I have read and understood the Information Sheet provided (version 2, 29/10/2015).  
I have been given a full explanation by the investigators of the nature, purpose, 
location and likely duration of the study, and of what I will be expected to do.   
• I agree to comply with the requirements of the study as outlined to me to the best of 
my abilities. I shall inform the investigators immediately if I have any concerns. 
• I understand that in accordance with the English law, insurance is in place which 
covers harm that is likely to result from my participation in this study as detailed in 
the participant information sheet                                                                                                 
• I agree for my anonymised data to be used for this study and future research that 
will have received all relevant legal, professional and ethical approvals. 
• I give consent for the interview to be audio recorded 
• I give consent to anonymous verbatim quotations being used in reports 
• I understand that all project data will be held for at least 6 years and all research 
data for at least 10 years in accordance with University policy and that my personal 
data is held and processed in the strictest confidence, and in accordance with the UK 
Data Protection Act (1998). 
• I understand that all data collected during the study, may be looked at for 
monitoring and auditing purposes by authorised individuals from University of 
Surrey, or from regulatory authorities, where it is relevant to my taking part in this 
research. I give permission for these individuals to have access to my records.  
• I understand that I am free to withdraw from the study at any time without needing 
to justify my decision, without prejudice and without my legal rights and medical 
care being affected.  
• I confirm that I have read and understood the above and freely consent to 
participating in this study.  I have been given adequate time to consider my 
participation. 
• I agree for the researchers to contact me to provide me with a study results 
summary. (optional) 
Name of participant (BLOCK CAPITALS)   ......................................................  
Signed  ......................................................  
Date  ......................................................                                                   
Name of researcher taking consent (BLOCK CAPITALS) ................................ 
Signed   .................................................... 
Date   ………………………………………………..                
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Appendix H: Study 1 Debrief Sheet 
 
Sam Cockle 
PhD Researcher  
& Trainee Health Psychologist 
School of Psychology 
University of Surrey 
Guildford, GU2 7XH 
E-mail: s.cockle@surrey.ac.uk 
Work Tel: 07497 763887 
Hours: Mon-Fri, 9am-5pm 
Participant Debrief Sheet (Version 1, 29/10/2015) 
Expectations of Cancer Treatment 
 
Thank you so much for taking the time to participate in the study; it is very much 
appreciated. 
 
 
If you are upset, please ask for help 
 
If you have become upset as a result of participating in the research, please seek the help you 
need. This may mean talking to family and friends or you may feel you would like to talk to 
someone else so do contact the University’s Centre for Wellbeing on 01483 68 9498 or 
centreforwellbeing@surrey.ac.uk for access to professional support services or speak to your 
GP.  Alternatively, you can get confidential support from Macmillan Cancer Support 0808 808 
00 00 (Monday-Friday 9am-8pm). 
 
 
The purpose of the study and ongoing aims 
 
As you will be aware this study aims to understand more about the expectations people have 
before starting their treatment for cancer.  The part you have participated in makes up part of 
a larger study which aims to see whether these expectations relate to experiences of treatment 
and how expectations and experiences change over time and with different treatment types.  
By researching whether patients’ expectations impact upon their treatment experiences, we 
can understand more about how expectations should be managed prior to treatments.  This 
might then have a positive influence on how patients feel during their treatment.  By 
participating in this research you have helped to explore a potential way of improving patient 
experiences of treatment. 
 
If you would like more information 
 
If you would like any further information at any stage, please contact the researcher using the 
details above. 
 
 
Thank you once again for your time. 
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Appendix I: Study 2 Initial Version of the Expectations of Cancer Treatment Questionnaire with Additional Feedback Questions 
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Appendix J: Study 2 Revised Version of the Expectations of Cancer Treatment Questionnaire with Additional Feedback Questions 
 
  
  
275 
 
  
  
276 
 
  
  
277 
 
  
  
278 
 
  
  
279 
 
 
• Do you feel the questionnaire would measure pre-treatment expectations in cancer patients? 
• What other expectations did you have?  Are there any questions/statements you would add to the above? 
• What do you feel about the length of the questionnaire? 
• Any other comments or queries regarding the questionnaire? 
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Appendix K: Study 2 Instructions for Completing Expectations of Cancer 
Treatment Questionnaire Feedback 
 
Expectations of Cancer Treatment Questionnaire 
Purpose of the questionnaire 
This questionnaire is being designed in order to ask about what a patient who is due 
to receive cancer treatment expects from their upcoming treatment, in terms of the 
outcome they are expecting, the physical side effects they think they will experience, 
how the treatment will affect them emotionally or psychologically and the impact 
they anticipate it will have on daily life. The idea of the questionnaire is to be able to 
gain an overall picture of what a patient is expecting before they start their cancer 
treatment. This will be given to patients when they are just about to start one 
particular type of treatment (e.g. just before surgery or before starting 
chemotherapy).  The statements have been created on the basis of answers from 
interviews, including yours, and with reference to previous research. 
Instructions 
Please could you read each statement on the questionnaire in turn and think about 
whether it is relevant to expectations prior to cancer treatment and if the wording is 
clear and appropriate. You might find it useful to indicate an answer on a scale of 1 
to 7 (with 1 being strongly disagree and 7 being strongly agree) based on the sort of 
response you believe you would have given at the start of your treatment, as thinking 
about it in this way may highlight potential problems with statements.  
Please indicate towards the right-hand side of the page, whether you think each 
statement is clearly relevant, somewhat relevant or not relevant at all. There is an 
additional box for comments but please feel free to use other space if necessary. The 
comments may be on the wording of the statement or whether it is clear, for 
example. 
If you have any questions or queries throughout, please do not hesitate to get in 
touch with me. 
Thank you once again for your input, I really appreciate you taking the time to 
provide feedback on the questionnaire 
  
  
281 
 
Appendix L: Study 2 Expert Feedback Received on the Expectations of Cancer 
Treatment Questionnaire Draft 
The following represents the comments received from cancer patients (or former 
cancer patients), researchers, and a Macmillan Healthcare Professional.  Not all 
respondents answered regarding whether the items were clearly, somewhat or not 
relevant but instead just made comments about individual items and the scale as a 
whole.  Some respondents did both and some of the cancer patients completed the 
scale as they believe they would have done at the start of treatment.  There were 
some useful and interesting comments that will be discussed further in the next 
section. 
Item 1: ‘I trust the healthcare professionals (e.g. doctors, oncologists, nurses) that 
my treatment is the right approach’ 
Clearly relevant: x4 Somewhat relevant: x0 Not relevant: x0 
Comments: None 
Item 2: ‘I have faith in the healthcare professionals’ confidence that everything 
will be fine’ 
Clearly relevant: x2 Somewhat relevant: x0 Not relevant: x0 
Comments: 
• This seems a little ambiguous. ‘will be fine’ – with regards to what? 
• This one I find difficult as they didn’t use this language; also what if the 
prognosis for a patient is not so good and they are just trying chemo in 
attempt to find something that works. In my experience, prior to treatment, 
they are very cautious with the language they use. 
• Not sure if this is appropriate – not everyone will be fine 
• I have a bit of a problem with this one because I cannot imagine any 
professional saying something like that. If I did feel this then you would be 
able to interpret my answer. If I disagreed you wouldn’t know whether I 
lacked confidence in what they were saying or that they didn’t say 
something like that. Psychometrically this would be a problem I think 
Item 3: ‘Healthcare professionals have helped me feel confident that treatment is 
going to work’ 
Clearly relevant: x3 Somewhat relevant: x0 Not relevant: x0 
Comments: 
• Not necessarily going to work, but maybe the best option? 
• This one will be tricky to interpret too. They may have given a realistic 
evaluation of effectiveness but predicted a poor outcome. 
Item 4: ‘Healthcare professionals have reassured me about my treatment’s 
effectiveness’ 
Clearly relevant: x3 Somewhat relevant: x0 Not relevant: x0 
Comments: 
• Not always, as above, they generally don’t commit to much at the 
beginning. 
• Similar (to the previous item)? 
Item 5: ‘…treatment will make me live longer’ 
Clearly relevant: x4 Somewhat relevant: x0 Not relevant: x0 
Comments: 
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• All these items imply positive outcomes. All are framed from the same 
positive outcome perspective and all scored in the same direction. 
Psychometrically this weakens your measure and makes demand 
characteristics more of a risk. 
Item 6: ‘…treatment will be successful’ 
Clearly relevant: x3 Somewhat relevant: x0 Not relevant: x0 
Comments: 
• I was never given a clear indication of this; it could concern someone who 
hadn’t been given it – wondering why they hadn’t? 
Item 7: ‘…all the cancer will be cleared up’ 
Clearly relevant: x3 Somewhat relevant: x0 Not relevant: x0 
Comments: 
• Again, this is not the message I received. I would be concerned if I read 
this as I may have assumed the worst? 
Item 8: ‘…treatment will work’ 
Clearly relevant: x3 Somewhat relevant: x1 Not relevant: x0 
Comments: 
• What’ the difference between this and ‘will be successful’? 
• Does this repeat the above? (‘treatment will be successful’)? 
Item 9: ‘…treatment will make me better’ 
Clearly relevant: x2 Somewhat relevant: x2 Not relevant: x0 
Comments: Does this repeat the above? (‘treatment will be successful’)? 
Item 10: ‘I will be cured’ 
Clearly relevant: x2 Somewhat relevant: x2 Not relevant: x0 
Comments: 
• Same as above (‘all the cancer will be cleared up’)? 
• Questions are all rather similar (items 6-10) 
Item 11: ‘…I will experience pain as a result of treatment’ 
Clearly relevant: x2 Somewhat relevant: x2 Not relevant: x0 
Comments: 
• See general comments for comment on pain items. 
• Would it be helpful to ask about the level of pain anticipated – none, some, 
extreme? 
Item 12: ‘…I will experience pain as a result of my cancer’ 
Clearly relevant: x2 Somewhat relevant: x2 Not relevant: x0 
Comments: See general comments for comment on pain items. 
Item 13: ‘…I will experience pain as a result of medication given during 
treatment’ 
Clearly relevant: x1 Somewhat relevant: x3 Not relevant: x0 
Comments: 
• Same as the above (‘I will experience pain as a result of treatment’)? 
• See general comments for comment on pain items. 
Item 14: ‘…I will feel sick (nauseous)’ 
Clearly relevant: x4 Somewhat relevant: x0 Not relevant: x0 
Comments: 
• Some of these are a problem. Feeling sick fleetingly once during treatment 
isn’t an issue. Shouldn’t the items draw out whether or not they anticipate 
nausea to be a big, or enduring issue? 
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Item 15: ‘…I will be physically sick’ 
Clearly relevant: x4 Somewhat relevant: x0 Not relevant: x0 
Comments: Would it be better to use a word like vomit, as they are actually 
physically sick in another sense? 
Item 16: ‘…I will lose my appetite’ 
Clearly relevant: x4 Somewhat relevant: x0 Not relevant: x0 
Comments: None 
Item 17: ‘…I will be constipated’ 
Clearly relevant: x4 Somewhat relevant: x0 Not relevant: x0 
Comments: None 
Item 18: ‘…I will get diarrhoea’ 
Clearly relevant: x4 Somewhat relevant: x0 Not relevant: x0 
Comments: None 
Item 19: ‘…I will lose my hair’ 
Clearly relevant: x4 Somewhat relevant: x0 Not relevant: x0 
Comments: What about ALL hair – eyelashes, pubic hair – this is not always 
communicated! Also, nails? 
Item 20: ‘…my hair will change’ 
Clearly relevant: x4 Somewhat relevant: x0 Not relevant: x0 
Comments: None 
Item 21: ‘…my weight will change’ 
Clearly relevant: x4 Somewhat relevant: x0 Not relevant: x0 
Comments: None 
Item 22: ‘…my weight will be out of my control’ 
Clearly relevant: x4 Somewhat relevant: x0 Not relevant: x0 
Comments: None 
Item 23: ‘…I will feel tense’ 
Clearly relevant: x4 Somewhat relevant: x0 Not relevant: x0 
Comments: None 
Item 24: ‘…I will feel worried’ 
Clearly relevant: x4 Somewhat relevant: x0 Not relevant: x0 
Comments: Similar (to the previous item) 
Item 25: ‘I will feel irritated’ 
Clearly relevant: x4 Somewhat relevant: x0 Not relevant: x0 
Comments: None 
Item 26: ‘…I will feel depressed’ 
Clearly relevant: x4 Somewhat relevant: x0 Not relevant: x0 
Comments: Do you think having three statements about more or less the same 
thing will distort the measure? 
Item 27: ‘I will feel sad’ 
Clearly relevant: x4 Somewhat relevant: x0 Not relevant: x0 
Comments: None 
Item 28: ‘…I will feel down’ 
Clearly relevant: x4 Somewhat relevant: x0 Not relevant: x0 
Comments: 
• Similar (to the previous item) 
• Would it make sense to ask whether they anticipate any of this set of 
symptoms to be problematic for them. Could they rank order them in terms 
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of how problematic they would be if they did occur and how likely they 
feel it is that they would occur? I don’t know what your research questions 
are, but I wonder how directly these questions operationalise your research 
question. 
Item 29: ‘…I will feel happy’ 
Clearly relevant: x4 Somewhat relevant: x0 Not relevant: x0 
Comments: I think I would have used may in place of will in these questions 
(labelled by items 14-29 but could be representative of a wider number of items) 
Item 30: ‘…I will feel content’ 
Clearly relevant: x4 Somewhat relevant: x1 Not relevant: x0 
Comments: None 
Item 31: ‘…I will feel upbeat’ 
Clearly relevant: x3 Somewhat relevant: x1 Not relevant: x0 
Comments: None 
Item 32: ‘…I will feel hopeful’ 
Clearly relevant: x4 Somewhat relevant: x0 Not relevant: x0 
Comments: None 
Item 33: ‘…I will feel optimistic’ 
Clearly relevant: x4 Somewhat relevant: x0 Not relevant: x0 
Comments: None 
Item 34: ‘…I will feel cheerful’ 
Clearly relevant: x3 Somewhat relevant: x1 Not relevant: x0 
Comments: None 
Item 35: ‘…who I am will change’ 
Clearly relevant: x3 Somewhat relevant: x0 Not relevant: x1 
Comments: I wonder if this is too cryptic for some people? 
Item 36: ‘…the experience will transform me’ 
Clearly relevant: x3 Somewhat relevant: x1 Not relevant: x0 
Comments: None 
Item 37: ‘…I will end up a different person’ 
Clearly relevant: x3 Somewhat relevant: x1 Not relevant: x0 
Comments: 
• Physically? Emotionally? Spiritually? 
• You have three items here that are essentially the same? 
Item 38: ‘…I will look different’ 
Clearly relevant: x4 Somewhat relevant: x0 Not relevant: x0 
Comments: None 
Item 39: ‘…I will not be able to recognise me’ 
Clearly relevant: x3 Somewhat relevant: x0 Not relevant: x1 
Comments: None of the last few questions indicate whether you mean positively 
or negatively. This may only be relevant in your write up as you won’t be able to 
comment whether people meant ‘this experience will transform me’ in a positive 
or negative way. 
Item 40: ‘…I will be able to continue with my work (paid or unpaid), as usual’ 
Clearly relevant: x3 Somewhat relevant: x0 Not relevant: x0 
Comments: None 
Item 41: ‘…I will be able to do housework/gardening to the same extent’ 
Clearly relevant: x3 Somewhat relevant: x0 Not relevant: x0 
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Comments: None 
Item 42: ‘…I will be able to participate in pastimes/hobbies to the same extent 
(e.g. clubs, classes, etc.)’ 
Clearly relevant: x4 Somewhat relevant: x0 Not relevant: x0 
Comments: I experienced different things throughout my treatment – very much in 
response to the treatment cycles  - so I could work/etc for 2 weeks out of 3 – is it 
worth making this distinction somewhere? 
Item 43: ‘…I will be able to do the same things socially with friends/family’ 
Clearly relevant: x4 Somewhat relevant: x0 Not relevant: x0 
Comments: I experienced different things throughout my treatment – very much in 
response to the treatment cycles  - so I could work/etc for 2 weeks out of 3 – is it 
worth making this distinction somewhere? 
Item 44: ‘…treatment will not impact the care I am able to give to others (e.g. 
family, friends, neighbours)’ 
Clearly relevant: x4 Somewhat relevant: x0 Not relevant: x0 
Comments: I experienced different things throughout my treatment – very much in 
response to the treatment cycles  - so I could work/etc for 2 weeks out of 3 – is it 
worth making this distinction somewhere? 
Item 45: ‘…treatment will not have a negative effect on family life’ 
Clearly relevant: x4 Somewhat relevant: x0 Not relevant: x0 
Comments: I experienced different things throughout my treatment – very much in 
response to the treatment cycles  - so I could work/etc for 2 weeks out of 3 – is it 
worth making this distinction somewhere? 
Item 46: ‘…I will become more dependent on others’ 
Clearly relevant: x4 Somewhat relevant: x0 Not relevant: x0 
Comments: I experienced different things through out my treatment – very much 
in response to the treatment cycles  - so I could work/etc for 2 weeks out of 3 – is 
it worth making this distinction somewhere? 
Item 47: ‘…I will need to be looked after’ 
Clearly relevant: x4 Somewhat relevant: x0 Not relevant: x0 
Comments: I experienced different things throughout my treatment – very much in 
response to the treatment cycles  - so I could work/etc for 2 weeks out of 3 – is it 
worth making this distinction somewhere?  
Item 48: ‘…I will not be able to be on my own’ 
Clearly relevant: x4 Somewhat relevant: x0 Not relevant: x0 
Comments: I experienced different things throughout my treatment – very much in 
response to the treatment cycles  - so I could work/etc for 2 weeks out of 3 – is it 
worth making this distinction somewhere? 
Item 49: ‘…I will not be able to do a great deal for myself’ 
Clearly relevant: x4 Somewhat relevant: x0 Not relevant: x0 
Comments: I experienced different things throughout my treatment – very much in 
response to the treatment cycles  - so I could work/etc for 2 weeks out of 3 – is it 
worth making this distinction somewhere? 
Item 50: ‘…I will be unable to carry out basic daily tasks for myself e.g. getting 
dressed’ 
Clearly relevant: x4 Somewhat relevant: x0 Not relevant: x0 
Comments: I experienced different things throughout my treatment – very much in 
response to the treatment cycles  - so I could work/etc for 2 weeks out of 3 – is it 
worth making this distinction somewhere? 
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Item 51: ‘…I will have greater difficulty walking than I do currently’ 
Clearly relevant: x4 Somewhat relevant: x0 Not relevant: x0 
Comments: None 
Item 52: ‘…I will not be able to drive or get around (e.g. on public transport) as 
easily’ 
Clearly relevant: x4 Somewhat relevant: x0 Not relevant: x0 
Comments: None 
Item 53: ‘…I will have greater difficulty climbing the stairs’ 
Clearly relevant: x4 Somewhat relevant: x0 Not relevant: x0 
Comments: None 
Item 54: ‘…I will have difficulty feeding myself’ 
Clearly relevant: x4 Somewhat relevant: x0 Not relevant: x0 
Comments: None 
Item 55: ‘…I will have greater difficulty with personal hygiene e.g. washing, 
dressing, brushing hair’ 
Clearly relevant: x4 Somewhat relevant: x0 Not relevant: x0 
Comments: None 
Item 56: ‘…I will have greater difficulty with toilet hygiene e.g. getting to the 
toilet, cleaning oneself, getting back up’ 
Clearly relevant: x4 Somewhat relevant: x0 Not relevant: x0 
Comments: None 
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Appendix M: Study 2 64-Item Expectations of Cancer Treatment Questionnaire 
for Validation, with Subscale Labels 
 
Expectations of Cancer Treatment 
The following statements are about the cancer treatment you are about to receive.  
We would like to know what you are expecting from your treatment.  Please note 
that this questionnaire is designed to be given to a range of cancer patients, 
experiencing different cancers and treatments.  All cancer and its treatment is 
different, statements here are not necessarily to be expected from your cancer and its 
treatment, so please do not be concerned. 
For this part, please circle a number to show how much you agree or disagree with 
each statement, on a scale of 1 to 7, where 1 is strongly disagree and 7 is strongly 
agree. 
Treatment Efficacy 
To what extent do you agree with the following statements? :- 
 Strongly 
disagree 
     Strongly 
agree 
Trust        
I trust the healthcare 
professionals (e.g. 
doctors, oncologists, 
nurses) that my 
treatment is the right 
approach 
1 2 3 4 5 6 7 
        
I have faith that the 
healthcare 
professionals will do 
what’s right for me 
1 2 3 4 5 6 7 
        
I believe what my 
healthcare 
professionals tell me 
1 2 3 4 5 6 7 
        
I have confidence in 
what the healthcare 
professionals have to 
say 
1 2 3 4 5 6 7 
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To what extent do you expect the following from your treatment? :- 
I expect… Strongly 
disagree 
     Strongly 
agree 
Cure        
…I will be cured 1 2 3 4 5 6 7 
… treatment will 
make me better 
1 2 3 4 5 6 7 
…all the cancer will 
be cleared up 
1 2 3 4 5 6 7 
Efficacy        
…treatment will 
work 
1 2 3 4 5 6 7 
…treatment will be 
effective 
1 2 3 4 5 6 7 
…treatment will be 
successful 
1 2 3 4 5 6 7 
Life Expectancy        
…treatment will 
make me live longer 
1 2 3 4 5 6 7 
…treatment will give 
me extra life 
1 2 3 4 5 6 7 
…treatment will 
improve my life 
expectancy 
1 2 3 4 5 6 7 
 
For this part, please circle a number to show to how severely you are expecting each 
statement to occur during treatment, on a scale of 1 to 7, where 1 is none or not at all and 7 
is extreme/extremely. 
Physical Side Effects 
To what extent do you expect to experience the following during this treatment? :- 
 None      Extreme 
During this treatment, I 
expect… 
       
Pain        
…I will experience pain 
as a result of the process 
of treatment (e.g. 
needles, surgery, etc.) 
1 2 3 4 5 6 7 
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…I will experience pain 
as a result of my cancer 
1 2 3 4 5 6 7 
…I will experience pain 
as a consequence of 
medication given during 
treatment (e.g. muscle 
pain, joint pain, 
headaches) 
1 2 3 4 5 6 7 
 
Gastro-intestinal  
Not at 
all 
      
Extremely 
…I will feel sick 
(nauseous) 
1 2 3 4 5 6 7 
…I will be physically 
sick (vomit) 
1 2 3 4 5 6 7 
…I will lose my 
appetite 
1 2 3 4 5 6 7 
…I will be constipated 1 2 3 4 5 6 7 
…I will get diarrhoea 1 2 3 4 5 6 7 
Fatigue        
…I will feel very tired 1 2 3 4 5 6 7 
…my energy levels will 
be low 
1 2 3 4 5 6 7 
…I will feel exhausted 1 2 3 4 5 6 7 
Hair        
…I will lose the hair 
from my head 
1 2 3 4 5 6 7 
…I will lose the hair 
from my body (e.g. 
eyebrows) 
1 2 3 4 5 6 7 
…my hair will change 1 2 3 4 5 6 7 
Weight        
…I will lose weight 1 2 3 4 5 6 7 
…I will gain weight 1 2 3 4 5 6 7 
…my weight will be out 
of my control 
1 2 3 4 5 6 7 
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Psychological Side Effects 
To what extent do you expect the following during this treatment? :- 
 Not at 
all 
     Extremely 
During this 
treatment, I expect… 
       
Negative Emotion        
…I will feel tense 1 2 3 4 5 6 7 
…I will feel worried 1 2 3 4 5 6 7 
…I will feel irritated 1 2 3 4 5 6 7 
…I will feel 
depressed 
1 2 3 4 5 6 7 
…I will feel sad 1 2 3 4 5 6 7 
…I will feel down 1 2 3 4 5 6 7 
Positive Emotion        
…I will feel happy 1 2 3 4 5 6 7 
…I will feel content 1 2 3 4 5 6 7 
…I will feel upbeat 1 2 3 4 5 6 7 
…I will feel hopeful 1 2 3 4 5 6 7 
…I will feel 
optimistic 
1 2 3 4 5 6 7 
…I will feel cheerful 1 2 3 4 5 6 7 
Positive 
Transformation 
       
…I will become a 
stronger person 
1 2 3 4 5 6 7 
…I will become 
more confident 
1 2 3 4 5 6 7 
…I will become 
more kind 
1 2 3 4 5 6 7 
…it will make me 
value the little things 
in life more 
1 2 3 4 5 6 7 
        
For this part, please circle a number to show how much you agree or disagree with each 
statement, on a scale of 1 to 7, where 1 is strongly disagree and 7 is strongly agree. 
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Daily Life 
To what extent do you expect the following during this treatment? :- 
 Strongly 
disagree 
     Strongly 
agree 
During this treatment, 
I expect… 
       
Daily Activities        
…I will be able to 
continue with my 
work (paid or 
unpaid), as usual 
1 2 3 4 5 6 7 
…I will be able to do 
housework/gardening 
to the same extent 
1 2 3 4 5 6 7 
…I will be able to 
participate in 
pastimes/hobbies to 
the same extent (e.g. 
clubs, classes, etc.) 
1 2 3 4 5 6 7 
Social        
…I will not be able to 
do the same things 
socially with 
friends/family 
1 2 3 4 5 6 7 
…treatment will 
negatively impact the 
care I am able to give 
to others (e.g. family, 
friends, neighbours) 
1 2 3 4 5 6 7 
…treatment will have 
a negative effect on 
family life 
1 2 3 4 5 6 7 
…treatment will 
place a strain on my 
close relationships 
1 2 3 4 5 6 7 
Dependency        
…I will become more 
dependent on others 
1 2 3 4 5 6 7 
…I will need to be 
looked after 
1 2 3 4 5 6 7 
…I will not be able to 
be on my own 
1 2 3 4 5 6 7 
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…I will not be able to 
do a great deal for 
myself 
1 2 3 4 5 6 7 
Mobility        
…I will have greater 
difficulty walking 
than I do currently 
1 2 3 4 5 6 7 
…I will not be able to 
drive or get around 
(e.g. on public 
transport) as easily 
1 2 3 4 5 6 7 
…I will have greater 
difficulty climbing 
the stairs 
1 2 3 4 5 6 7 
Self-Care        
…I will have greater 
difficulty getting 
dressed 
1 2 3 4 5 6 7 
…I will have greater 
difficulty feeding 
myself 
1 2 3 4 5 6 7 
…I will have greater 
difficulty with 
personal hygiene e.g. 
washing, brushing 
hair or teeth 
1 2 3 4 5 6 7 
…I will have greater 
difficulty with toilet 
hygiene e.g. getting 
to the toilet, cleaning 
oneself, getting back 
up 
1 2 3 4 5 6 7 
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Appendix N: Study 2 51-Item Experiences of Cancer Treatment Questionnaire 
for Validation 
Experiences of Cancer Treatment 
The following statements are about the cancer treatment you are currently receiving.  
We would like to know what you are experiencing from your treatment.   
For this part, please circle a number to show to how severely you are experiencing 
each statement during this treatment, on a scale of 1 to 7, where 1 is none or not at 
all and 7 is extreme/extremely. 
Physical Side Effects 
To what extent are you experiencing the following during this treatment? :- 
 None      Extreme 
During this treatment, 
I am… 
       
Pain        
…experiencing pain 
as a result of the 
process of treatment 
(e.g. needles, surgery, 
etc.) 
1 2 3 4 5 6 7 
…experiencing pain 
as a result of my 
cancer 
1 2 3 4 5 6 7 
…experiencing pain 
as a consequence of 
medication given 
during treatment (e.g. 
muscle pain, joint 
pain, headaches) 
1 2 3 4 5 6 7 
Gastro-intestinal  Not 
at all 
     Extremely 
…feeling sick 
(nauseous) 
1 2 3 4 5 6 7 
…physically being 
sick (vomit) 
1 2 3 4 5 6 7 
…losing my appetite 1 2 3 4 5 6 7 
… experiencing 
constipation 
1 2 3 4 5 6 7 
…experiencing 
diarrhoea 
1 2 3 4 5 6 7 
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Fatigue        
…feeling very tired 1 2 3 4 5 6 7 
…experiencing low 
energy levels 
1 2 3 4 5 6 7 
…feeling exhausted 1 2 3 4 5 6 7 
Hair        
…losing the hair from 
my head 
1 2 3 4 5 6 7 
…losing the hair from 
my body (e.g. 
eyebrows) 
1 2 3 4 5 6 7 
…experiencing my 
hair changing 
1 2 3 4 5 6 7 
Weight        
…losing weight 1 2 3 4 5 6 7 
…gaining weight 1 2 3 4 5 6 7 
…experiencing my 
weight being out of 
my control 
1 2 3 4 5 6 7 
Psychological Side Effects 
To what extent are you experiencing the following during this treatment? :- 
 Not 
at all 
     Extremely 
During this treatment, 
I am… 
       
Negative Emotion        
…feeling tense 1 2 3 4 5 6 7 
…feeling worried 1 2 3 4 5 6 7 
…feeling irritated 1 2 3 4 5 6 7 
…feeling depressed 1 2 3 4 5 6 7 
…feeling sad 1 2 3 4 5 6 7 
…feeling down 1 2 3 4 5 6 7 
Positive Emotion        
…feeling happy 1 2 3 4 5 6 7 
…feeling content 1 2 3 4 5 6 7 
  
295 
 
…feeling upbeat 1 2 3 4 5 6 7 
…feeling hopeful 1 2 3 4 5 6 7 
…feeling optimistic 1 2 3 4 5 6 7 
…feeling cheerful 1 2 3 4 5 6 7 
Positive 
Transformation 
       
…becoming a 
stronger person 
1 2 3 4 5 6 7 
…becoming more 
confident 
1 2 3 4 5 6 7 
…becoming more 
kind 
1 2 3 4 5 6 7 
…valuing the little 
things in life more 
1 2 3 4 5 6 7 
For this part, please circle a number to show how much you agree or disagree with 
each statement, on a scale of 1 to 7, where 1 is strongly disagree and 7 is strongly 
agree. 
Daily Life 
To what extent are you experiencing the following during this treatment? :- 
 Strongly 
disagree 
     Strongly 
agree 
During this treatment, I am…        
Daily Activities        
…able to continue with my 
work (paid or unpaid), as usual 
1 2 3 4 5 6 7 
…able to do 
housework/gardening to the 
same extent 
1 2 3 4 5 6 7 
…able to participate in 
pastimes/hobbies to the same 
extent (e.g. clubs, classes, etc.) 
1 2 3 4 5 6 7 
Social        
…not be able to do the same 
things socially with 
friends/family 
1 2 3 4 5 6 7 
…experiencing treatment 
negatively impacting the care I 
1 2 3 4 5 6 7 
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am able to give to others (e.g. 
family, friends, neighbours) 
…experiencing treatment 
having a negative effect on 
family life 
1 2 3 4 5 6 7 
…experiencing treatment 
placing a strain on my close 
relationships 
1 2 3 4 5 6 7 
Dependency        
…becoming more dependent 
on others 
1 2 3 4 5 6 7 
…needing to be looked after 1 2 3 4 5 6 7 
…not be able to be on my own 1 2 3 4 5 6 7 
…not be able to do a great deal 
for myself 
1 2 3 4 5 6 7 
Mobility        
…having greater difficulty 
walking than I did previously 
1 2 3 4 5 6 7 
…not be able to drive or get 
around (e.g. on public 
transport) as easily 
1 2 3 4 5 6 7 
…having greater difficulty 
climbing the stairs 
1 2 3 4 5 6 7 
Self-Care        
…having greater difficulty 
getting dressed 
1 2 3 4 5 6 7 
…having greater difficulty 
feeding myself 
1 2 3 4 5 6 7 
…having greater difficulty with 
personal hygiene e.g. washing, 
brushing hair or teeth 
1 2 3 4 5 6 7 
…having greater difficulty with 
toilet hygiene e.g. getting to the 
toilet, cleaning oneself, getting 
back up 
1 2 3 4 5 6 7 
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Appendix O: Study 2 & Study 3 University Ethics Committee Favourable 
Ethical Opinion 
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Appendix P: Study 2 & Study 3 Advertisement 
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Appendix Q: Study 2 & Study 3 Participant Information Sheet 
Version 2, 25/04/2017 
INFORMATION SHEET FOR PARTICIPANTS 
Expectations of Cancer Treatment 
Invitation Paragraph 
My name is Sam Cockle and I would like to invite you to take part in a research 
project.  I am a PhD student at the University of Surrey and this research forms part 
of my PhD research in Health Psychology.  You should only participate if you want 
to; choosing not to take part will not disadvantage you in any way. Before you 
decide whether you want to take part, it is important for you to understand why the 
research is being done and what your participation will involve. Please take time to 
read the following information carefully and discuss it with others if you wish. Ask 
me if there is anything that is not clear or if you would like more information. 
What is the purpose of the study? 
The study aims to understand more about expectations and experiences of treatment 
for cancer in the UK. 
Why have I been invited to take part? 
You have been invited to take part in this study because you are an adult who has 
received a cancer diagnosis and are either due to receive cancer treatment, are 
currently receiving cancer treatment, or have received cancer treatment in the past. 
To be eligible to take part in the study, you must meet the following criteria: 
• You must have received a diagnosis of cancer 
• You must be due to start treatment for cancer, be currently receiving 
treatment for cancer, or have received treatment for cancer in the past 
• Your treatment must be due to take place/be taking place/have taken place in 
the UK 
• You must be 18 years of age or older 
At least 200 participants will take part in this study. 
Do I have to take part? 
No, you do not have to participate.  Participation is voluntary. There will be no 
adverse consequences in terms of your legal rights, your care or your treatment, if 
you decide not to participate or to withdraw at a later stage.  You should read this 
information sheet and if you have any questions you should ask the research team.  
You can stop your participation in the study at any time.  Data already submitted is 
anonymous, therefore it will not be possible to identify you or to withdraw your data. 
What will happen to me if I take part? 
If you decide to take part, you will be asked on the next page to agree to some 
statements and confirm your consent to participate.  If you wish to obtain a copy of 
this information sheet and/or the consent information, please email me at 
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s.cockle@surrey.ac.uk and I will send you a copy.  Alternatively, you could print a 
copy from your browser or save screen shots.  Your involvement in the study would 
involve participating in an online questionnaire, on one occasion, and will last 
approximately 15 minutes. 
The website will take you through a series of questions, which will ask about your 
treatment expectations and/or your experiences of treatment.  Please use the buttons 
to navigate through the questions.  You will receive a message onscreen when you 
have come to the end of the questions with some further information, including how 
to contact the researcher if you have any queries.   
If you withdraw from the study this will mean the following for your participation 
and data: 
All data which has been submitted is not identifiable to the research team and 
therefore will be retained and used in the study because we cannot trace this 
information back to you, including any answers given.  This may be the case even if 
you have not completed the survey in full. 
What are the possible benefits and risks of taking part? 
You may find benefit in assisting research that will provide information which may 
be used to help other cancer patients in future.  Furthermore, if you wish, I will 
provide you with a summary of a final report describing the main findings. 
The main risk involved in taking part in the study is that you become upset by 
thinking, and answering questions, about your cancer and its treatment. 
Please carefully consider this when deciding whether or not to take part. 
Will my taking part be kept confidential? 
Data collected is regarded as strictly confidential and will be held securely until the 
research is finished. All data for analysis will be anonymised when submitted to the 
research team and so your survey responses will not be traceable to you. 
All project data (e.g. consent forms) will be held for at least 6 years and all research 
data for at least 10 years in accordance with University policy. 
All information gathered will be held for long-term storage on University secure 
servers. Hard files will be kept in locked cabinets within the University. 
How is the project being funded? 
The project is being funded by the Economic and Social Research Council (ESRC). 
This study has been reviewed and been given a favourable ethical opinion by the 
University of Surrey Ethics Committee. 
What will happen to the results of the study? 
I will produce a final report summarising the main findings, which will be sent to 
you, should you wish. Please email me if you would like to receive a copy. I also 
plan to disseminate the research findings (which will be anonymous) through 
publication and conferences.  The funder requires that all publications resulting from 
research they fund are open access, which means that anyone can read them for free, 
without a subscription. 
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With your consent, to make the most of your participation and support efficient 
advancements in science, any anonymised data may be used for future research. We 
cannot tell you at this moment in time what this research will entail or what analyses 
will be carried out but we can assure you that all appropriate legal, ethical and other 
approvals will be in place. For practical reasons your consent will not be sought 
again. Your data will not be used for commercial purposes. 
Who should I contact for further information? 
If you have any questions or require more information about this study, please 
contact me using the following contact details:  
Sam Cockle, School of Psychology, University of Surrey, Guildford, GU2 7XH 
Email: s.cockle@surrey.ac.uk 
Phone: 07497 763887 
What if something goes wrong? 
Any complaint or concern about the conduct of the study will be addressed; please 
contact me, Sam Cockle, on 07497 763887 or s.cockle@surrey.ac.uk in the first 
instance or my supervisor, Professor Jane Ogden, using the details below for further 
advice and information: 
Professor Jane Ogden, School of Psychology, University of Surrey, Guildford, GU2 
7XH. Email: j.ogden@surrey.ac.uk. Phone: 01483 686929 
You may also contact Professor Derek Moore, Head of the School of Psychology, 
University of Surrey as someone who is independent of the research team on 
d.g.moore@surrey.ac.uk. 
Thank you for reading this information sheet and for considering taking part in 
this research. 
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Appendix R: Study 2 & Study 3 Consent Form 
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Appendix S: Study 2 & Study 3 Debrief Sheet 
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Appendix T: Final Expectations of Cancer Treatment Questionnaire 
(EXPECT-CTQ) 
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Appendix U: Final Experiences of Cancer Treatment Questionnaire (EXPER-
CTQ) 
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Appendix V: Study 4 NHS Research Ethics Committee Favourable Ethical 
Opinion (Following Substantial Amendment) 
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Appendix W: Study 4 Advertisement 
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Appendix X: Study 4 Participant Information Sheet 
 
 
 
 
Sam Cockle 
PhD Researcher  
& Trainee Health Psychologist 
School of Psychology 
University of Surrey 
Guildford, GU2 7XH 
E-mail: s.cockle@surrey.ac.uk 
Work Tel: 07497 763887 
Hours: Mon-Fri, 9am-5pm 
Participant Information Sheet [phase 3, version 2, 11/07/2016] 
Patients’ Expectations of Cancer Treatment 
Cancer Patients 
Patients’ Expectations of Cancer Treatment 
Introduction 
My name is Sam Cockle and I would like to invite you to take part in a research 
project. This research will form part of my PhD studies in Health Psychology at the 
University of Surrey.  Before you decide you need to understand why the research is 
being done and what it will involve for you. Please take the time to read the 
following information carefully and ask questions about anything you do not 
understand. Talk to others about the study if you wish. 
What is the purpose of the study? 
The study aims to understand more about patients’ expectations and experiences of 
treatment for cancer. 
Why have I been invited to take part in the study? 
You have been invited to take part in this study because you are an adult patient due 
to receive treatment for cancer from Maidstone and Tunbridge Wells NHS Trust 
(Kent Oncology Centre). 
To be eligible to take part in the study, you must meet the following criteria: 
• You must be a patient of Maidstone and Tunbridge Wells NHS Trust (Kent 
Oncology Centre) 
• You must be due to start treatment for cancer 
• You must be 18 years of age or older 
About 200 participants from Maidstone and Tunbridge Wells NHS Trust (Kent 
Oncology Centre) will take part in this study. 
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Do I have to take part? 
No, you do not have to participate. There will be no adverse consequences in terms 
of your legal rights, your care or your treatment, if you decide not to participate or to 
withdraw at a later stage. You can withdraw your participation at any time. You can 
request for your data to be withdrawn until the study is complete, which is expected 
to be at the end of December 2017, without giving a reason and without prejudice. 
If you withdraw from the study this will mean the following for your participation 
and data: 
All identifiable data collected would be withdrawn from the study. Data which is not 
identifiable to the research team may be retained because we cannot trace this 
information back to you. No further data would be collected or any other research 
procedures would be carried out on or in relation to you, apart from providing you 
with debrief information. 
What will my involvement require? 
If you agree to take part, I will then ask you to sign a consent form and you will be 
given this information sheet to keep along with a copy of your signed consent form.  
Your involvement would involve participating on a maximum of two occasions, 
each lasting approximately 30 minutes. 
What will I have to do? 
On each occasion, I will ask you to fill out a questionnaire, which asks questions 
about your expectations for treatment or your experiences of treatment.  Each time 
we will arrange a suitable time to meet for me to give you the paper questionnaires 
or these can be completed online if it is more convenient.  You will need to fill out 
the first one just before you start treatment, which will ask about your expectations 
of that upcoming treatment.  The second questionnaire will need to be filled out 
during the time you are having treatment.   
What will happen to data that I provide? 
Research data are stored securely for at least 10 years following their last access and 
project data (related to the administration of the project, e.g. your consent form) for 
at least 6 years in line with the University of Surrey policies.  
Personal data will be handled in accordance with the UK Data Protection Act (1998). 
With your consent, to make the most of your participation and support efficient 
advancements in science, any anonymised data may be used for future research. We 
cannot tell you at this moment in time what this research will entail or what analyses 
will be carried out but we can ensure you that all appropriate legal, ethical and other 
approvals will be in place. For practical reasons your consent will not be sought 
again. Your data will not be used for commercial purposes. 
What are the possible disadvantages or risks of taking part? 
It may be an upsetting topic to think about and you may find you become upset. 
Please carefully consider this when deciding whether or not to take part. 
What are the possible benefits of taking part? 
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There are no financial incentives to take part in this study. However, you may find 
that participating provides a welcome distraction.  You may also benefit from being 
able to assist with research that will provide information which may be used to help 
other patients like you in future. 
If you have paid extra car parking charges as a result of participating in the study, it 
will be possible to reimburse you should you wish. 
What happens when the research study stops? 
At the end of the study you will be debriefed which will include being provided with 
further information about the study and future directions, should you be interested. 
You will also be provided with support information in case you should need it. 
What if there is a problem? 
Any complaint or concern about any aspect of the way you have been dealt with 
during the course of the study will be addressed; please contact the Principal 
Investigator, Sam Cockle on 07497 763887 or s.cockle@surrey.ac.uk in the first 
instance or her Supervisor, Professor Jane Ogden on 01483 686929 or 
j.ogden@surrey.ac.uk. You may also contact Professor Derek Moore, Head of the 
School of Psychology, University of Surrey as someone who is independent of the 
research team on d.g.moore@surrey.ac.uk. If you remain unhappy you can file a 
complaint using the NHS complaint procedure. 
The University of Surrey holds insurance policies that apply to this study.  If you 
experience harm or injury as a result of taking part in this study, you will be eligible 
to claim compensation. This does not affect your legal rights to seek compensation. 
If you are harmed due to someone's negligence then you may have grounds for legal 
action for compensation against Maidstone and Tunbridge Wells NHS Trust and/or 
the University of Surrey but you may have to pay your legal costs. Regardless of 
this, if you wish to complain, or have any concerns about any aspect of the way you 
have been treated during the course of this study then you should follow the 
instructions given above. 
Will my taking part in the study be kept confidential? 
Yes. Your details will be held in complete confidence and we will follow ethical and 
legal practice in relation to all study procedures. Personal data (name, contact 
details) will be handled in accordance with the UK Data Protection Act 1998 so that 
unauthorised individuals will not have access to them. 
Your personal data will be accessed, processed and securely destroyed by members 
of the research team only: the Principle Investigator, Sam Cockle and her Supervisor, 
Professor Jane Ogden. In order to check that this research is carried out in line with 
the law and good research and clinical practice, monitoring and auditing can be 
carried out by independent authorised individuals. Data collected during the study, 
may be looked at by authorised individuals from the University of Surrey, from 
regulatory authorities or from Maidstone and Tunbridge Wells NHS Trust, where it 
is relevant to your taking part in this research. All will have a duty of confidentiality 
to you as a participant and we will do our best to meet this duty.  
The data you provide will be anonymised and your personal data will be stored 
securely, separately from those anonymised data. You will not be identified in any 
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reports or publications resulting from this research and those reading them will not 
know who has contributed to it. 
In certain exceptional circumstances where you or others may be at significant risk 
of harm, the researcher may need to report this to an appropriate authority, in 
accordance with the UK Data Protection Act 1998. This would usually be discussed 
with you first. 
Examples of those exceptional circumstances when confidential information may 
have to be disclosed are: 
- The researcher believes you are at serious risk of harm, either from yourself 
or others 
- The researcher suspects a child may be at risk of harm 
- You pose a serious risk of harm to, or threaten or abuse others 
- As a statutory requirement e.g. reporting certain infectious diseases 
- Under a court order requiring the University to divulge information 
- We are passed information relating to an act of terrorism 
Full Contact details of researcher and supervisor 
Sam Cockle, PhD Researcher & Trainee Health Psychologist 
School of Psychology, University of Surrey, Guildford, GU2 7XH 
Email: s.cockle@surrey.ac.uk 
Phone: 07497 763887 (Mon-Fri 9am-5pm) 
Professor Jane Ogden, Academic Supervisor & Director of the Psychology PhD 
Programme 
School of Psychology, University of Surrey, Guildford, GU2 7XH 
Email: j.ogden@surrey.ac.uk 
Phone: 01483 686929 
Who is organising and funding the research? 
This research is organised by the University of Surrey and funded by the Economic 
and Social Research Council (ESRC). The funder is has no conflict of interest. 
Who has reviewed the project? 
All research from the University of Surrey and in the NHS is looked at by an 
independent group of people, called a Research Ethics Committee, to protect your 
interests. This study has been reviewed and received a favourable ethical opinion 
from an NHS Research Ethics Committee. 
Thank you for taking the time to read this Information Sheet. 
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Appendix Y: Study 4 Consent Form 
Consent Form [phase 3, version 2, 11/07/2016] Cancer Patients 
Patients Expectations and Experiences of Cancer Treatment 
  Please initial each box                           
• I have read and understood the Information Sheet provided (version 2, 
11/07/2016).  I have been given a full explanation by the investigators of the 
nature, purpose, location and likely duration of the study, and of what I will be 
expected to do.   
• I agree to comply with the requirements of the study as outlined to me to the best 
of my abilities. I shall inform the investigators immediately if I have any 
concerns. 
• I agree for my anonymised data to be used for this study and future research that 
will have received all relevant legal, professional and ethical approvals. 
• I understand that all project data will be held for at least 6 years and all research 
data for at least 10 years in accordance with University policy and that my 
personal data is held and processed in the strictest confidence, and in accordance 
with the UK Data Protection Act (1998). 
• I understand that all data collected during the study, may be looked at for 
monitoring and auditing purposes by authorised individuals from University of 
Surrey, from regulatory authorities or from Maidstone and Tunbridge Wells NHS 
Trust, where it is relevant to my taking part in this research. I give permission for 
these individuals to have access to my records.  
• I understand that I am free to withdraw from the study at any time without 
needing to justify my decision, without prejudice and without my legal rights and 
medical care being affected.  
• I understand that I can request for my data to be withdrawn until the end of 
December 2017 and that following my request all personal data will be destroyed 
but I allow the researchers to use anonymous data already collected.  
• I confirm that I have read and understood the above and freely consent to 
participating in this study.  I have been given adequate time to consider my 
participation. 
• I agree for the researchers to contact me for the purposes of follow-up in this 
study. 
• If I am unable to answer any of the background information questions, I give 
consent for the researcher to contact a member of my usual care team for the 
answer(s).  I understand that this may involve the care team member looking up 
information from my patient notes (the researcher will not access these directly).  
(optional) 
• I agree for the researchers to contact me to provide me with a study results 
summary. (optional) 
 
Name of participant (BLOCK CAPITALS)    ...............................................  
Signed  ......................................................  
Date  ......................................................  
                                                 
Name of researcher taking consent (BLOCK CAPITALS) ......................................... 
Signed   .................................................... 
Date   ………………………………………………..                            
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Appendix Z: Study 4 Debrief Sheet 
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Appendix AA: Study 5 & Study 6 Interview Schedule 
Interview Schedule 
Healthcare Professionals’ Beliefs about Patient Experiences of Cancer Treatment 
Introductions, reiterate information about the study, the right to decline to answer 
any particular question(s) and the right to withdraw.  Also include some general 
icebreaker questions to help make the participant more comfortable and accustomed 
to speaking to the interviewer. 
• If it’s OK with you, I’d like to begin by asking a bit about what you have seen of 
patients’ experiences.  There must be huge variability in the ways in which patients 
experience their cancer treatment. What factors influence how patients experience 
treatment for cancer? 
o What can be helpful? 
o What can be unhelpful? 
• Next, I’d like to focus on what patients are thinking about their treatment before 
they start receiving it.  What kind of expectations do patients have of their treatment 
before treatment has started? 
o What about in terms of effectiveness? 
o What about in terms of physical effects? 
o What about in terms of psychological effects? 
o What about in terms of the impact it will have on daily life? 
• How, if at all, do you think these expectations influence their experiences of their 
treatment? 
o What about in terms of effectiveness? 
o What about in terms of physical effects? 
o What about in terms of psychological effects? 
o What about in terms of the impact it will have on daily life? 
• So overall then, what do you think could be done to improve patients’ experiences 
of their cancer treatment? 
Evaluation/Wrap Up 
• As you know, this study aims to find out more about the beliefs you, as a healthcare 
professional working with cancer patients, hold about what makes a difference to 
patient experiences of treatment.  Is there anything you feel you would like to add 
here, anything we may have missed? 
• Thank you very much for your time. 
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Appendix AB: Study 5 & Study 6 University Ethics Committee Favourable 
Ethical Opinion 
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Appendix AC: Study 5 & Study 6 Advertisement 
 
This advertisement was distributed via email: 
 
Subject: What makes a difference to patients’ experiences of cancer treatment? 
Dear (Healthcare Professional), 
What makes a difference to patients’ experiences of cancer treatment? Would you 
like to tell me what you think? 
Research participants needed: I am looking for healthcare professionals who 
currently work, or have worked previously, with adult cancer patients. Would you 
like to participate or do you know someone who would like to participate? 
One-off interview: This will involve a one-off interview lasting approximately 30-40 
minutes (although this will be led by you). The interview can be conducted in 
person, on the telephone or via Skype, whichever is most convenient and suitable for 
you.  You will be asked about what you believe makes a difference to patients’ 
experiences of cancer treatment. 
Benefits: There is no financial incentive but it is an opportunity to talk about your 
views on patients’ experiences, which may be something you find beneficial. You 
will also be helping research which could assist future patients. 
Interested?: Please contact me for more information on s.cockle@surrey.ac.uk, 
07497 763887 or at the address below. 
Many thanks, 
Sam 
Sam Cockle 
PhD Researcher & Trainee Health Psychologist 
School of Psychology, University of Surrey, Guildford, GU2 7XH 
This research has been reviewed and received a favourable ethical opinion from the 
University of Surrey ethics committee.  
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Appendix AD: Study 5 & Study 6 Participant Information Sheet 
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Appendix AE: Study 5 & Study 6 Consent Form 
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Appendix AF: Study 5 & Study 6 Participant Debrief Sheet 
 
